0001520138-23-000260.txt : 20230609 0001520138-23-000260.hdr.sgml : 20230609 20230609164107 ACCESSION NUMBER: 0001520138-23-000260 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 62 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBAL DIGITAL SOLUTIONS INC CENTRAL INDEX KEY: 0001011662 STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844] IRS NUMBER: 223392051 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26361 FILM NUMBER: 231005974 BUSINESS ADDRESS: STREET 1: 777 SOUTH FLAGLER DRIVE STREET 2: SUITE 800 WEST CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: 561-515-6163 MAIL ADDRESS: STREET 1: 6220 MAIN AVE #2 CITY: ORANGEVALE STATE: CA ZIP: 95662 FORMER COMPANY: FORMER CONFORMED NAME: CREATIVE BEAUTY SUPPLY INC DATE OF NAME CHANGE: 19960403 10-K 1 gdsi-20221231_10k.htm 10-K
0001011662 false 2022 FY 0001011662 2022-01-01 2022-12-31 0001011662 2022-09-30 0001011662 2022-12-31 0001011662 2021-12-31 0001011662 2021-01-01 2021-12-31 0001011662 us-gaap:CommonStockMember 2020-12-31 0001011662 us-gaap:PreferredStockMember 2020-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001011662 gdsi:SharesPayableMember 2020-12-31 0001011662 us-gaap:RetainedEarningsMember 2020-12-31 0001011662 2020-12-31 0001011662 us-gaap:CommonStockMember 2021-12-31 0001011662 us-gaap:PreferredStockMember 2021-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001011662 gdsi:SharesPayableMember 2021-12-31 0001011662 us-gaap:RetainedEarningsMember 2021-12-31 0001011662 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001011662 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001011662 gdsi:SharesPayableMember 2021-01-01 2021-12-31 0001011662 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001011662 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001011662 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001011662 gdsi:SharesPayableMember 2022-01-01 2022-12-31 0001011662 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001011662 us-gaap:CommonStockMember 2022-12-31 0001011662 us-gaap:PreferredStockMember 2022-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001011662 gdsi:SharesPayableMember 2022-12-31 0001011662 us-gaap:RetainedEarningsMember 2022-12-31 0001011662 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001011662 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001011662 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001011662 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001011662 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001011662 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001011662 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001011662 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001011662 us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001011662 us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001011662 us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001011662 us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001011662 us-gaap:DerivativeMember us-gaap:FairValueInputsLevel3Member 2022-12-31 0001011662 2020-01-01 2020-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2015-01-01 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2021-01-01 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2022-01-01 2022-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:JMJFinancialMember 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:JMJFinancialMember 2015-01-01 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:JMJFinancialMember 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:AdarAlefLLCMember 2020-08-05 0001011662 gdsi:ConvertibleNotePayableMember gdsi:AdarAlefLLCMember 2020-08-01 2020-08-05 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LeoniteCapitalMember 2021-02-01 2021-02-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LeoniteCapitalMember 2021-02-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LeoniteCapitalMember 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2021-03-01 2021-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2021-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GenevaRothRemarkHoldingsMember 2021-06-01 2021-06-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GenevaRothRemarkHoldingsMember 2021-06-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-02-01 2022-02-03 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-02-03 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-03-01 2022-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-06-01 2022-06-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-06-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2022-08-01 2022-08-18 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2022-08-18 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GaryShoverMember 2022-11-01 2022-11-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GaryShoverMember 2022-11-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:RonalMinorMember 2022-12-01 2022-12-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:RonalMinorMember 2022-12-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:HarborGatesCapitalMember 2020-08-01 2020-08-17 0001011662 gdsi:ConvertibleNotePayableMember gdsi:HarborGatesCapitalMember 2020-08-17 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2020-05-01 2020-05-20 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2020-05-20 0001011662 gdsi:ConvertibleNotePayableMember gdsi:FirstFireGlobalOpportunityMember 2020-04-01 2020-04-06 0001011662 gdsi:ConvertibleNotePayableMember gdsi:PowerUpLendingGroupMember 2020-04-06 0001011662 gdsi:ConvertibleNotePayableMember gdsi:FirstFireGlobalOpportunityMember 2019-05-01 2019-05-10 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GHSInvestmentsMember 2019-05-10 0001011662 gdsi:WilliamDelgadoMember 2017-08-31 0001011662 gdsi:WilliamDelgadoMember 2018-08-31 0001011662 gdsi:WilliamDelgadoMember 2021-12-31 0001011662 gdsi:ParabellumMember 2017-12-22 0001011662 gdsi:ParabellumMember 2022-12-31 0001011662 gdsi:VoxMember 2017-12-23 0001011662 gdsi:VoxMember 2017-12-01 2017-12-23 0001011662 gdsi:VoxMember 2022-01-01 2022-12-31 0001011662 gdsi:VoxMember 2022-12-31 0001011662 gdsi:VoxMember 2021-12-31 0001011662 gdsi:RLTMember 2017-12-26 0001011662 gdsi:RLTMember 2017-12-01 2017-12-26 0001011662 gdsi:RLTMember 2022-01-01 2022-12-31 0001011662 gdsi:RLTMember 2022-12-31 0001011662 gdsi:RLTMember 2021-12-31 0001011662 gdsi:ThirdPartyVendorMember 2018-04-30 0001011662 gdsi:ThirdPartyVendorMember 2018-04-01 2018-04-30 0001011662 gdsi:ThirdPartyVendorMember 2022-12-31 0001011662 gdsi:PurchaserMember 2018-05-01 2018-05-31 0001011662 gdsi:AccreditedInvestorMember 2018-06-30 0001011662 gdsi:AccreditedInvestorMember 2018-06-01 2018-06-30 0001011662 gdsi:PPPMember 2020-05-01 2020-05-12 0001011662 gdsi:PPPMember 2020-05-12 0001011662 gdsi:Range1Member 2022-12-31 0001011662 gdsi:Range1Member 2022-01-01 2022-12-31 0001011662 gdsi:Range2Member 2022-12-31 0001011662 gdsi:Range2Member 2022-01-01 2022-12-31 0001011662 gdsi:Range3Member 2022-12-31 0001011662 gdsi:Range3Member 2022-01-01 2022-12-31 0001011662 gdsi:Range4Member 2022-12-31 0001011662 gdsi:Range4Member 2022-01-01 2022-12-31 0001011662 gdsi:Range5Member 2022-12-31 0001011662 gdsi:Range5Member 2022-01-01 2022-12-31 0001011662 gdsi:Range6Member 2022-12-31 0001011662 gdsi:Range6Member 2022-01-01 2022-12-31 0001011662 gdsi:Range7Member 2022-12-31 0001011662 gdsi:Range7Member 2022-01-01 2022-12-31 0001011662 gdsi:Range8Member 2022-12-31 0001011662 gdsi:Range8Member 2022-01-01 2022-12-31 0001011662 gdsi:Range9Member 2022-12-31 0001011662 gdsi:Range9Member 2022-01-01 2022-12-31 0001011662 gdsi:Range10Member 2022-12-31 0001011662 gdsi:Range10Member 2022-01-01 2022-12-31 0001011662 gdsi:Range11Member 2022-12-31 0001011662 gdsi:Range11Member 2022-01-01 2022-12-31 0001011662 gdsi:Range12Member 2022-12-31 0001011662 gdsi:Range12Member 2022-01-01 2022-12-31 0001011662 gdsi:Range13Member 2022-12-31 0001011662 gdsi:Range13Member 2022-01-01 2022-12-31 0001011662 gdsi:Range14Member 2022-12-31 0001011662 gdsi:Range14Member 2022-01-01 2022-12-31 0001011662 gdsi:Range15Member 2022-12-31 0001011662 gdsi:Range15Member 2022-01-01 2022-12-31 0001011662 gdsi:Range16Member 2022-12-31 0001011662 gdsi:Range16Member 2022-01-01 2022-12-31 0001011662 gdsi:Range17Member 2022-12-31 0001011662 gdsi:Range17Member 2022-01-01 2022-12-31 0001011662 gdsi:Range18Member 2022-12-31 0001011662 gdsi:Range18Member 2022-01-01 2022-12-31 0001011662 gdsi:Range1Member 2021-12-31 0001011662 gdsi:Range1Member 2021-01-01 2021-12-31 0001011662 gdsi:Range2Member 2021-12-31 0001011662 gdsi:Range2Member 2021-01-01 2021-12-31 0001011662 gdsi:Range3Member 2021-12-31 0001011662 gdsi:Range3Member 2021-01-01 2021-12-31 0001011662 gdsi:Range4Member 2021-12-31 0001011662 gdsi:Range4Member 2021-01-01 2021-12-31 0001011662 gdsi:Range5Member 2021-12-31 0001011662 gdsi:Range5Member 2021-01-01 2021-12-31 0001011662 gdsi:Range6Member 2021-12-31 0001011662 gdsi:Range6Member 2021-01-01 2021-12-31 0001011662 gdsi:Range7Member 2021-12-31 0001011662 gdsi:Range7Member 2021-01-01 2021-12-31 0001011662 gdsi:Range8Member 2021-12-31 0001011662 gdsi:Range8Member 2021-01-01 2021-12-31 0001011662 gdsi:Range9Member 2021-12-31 0001011662 gdsi:Range9Member 2021-01-01 2021-12-31 0001011662 gdsi:Range10Member 2021-12-31 0001011662 gdsi:Range10Member 2021-01-01 2021-12-31 0001011662 gdsi:Range11Member 2021-12-31 0001011662 gdsi:Range11Member 2021-01-01 2021-12-31 0001011662 gdsi:Range12Member 2021-12-31 0001011662 gdsi:Range12Member 2021-01-01 2021-12-31 0001011662 gdsi:Range13Member 2021-12-31 0001011662 gdsi:Range13Member 2021-01-01 2021-12-31 0001011662 gdsi:Range14Member 2021-12-31 0001011662 gdsi:Range14Member 2021-01-01 2021-12-31 0001011662 gdsi:Range15Member 2021-12-31 0001011662 gdsi:Range15Member 2021-01-01 2021-12-31 0001011662 gdsi:Range16Member 2021-12-31 0001011662 gdsi:Range16Member 2021-01-01 2021-12-31 0001011662 gdsi:Range17Member 2021-12-31 0001011662 gdsi:Range17Member 2021-01-01 2021-12-31 0001011662 gdsi:Range18Member 2021-12-31 0001011662 gdsi:Range18Member 2021-01-01 2021-12-31 0001011662 gdsi:Range19Member 2021-12-31 0001011662 gdsi:Range19Member 2021-01-01 2021-12-31 0001011662 gdsi:MathewKelleyMember 2022-01-01 2022-12-31 0001011662 gdsi:MathewKelley1Member 2022-01-01 2022-12-31 0001011662 gdsi:RichardJFeldmanMember 2022-01-01 2022-12-31 0001011662 gdsi:RichardJFeldman1Member 2022-01-01 2022-12-31 0001011662 gdsi:GaryGrayMember 2022-01-01 2022-12-31 0001011662 gdsi:RossTrevinoMember 2022-01-01 2022-12-31 0001011662 gdsi:ActivityMember 2022-12-31 0001011662 gdsi:Mr.DelgadoMember 2022-12-31 0001011662 gdsi:MrDelgadoMember 2021-01-01 2021-12-31 0001011662 gdsi:WilliamDelgadoMember 2022-12-31 0001011662 gdsi:WilliamJDelgadoMember 2022-12-31 0001011662 gdsi:JeromeGomolskiMember 2021-12-31 0001011662 gdsi:JerryGomolskiMember 2022-12-31 0001011662 gdsi:JerryGomolskiMember 2021-12-31 0001011662 gdsi:Charter804CSMember 2022-12-31 0001011662 gdsi:Charter804CSMember 2021-12-31 0001011662 gdsi:GaryGrayMember 2022-12-31 0001011662 gdsi:GaryGrayMember 2021-12-31 0001011662 gdsi:JeromeGomolskiMember 2021-12-31 0001011662 gdsi:WilliamDelgadoMember 2022-01-01 2022-12-31 0001011662 gdsi:JeromeGomolskiMember 2022-01-01 2022-12-31 0001011662 gdsi:JeromeGomolskiMember 2022-12-31 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-01-01 2023-01-04 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-01-04 0001011662 us-gaap:SubsequentEventMember gdsi:GSCapitalPartnersLLCMember 2023-01-01 2023-01-12 0001011662 us-gaap:SubsequentEventMember gdsi:GSCapitalPartnersLLCMember 2023-01-12 0001011662 us-gaap:SubsequentEventMember gdsi:SixthStreetLendingMember 2023-01-01 2023-01-26 0001011662 us-gaap:SubsequentEventMember gdsi:FourthManLLCMember 2023-02-01 2023-02-06 0001011662 us-gaap:SubsequentEventMember gdsi:GSCapitalPartnersLLCMember 2023-02-01 2023-02-07 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-02-01 2023-02-08 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-02-01 2023-02-21 0001011662 us-gaap:SubsequentEventMember gdsi:GSCapitalPartnersLLCMember 2023-02-01 2023-02-23 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-02-27 2023-03-02 0001011662 us-gaap:SubsequentEventMember gdsi:GSCapitalPartnersLLCMember 2023-03-01 2023-03-07 0001011662 us-gaap:SubsequentEventMember gdsi:GSCapitalPartnersLLCMember 2023-03-01 2023-03-27 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-06-01 2023-06-30 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-04-01 2023-04-18 0001011662 us-gaap:SubsequentEventMember gdsi:LeoniteCapitalLLCMember 2023-03-01 2023-03-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

 

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Fiscal Year Ended December 31, 2022

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________________________ to __________________________

 

Commission file number 000-26361

 

 

GLOBAL DIGITAL SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

New Jersey   22-3392051
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     
777 South Flagler Drive, Suite 800 West Tower, West Palm Beach, FL   33401
(Address of principal executive offices)   (Zip Code)

 

(561) 515-6163

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Symbol   Name of each exchange on which registered
None   N/A   N/A

 

Securities registered pursuant to section 12(g) of the Act:

 

Shares of common stock with a par value of $0.001

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
(Do not check if a smaller reporting company) Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒.

 

The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant’s most recently completed third fiscal quarter was $18,278,068.

 

(APPLICABLE ONLY TO CORPORATE REGISTRANTS)

 

The number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date, was 798,168,896 of common shares as of December 31,2022.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

None.

 

 

 

 

 

TABLE OF CONTENTS

 

  Page
PART I  
   
ITEM 1. BUSINESS -1-
   
ITEM 1A. RISK FACTORS -5-
   
ITEM 1B. UNRESOLVED STAFF COMMENTS -15-
   
ITEM 2. PROPERTIES -15-
   
ITEM 3. LEGAL PROCEEDINGS -15-
   
ITEM 4. MINE SAFETY DISCLOSURES -15-
   
PART II  
   
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES -16-
   
ITEM 6. SELECTED FINANCIAL DATA -17-
   
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS -17-
   
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK -26-
   
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA -26-
   
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE -26-
   
ITEM 9A. CONTROLS AND PROCEDURES -26-
   
ITEM 9B. OTHER INFORMATION -27-
   
PART III  
   
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE -28-
   
ITEM 11. EXECUTIVE COMPENSATION -30-
   
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS -33-
   
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE -34-
   
ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES -34-
   
PART IV  
   
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES -35-
   
SIGNATURES -38-

i

 

 

PART I

 

ITEM 1. BUSINESS

 

Forward-Looking Statements

 

This Annual Report on Form 10-K includes a number of forward-looking statements that reflect management’s current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates.” “predicts,” “potential” or “continue” or the negative of these terms or other comparable terminology. Those statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks in the section entitled “Risk Factors” set forth in this Annual Report on Form 10-K for the fiscal year ended December 31, 2022, any of which may cause our company’s or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks include, by way of example and without limitation: 

 

  our ability to successfully commercialize and our products and services on a large enough scale to generate profitable operation;

 

  our ability to maintain and develop relationships with customers and suppliers;

 

  our ability to successfully integrate acquired businesses or new brands;

 

  the impact of competitive products and pricing;

 

  supply constraints or difficulties;

 

  the retention and availability of key personnel;

 

  general economic and business conditions;

 

  substantial doubt about our ability to continue as a going concern;

 

  our need to raise additional funds in the future;

 

  our ability to successfully recruit and retain qualified personnel in order to continue our operations;

 

  our ability to successfully implement our business plan;

 

  our ability to successfully acquire, develop or commercialize new products and equipment;

 

  intellectual property claims brought by third parties; and

 

  the impact of any industry regulation.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or performance. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Readers are urged to carefully review and consider the various disclosures made by us in this report and in our other reports filed with the Securities and Exchange Commission (the “SEC”). We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in the future operating results over time except as required by law. We believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions.

 

As used in this Annual Report on Form 10-K and unless otherwise indicated, the terms “GDSI,” “Company,” “we,” “us,” and “our” refer to Global Digital Solutions, Inc. and our wholly owned subsidiaries GDSI Florida, LLC, and North American Custom Specialty Vehicles, Inc. Unless otherwise specified, all dollar amounts are expressed in United States dollars.

 

-1-

 

 

Corporate History

 

We were incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation. The merger was treated as a recapitalization of Global Digital Solutions, Inc., and Creative changed its name to Global Digital Solutions, Inc. (“GDSI”). We are focused in the area of cyber arms technology and complementary security and technology solutions. On October 22, 2012, we entered into an Agreement of Merger and Plan of Reorganization to acquire 70% of Airtronic USA, Inc. (“Airtronic”), a then debtor in possession under chapter 11 of the Bankruptcy Code once Airtronic successfully reorganized and emerged from bankruptcy (the “Merger”). During the period from October 2012 through November 2013, we were actively involved in the day to day management of Airtronic pending the completion of the Merger. The Merger did not occur and we ceased involvement with Airtronic. In December 2012 we incorporated GDSI Florida LLC (“GDSI FL”), a Florida limited liability company. Except for the payment of administrative expenses on behalf of the Company, GDSI FL has no business operations. In January 2013, we incorporated Global Digital Solutions, LLC, a Florida limited liability company. In November 2013, we incorporated GDSI Acquisition Corporation, a Delaware corporation. On June 16, 2014, we acquired North American Custom Specialty Vehicles, LLC, into GDSI Acquisition Corporation, and changed the latter’s name to North American Custom Specialty Vehicles, Inc. (“NACSV”). In July 2014, we announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead our efforts overseas.

 

In March of 2019, the Company acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA has developed a system known as Pilot Assisted Landing Systems (PALS). We believe the precision and robustness of PALS has generated a host of new applications mainly through “landing trajectory” optimization which provides additional safety margin against weather related hazardous conditions, like wind shear, wake turbulence, icing, as well as low ceilings and fog. The Company had determined that due to a lack of funding it is not able to continue the program and has written off the investment and recorded a loss of $97,555 at December 31, 2022.

 

History of Business – December 31, 2016 to Present

 

On May 13, 2016, as more fully discussed below, we appointed William Delgado as our Chief Executive Officer (“CEO”) and Chairman of our Board of Directors. Mr. Delgado was serving at that time as a director and our Executive Vice President in charge of business development. He served as our President, Chief Executive Officer, and Chief Financial Officer from August 2004 to August 2013. Mr. Delgado began his career with Pacific Telephone in the Outside Plant Construction. He moved to the network engineering group and concluded his career at Pacific Bell as the Chief Budget Analyst for the Northern California region. Mr. Delgado founded All Star Telecom in late 1991, specializing in OSP construction and engineering and systems cabling. All Star Telecom was sold to International Fiber Com in April of 1999. After leaving International Fiber Com in 2002, Mr. Delgado became President/CEO of Pacific Comtel in San Diego, California. After he acquired Pacific Comtel in 2004, he became part of our management and held the positions of Director, CEO, President, and CFO.

 

-2-

 

 

Events Since December 31, 2016:

 

The following events have occurred since December 31, 2016:

 

Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A.

 

Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”), and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date (the “Rontan Transaction”).

 

The purchase price consisted of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date.

 

Under the terms of a finder’s fee Agreement dated April 14, 2014, we have agreed to pay RLT Consulting, Inc., a related party, a fee of 2% (two percent) of the transaction value, as defined in the agreement, of Rontan upon closing. The fee is payable one half in cash and one half in shares of our common stock. Specific conditions to closing include, but are not limited to: 

 

  a) Purchaser’s receipt of written limited assurance of an unqualified opinion with respect to Rontan’s audited financial statements for the years ended December 31, 2013 and 2014 (the “Opinion”);

 

  b) The commitment of sufficient investment by General American Capital Partners LLC (the “Institutional Investor”), in the Purchaser following receipt of the Opinion;

 

  c) The accuracy of each party’s representations and warranties contained in the SPSA;

 

  d) The continued operation of Rontan’s business in the ordinary course;

 

  e) The maintenance of all of Rontan’s bank credit lines in the maximum amount of R$200 million (approximately US$52 million) under the same terms and conditions originally agreed with any such financial institutions, and the maintenance of all other types of funding arrangements. As of the date of the SPSA, Rontan’s financial institution debt consists of not more than R$200 million (approximately US$52 million), trade debt of not more than R$50 million (approximately US$13 million), and other fiscal contingencies of not more that R$95 million (approximately US$24.7 million);

 

  f) Rontan shall enter into employment or consulting service agreements with key employees and advisors identified by the Purchaser, including Rontan’s Chief Executive Officer; and

 

  g) The Sellers continued guarantee of Rontan’s bank debt for a period of 90 days following issuance of the opinion.

 

The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, among other conditions. Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion. Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets.

 

On April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions, which were waivable by us), and on April 1, 2016, we advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA.

 

The Company has been in litigation concerning Rontan Metallurgica in Sao Paulo, Brazil and has been awarded a default judgment regarding the acquisition of the company. The company is currently awaiting final damages in the case. 

 

-3-

 

  

Liquidity

 

Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern.

 

Business Strategy –

 

Competition

 

The Company is and will continue to be an insignificant participant in the business of seeking mergers with, joint ventures with, and acquisitions of other entities. A large number of established and well-financed entities, including venture capital firms, private equity firms, and family offices, are active in mergers and acquisitions of companies that may be desirable target candidates for the Company. Nearly all such entities have significantly greater financial resources, technical expertise, and managerial capabilities than the Company, and, consequently, the Company will be at a competitive disadvantage in identifying possible business opportunities and successfully completing a business combination. Moreover, the Company will also compete in seeking merger or acquisition candidates with numerous other small public companies.

 

-4-

 

 

Research and Development

 

We have not incurred any research and development expense.

 

Intellectual Property

 

We currently do not have any intellectual property. 

 

Government Approvals and Regulations

 

We do not expect to encounter any significant governmental approval or regulation issues, as we do not intend to monopolize any target business areas. We do expect to be subject to the traditional government regulation related to business licenses, foreign corporation rules, etc.

 

Subsidiaries

 

We currently have two subsidiaries including GDSI Florida, LLC, North American Custom Specialty Vehicles, Inc.

 

Employees

 

As of December 31, 2022, we had two full-time employees, William Delgado and Jerome Gomolski, and 0 part-time employees. We intend to hire additional staff and to engage consultants in general administration on an as-needed basis. We also intend to engage experts in operations, finance, and general business to advise us in various capacities. None of our employees are covered by a collective bargaining agreement, and we believe our relationship with our employees is good to excellent.

 

Our future success depends, in part, on our ability to continue to attract, retain, and motivate highly qualified technical, marketing, and management personnel and, as of the end of the period covered by this report and as of the date of filing, we continue to rely on the services of independent contractors for much of our sales/marketing. We believe technical, accounting, and other functions are also critical to our continued and future success.

 

ITEM 1A. RISK FACTORS

 

You should carefully consider the risks described below together with all of the other information included in our public filings before making an investment decision with regard to our securities. The statements contained in or incorporated into this document that are not historic facts are forward-looking statements that are subject to risks and uncertainties. If any of the following events described in these risk factors actually occur, our business, financial condition, or results of operations could be harmed. In that case, the trading price of our common stock could decline, and you may lose all or part of your investment. Moreover, additional risks not currently known to us or that we currently deem less significant may also impact our business, financial condition, or results of operations, perhaps materially. For additional information regarding risk factors, see Item 1 – “Forward-Looking Statements.”

 

Risks Related to Our Company

 

There is substantial doubt about our ability to continue as a going concern.

 

We have not generated any profit from combined operations since our inception. We expect that our operating expenses will increase over the next twelve months to continue our development activities. Based on our average monthly expenses and current burn rate of $20,032 per month, we estimate that our cash on hand will not be able to support our operations through the balance of this calendar year. This amount could increase if we encounter difficulties that we cannot anticipate at this time or if we acquire other businesses. On February 2, 2018, we announced that we had secured $1.2 million in a non-convertible financing from a New York-based institution. The agreement was amended on December 12, 2020, and the Company received an additional $650,000 of funding from the same New York-based institution. Should this amount not be sufficient to support our continuing operations, we do not expect to be able to raise any additional capital through debt financing from traditional lending sources since we are not currently generating a profit from operations. Therefore, we only expect to raise money through equity financing via the sale of our common stock or equity-linked securities such as convertible debt. If we cannot raise the money that we need to continue to operate our business beyond the period indicated above, we will be forced to delay, scale back or eliminate some or all of our proposed operations. If any of these were to occur, there is a substantial risk that our business would fail. If we are unsuccessful in raising additional financing, we may need to curtail, discontinue, or cease operations.

 

-5-

 

 

We have limited operating history with our operating subsidiary, and as a result, we may experience losses and cannot assure you that we will be profitable.

 

We have a limited operating history with our single operating subsidiary, NACSV, on which to evaluate our business. Our operations are subject to all of the risks inherent in the establishment and expansion of a business enterprise. Accordingly, the likelihood of our success must be considered in the light of the problems, expenses, difficulties, complications, and delays frequently encountered in connection with the starting and expansion of a business and the relatively competitive environment in which we operate. Unanticipated delays, expenses, and other problems such as setbacks in product development, product manufacturing, and market acceptance are frequently encountered in establishing a business such as ours. There can be no assurance that the Company will be successful in addressing such risks, and any failure to do so could have a material adverse effect on the Company’s business, results of operations, and financial condition.

 

Because of our limited operating history with our operating subsidiary, we have limited historical financial data on which to base planned operating expenses. Accordingly, our expense levels, which are, to a large extent, variable, will be based in part on our expectations of future revenues. As a result of the variable nature of many of our expenses, we may be unable to adjust spending in a timely manner to compensate for any unexpected delays in the development and marketing of our products or any subsequent revenue shortfall. Any such delays or shortfalls will have an immediate adverse impact on our business, operating results, and financial condition.

 

We have not achieved profitability on a quarterly or annual basis to date. To the extent that net revenue does not grow at anticipated rates or that increases in our operating expenses precede or are not subsequently followed by commensurate increases in net revenue, or that we are unable to adjust operating expense levels accordingly, our business, results of operations, and financial condition will be materially and adversely affected. There can be no assurance that our operating losses will not increase in the future or that we will ever achieve or sustain profitability.

 

No Assurance of Sustainable Revenues.

 

There can be no assurance that our subsidiaries will generate sufficient and sustainable revenues to enable us to operate at profitable levels or to generate positive cash flow. As a result of our limited operating history and the nature of the markets in which we compete, we may not be able to accurately predict our revenues. Any failure by us to accurately make such predictions could have a material adverse effect on our business, results of operations, and financial condition. Further, our current and future expense levels are based largely on our investment plans and estimates of future revenues. We expect operating results to fluctuate significantly in the future as a result of a variety of factors, many of which are outside of our control. Factors that may adversely affect our operating results include, among others, demand for our products and services, the budgeting cycles of potential customers, lack of enforcement of or changes in governmental regulations or laws, the amount and timing of capital expenditures and other costs relating to the expansion of our operations, the introduction of new or enhanced products and services by us or our competitors, the timing and number of new hires, changes in our pricing policy or those of our competitors, the mix of our products, increases in the cost of raw materials, technical difficulties with the products, incurrence of costs relating to future acquisitions, general economic conditions, and market acceptance of our products. As a strategic response to changes in the competitive environment, we may, from time to time, make certain decisions regarding pricing, service, marketing or business combinations that could have a material adverse effect on our business, results of operations, and financial condition. Any seasonality is likely to cause quarterly fluctuations in our operating results, and there can be no assurance that such patterns will not have a material adverse effect on our business, results of operations, and financial condition. We may be unable to adjust spending in a timely manner to compensate for any unexpected revenue shortfall.

 

We may need to raise additional funds in the future that may not be available on acceptable terms or available at all.

 

We may consider issuing additional debt or equity securities in the future to fund our business plan, for potential investment acquisitions, or general corporate purposes. If we issue equity or convertible debt securities to raise additional funds, our existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences, and privileges senior to those of our existing stockholders. If we incur additional debt, it may increase our leverage relative to our earnings or to our equity capitalization, requiring us to pay additional interest expenses. We may not be able to obtain financing on favorable terms, or at all, in which case, we may not be able to develop or enhance our products, execute our business plan, take advantage of future opportunities, or respond to competitive pressures.

 

While a major part of our business strategy is to pursue strategic acquisitions, we may not be able to identify businesses for which we can obtain necessary financing to acquire on acceptable terms, face risks due to additional indebtedness, and our acquisition strategy may incur significant costs or expose us to substantial risks inherent in the acquired business’s operations.

 

Our strategy of pursuing strategic acquisitions may be negatively impacted by several risks, including the following: 

 

  We may not successfully identify companies that have complementary product lines or technological competencies or that can diversify our revenue or enhance our ability to implement our business strategy;

 

  We may not successfully acquire companies if we fail to obtain financing, if we fail to negotiate the acquisition on acceptable terms, or for other related reasons.

 

  We may incur additional expenses due to acquisition due diligence, including legal, accounting, consulting, and other professional fees and disbursements. Such additional expenses may be material, will likely not be reimbursed, and would increase the aggregate cost of any acquisition.

 

-6-

 

 

  Any acquired business will expose us to the acquired company’s liabilities and to risks inherent to its industry, and we may not be able to ascertain or assess all of the significant risks.

 

  We may require additional financing in connection with any future acquisition, and such financing may adversely impact, or be restricted by, our capital structure.

 

  Achieving the anticipated potential benefits of a strategic acquisition will depend in part on the successful integration of the operations, administrative infrastructures, and personnel of the acquired company or companies in a timely and efficient manner. Some of the challenges involved in such an integration include: (i) demonstrating to the customers of the acquired company that the consolidation will not result in adverse changes in quality, customer service standards, or business focus; (ii) preserving important relationships of the acquired company; (iii) coordinating sales and marketing efforts to effectively communicate the expanded capabilities of the combined company; and (iv) coordinating the supply chains.

 

Any future acquisitions could disrupt business.

 

If we are successful in consummating acquisitions, those acquisitions could subject us to a number of risks, including that: 

 

  the purchase price we pay could significantly deplete our cash reserves or result in dilution to our existing stockholders;

 

  we may find that the acquired company or assets do not improve our customer offerings or market position as planned;

 

  we may have difficulty integrating the operations and personnel of the acquired company;

 

  key personnel and customers of the acquired company may terminate their relationships with the acquired company as a result of the acquisition;

 

  we may experience additional financial and accounting challenges and complexities in areas such as tax planning and financial reporting;

 

  we may assume or be held liable for risks and liabilities as a result of our acquisitions, some of which we may not discover during our due diligence or adequately adjust for in our acquisition arrangements;

 

  we may incur one-time write-offs or restructuring charges in connection with the acquisition;

 

  we may acquire goodwill and other intangible assets that are subject to amortization or impairment tests, which could result in future charges to earnings; and

 

  we may not be able to realize the cost savings or other financial benefits we anticipated.

 

These factors could have a material adverse effect on our business, financial condition, and operating results.

 

Our business is at risk if we lose key personnel or are unable to attract and integrate additional skilled personnel.

 

The success of our business depends, in large part, on the skill of our personnel. Accordingly, it is critical that we maintain and continue to build a highly experienced management team and specialized workforce, including engineers, experts in project management and business development, and sales professionals. Competition for personnel, particularly those with expertise in the specialty vehicle industry and, as we expect, in the industries of any future acquisition targets, is high, and identifying candidates with the appropriate qualifications can be difficult. We may not be able to hire the necessary personnel to implement our business strategy given our anticipated hiring needs, or we may need to provide higher compensation or more training to our personnel than we currently anticipate.

 

In the event, we are unable to attract, hire and retain the requisite personnel and subcontractors, we may experience delays in growing our business plan in accordance with project schedules and budgets, which may have an adverse effect on our financial results, harm our reputation and cause us to curtail our pursuit of new initiatives. Further, any increase in demand for personnel and specialty subcontractors may result in higher costs, causing us to exceed the budget on a project, which in turn may have an adverse effect on our business, financial condition and operating results and harm our relationships with our customers.

 

Our future success is particularly dependent on the vision, skills, experience and effort of our senior management team, including our president and chief executive officer. If we were to lose the services of our president and chief executive officer or any of our key employees, our ability to effectively manage our operations and implement our strategy could be harmed and our business may suffer.

 

-7-

 

 

We may not be able to protect intellectual property that we hope to acquire, which could adversely affect our business.

 

The companies that we hope to acquire may rely on patent, trademark, trade secret, and copyright protection to protect their technology. We believe that technological leadership can be achieved through additional factors such as the technological and creative skills of our personnel, new product developments, frequent product enhancements, name recognition, and reliable product maintenance. Nevertheless, our ability to compete effectively depends in part on our ability to develop and maintain proprietary aspects of our technology, such as patents. We may not secure future patents; and patents that we may secure may become invalid or may not provide meaningful protection for our product innovations. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as the United States. Furthermore, there can be no assurance that competitors will not independently develop similar products, “reverse engineer” our products, or, if patents are issued to us, design around such patents. We also expect to rely upon a combination of copyright, trademark, trade secret, and other intellectual property laws to protect our proprietary rights by entering into confidentiality agreements with our employees, consultants, and vendors, and by controlling access to and distribution of our technology, documentation, and other proprietary information. There can be no assurance, however, that the steps to be taken by us will not be challenged, invalidated, or circumvented, or that the rights granted thereunder will provide a competitive advantage to us. Any such circumstance could have a material adverse effect on our business, financial condition and results of operations. While we are not currently engaged in any intellectual property litigation or proceedings, there can be no assurance that we will not become so involved in the future or that our products do not infringe any intellectual property or other proprietary right of any third party. Such litigation could result in substantial costs, the diversion of resources and personnel, and significant liabilities to third parties, any of which could have a material adverse effect on our business.

 

We may not be able to protect our trade names and domain names.

 

We may not be able to protect our trade names and domain names against all infringers, which could decrease the value of our brand name and proprietary rights. We currently hold the Internet domain names “www.gdsi.co” and “www.nacsvehicles.com,” and we use “GDSI” and “NACS Vehicles” as trade names. Domain names generally are regulated by Internet regulatory bodies are subject to change, and in some cases, may be superseded, in some cases by laws, rules and regulations governing the registration of trade names and trademarks with the United States Patent and Trademark Office as well as ascertain other common law rights. If the domain registrars are changed, if new ones are created, or if we are deemed to be infringing upon another’s trade name or trademark, we may be unable to prevent third parties from acquiring or using, as the case may be, our domain name, trade names or trademarks, which could adversely affect our brand name and other proprietary rights.

 

We may be subject to liability claims for damages and other expenses not covered by insurance that could reduce our earnings and cash flows.

 

Our business, profitability, and growth prospects could suffer if we pay damages or defense costs in connection with a liability claim that is outside the scope of any applicable insurance coverage. We intend to maintain, but do not yet have, general and product liability insurance. There is no assurance that we will be able to obtain insurance in amounts, or for a price, that will permit us to purchase desired amounts of insurance. Additionally, if our costs of insurance and claims increase, then our earnings could decline. Further, market rates for insurance premiums and deductibles have been steadily increasing, which may prevent us from being adequately insured. A product liability or negligence action in excess of insurance coverage could harm our profitability and liquidity.

 

Insurance and contractual protections may not always cover lost revenue.

 

We possess insurance and warranties from suppliers, and our subcontractors make contractual obligations to meet certain performance levels. We also attempt, where feasible, to pass risks we cannot control to our customers. The proceeds of such insurance, warranties, performance guarantees, and risk-sharing arrangements may not be adequate to cover lost revenue, increased expenses, or liquidated damages payments that may be required in the future.

 

We currently carry customary insurance for business liability. For our work as a general contractor, we carry workers comp insurance for our employees, and we have performance bonding insurance. Certain losses of a catastrophic nature, such as from floods, tornadoes, thunderstorms, and earthquakes, are uninsurable or not economically insurable. Such “Acts of God,” work stoppages, regulatory actions, or other causes, could interrupt operations and adversely affect our business.

 

We rely on outside consultants and employees.

 

We will rely on the experience of outside consultants and employees. In the event that one or more of these consultants or employees terminates employment with the Company, or becomes unavailable, suitable replacements will need to be retained, and there is no assurance that such employees or consultants could be identified under conditions favorable to us.

 

-8-

 

 

Our financial and operating performance is adversely affected by the coronavirus pandemic.

 

The recent outbreak of a strain of coronavirus (COVID-19) in the U.S. has had an unfavorable impact on our business operations. Mandatory closures of businesses imposed by the federal, state, and local governments to control the spread of the virus is disrupting the operations of our management, business and finance teams. In addition, the COVID-19 outbreak has adversely affected the U.S. economy and financial markets, which may result in a long-term economic downturn that could negatively affect future performance. The extent to which COVID-19 will impact our business and our consolidated financial results will depend on future developments which are highly uncertain and cannot be predicted at the time of the filing of this Form 10-K, a material adverse impact on our business, results of operations and financial condition.

 

Risks Related to NACSV’s Business

 

We may face strong competition from larger, established companies.

 

We likely will face intense competition from other companies that provide the same or similar custom specialty vehicle manufacturing and other services that compete with acquired businesses, virtually all of which can be expected to have longer operating histories, greater name recognition, larger installed customer bases, and significantly more financial resources, R&D facilities, and manufacturing and marketing experience than we have. There can be no assurance that developments by our potential competitors will not render our existing and future products or services obsolete. In addition, we expect to face competition from new entrants into the custom specialty vehicle business. As the demand for products and services grows and new markets are exploited, we expect that competition will become more intense, as current and future competitors begin to offer an increasing number of diversified products and services. We may not have sufficient resources to maintain our research and development, marketing, sales, and customer support efforts on a competitive basis. Additionally, we may not be able to make the technological advances necessary to maintain a competitive advantage with respect to our products and services. Increased competition could result in price reductions, fewer product orders, obsolete technology, and reduced operating margins, any of which could materially and adversely affect our business, financial condition, and results of operations.

 

If we are unable to keep up with technological developments, our business could be negatively affected.

 

The markets for our products and services are expected to be characterized by rapid technological change and be highly competitive with respect to timely innovations. Accordingly, we believe that our ability to succeed in the sale of our products and services will depend significantly upon the technological quality of our products and services relative to those of our competitors, and upon our ability to continue to develop and introduce new and enhanced products and services at competitive prices and in a timely and cost-effective manner. In order to develop such new products and services, we will depend upon close relationships with existing customers and our ability to continue to develop and introduce new and enhanced products and services at competitive prices and in a timely and cost-effective manner. There can be no assurance that we will be able to develop and market our products and services successfully or respond effectively to the technological changes or new product and service offerings of our potential competitors. We may not be able to develop the required technologies, products, and services on a cost-effective and timely basis, and any inability to do so could have a material adverse effect on our business, financial condition, and results of operations.

 

We operate in a highly competitive industry and competitors may compete more effectively.

 

The industries in which we operate are highly competitive, with many companies of varying size and business models, many of which have their own proprietary technologies, competing for the same business as we do. Many of our competitors have longer operating histories and greater resources than us, and they could use their substantial financial resources to develop a competing business model, develop products or services that are more attractive to potential customers than those we offer, or convince our potential customers that they require financing arrangements that are impractical for smaller companies to offer. Our competitors may also offer similar products and services at prices below cost, devote significant sales forces to competing with us, or attempt to recruit our key personnel by increasing compensation, any of which could improve their competitive positions. Any of these competitive factors could make it more difficult for us to attract and retain customers, cause us to lower our prices in order to compete or reduce our market share and revenue, any of which could have a material adverse effect on our financial condition and operating results. We can provide no assurance that we will continue to compete effectively against our current competitors or additional companies that may enter our markets. We also expect to encounter competition from customers who elect to develop solutions or perform services internally rather than engaging an outside provider such as us.

 

Operating results may fluctuate and may fall below expectations in any fiscal quarter.

 

Our operating results are difficult to predict and are expected to fluctuate from quarter to quarter due to a variety of factors, many of which are outside of our control. As a result, comparing our operating results on a period-to-period basis may not be meaningful, and investors should not rely on our past results or on predictions prepared by the Company to determine future performance. If our revenue or operating results fall in any period, the value of our common stock would likely decline.

 

-9-

 

 

Risks Related to Our Financial Condition

 

Dependence on financing and losses for the foreseeable future.

 

Our independent registered public accounting firm has issued its audit opinion on our consolidated financial statements appearing in this Annual Report on Form 10-K, including an explanatory paragraph as to substantial doubt with respect to our ability to continue as a going concern. The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, assuming we will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the fiscal year ended December 31, 2022, our net loss was $5,761,061. As of December 31, 2022, we had an accumulated deficit of $55,110,636, and a working capital deficit of $16,075,382. These factors raise substantial doubt about our ability to continue as a going concern which is dependent on our ability to raise the required additional capital or debt financing to meet short- and long-term operating requirements. We may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a need for additional cash. If we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our current shareholders could be reduced, and such securities might have rights, preferences, or privileges senior to our common stock. Additional financing may not be available upon acceptable terms, or available at all. If adequate funds are not available on acceptable terms, we may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict our operations. If we are unable to obtain necessary capital, we may have to cease operations. For additional information, see Item 7 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – “Going Concern.”

 

Dependence on financing and losses for the foreseeable future

 

As of December 31, 2022, we had current liabilities of $16,076,425 and current assets of $1,043 We had a working capital deficiency of $16,075,382.

 

To develop and expand our business, we will need to make significant up-front investments in our manufacturing capacity and incur research and development, sales and marketing, and general and administrative expenses. In addition, our growth will require a significant investment in working capital. Our business will require significant amounts of working capital to meet our project requirements and support our growth. We cannot provide any assurance that we will be able to raise the capital necessary to meet these requirements. If adequate funds are not available or are not available on satisfactory terms, we may be required to significantly curtail our operations and may not be able to fund our current production requirements, let alone fund expansion, take advantage of unanticipated acquisition opportunities, develop, or enhance our products, and respond to competitive pressures. Any failure to obtain such additional financing could have a material adverse effect on our business, results of operations, and financial condition.

 

Because we may never have net income from our operations, our business may fail.

 

We have no history of profitability from operations. There can be no assurance that we will ever operate profitably. Our success is significantly dependent on uncertain events, including successful developing our products, establishing satisfactory manufacturing arrangements and processes, and distributing and selling our products. If we are unable to generate significant revenues from sales of our products, we will not be able to earn profits or continue operations. We can provide no assurance that we will generate any revenues or ever achieve profitability. If we are unsuccessful in addressing these risks, our business will fail, and investors may lose all of their investment in our Company.

 

-10-

 

 

We need to raise additional funds, and such funds may not be available on acceptable terms.

 

We may consider issuing additional debt or equity securities in the future to fund our business plan, for general corporate purposes or for potential acquisitions or investments. If we issue equity or convertible debt securities to raise additional funds, our existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences, and privileges senior to those of our existing stockholders. If we incur additional debt, it may increase our leverage relative to our earnings or to our equity capitalization, requiring us to pay additional interest expenses. We may not be able to obtain financing on favorable terms, in which case, we may not be able to develop or enhance our products, execute our business plan, take advantage of future opportunities, or respond to competitive pressures.

 

Risks Related to Our Common Stock and Its Market Value

 

We have limited capitalization and may require financing, which may not be available.

 

We have limited capitalization, which increases our vulnerability to general adverse economic and industry conditions, limits our flexibility in planning for and reacting to changes in our business and industry, and may place us at a competitive disadvantage to competitors with sufficient capitalization. If we are unable to obtain sufficient financing on satisfactory terms and conditions, we will be forced to curtail or abandon our plans or operations. Our ability to obtain financing will depend upon a number of factors, many of which are beyond our control.

 

A limited public trading market exists for our common stock, which makes it difficult for our stockholders to sell their common stock on the public markets. Any trading in our shares may have a significant effect on our stock prices.

 

Although our common stock is listed for quotation on the OTC Marketplace, Pink Tier, under the symbol “GDSI,” the trading activity of our common stock is volatile and may not develop or be sustained. As a result, any trading price of our common stock may not be an accurate indicator of the valuation of our common stock. Any trading in our shares could have a significant effect on our stock price. If a more liquid public market for our common stock does not develop, then investors may not be able to resell the shares of our common stock that they have purchased and may lose all of their investment. No assurance can be given that an active market will develop or that a stockholder will ever be able to liquidate its shares of common stock without considerable delay, if at all. Many brokerage firms may not be willing to effect transactions in the securities. Even if an investor finds a broker willing to affect a transaction in our securities, the combination of brokerage commissions, state transfer taxes, if any, and any other selling costs may exceed the selling price. Furthermore, our stock price may be impacted by factors that are unrelated or disproportionate to our operating performance. These market fluctuations, as well as general economic, political, and market conditions, such as recessions, interest rates, and international currency fluctuations, may adversely affect the market price and liquidity of our common stock.

 

Our stock price has undergone a great deal of volatility, including a significant decrease over the past few years. The volatility may mean that, at times, our stockholders may be unable to resell their shares at or above the price at which they acquired them.

 

From January 1, 2019, through the date of this report, the price per share of our common stock has ranged from a high of $0.020 to a low of $0.0055. The price of our common stock has been, and may continue to be, highly volatile and subject to wide fluctuations. The market value of our common stock has declined in the past, due in part to our operating performance and to conversions of dilutive debt instruments that we have issued to fund operations. In the future, broad market and industry factors may decrease the market price of our common stock, regardless of our actual operating performance. Recent declines in the market price of our common stock have and could continue to affect our access to capital, and may, if they continue, impact our ability to continue operations at the current level. In addition, any continuation of the recent declines in the price of our common stock may curtail investment opportunities presented to us and negatively impact other aspects of our business, including our ability to fund our operations. As a result of any such declines, many stockholders have been or may become unable to resell their shares at or above the price at which they acquired them.

 

-11-

 

 

The volatility of the market price of our common stock could fluctuate widely in price in response to numerous factors, many of which are beyond our control, including the following: 

 

  our stock being held by a small number of persons whose sales (or lack of sales) could result in positive or negative pricing pressure on the market price for our common stock;

 

  actual or anticipated variations in our quarterly operating results;

 

  changes in our earnings estimates;

 

  our ability to obtain adequate working capital financing;

 

  changes in market valuations of similar companies;

 

  publication (or lack of publication) of research reports about us;

 

  changes in applicable laws or regulations, court rulings, enforcement, and legal actions;

 

  loss of any strategic relationships;

 

  additions or departures of key management personnel;

 

  actions by our stockholders (including transactions in our shares);

 

  speculation in the press or investment community;

 

  increases in market interest rates, which may increase our cost of capital;

 

  changes in our industry;

 

  competitive pricing pressures;

 

  our ability to execute our business plan; and

 

  economic and other external factors.

 

In addition, the securities markets have from time-to- time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of our common stock.

 

Our common stock may never be listed on a national exchange and is subject to being removed from the OTC Pink Marketplace.

 

Our common stock is quoted for trading on the OTC Pink Marketplace (“OTC Pink”). On December 26, 2017, the Securities and Exchange Commission instituted public administrative proceedings pursuant to Section 12(j) of the Securities Exchange Act of 1934 (“Exchange Act”) against the Respondent Global Digital Solutions, Inc. On January 8, 2018, Respondent Global Digital Solutions, Inc. (“GDSI”) filed its answer to the allegations contained in the Order Instituting Administrative Proceedings and Notice of Hearing Pursuant to Section 12U - of the Exchange Act. A briefing schedule was entered into and on February 15, 2018, the Securities and Exchange Commission filed a motion for an order of summary disposition against Respondent GDSI on the grounds that there is no genuine issue with regard to any material fact, and the Division was entitled as a matter of law to an order revoking each class of GDSI’s securities registered pursuant to Section 12 of the Exchange Act. Respondent GDSI opposed the Securities and Exchange Commission’s motion on the grounds that there were material issues of fact. The Securities and Exchange Commission replied, and a hearing was held on April 9, 2018. The Administrative Law Judge ordered supplemental evidence and briefing on the issues of material fact. In the event that we are able to file the required reports with the SEC to be current under the Exchange Act of 1934 (the “Exchange Act”), we still will be unable to list our stock on the OTCQB since the price of our stock is below $0.01, and we do not meet the eligibility standards for listing under the OTCQB per OTC Markets guidelines. Should we continue to fail to satisfy the eligibility standards of OTC Markets for the OTCQB, the trading price of our common stock could continue to suffer and the trading market for our common stock may be less liquid and our common stock price may be subject to increased volatility.

 

-12-

 

 

Our stock is categorized as a penny stock. Trading of our stock may be restricted by the SEC’s penny stock regulations which may limit a stockholder’s ability to buy and sell our stock.

 

Our stock is categorized as a “penny stock”, as that term is defined in SEC Rule 3a51-1, which generally provides that a “penny stock”, is any equity security that has a market price (as defined) less than US$5.00 per share, subject to certain exceptions. Our securities are covered by the penny stock rules, including Rule 15g-9, which imposes additional sales practice requirements on broker-dealers who sell to persons other than established customers and accredited investors. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not otherwise exempt from the rules, to deliver a standardized risk disclosure document in a form prepared by the SEC which provides information about penny stocks and the nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and monthly account statements showing the market value of each penny stock held in the customer’s account. The bid and offer quotations, and the broker-dealer and salesperson compensation information, must be given to the customer orally or in writing prior to effecting the transaction and must be given to the customer in writing before or with the customer’s confirmation. In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from these rules, the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction. These disclosure requirements may have the effect of reducing the level of trading activity in the secondary market for the stock that is subject to these penny stock rules. Consequently, these penny stock rules may affect the ability of broker-dealers to trade our securities and reduce the number of potential investors. We believe that the penny stock rules discourage investor interest in and limit the marketability of our common stock.

 

According to SEC Release No. 34-29093, the market for “penny stocks” has suffered in recent years from patterns of fraud and abuse. Such patterns include: (1) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (2) manipulation of prices through prearranged matching of purchases and sales and through false and misleading press releases; (3) boiler-room practices involving high-pressure sales tactics and unrealistic price projections by inexperienced salespersons; (4) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (5) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, along with the resulting inevitable collapse of those prices and with consequent investor losses. The occurrence of these patterns or practices could increase the future volatility of our share price.

 

FINRA sales practice requirements may also limit a stockholder’s ability to buy and sell our stock.

 

In addition to the “penny stock” rules described above, FINRA has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative low-priced securities to their noninstitutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives, and other information. Under interpretations of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least some customers. The FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may limit your ability to buy and sell our stock and have an adverse effect on the market for our shares.

 

To date, we have not paid any cash dividends, and no cash dividends will be paid in the foreseeable future.

 

We do not anticipate paying cash dividends on our common stock in the foreseeable future and we may not have sufficient funds legally available to pay dividends. Even if the funds are legally available for distribution, we may nevertheless decide not to pay any dividends. We currently intend to retain all earnings for our operations.

 

If we fail to develop or maintain an effective system of internal controls, we may not be able to accurately to report our financial results or prevent financial fraud. As a result, current and potential stockholders could lose confidence in our financial reporting.

 

We are subject to the risk that sometime in the future our independent registered public accounting firm could communicate to the board of directors that we have deficiencies in our internal control structure that they consider to be “significant deficiencies.” A “significant deficiency” is defined as a deficiency, or a combination of deficiencies, in internal controls over financial reporting such that there is more than a remote likelihood that a material misstatement of the entity’s financial statements will not be prevented or detected by the entity’s internal controls.

 

Effective internal controls are necessary for us to provide reliable financial reports and effectively prevent fraud. If we cannot provide reliable financial reports or prevent fraud, we could be subject to regulatory action or other litigation and our operating results could be harmed. We are required to document and test our internal control procedures to satisfy the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act,” or “SOX”), which requires our management to annually assess the effectiveness of our internal control over financial reporting.

 

-13-

 

 

We currently are not an “accelerated filer” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended. Section 404 of the Sarbanes-Oxley Act of 2002 (“Section 404”) requires us to include an internal control report with our Annual Report on Form 10-K. That report must include management’s assessment of the effectiveness of our internal control over financial reporting as of the end of the fiscal year. This report must also include disclosure of any material weaknesses in internal control over financial reporting that we have identified. As of December 31, 2019, the management of the Company assessed the effectiveness of the Company’s internal control over financial reporting based on SEC guidance on conducting such assessments and on the criteria for effective internal control over financial reporting established in Internal Control and Integrated Framework, issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Management concluded, during the year ended December 31, 2019, that the Company’s internal controls and procedures were not effective to detect the inappropriate application of U.S. GAAP rules. Management realized there were deficiencies in the design or operation of the Company’s internal control that adversely affected the Company’s internal controls, which management considers to be material weaknesses. A material weakness in the effectiveness of our internal controls over financial reporting may increase the chance of fraud and the loss of customers, reduce our ability to obtain financing, and require additional expenditures to comply with these requirements. Any of these consequences could have a material adverse effect on our business, results of operations and financial condition. For additional information, see Item 9A – Controls and Procedures.

 

It may be time-consuming, difficult, and costly for us to develop and implement the internal controls and reporting procedures required by the Sarbanes-Oxley Act. We may need to hire additional financial reporting, internal controls, and other finance personnel in order to develop and implement appropriate internal controls and reporting procedures. If we are unable to comply with the internal controls requirements of the Sarbanes-Oxley Act, then we may not be able to obtain the independent accountant certifications required by such act, which may preclude us from keeping our filings with the SEC current.

 

If we are unable to maintain the adequacy of our internal controls, as those standards are modified, supplemented, or amended from time to time, we may not be able to ensure that we may conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with Section 404. Failure to achieve and maintain an effective internal control environment could cause us to face regulatory action and cause investors to lose confidence in our reported financial information, either of which could adversely affect the value of our common stock.

 

Because our current directors, executive officers, and one preferred stockholder beneficially hold 47.5% of our common stock, they can exert significant control over our business and affairs and have actual or potential interests that may depart from those of subscribers in our private placements.

 

Our current directors, our executive officers, and 5% or more stockholders beneficially own or control approximately 47.5% of our issued and outstanding shares of common stock as of December 31, 2022. Additionally, the holdings of our directors, and executive officers, and preferred stockholders may increase in the future upon vesting or other maturation of exercise rights under any of the restricted stock grants, options, or warrants they may hold or in the future be granted, or if they otherwise acquire additional shares of our common stock. The interests of such persons may differ from the interests of our other stockholders. As a result, in addition to their board seats and offices, such persons, irrespective of how the Company’s other stockholders vote, may have significant influence over and may control corporate actions requiring stockholder approval, including the following actions:

 

  electing or defeating the election our directors;

 

  to amending or preventing the amendment of our Certificate of Incorporation or By-laws;

 

  effecting or preventing a transaction, sale of assets, or other corporate transaction; and

 

  controlling the outcome of any other matter submitted to our stockholders for vote.

 

Such persons’ stock ownership may discourage a potential acquirer from making a tender offer or otherwise attempting to obtain control of the Company, which in turn could reduce our stock price or prevent our stockholders from realizing a premium over our stock price.

 

Our certificate of incorporation allows our board to create new series of preferred stock without approval by our stockholders, which could adversely affect the rights of the holders of our common stock.

 

Our board of directors has the authority to fix and determine the relative rights and preferences of preferred stock. Our board of directors also has the authority to issue preferred stock without stockholder approval. As a result, our board of directors could authorize the issuance of a series of preferred stock granting holders a preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed to the holders of common stock, and the right to redemption of the shares, together with a premium prior to the redemption of our common stock. In addition, our board of directors could authorize the issuance of a series of preferred stock that has greater voting power than our common stock or that is convertible into our common stock, which could decrease the relative voting power of our common stock or result in dilution to our existing stockholders.

 

-14-

 

 

ITEM 1B. UNRESOLVED STAFF COMMENTS

 

Not Applicable.

 

ITEM 2. PROPERTIES

 

Our principal executive offices are located at 777 South Flagler Drive, Suite 800 West Tower, West Palm Beach, FL 33401, and our telephone number is (561) 515-6163. Our executive office is a virtual office and is used for meetings, conferences, and telephone and message support. On August 19, 2013, we entered into a lease agreement located at such address for a total monthly rental of $299.

 

We own no other real property.

 

Our registered agent is V Stock Transfer, LLC. 18 Lafayette Place Woodmere, New York 11598

 

ITEM 3. LEGAL PROCEEDINGS

 

We may be involved in legal proceedings in the ordinary course of our business, and our management cannot predict the ultimate outcome of these legal proceedings with certainty. The Company is plaintiff or defendant in the following actions:

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

-15-

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Market Information

 

Our common stock is quoted on the OTC Markets, Pink No Information Tier, under the symbol “GDSI.” Set forth below are the range of high and low bid quotations for the period indicated as reported by the OTC Markets Group (www.otcmarkets.com). The market quotations reflect interdealer prices, without retail markup, markdown, or commissions, and may not represent actual transactions.

 

    High     Low  
March 31, 2023        0.01705              0.01  
                 
December 30, 2022          0.0294              0.01  
                 
September 30, 2022          0.0089             0.05  
                 
June 30, 2022          0.0152              0.01  
                 
March 31, 2022            0.015              0.01  

 

Transfer Agent

 

Our transfer agent is V Stock Transfer, LLC. and is located 18 Lafayette Place, Woodmere, New York 11598. Their telephone number is (212-828-8436 and their website is www. V Stock Transfer.com

 

Holders of Common Stock

 

As of December 31, 2022, there were 212 shareholders of record of our common stock. As of such date 800,543,896 shares were issued and outstanding.

 

Dividends

 

We have never declared or paid any cash dividends on our common stock. We currently intend to retain future earnings, if any, to increase our working capital and do not anticipate paying any cash dividends in the foreseeable future.

 

Stock-Based Compensation

 

For information on securities authorized for issuance under our equity compensation plans, see “Item 11. Executive Compensation” below.

 

Recent Sales of Unregistered Securities

 

The Company did not sell any common stock in 2021, and 2022.

 

-16-

 

 

Issuer Purchases of Equity Securities

 

We did not repurchase any shares of our common stock during the year ended December 31, 2022.

 

ITEM 6. SELECTED FINANCIAL DATA

 

Not applicable.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Use of Generally Accepted Accounting Principles (“GAAP”) Financial Measures

 

We use United States GAAP financial measures in the section of this report captioned “Management’s Discussion and Analysis or Plan of Operation” (MD&A), unless otherwise noted. All of the GAAP financial measures used by us in this report relate to the inclusion of financial information. This discussion and analysis should be read in conjunction with our financial statements and the notes thereto included elsewhere in this annual report. All references to dollar amounts in this section are in United States dollars, unless expressly stated otherwise. Please see Item 1A [Missing Graphic Reference] “Risk Factors” for a list of our risk factors.

 

Results of Operations

 

Comparison of the Fiscal Years Ended December 31, 2022, and December 31, 2021

 

A comparison of the Company’s operating results for the fiscal years ended December 31, 2022, and December 31, 2021, are as follows:

 

For the year ended December 31, 2022:      

 

    Global Digital
Solutions, Inc
    Totals  
Revenue   $     $  
Cost of Sales            
Gross Profit            
Operating Expenses     427,132       427,132  
Operating Income (Loss)     (427,132 )     (427,132 )
Other Income (Expenses)     (5,333,929 )     (4,602,429 )
Income (Loss) – Before Tax   $ (5,761,061 )    $ (5,029,561 ) 

 

For the year ended December 31, 2021: 

 

   Global Digital
Solutions, Inc
    Totals 
Revenue  $    $ 
Cost of Sales         
Gross Profit         
Operating Expenses   2,240,437     2,240,437 
Operating Income (Loss)   (2,240,437)    (2,240,437)
Other Income (Expenses)   4,451,746    4,451,746
Income (Loss) – Before Tax  $2,211,309    $ 2,211,309 

 

-17-

 

 

The variances between fiscal years ending December 31, 2022, and 2021, are as follows:  

 

    Global Digital
Solutions, Inc
    Totals  
Revenue   $     $  
Cost of Sales            
Gross Profit            
Operating Expenses     1,813,305       1,813,305  
Operating Income (Loss)     (1,813,305 )     1,813,305
Other Income (Expenses)     (9,785,675 )      (9,785,675 ) 
Income (Loss) – Before Tax   $ (7,972,370 )    $ (7,972,370 ) 

 

Operating Loss

 

Loss from operations for the years ended December 31, 2022, and 2021 was $427,132 and $2,240,437 respectively. The decrease in operating loss is due to decrease in Selling and Administrative costs.

 

Liquidity, Financial Condition and Capital Resources

 

As of December 31, 2022, we had cash of $1,043 on hand and a working capital deficiency of $16,075,382 compared to cash on hand of $98,800 and a working capital deficiency of $11,158,772 as of December 31, 2021.

 

The decrease in working capital is mainly due to the overall reduction in our business activities and lack of outside funding.

 

Note Financing

 

On January 26, 2015, the Company agreed to a $250,000 principal (and a $25,000 original discount amount) Convertible Note with JMJ Financial (“JMJ”). The Note matures on January 26, 2017, unless earlier converted pursuant to the terms of the Convertible Note. The Note bears interest at 0% if repaid in the first 90 days and then a one-time interest charge of 12% applied on the principal sum. The outstanding principal and interest under the Note is convertible, solely upon an Event of Default (as defined in the Note), at the option of the Holder of the Note into shares of the Company’s common stock as set forth in the Note.

 

During the year ended December 31, 2017, in settlement of the default, we entered into a Repayment Agreement with JMJ Financial. The Company agreed to repay the balance as follows by wire:

 

  $12,500 within five business days of the Issuer securing funding, provided that such payment shall be made on January 31, 2018.

 

  $12,500 within 45 days after the first payment.

 

  $12,500 within 45 days after the second payment.

 

  $47,014 within 30 days after the third payment.

 

A total of $25,000 has been paid through the date of this filing. The first payment of $12,500 was made on February 14, 2018, and the second payment of $12,500 was made on May 17, 2018. No payments have been made since then. The outstanding principal balance at December 31, 2022 and through the date of this report was, $59,514.

 

On January 16, 2015, the Company agreed to a $78,750 principal Convertible Redeemable Note with LG Capital Funding, LLC (“LG Capital”). The Note matures on January 16, 2016, unless earlier converted pursuant to the terms of the Convertible Note. The Note bears interest at 8% per annum. The outstanding principal and interest under the Note is convertible, solely upon an Event of Default (as defined in the Note), at the option of the Holder of the Note into shares of the Company’s common stock as set forth in the Note. On December 12, 2017, the Company entered into a redemption agreement with LG Capital Funding, LLC, to repay the outstanding balance. The outstanding principal balance at December 31, 2022, and through the date of this report was, $48,610.

 

During the year ended December 31, 2017, in settlement of the default, we entered into a Convertible Note Redemption Agreement with LG Capital Funding, LLC. The Company is to wire redemption payment as follows:

 

  $6,500 by December 29, 2017 (paid on January 2, 2018)

 

  $6,500 by January 31, 2018 (paid on March 5, 2019)

 

  $6,500 by February 28, 2018 (paid on March 5, 2019)

 

  $25,000 by March 30, 2018

 

  The remaining balance by April 30, 2018

 

A total of $19,500 has been paid at the date of this filing, with the remaining scheduled payments not yet made.

 

-18-

 

 

On December 22, 2017, the Company entered into a financing agreement with an accredited investor for $1.2 million amended on December 10, 2019, and increased to $1,850,000.

 

Under the terms of the agreement, the Company is to receive milestone payments based on the progress of the Company’s lawsuit for damages against Grupo Rontan Metalurgica, S.A (the “Lawsuit”). Such milestone payments consist of (i) an initial purchase price payment of $300,000, which the Company received on December 22, 2017 (ii) $150,000 within 30 days of the Lawsuit surviving a motion to dismiss on the primary claims; (iii) $100,000 within 30 days of the close of all discovery in the Lawsuit; and (iv) $650,000 within 30 days of the Lawsuit surviving a motion for summary judgment and challenges on the primary claims. As part of the agreement, the Company shall pay the investor an investment return of 100% of the litigation proceeds to recoup all money invested, plus 27.5% of the total litigation proceeds received by the Company. As of December 31, 2021, and through the date of this report $2,550,000 remains outstanding.

 

On December 23, 2017, the Company entered into a $485,000 Demand Promissory Note with Vox Business Trust, LLC (the “Purchaser”). The note was in settlement of the amounts accrued under a consulting agreement (Note 7), including $200,000 owed for retainer payments through December 2017 and $285,000 owed to the Purchaser when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, the Purchaser may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. As of December 31, 2022, and through the date of this report $861,500 of the Demand Promissory note remains outstanding.

 

On December 26, 2017, the Company entered into a $485,000 Demand Promissory Note with RLT Consulting, Inc (the “Purchaser”). The note was in settlement of the amounts accrued under a consulting agreement (Note 7), including $200,000 owed for retainer payments through December 2017, and $285,000 owed to the Purchaser when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, the Purchaser may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018 (along with an additional 4,000,000 for further services). As of December 31, 2022, and through the date of this report $861,500 of the Demand Promissory note remains outstanding.

 

 On May 15, 2018, the Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. The Investment Return is being recognized as interest expense over the three months. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three (3) years. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and expected volatility of the Company’s common stock, of 274.39%, Due to the short-term nature of the Investment Agreement, the warrant fair value was immediately expensed as a financing cost. As of December 31, 2022, the Investment Return has not been paid to the Purchaser, and $200,000 is outstanding.

 

-19-

 

 

Notes Payable

 

On May 12, 2020, the Company and BBVA USA entered into a 1% SBA PPP, Promissory Note, in the aggregate principal of $103,125. The note is payable in monthly payments of $5,805 beginning on December 12, 2020, ending on May 12, 2022. The Company has requested a debt forgiveness from the SBA and is waiting for a response. BBVA USA has waived the monthly repayment requirement until the SBA responds.

 

On August 31, 2017, the Company entered into a $20,000 6% promissory note with an individual. The note is due on February 15, 2018. Upon default, the interest rate increases to 18% until the principal is fully repaid.

 

On May 1, 2018, the Company entered into a $36,000 promissory note with an individual with $5,000 original issue discount for net proceeds of $31,000. As of December 31, 2022, and through the date of this report the outstanding balance of the demand Promissory note is $11,000.

 

On June 1, 2018, the Company entered into a $300,000 non-convertible note with an accredited investor with $150,000 original issue discount (“OID”) for net proceeds of $150,000. As part of the note agreement, the Company also agreed to issue the investor 5,000,000 warrants at an exercise price of $0.01, exercisable for a period of three (3) years. The warrants were valued using the Black Scholes Merton model, resulting in a relative fair value after allocation of $28,378. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.62% and expected volatility of the Company’s common stock, of 275.26%, The relative fair value of the warrants as well as the OID have been classified as a debt discount to be amortized over the life of the note using the effective interest method. Payments of $100,000 were made on May 31, 2019, and June 24, 2019. The final payment of $100,000 was made on March 10, 2021

 

Securities Purchase Agreement/Convertible Notes

 

On May 10, 2019, the Company and GHS Investments LLC entered into a security agreement for a 10% Convertible Note in the aggregate principal of $335,000 due on February 10, 2020. The note carries original issue discount or $35,000. The note is convertible into shares of common stock of the Company. The “Conversion Price” shall mean 60% multiplied by the Market Price (as defined herein), representing a discount rate of 40%. “Market Price” means the lowest Traded Price for the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. The Company is required to maintain a common share reserve of not less than three times the number of shares that is actually issuable upon full conversion of the note. The purchaser will also receive warrants to purchase 5,000,000 shares of GDSI common stock at $.01/share. Warrants will have a three-year term to exercise. The Convertible Note is personally guaranteed by William Delgado, CEO.

 

The note was extended by the lender on October 21, 2021. The principal balance owed as of December 31, 2020, was $608,760. On June 11, 2021, interest on the note in the amount of $115,200.00 was converted into 8,000,000 shares of the Company’s common stock. The outstanding balance as of October 21, 2021, of $737,597, was converted into 25,500,000 shares of the Company’s common stock. The lender also received the 5,000,000 warrants mentioned in the above paragraph. 

 

-20-

 

 

 Convertible Promissory Note

  

On April 7, 2020, The Company entered into a convertible promissory note arrangement with Actus Fund, LLC in the principal amount of $197,000. The principal amount of the note with interest at 12% is due on February 7, 2021. The note is convertible into shares of The Company’s common stock. The conversion price shall equal the lessor of (i) Current Market price or (ii) Variable Market price as defined as Market Price less a 50% discount price. As of December 31, 2022, and through the date of this report, the principal balance Totaling $197,000 is outstanding.

 

On May 20, 2020, the Company and GS Capital Partners, LLC entered into a 10% Convertible Note in the aggregate principal of $165,000 due on February 20, 2021. The note can be converted into shares of common stock of the Company. at any time after the issue date, at a price of $0.01 per share. GS Capital made the following conversion in 2021. On January 21, 2021 converted $26,678 of principal and interest for 2,667808 shares, On March 9, 2021, converted $27,007 of principal and interest for 2,700,685 shares. The outstanding balance of $115,000 was paid off by the Company on March 10, 2021.

 

On March 25, 2021, the Company and GS Capital Partners LLC entered into a security purchase agreement for a Prime rate plus 8% Convertible Note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request. On April 1, 2021, the Company received the first tranche of $1,000,000. Upon the receipt of the first tranche, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $917,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $184,000. On May 24, 2021, the Company received the second tranche from GS Capital Partners LLC, for $796,000’ less an OID of $99,500. On May 24, 2021, the Company received the balance of the second tranche for $346,857 less an OID of $48,357.

 

On November 23, 2021, and December 17, 2021, GS Capital Partners converted $14,020 and $30,762 of principal and interest for 1,164,519 and 3,076,168 shares of the Company’s Common Stock. As of December 31, 2021, and through the date of this report, the principal balance totaling $2,244,846 is outstanding. 

 

On November 23, 2021, and December 17, 2021, GS Capital Partners converted $14,020 and $30,762 of principal and interest for 1,164,519 and 3,076,168 shares of the Company’s Common Stock.

 

In 2022, GS Capital Partners converted $113,750 and $13,491 of principal and interest for 12,825,461 shares of the Company’s Common Stock. As of December 31, 2022, and through the date of this report, the principal balance totaling $2,141,632 is outstanding.

 

 

 

-21-

 

 

On June 29, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a 10% Convertible Note in the aggregate principal of $53,000 due on June 29, 2021. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The note was paid off by a related party on January 21, 2021.

 

On August 25, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a 10% Convertible Note in the aggregate principal of $103,000 due on August 25, 2021. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The note was paid off by the CEO of the Company on February 24, 2021.

 

On October 6, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a 10% Convertible Note in the aggregate principal of $75,000 due on August 25, 2021. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. The note was paid off by the Company on April 8, 2021.   

 

On December 10, 2021, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $128,750, due on December 10, 2022. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2021, and through the date of this report, the principal balance totaling $128,750.00 is outstanding.

 

On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% promissory note in the aggregate principal of $251,625, with a maturity date of June 7, 2022. The note included a original issuance discount (“OID”) of $22,875, for a purchase price of $228,750. The interest was applied as a one - time interest charge upon the issuance date, in the amount of $20,130, recognized in accrued interest. The monthly payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company is required at have authorized and reserved four times the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease, or otherwise dispose of any significant portion of its assets outside the ordinary course of business.  In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $03, with a 3-year term. The note was paid off by the Company on March 25, 2022.

 

-22-

 

 

On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.

 

On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period.

 

In 2022, Leonite Capital, LLC converted $454,546 of principal for 45,454,577 shares of the Company’s Common Stock. As of December 31, 2022, and through the date of this report, the principal balance totaling $970,111 is outstanding.

 

On February 3, 2022, the Company and Sixth Street Lending Group entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $103,750 due on February 3, 2023. The note is convertible into shares of common stock of the Company beginning on the date which is one hundred eighty (180) days following the date on this note and ending on later of the Maturity date and the date of payment of the Default mount. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date.  As of December 31, 2022, and through the date of this report, the principal balance Totaling $131,096 is outstanding.

 

On March 25, 2022, the Company and Sixth Street Lending Group entered into a security purchase agreement f Convertible Note in the aggregate principal of $258,638.00 due on March 25, 2023. A one-time interest charge of 12%, $31,036.500, shall be added to the principal amount due. The note is convertible into shares of common stock of the Company beginning on the date which is one hundred eighty (180) days following the date on this note and ending on later of the Maturity date and the date of payment of the Default mount. The conversion price is equal to the Variable Conversion price which is defined as 75% of the Market Price during the ten, 10 days trading days prior to the Conversion date.  As of December 31, 2022, and through the date of this report, the principal balance of $256,219 and interest of $24,823.60 is outstanding.

 

On June 14,2022, the Company and 1800 Diagonal Lending LLC, entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $128,750, due on June 14, 2023 The note is convertible into shares of common stock of the Company beginning on the date which is one hundred eighty (180) days following the date on this note and ending on later of the Maturity date and the date of payment of the Default mount. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date.  As of December 31, 2022, and through the date of this report, the principal balance totaling $162,685 is outstanding.

 

Going Concern

 

The audited consolidated financial statements contained in this annual report on Form 10-K have been prepared on the assumption that the Company will continue as a going concern. The Company has accumulated losses from inception through the period ended December 31, 2022, of $55,110,636 as well as negative cash flows from operating activities. Furthermore, as of the date of this filing, the Company does not have sufficient cash resources to achieve its goals through December 31, 2023.

 

The consolidated financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern. The Company’s continuation as a going concern is dependent on its ability to obtain any additional financing required and ultimately to attain profitability. If the Company raises additional funds through the issuance of equity, the percentage ownership of current shareholders could be reduced, and such securities might have rights, preferences, or privileges senior to the rights, preferences, and privileges of the Company’s common stock. Additional financing may not be available upon acceptable terms. If adequate funds are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict its future plans for developing its business and achieving commercial revenues. If the Company is unable to obtain necessary capital, the Company may have to cease operations.

 

Working Capital Deficiency

 

    December 31,     December 31,  
    2022     2021  
Current Assets   $ 1,043     $ 98,800  
Current Liabilities     16,076,425       11,257,572  
Working Capital   $ (16,075,382 )   $ (11,128,449 )

 

The decrease in current assets from 2021 to 2022 is due to an Increase in cash provided by financing activities. The increase in current liabilities is mainly due to increases in Convertible Notes Payable and Notes Payable during the year ended December 31, 2022.

 

-23-

 

 

Cash Flow

 

   Year Ended 
   December 31,   December 31, 
   2022   2021 
Net cash (used in) operating activities  $(523,125  $(2,639,564)
Net cash (used in) investing activities   (138,917   
Net cash provided by financing activities   564,285    2,738,100 
Increase(decrease) in cash  $(97,757  $98,536

 

Operating Activities

 

Net cash used in operating activities was $523,125 for the year ended December 31, 2022. Cash used during the year ended December 31, 2022, was primarily due to the net loss of $5,761,061

 

Net cash used in operating activities was $2,639,564 for the year ended December 31, 2021. Cash provided during the year ended December 31, 2021, was $98,536 was primarily due to the cash provided by financing activities of $2,738,100.

 

Investing Activities

 

For the years ended December 31, 2022, and 2021, there was $138,917 and $0.00 of cash used for investing activities.

 

Financing Activities

 

For the years ended December 31, 2022, and 2021, net cash provided by financing activities was $ and $2,738,100 respectively. Cash provided by financing activities was due to the proceeds from convertible payable and notes payable.

 

Future Financing

 

We will require additional funds to implement our growth strategy for our business. In addition, while we have received capital from various private placements of equity and convertible debt that have enabled us to fund our operations, additional funds will be needed for further business development. 

 

-24-

 

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that are material to stockholders.

 

Effects of Inflation

 

We do not believe that inflation has had a material impact on our business, revenues, or operating results during the periods presented.

 

Critical Accounting Policies and Estimates

 

Our significant accounting policies are more fully described in the notes to our financial statements included in this Annual Report on Form 10-K for the year ended December 31, 2022. We believe that the accounting policies below are critical for one to fully understand and evaluate our financial condition and results of operations.

 

Recent Accounting Standards 

 

-25-

 

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not Applicable.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

The information called for by Item 8 is included following the “Index to Financial Statements” on page F-1 contained in this annual report on Form 10-K.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We carried out an evaluation, under the supervision and with the participation of our management, including our sole executive officer, William Delgado, who is our Chief Executive Officer (Principal Executive Officer), of the effectiveness of the design of our disclosure controls and procedures (as defined by Exchange Act Rules 13a-15(e) or 15d-15(e)) as of December 31, 2019 pursuant to Exchange Act Rule 13a-15. Based upon that evaluation, our Principal Executive and Financial Officer concluded that our disclosure controls and procedures were not effective as of December 31, 2022, and December 31, 2021, in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms. This conclusion is based on findings that constituted material weaknesses. A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the Company’s interim financial statements will not be prevented or detected on a timely basis.

 

Management’s Report on Internal Control Over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. Under the supervision and with the participation of our management, which currently consists of William Delgado serving as our Chief Executive Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on criteria established in the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO” - 2013) and SEC guidance on conducting such assessments. Our management concluded, as of December 31, 2022, that our internal control over financial reporting was not effective. Management realized there were deficiencies in the design or operation of the Company’s internal control that adversely affected the Company’s internal controls which management considers to be material weaknesses.

 

In performing the above-referenced assessment, management had concluded that as of December 31, 2022, there were deficiencies in the design or operation of our internal control that adversely affected our internal controls, which management considers to be material weaknesses, including those described below:

 

(i) Lack of Formal Policies and Procedures. We use a third-party independent contractor for the preparation of our financial statements. Although the financial statements and footnotes are reviewed by our management, we do not have a formal policy to review significant accounting transactions and the accounting treatment of such transactions. The third-party independent contractor is not involved in the day-to-day operations of the Company and may not be provided information to management on a timely basis to allow for adequate reporting/consideration of certain transactions.

 

(ii) Audit Committee and Financial Expert. We do not have a formal audit committee with a financial expert, and thus we lack the board oversight role within the financial reporting process.

 

(iii) Insufficient Resources. We have insufficient quantity of dedicated resources and experienced personnel involved in reviewing and designing internal controls. As a result, a material misstatement of the interim and annual financial statements could occur and not be prevented or detected on a timely basis.

 

(iv) Entity-Level Risk Assessment. We did not perform an entity level risk assessment to evaluate the implication of relevant risks on financial reporting, including the impact of potential fraud related risks and the risks related to non-routine transactions, if any, on internal control over financial reporting. Lack of an entity-level risk assessment constituted an internal control design deficiency which resulted in more than a remote likelihood that a material error would not have been prevented or detected and constituted a material weakness. 

 

-26-

 

 

Our management feels the weaknesses identified above have not had any material effect on our financial results. However, we are currently reviewing our disclosure controls and procedures related to these material weaknesses and expect to implement changes in the near term as resources permit, including identifying specific areas within our governance, accounting, and financial reporting processes to add adequate resources to potentially mitigate these material weaknesses.

 

Our management will continue to monitor and evaluate the effectiveness of our internal controls and procedures and our internal controls over financial reporting on an ongoing basis and is committed to taking further action and implementing additional enhancements or improvements, as necessary and as funds allow.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. All internal control systems, no matter how well designed, have inherent limitations. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting during the year ended December 31, 2022, that have materially affected or are reasonably likely to materially affect our internal control over financial reporting. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within any company have been detected.

 

ITEM 9B. OTHER INFORMATION

 

The information required by this section is disclosed in Part II, Item 5. 

 

-27-

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

 

Set forth below are the directors and executive officers of the Company as of December 31, 2022 Except as set forth below, there are no other persons who have been nominated or chosen to become directors, nor are there any other persons who have been chosen to become executive officers. Other than as set forth below, there are no arrangements or understandings between any of the directors, officers and other persons pursuant to which such person was selected as a director or an officer.

 

Name Position Held with Company Age Date First Elected or
Appointed
William J. Delgado Chief Executive Officer, Chairman of the Board 62 May 13, 2016
Jerome J. Gomolski Chief Financial Officer 74 April 10, 2015
Gary A. Gray Vice President, Chief Technology Officer 69 August 12, 2013

 

Our Board of Directors believes that all members of the Board and all executive officers encompass a range of talent, skill, and experience sufficient to provide sound and prudent guidance with respect to our operations and interests. The information below with respect to our sole officer and director includes his experience, qualifications, attributes, and skills necessary for him to serve as a director and/or executive officer.

 

Biographies

 

William J. Delgado – Director & Executive Vice President

 

Mr. Delgado has served as our President, Chief Executive Officer and Chief Financial Officer from August 2004 to August 2013. Effective August 12, 2013, Mr. Delgado assumed the position of Executive Vice President, and is responsible, along with Mr. Sullivan, for business development. Mr. Delgado has over 33 years of management experience including strategic planning, feasibility studies, economic analysis, design engineering, network planning, construction, and maintenance. He began his career with Pacific Telephone in the Outside Plant Construction. He moved to the network engineering group and concluded his career at Pacific Bell as the Chief Budget Analyst for the Northern California region. Mr. Delgado founded All Star Telecom in late 1991, specializing in OSP construction and engineering and systems cabling. All Star Telecom was sold to International FiberCom in April of 1999. After leaving International FiberCom in 2002, Mr. Delgado became President/CEO of Pacific Comtel in San Diego, California. After the Company acquired Pacific Comtel in 2004, Mr. Delgado became Director, President, CEO and CFO of the Company. Management believes that Mr. Delgado’s many years of business experience uniquely qualifies him for his positions with the Company.

 

On May 13, 2016, Mr. Delgado assumed the role of Chief Executive Officer and Chairman of the Board of Directors and currently serves in that position.

 

Jerome J. Gomolski – Chief Financial Officer

 

Mr. Gomolski became the Chief Financial Officer of our subsidiary, NACSV, on January 1, 2015, and was appointed the Company’s Chief Financial Officer on April 10, 2015. Mr. Gomolski has specialized in auditing, corporate and individual income tax, and forensic accounting for over 30 years. Mr. Gomolski began his financial career in the corporate accounting department of International Harvester in Chicago. After graduating from DePaul University in Chicago with a BSC in Accounting he passed the Illinois CPA exam and began working for several large accounting firms. Several years later, he returned to International Harvester as Manager of Financial Planning and Analysis. In 1982, Jerry was offered an opportunity to relocate to South Florida and return to public accounting. There he brought his experience and talent to work with two large accounting firms. His increasing responsibility led to a partnership.

 

Family Relationships

 

There are no other family relationships between and among any of our directors or executive. 

 

-28-

 

 

Involvement in Certain Legal Proceedings

 

No director, executive officer, significant employee or control person of the Company has been involved in any legal proceeding listed in Item 401(f) of Regulation S-K in the past 10 years.

 

Committees of the Board

 

Our Board of Directors held no formal meetings in the year-ended December 31, 2022. Otherwise, all proceedings of the Board of Directors were conducted by resolutions consented to in writing by the sole director and filed with the minutes of the Company.

 

Board Nominations and Appointments

 

In considering whether to nominate any particular candidate for election to the Board of Directors, we will use various criteria to evaluate each candidate, including an evaluation of each candidate’s integrity, business acumen, knowledge of our business and industry, experience, diligence, conflicts of interest and the ability to act in the interests of our stockholders. The Board of Directors plans to evaluate biographical information and interview selected candidates in the next fiscal year and plans to consider whether a potential nominee would satisfy the listing standards for “independence” of The Nasdaq Stock Market and the SEC’s definition of “audit committee financial expert.” The Board of Directors does not plan to assign specific weights to particular criteria and no particular criterion will be a prerequisite for each prospective nominee.

 

We do not have a formal policy with regards to the consideration of director candidates recommended by our stockholders, however, stockholder recommendations relating to director nominees may be submitted in accordance with the procedures set forth below under the heading “Communicating with the Board of Directors”.

 

Communicating with the Board of Directors

 

Stockholders who wish to send communications to the Board of Directors may do so by writing to 777 South Flagler Drive, Suite 800 West Tower, West Palm Beach, FL 33401. The mailing envelope must contain a clear notation indicating that the enclosed letter is a “Stockholder-Board Communication.” All such letters must identify the author as a stockholder and must include the stockholder’s full name, address and a valid telephone number. The name of any specific intended recipient should be noted in the communication. We will forward any such correspondence to the intended recipients; however, prior to forwarding any such correspondence, and we will review such correspondence, and in our discretion, may not forward communications that relate to ordinary business affairs, communications that are primarily commercial in nature, personal grievances or communications that relate to an improper or irrelevant topic or are otherwise inappropriate for the Board of Director’s consideration.

 

Communicating with the Board of Directors

 

Special Litigation Committee of the Board of Directors

 

Certain current and former directors and officers of the Company are parties to certain derivative litigations. The claims asserted in these litigations are assets of the Company. The Board of Directors of the Company (the “Board”) has determined that it is in the best interests of the Company and its shareholders to form a Special Litigation Committee of the Board (“Special Litigation Committee”) to investigate and evaluate the claims and allegations asserted in the Litigations and make a determination as to how the Company should proceed with respect to the Litigations and the asserted claims and allegations.

 

The Board has determined that it is advisable and in the best interests of the Company and its shareholders that a Special Litigation Committee shall investigate the claims and allegations in the litigations and evaluate whether the Company should pursue any of the claims asserted in the litigations, as well as prepare such reports, arrive at such decisions, and take such other actions in connection with the litigations, as the Special Litigation Committee in its discretion deems appropriate and in the best interests of the Company and its stockholders, in accordance with New Jersey law.

 

The Board of Directors will appoint independent and disinterested directors to serve on the Special Litigation Committee, or, in the alternative, appoint a special counsel to report to the board on his investigation.

 

-29-

 

 

Compensation of Directors

 

We have no standard arrangement to compensate directors for their services in their capacity as directors. Directors are not paid for meetings attended. However, we intend to review and consider future proposals regarding board compensation. All travel and lodging expenses associated with corporate matters are reimbursed by us, when incurred.

 

Compensation Committee Interlocks and Insider Participation

 

No interlocking relationship exists between our Board of Directors and the board of directors or compensation committee of any other company, nor has any interlocking relationship existed in the past.

 

Code of Ethics

 

As part of our system of corporate governance, our Board of Directors has adopted a Code of Business Conduct and Ethics (the “Code”) for directors and executive officers of the Company. This Code is intended to focus each director and executive officer on areas of ethical risk, provide guidance to directors and executive officer to help them recognize and deal with ethical issues, provide mechanisms to report unethical conduct, and help foster a culture of honesty and accountability. Each director and executive officer must comply with the letter and spirit of this Code. We have also adopted a Code of Ethics for Financial Executives applicable to our Chief Executive Officer and senior financial officers to promote honest and ethical conduct; full, fair, accurate, timely and understandable disclosure; and compliance with applicable laws, rules, and regulations. We intend to disclose any changes in or waivers from our Code of Business Conduct and Ethics and our Code of Ethics for Financial Executives by filing a Form 8-K or by posting such information on our website.

 

Compliance with Section 16(a) of the Securities Exchange Act of 1934

 

Section 16(a) of the Securities Exchange Act requires our executive officers and directors, and persons who own more than 10% of our common stock, to file reports regarding ownership of, and transactions in, our securities with the Securities and Exchange Commission and to provide us with copies of those filings.

 

Based solely on our review of the copies of such forms received by us, or written representations from certain reporting persons, we believe that during the year ended December 31, 2022, none of our greater than 10% percent beneficial owners failed to comply on a timely basis with all applicable filing requirements under Section 16(a) of the Exchange Act.

 

ITEM 11. EXECUTIVE COMPENSATION

 

General Philosophy

 

Our Board of Directors is responsible for establishing and administering the Company’s executive and director compensation. 

 

-30-

 

 

Executive Compensation

 

The following summary compensation table indicates the cash and non-cash compensation earned from the Company during the years ended December 31, 2022, and 2021, of our named executive officers.

 

Summary Compensation Table

 

Name and         Salary     Bonus     Stock Award     Option Award     Nonequity
Incentive
Plan Compensation
    Change
in Pension
Value
and
Non-Qualified
Deferred
Compensation Earnings
    All Other
Compensation
    Total  
Principal Position   Year     ($)     ($)     ($)     ($)     ($)     ($)     ($)     ($)  
Jerome J. Gomolski     2022       60,000                                           60,000  
                                                                         
Jerome J. Gomolski (1)     2021       48,000                                           48,000  
                                                                         
Wiliam J. Delgado (2)     2021       240,000                                           240,000  
                                                                         
Wiliam J. Delgado (2)     2021       1,060,158                                           1,060,158  

 

  (1) Mr. Gomolski joined the company as Chief Financial Officer of our subsidiary, NACSV, on January 5, 2015. He was appointed the Company’s Chief Financial Officer effective April 10, 2015.

 

  (2) Mr. Delgado was appointed Chief Executive Officer and Chairman of the Board on May 13, 2016. He was appointed Executive Vice President on August 12, 2013. Prior thereto he served as our CEO, President and Chief Financial Officer.

 

  (3) The amounts in these columns represent the fair value of the award as of the grant date as computed in accordance with ASC 718. These amounts represent restricted stock awards and stock options granted to the named executive officers, and do not reflect the actual amounts that may be realized by those officers.

 

Key Employee Employment Agreements

 

We have an employment agreement with Chief Executive Officer, William Delgado.

 

-31-

 

 

Outstanding Equity Awards at Fiscal Year End

 

The following table provides information as of December 31, 2022, and December 31, 2021, regarding unexercised stock options and restricted stock awards granted to each of our named executive officers:

 

    Number of
Securities
Underlying
Unexercised
Options
Exercisable
(#) 
    Number of
Securities
Underlying
Unexercised
Options
Unexercisable
(#) 
    Equity
Incentive
Plan
Awards:
Number of
Securities
Underlying
Unexercised
Unearned
Options
(#)
    Option
Exercise
Price
($)
    Option
Expiration
Date
  Number of
Shares or
Units
of Stock
that have
not Vested
(#)
    Market
Value of
Shares or
Units of
Stock that
have not
Vested
(#)
    Equity
Incentive
Plan
Awards:
Number of
Unearned
Shares,
Units or
Other
Rights that
have not
Vested
(#)
    Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units or
Other
Rights that
Have not
Vested
($)
 
Jerome J. Gomolski     166,667                   0.10     4/1/2025                        
Jerome J. Gomolski     1,000,000                   0.006     11/30/2025                        
William J. Delgado     166,667                   0.14     3/31/2025                        
William J. Delgado     750,000                   0.008     12/14/2025                        

 

Equity Compensation Plan Information and Issuances

 

Our current policy is that all full-time key employees are considered annually for the possible grant of stock options, depending upon qualifying performance criteria. The criteria for the awards are experience, uniqueness of contribution to our business and the level of performance shown during the year. Stock options are intended to enhance the ability of the Company and its Affiliates to attract and retain exceptionally qualified individuals upon whom, in large measure, the sustained progress, growth and profitability of the Company depend.

  

-32-

 

 

Pension Benefits

 

None of our named executive officers is covered by a pension plan or other similar benefit plan that provides for payments or other benefits at, following, or in connection with retirement.

 

Nonqualified Deferred Compensation

 

None of our named executive officers is covered by a defined contribution or other plan that provides for the deferral of compensation on a basis that is not tax qualified.

 

2014 Equity Incentive Plan

 

On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 shares of our common stock for issuance pursuant to awards thereunder, including options, stock appreciation right, restricted stock, restricted stock units, performance awards, dividend equivalents, or other stock-based awards. The Plan is intended as an incentive, to retain in the employ of the Company, our directors, officers, employees, consultants, and advisors, and to attract new officers, employees, directors, consultants, and advisors whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries. Under the Plan, we are authorized to issue incentive stock options intended to qualify under Section 422 of the Internal Revenue Code of 1986, as amended, non-qualified stock options, stock appreciation rights, performance shares, restricted stock and long-term incentive awards. The Plan is administered by the Board of Directors.

 

In accordance with the ACS 718, Compensation – Stock Compensation, awards granted are valued at fair value at the grant date. The Company recognizes compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. The Company recognizes the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. The Company has not capitalized any portion of its stock-based compensation.

 

Director Compensation

 

We do not have a compensation arrangement in place for members of our Board and we have not finalized any plan to compensate directors in the future for their services as directors. We anticipate that we will develop a compensation plan for our independent directors in order to attract qualified persons and to retain them. We expect that the compensation arrangements will generally be comprised of equity awards and cash for reimbursement of expenses only; however, exceptions may be made if circumstances warrant.

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.

 

Except as otherwise stated, the table below sets forth information concerning the beneficial ownership of Common Stock as of December 31, 2022, (1) each director currently serving on our Board of Directors; (2) each of our named executive officers; (3) our directors and executive officers as a group; and (4) each person known to the Company to beneficially own more than 5% of the outstanding shares of Common Stock. As of December 31, 2021, there were 800,543,896 shares of Common Stock outstanding. Except as otherwise noted, each stockholder has sole voting and investment power with respect to the shares beneficially owned. 

 

Title of Class   Name and Address of
Beneficial Owner (4)
  Amount and Nature of
Beneficial Ownership
  Percent of
Class (1)
Common Stock   William J. Delgado (2)   6,358,032   0.08 %
Common Stock   Jerome J. Gomolski (3)   5,000,000   0.06 %
Common Stock   Gary Gray   4,000,000   0.05%
    Total Beneficial Holders as a Group   15,358,032   0.0192%

 

Applicable percentages are based on 800,543,896 shares outstanding as of December 31, 2022, and includes issued and outstanding shares of common stock as well as vested but unissued restricted shares. Beneficial ownership is determined under the rules of the SEC and generally includes voting or investment power with respect to securities. A person is deemed to be the beneficial owner of securities that can be acquired by such person within 60 days whether upon the exercise of options or otherwise. Shares of Common Stock subject to options and warrants currently exercisable, or exercisable within 60 days after the date of this report, are deemed outstanding for computing the percentage of the person holding such securities but are not deemed outstanding for computing the percentage of any other person. Unless otherwise indicated in the footnotes to this table, the Company believes that each of the shareholders named in the table has sole voting power.

 

Includes (a) 3,221,032 shares owned by Bronco Communications, LLC, an entity which Mr. Delgado controls and (b) 3,137,000 shares owned by Mr. Delgado’s daughters.

 

Mr. Gomolski has 1,167,667 options of which all have vested.

 

-33-

 

 

Changes in Control.

 

There are currently no arrangements which may result in a change of control of our company.

 

Non-Cumulative Voting

 

The holders of our shares of common stock do not have cumulative voting rights, which means that the holders of more than 50% of such outstanding shares, voting for the election of Directors, can elect all of the Directors to be elected if they so choose. In such event, the holders of the remaining shares will not be able to elect any of our Directors.

 

ITEM 13. DIRECTOR INDEPENDENCE

 

Named Executive Officers and Current Directors

 

For information regarding compensation for our named executive officers and current directors, see “Executive Compensation.”

 

Director Independence

 

Our board of directors consists of one director, William J. Delgado. Our securities are quoted on the OTC Markets Group, Pink No Information Tier, which does not have any director independence requirements. We evaluate independence by the standards for director independence established by applicable laws, rules, and listing standards including, without limitation, the standards for independent directors established by The New York Stock Exchange, Inc., the NASDAQ National Market, and the Securities and Exchange Commission.

 

Subject to some exceptions, these standards generally provide that a director will not be independent if (a) the director is, or in the past three years has been, an employee of ours; (b) a member of the director’s immediate family is, or in the past three years has been, an executive officer of ours; (c) the director or a member of the director’s immediate family has received more than $120,000 per year in direct compensation from us other than for service as a director (or for a family member, as a non-executive employee); (d) the director or a member of the director’s immediate family is, or in the past three years has been, employed in a professional capacity by our independent public accountants, or has worked for such firm in any capacity on our audit; (e) the director or a member of the director’s immediate family is, or in the past three years has been, employed as an executive officer of a company where one of our executive officers serves on the compensation committee; or (f) the director or a member of the director’s immediate family is an executive officer of a company that makes payments to, or receives payments from, us in an amount which, in any twelve-month period during the past three years, exceeds the greater of $1,000,000 or two percent of that other company’s consolidated gross revenues. Based on these standards, we have determined that our director is not an independent director.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES

 

Audit Fees

 

The aggregate audit fees billed by our independent accounting firm, Turner, Stone & Company, LLP (“TSC”), for the years ended December 31, 2022, and 2021, $70,500 and $61,000, respectively.

 

Other Fees

 

 There were no other services provided by TSC during the years ended December 31, 2022, and 2021. 

 

-34-

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

Exhibit Number Description
(2) Plan of acquisition, reorganization, arrangement, liquidation or succession
2.1 Purchase Agreement with Bronco Communications, LLC dated January 1, 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
2.2 Amendment to Purchase Agreement with Bronco Communications, LLC dated October 15, 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
2.3 Agreement of Merger and Plan of Reorganization with Airtronic USA, Inc. dated October 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
2.4 First Amendment to Agreement of Merger and Plan of Reorganization with Airtronic, USA, Inc. dated August 5, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
2.5 Equity Purchase Agreement with Brian A. Dekle, John Ramsey, GDSI Acquisition Corporation, Global Digital Solutions, Inc., and North American Custom Specialty Vehicle, LLC dated June 16, 2014 (incorporated by reference to our Current Report on Form 8-K filed on June 19, 2014)
2.6 Share Purchase and Sale Agreement with Global Digital Solutions, Inc., Grupo Rontan Electro Metalurgica, S.A., Joao Alberto Bolzan and Jose Carlos Bolzan dated October 8, 2015 (incorporated by reference to our Current Report on Form 8-K filed on October 19, 2015)
(3) (i) Articles of Incorporation; and (ii) Bylaws
3.1 Certificate of Incorporation dated August 28, 1995 (incorporated by reference to our Form 10 filed on August 8, 2013)
3.2 Articles of Merger dated March 18, 2004 (incorporated by reference to our Form 10 filed on August 8, 2013)
3.3 Certificate of Amendment to the Certificate of Incorporation dated August 06, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
3.4 Bylaws dated August 28, 1995 (incorporated by reference to our Form 10 filed on August 8, 2013)
3.5 Certificate of Amendment to Certificate of Incorporation dated July 7, 2014 (incorporated by reference to our Current Report on Form 8-K filed on July 30, 2014)
3.6 Certificate of Amendment to Certificate of Incorporation dated May 18, 2015 (incorporated by reference to our Current Report on Form 8-K filed on May 20, 2015)
(10) Material Agreements
10.1 Debtor in Possession Note Purchase Agreement with Airtronic USA, Inc. dated October 22, 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.2 Secured Promissory Note with Airtronic USA, Inc. dated October 22, 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.3 Security Agreement with Airtronic USA, Inc. dated October 22, 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.4 Bridge Loan Modification and Ratification Agreement with Airtronic USA, Inc. dated March, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.5 Second Bridge Loan Modification and Ratification Agreement with Airtronic USA, Inc. dated August 5, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.6 Secured Promissory Note with Airtronic USA, Inc. dated August 5, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.7 Intellectual Property Security Agreement with an individual dated August 5, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.8 Promissory Note Purchase Agreement with Bay Acquisition, LLC dated December 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.9 Secured Promissory Note with an individual dated December 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.10 Security Agreement with Bay Acquisition, LLC dated December, 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.11 Warrant to Purchase Common Stock with an individual dated December 2012 (incorporated by reference to our Form 10 filed on August 8, 2013)

 

-35-

 

 

10.12 Amendment to Promissory Note Agreement with an individual dated May 6, 2013 (incorporated by reference to our Form 10 filed on August 8, 2013)
10.13 Subscription Agreement and Securities Purchase Agreement (incorporated by reference to our Form 10 filed on August 8, 2013)
10.14 Form of Indemnification Agreement (incorporated by reference to our Form 10 filed on August 8, 2013)
10.15 Secured Promissory Note with Airtronic USA, Inc. dated October 10, 2013 (incorporated by reference to our Annual Report on Form 10-K filed on March 28, 2014)
10.16 Third Bridge Loan Modification and Ratification Agreement with Airtronic USA, Inc. dated October 10, 2013 (incorporated by reference to our Annual Report on Form 10-K filed on March 28, 2014)
10.17 Investment Banking Agreement with Midtown Partners & Co, LLC dated October 16, 2013 (incorporated by reference to our Annual Report on Form 10-K filed on March 28, 2014)
10.18 Addendum to Investment Bank Agreement with Midtown Partners & Co, LLC dated October 16, 2013 (incorporated by reference to our registration statement on Form S-1 filed on August 5, 2014)
10.19 2014 Equity Incentive Plan dated May 19, 2014 (incorporated by reference to our registration statement on Form S-1 filed on August 5, 2014)
10.20 Online Virtual Office Agreement dated August 19, 2013 (incorporated by reference to our registration statement on Form S-1 filed on August 5, 2014)
10.21 Restricted Stock Unit Agreement with Stephen L. Norris dated August 25, 2014 (incorporated by reference to our Current Report on Form 8-K/A filed on August 25, 2014)
10.22 Securities Purchase Agreement with Charter 804CS Solutions, Inc dated December 8, 2014 (incorporated by reference to our Current Report on Form 8-K filed on December 12, 2014)
10.23 Convertible Redeemable Note with Charter 804CS Solutions, Inc dated December 8, 2014 (incorporated by reference to our Current Report on Form 8-K filed on December 12, 2014)
10.24 First Amendment to Convertible Redeemable Note with Charter 804CS Solutions, Inc dated February 4, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 9, 2015)
10.25 Securities Purchase Agreement with an individual dated December 8, 2014 (incorporated by reference to our Current Report on Form 8-K filed on December 12, 2014)
10.26 Convertible Redeemable Note with an individual dated December 8, 2014 (incorporated by reference to our Current Report on Form 8-K filed on December 12, 2014)
10.27 First Amendment to Convertible Redeemable Note dated February 4, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 4, 2014)
10.28 Securities Purchase Agreement with LG Capital Funding, LLC dated January 16, 2015 (incorporated by reference to our Current Report on Form 8-K filed on January 20, 2015)
10.29 Convertible Redeemable Note with LG Capital Funding, LLC dated January 16, 2015 (incorporated by reference to our Current Report on Form 8-K filed on January 20, 2015)
10.30 Convertible Note with JSJ Investments Inc. dated January 26, 2015 (incorporated by reference to our Current Report on Form 8-K filed on January 30, 2015)
10.31 Securities Purchase Agreement with Adar Bays, LLC dated January 26, 2015 (incorporated by reference to our Current Report on Form 8-K filed on January 30, 2015)
10.32 Convertible Redeemable Note with Adar Bays dated January 26, 2015 (incorporated by reference to our Current Report on Form 8-K filed on January 30, 2015)
10.33 Convertible Note with JMJ Financial dated January 26, 2015 (incorporated by reference to our Current Report on Form 8-K filed on January 30, 2015)
10.34 Convertible Note with Vista Capital Investments, LLC dated February 4, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 9, 2015)
10.35 Securities Purchase Agreement with KBM Worldwide, Inc dated February 17, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 24, 2015)
10.36 Convertible Promissory Note with KBM Worldwide, Inc dated February 17, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 24, 2015)
10.37 Securities Purchase Agreement with EMA Financial, LLC dated February 19, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 24, 2015)
10.38 Convertible Note with EMA Financial, LLC dated February 19, 2015 (incorporated by reference to our Current Report on Form 8-K filed on February 24, 2015)
10.39 Note Purchase Agreement with Tangiers Investment Group, LLC dated March 8, 2015 (incorporated by reference to our Current Report on Form 8-K filed on March 13, 2015)

 

-36-

 

 

10.40 Convertible Promissory Note with Tangiers Investment Group, LLC dated March 8, 2015 (incorporated by reference to our Current Report on Form 8-K filed on March 13, 2015)
10.41 Non-Exclusive Agreement with Carter, Terry & Company dated December 18, 2014 (incorporated by reference to our Annual Report on Form 10-K filed on March 30, 2015)
10.42 Securities Purchase Agreement with VIS Vires Group, Inc. dated April 3, 2015 (incorporated by reference to our Quarterly Report on Form 10-Q filed on May 14, 2015)
10.43 Convertible Promissory Note with VIS Vires Group, Inc. dated April 3, 2015 (incorporated by reference to our Quarterly Report on Form 10-Q filed on May 14, 2015)
10.44 Revenue Based Factoring Agreement with Power Up dated October 1, 2015 (incorporated by reference to our Current Report on Form 8-K filed on October 5, 2015)
10.45 Security Agreement and Guarantee with Power Up dated October 1, 2015 (incorporated by reference to our Current Report on Form 8-K filed on October 5, 2015)
10.46 Revenue Based Factoring Agreement with Power Up dated October 23, 2015 (incorporated by reference to our Current Report on Form 8-K filed on November 5, 2015)
10.47 Security Agreement and Guarantee with Power Up dated October 23, 2015 (incorporated by reference to our Current Report on Form 8-K filed on November 5, 2015)
10.48 Settlement Agreement with an individual dated July 27, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.49 Settlement Agreement with Power Up Lending Group, Ltd. dated December 21, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.50 Repayment Agreement with JMJ Financial dated December 13, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.51 Convertible Note Redemption Agreement dated December 12, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.52 Exchange/Conversion Agreement with an individual dated August 15, 2016 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.53 Promissory Note with Dragon Acquisitions dated August 31, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.54 Stock Purchase Agreement with Empire Relations Group, Inc. dated August 16, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.55 Prepaid Forward Purchase Agreement with Boies Schiller Flexner LLP dated December 22, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.56 Demand Promissory Note with Vox Business Trust, LLC dated December 19, 2017 (incorporated by reference to our [LFY ENDED NO YEAR], 2015 Annual Report on Form 10-K filed on May 31, 2018)
10.57 Demand Promissory Note with RLT Consulting, Inc. dated December 26, 2017 (incorporated by reference to our Quarterly Report on Form 10-Q filed on June 13, 2018)
10.58 Promissory Note with an individual dated May 1, 2018 (incorporated by reference to our Quarterly Report on Form 10-Q filed on June 13, 2018)
10.59 Investment Return Purchase Agreement with an individual dated May 15, 2018 (incorporated by reference to our Quarterly Report on Form 10-Q filed on June 13, 2018)
(31) Rule 13a-14(a)/15d-14(a) Certifications
31.1* Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Executive Officer
31.2* Section 302 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Financial Officer and Principal Accounting Officer
(32) Section 1350 Certifications
32.1* Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Chief Executive Officer
32.2* Section 906 Certification under the Sarbanes-Oxley Act of 2002 of the Principal Accounting Officer
(101)* Interactive Data Files
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema Document
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF XBRL Taxonomy Extension Definition Linkbase Document
101.LAB XBRL Taxonomy Extension Label Linkbase Document
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document

 

  * Filed herewith.

 

  ** Furnished herewith. Pursuant to Rule 406T of Regulation S-T, the Interactive Data Files on Exhibit 101 hereto are deemed not filed or part of any registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, are deemed not filed for purposes of Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

 

-37-

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  GLOBAL DIGITAL SOLUTIONS, INC.  
       
Date: By:  /s/ William J. Delgado  
    William J. Delgado   
    Chief Executive Officer   

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signatures   Title(s)   Date
/s/ William J. Delgado   Chief Executive Officer    
William J. Delgado   and Chairman of the Board (Principal Executive Officer)    
         
/s/ Jerome J. Gomolski   Chief Financial Officer    
Jerome J. Gomolski   (Principal Financial Officer and Principal Accounting Officer)    
         
/s/ William J. Delgado   Director, Executive Vice President    
William J. Delgado        

 

-38-

 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

GLOBAL DIGITAL SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED FINANCIAL STATEMENTS AS OF DECEMBER 31, 2022, AND 2021

 

TABLE OF CONTENTS

 

  Page
   
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM F-2
   
CONSOLIDATED FINANCIAL STATEMENTS:  
   
Consolidated Balance Sheets F-4
   
Consolidated Statements of Operations F-5
   
Consolidated Statements of Stockholders’ Deficit F-6
   
Consolidated Statements of Cash Flows F-7
   
Notes to Consolidated Financial Statements F-8

 

F-1

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Director and Stockholders of Global Digital Solutions, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Global Digital Solutions, Inc. and its subsidiaries (the “Company”) as of December 31, 2022, and 2021 and the related consolidated statements of operations, stockholders’ deficit and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and 2021, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

 

Explanatory Paragraph – Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has suffered recurring losses from operations and negative cash flows since inception both of which raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 2. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

 

The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

Critical Audit Matter Description

 

As disclosed in Notes 4 and 5 to the consolidated financial statements, the Company had various debt instruments which included conversion features requiring bifurcation and separate accounting. Management evaluated the required accounting, significant estimates, and judgements around the valuation for these embedded derivatives. These embedded derivatives were initially measured at fair value and have subsequently been remeasured to fair value at each reporting period.

 

There is no current observable market for these types of features and, as such, the Company determined the fair value of the embedded derivatives using an option pricing model to measure the fair value of the bifurcated derivative. As a result, a high degree of auditor judgment and effort was required in performing audit procedures to evaluate the conclusions reached by management as well as the inputs to the Company’s option pricing model.

 

F-2

 

 

How the Critical Audit Matter Was Addressed In the Audit

 

Our principal audit procedures performed to address this critical audit matter included the following:

 

  - We obtained an understanding of the controls and processes surrounding the evaluation, initial measurement and revaluation of the bifurcated derivatives.

 

  - We evaluated management’s assessment and the conclusions reached to ensure these instruments were recorded in accordance with the relevant accounting guidance.

 

  - We evaluated the fair value of the bifurcated derivatives that included testing the valuation models and assumptions utilized by management. We reviewed and tested the fair value model used, significant assumptions, and underlying data used in the model.

 

Turner, Stone & Company, L.L.P.

We have served as the Company’s auditor since 2017.

 

Dallas, Texas

June 9, 2023 

 

F-3

 

 

GLOBAL DIGITAL SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS 

       
   December 31,
   2022  2021
       
Assets          
Current assets          
Cash  $1,043   $98,800 
Total current assets   1,043    98,800 
           
Other Assets          
Due from related entity, (Note 9)       80,914 
Prepaid Expense, (Note 9)       22,500 
Equipment net of accumulated depreciation of $ 17,773       33,009 
Software Development costs       64,547 
Total other assets       200,970 
           
Total assets  $1,043   $299,770 
           
Liabilities and Stockholders’ Deficit          
Current liabilities          
Accounts payable  $363,402   $361,813 
Accrued expenses   2,028,801    1,481,910 
Due to related entity, (Note 9)   50,233     
Due to Officer (Note 9)   3,281    50,000 
Financed insurance policy   11,187    11,187 
Derivative liability   3,421,000    809,000 
Warrant Liability   1,599,000    606,000 
Convertible notes payable, net of discount of $246,470 and $652,178, respectively    3,992,396    3,310,662 
Notes Payable   4,607,125    4,627,000 
Total Current Liabilities   16,076,425    11,257,572 
           
Commitments and Contingencies (Note 6)          
           
Long term liabilities          
Notes payable       103,125 
Total Liabilities   16,076,425    11,360,697 
           
Stockholders’ deficit          
Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 shares issued and outstanding at December 31, 2022, and 2021 respectively   1,000    1,000 
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 800,543,896 shares and 737,263,858 issued and outstanding at December 31, 2022, and 2021, respectively   800,544    737,264 
Additional paid-in capital      38,233,710     37,370,384 
Shares Issuable       180,000 
Accumulated deficit   (55,110,636)   (49,349,575)
Total stockholders’ deficit   (16,075,382)   (11,060,927)
Total liabilities and stockholders’ deficit  $1,043   $299,770 

 

The accompanying footnotes are an integral part of these consolidated financial statements.

  

F-4

 

 

GLOBAL DIGITAL SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

         
    For the years ended December 31,
    2022   2021
         
Revenues   $     $  
Cost of revenues            
Gross profit            
                 
Operating expenses                
Selling, general and administrative expenses     427,132        2,240,437  
Total operating expenses     427,132       2,240,437  
                 
 Loss from operations     427,132       2,240,437  
                 
Other expense (income)                
Change in fair value of derivative liability     2,090,500       (7,348,389  
Change in warrant liability       993,000       (1,782,000 )
Loss on disposal of fixed assets     97,555        
Loss on write off of prepaid expense             315,000  
Financing costs           63,000  
Interest expense     1,000,866       2,008,670  
Amortization of original issue discount     1,089,902       2,303,973  
Gain on settlement of accrued expenses           (12,000 )
Loss on conversion of notes payable     62,106        
Total other expense (income)     5,333,929       (4,451,746 )
                 
Income tax expense   $     $  
                 
Net (Loss) Income   $ (5,761,061)     $ 2,211,309  
                 
Net (Loss) per common share, basic and diluted   $     $  
                 
Weighted average common shares outstanding, basic     800,543,896       737,263,858  
Weighted average common shares outstanding, basic and diluted             1,420,563,361  

 

The accompanying footnotes are an integral part of these consolidated financial statements. 

 

F-5

 

 

GLOBAL DIGITAL SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2022, AND 2021

                                                 
    Common Stock     Preferred Stock     Paid-In           Accumulated        
    Shares     Amount     Shares     Amount     Capital     Shared Payable     Deficit     Total  
Balance, December 31, 2020     668,338,264     $ 668,338       1,000,000     $ 1,000     $ 34,086,086           $ (51,560,884)     $ (16,805,460)  
                                                                 
Shares Issued for conversion of debt     50,619,573       50,620                   1,027,933                   1,078,553  
                                                                 
Shares issued for financing fees     8,000,000       8,000                   384,000                   392,000  
                                                                 
Shares issued for services     5,000,000       5,000                   279,500       180,000             464,500  
                                                                 
Reduction in derivative liability                             1,602,171                   1,602,171  
                                                                 
Warrant Exercise     5,306,021       5,306                   (9,306)                   (4,000)  
                                                                 
Net Income                                         2,211,309       2,211,309  
                                                                 
Balance, December 31, 2021     737,263,858     $ 737,264       1,000,000     $ 1,000     $ 37,370,384      $ 180,000     $ (49,349,575 )   $ (11,060,927 )
                                                                 
Shares Issued for conversion of debt     58,280,038       58,280                   568,326                   626,606  
                                                                 
Shares issued for services     5,000,000       5,000                   175,000       (180,000 )              
                                                                 
Reduction in derivative liability                             120,000                   120,000  
                                                                 
Net (Loss)                                         (5,761,061 )     (5,761,061 )
                                                                 
Balance, December 31, 2022     800,543,896     $ 800,544           $ 1,000     $ 38,233,710     $       $ (55,110,636 )   $ (16,075,382 )

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

F-6

 

 

GLOBAL DIGITAL SOLUTIONS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS 

 

         
   2022   2021 
         
Cash flows from operating activities:          
Net Income (Loss)   (5,761,061)  $2,211,309 
Adjustments to reconcile net loss to net cash (used in) operating activities:          
Depreciation       12,695 
Amortization of debt discount   1,089,901    2,303,945 
Change in fair value of derivative liability   2,090,500    (7,348,389)
Change in fair value of warrant liability   993,000    (1,782,000)
Stock-based compensation       464,500 
Consulting fees added to note payable principal   (123,000)   240,000 
Interest expense from warrant liability       881,000 
Extension fees added to principal balance   176,536    250,000 
Penalty/other extension fees for notes payable   251,169     
Loss (gain) on Conversion of NP   62,105     
Loss on Disposal of Fixed assets   97,556     
Legal fees for note issuance       17,795 
           
Changes in operating assets and liabilities:          
Prepaid expenses   22,500    (22,500)
Prepaid expense from related party       315,000 
Due from related entity       (10,204)
Accounts payable   1,588    (124,780)
Accrued expenses   576,081    203,356 
Due to Related Party        
Due to officer        (251,291)
Net cash (used in) operating activities   (523,125)   (2,639,564)
           
Cash flows from investing activities:          
Advances to related party   (138,917)    
Net cash (used in) investing activities   (138,917)    
           
Cash flows from financing activities:          
Proceeds from notes payable   100,000     
Payments of notes payable       (125,000)
Proceeds from convertible notes payable   575,000    3,403,750 
Payments of convertible notes payable   (306,981)   (540,650)
Repayment of advanced to officer   (46,719)    
Proceeds from Related Party   242,985     
Net cash provided by (used in) financing activities   564,285    2,738,100 
           
Net increase (decrease) in cash   (97,757)   98,536 
           
Cash at beginning of year   98,800    264 
           
Cash at end of year  $1,043   $98,800 
           
Non-Cash Items          
Convertible notes and interest paid by officer   (27,176)   253,000 
Debt discount from derivative on convertible notes payable   (641,500)   386,823 
Reduction in derivative liability from payments on convertible notes payable   (120,000)   (4,000)
Debt discount from issuance of warrants with convertible note payable       1,507,000 
Discount on   convertible notes payable   (42,693)   (490,214)
Conversion of Convertible notes payable   (557,760)   (743,583)
Cashless exercise of warrants       5,306 
Settlement of derivative liability to APIC        1,743,908 
Convertible notes and interest paid by affiliate   (27,176)   53,000 
Convertible debt settled through issuance of common shares   564,501    1,078,552 
Reduction in accrued compensation due to officer       53,000 
Shares issued for accounts payable   (180,000)    
Warrant exercise shares       (4,000)
           
Supplemental Disclosure:          
           
During the Year ended December 31,2022 the company paid $29,449 of Loan Interest.          

 

The accompanying footnotes are an integral part of these consolidated financial statements.

 

F-7

 

 

GLOBAL DIGITAL SOLUTIONS, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – DESCRIPTION OF BUSINESS

 

We were incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation (“Global”). The merger was treated as a recapitalization of Global, and Creative changed its name to Global Digital Solutions, Inc. (“the Company”, “we”), Global provided structured cabling design, installation and maintenance for leading information technology companies, federal, state and local government, major businesses, educational institutions, and telecommunication companies. On May 1, 2012, we made the decision to wind down our operations in the telecommunications area and to refocus our efforts in the area of cyber arms technology and complementary security and technology solutions. From August 2012 through November 2013, we were actively involved in managing Airtronic USA, Inc., and effective as of June 16, 2014, we acquired North American Custom Specialty Vehicles (“NACSV”). In July 2014, we announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead our efforts overseas. The Company had limited operations from the NACSV subsidiary from December 31, 2015, until May 13, 2016. During the interim, the Company was pursuing acquisition opportunities and responding to the litigation with the Securities and Exchange Commission. Subsequent to May 13, 2016, the Company has been seeking acquisitions and additional financing.

 

In March of 2019, the Company acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA is developing an updated version of the system known as Pilot Assisted Landing Systems (PALS).

 

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Going Concern

 

The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $5,761,061 used net cash of $523,125 to fund operating activities. On December 31, 2022, we had cash of $1,043 an accumulated deficit of $55,110,636 a working capital deficit of $16,076,425 and stockholders’ deficit of $16,075,382. We have funded our activities to date almost exclusively from equity and debt financings.

 

Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern.

 

We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all.

 

We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities.

 

While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. 

 

Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. 

 

F-8

 

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 

Income Taxes

 

Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period.

 

Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.

 

On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact.

 

Cash and Cash Equivalents

 

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits.

 

Prepaid expenses

  

In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing.

 

As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts.

 

F-9

 

 

Fair Value of Financial Instruments

 

The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

 

The three levels of the fair value hierarchy defined by ASC 820 are as follows:

 

  Level 1 – Quoted prices in active markets for identical assets or liabilities

 

  Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly

 

  Level 3 – Significant unobservable inputs that cannot be corroborated by market data.

 

Derivative Financial Instruments

 

We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging”. Subtopic ASC 815-15, Embedded Derivatives generally requires companies to bifurcate conversion options embedded in the convertible notes from their host instruments and to account for them as free standing derivative financial instruments. Derivative liabilities are recognized in the consolidated balance sheet at fair value as Derivative Liabilities and based on the criteria specified in FASB ASC 815-40, Derivatives and Hedging – Contracts in Entity’s own Equity. The estimated fair value of the derivative liabilities is calculated using various assumptions and such estimates are revalued at each balance sheet date, with changes recorded to other income or expense as Change in fair value of derivative liability in the consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the instrument origination date and reviewed at the end of each event date (i.e. conversions, payments, etc.) and the measurement period end date for financial reporting. See Note 4 Fair Value Measurement.

 

Earnings (Loss) Per Share (“EPS”)

 

Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.

 

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: 

 

        
   Year Ended 
   December 31,   December 31, 
   2022   2021 
         
Convertible notes and accrued interest   268,563,014     361,265,001 
Preferred Stock   296,201,242    227,787,627 
Stock options   12,900,000    12,900,000 
Warrants   66,446,875    81,346,875 
Potentially dilutive securities   644,111,131    683,299,503 

 

F-10

 

 

Stock Based Compensation

 

In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award.

 

The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the advisor, consultant or vendor is reached or (ii) the date at which the advisor, consultant or vendor’s performance is complete. In the case of equity instruments issued to advisors and consultants, the fair value of the equity instrument is recognized over the term of the advisor or consulting agreement. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable.

 

          
Warrant liability        
   2022   2021 
Warrant Liability balance at beginning of period   606,000    560,000 
Additions to warrant liability       (1,736,000)
Change in fair value   993,000    1,782,000 
           
Balance at end of period   1,599,000    606,000 

 

At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company's Common stock of $0.0249; a risk free interest rate of 3.0% and expected volatility of the Company's common stock of 173.54%. 185.9% to 205.9% and the remaining terms of each warrant issuance.  

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.”

 

Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

 

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Convertible Securities

 

Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first. 

 

F-11

 

 

NOTE 3 – ACCRUED EXPENSES 

 

Accrued expenses consist of the following amounts:

 

          
   December 31,   December 31, 
   2022   2021 
Accrued compensation to executive officers  $141,997   $90,834 
Accrued professional fees and settlements   73,890    86,392 
Accrued interest   1,812,914    1,304,684 
Total accrued expenses  $2,028,801   $1,481,910 

 

NOTE 4 – FAIR VALUE MEASUREMENTS 

 

We had no Level 1 or Level 2 assets and liabilities at December 31, 2022, and December 31, 2021. The Derivative liabilities are Level 3 fair value measurements.

 

The following is a summary of activity of Level 3 liabilities during the years ended December 31, 2022, and 2021: 

 

          
Balance at beginning of period  $809,000   $9,367,159 
Additions   641,500    266,000 
Settlements   (120,000   (1,580,000)
Change in fair value   2,090,500    (7,244,159)
Balance at end of year  $3,421,000   $809,000 

 

Embedded Derivative Liabilities of Convertible Notes

 

At December 31, 2022, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — 4.73%; term — 1 years; volatility — 173.74%; dividend rate — 0%. At December 31, 2021, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — 0.082.45%; term — 0.31.25 years; volatility — dividend rate — 173.74%.

 

F-12

 

 

NOTE 5 – NOTE PAYABLE  

 

Convertible Note Payable

 

During January 2015, the Company entered into a one-year $78,750 convertible note payable with LG Capital Funding (LG). The note bears interest at 8% per annum and is convertible at any time at the option of LG into shares of our common stock at a conversion price equal to a 40% discount of the lowest closing bid price for 20 prior trading days including the notice of conversion date. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve four times the potential number of shares of common stock issuable upon conversion, or 35,015,467 and 33,408,936 at December 31, 2022 and 2021, respectively. The Company defaulted on the note in January 2016. Additionally, as a result of declines in the fair value of the Company’s common stock, from time to time the Company did not have sufficient authorized shares to maintain this required four times share reserve. Accordingly, the note holder had the right to accelerate the repayment of the note and unpaid interest. In addition, LG has the right to require that additional shares and/or monies be paid in connection with the defaults. During December 2017, in settlement of default, the Company and LG entered into a Convertible Note Redemption Agreement under which the Company was to repay $68,110, $39,921 in unpaid principal outstanding at December 31, 2017, and $28,189 in accrued interest, in five payments through April 2018. Through April 2018, the Company repaid $6,500 of principal under the Convertible Note Redemption Agreement. The Company defaulted on the Convertible Note Redemption Agreement in April 2018 and the $28,189 in accrued interest was converted to principal. As of December 31, 2022, and through the date of this report, the principal balance totaling $48,610 is outstanding and remains in default.

 

During January 2015, the Company entered into a two-year convertible note payable for up to $250,000 with JMJ Financial (JMJ), of which $110,000 was funded between January and April 2015. The note was issued with an original issue discount of 10% of amounts funded, had a one-time 12% interest charge as it was not repaid within 90 days of the funding date, and is convertible at any time at the option of JMJ into shares of our common stock at the lesser of $0.075 per share or 60% of the average of the trading price in the 25 trading days prior to conversion. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve 26,650,000 shares of common stock. JMJ had the option to finance additional amounts up to the balance of the $250,000 during the term of the note. The Company defaulted on the note during January 2017. During December 2017, in settlement of default, the Company and JMJ entered into a Repayment Agreement under which the Company was to repay $84,514, $69,070 in unpaid principal outstanding at December 31, 2017, and $15,444 in accrued interest, in four payments through May 2018. Through May 2018, the Company repaid $25,000 of principal under the Repayment Agreement. The Company defaulted on the Repayment Agreement in May 2018 and the $15,444 in accrued interest was converted to principal. As of December 31, 2022, and through the date of this report, the principal balance totaling $59,514 is outstanding and remains in default. 

 

On April 7, 2020, the Company entered into a convertible promissory note arrangement with Actus Fund, LLC in the principal amount of $197,000. The principal amount of the note with interest at 12% is due on February 7, 2021. The note is convertible into shares of the Company’s common stock. The conversion price shall equal the lessor of (i) Current Market price or (ii) Variable Market price as defined as Market Price less a 50% discount price. As of December 31, 2022, and through the date of this report, the principal balance totaling $197,000 is outstanding.

 

On August 5, 2020, The Company and Adar Alef, LLC entered into a security purchase agreement in the aggregate principal  of $150,000. The notes shall contain a 5% OID such that the purchase price shall be $142,500. The note was paid off on May 12, 2021, by the CEO of the Company.   

 

On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.

 

F-13

 

 

On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of December 31, 2022, and through the date of this report, the principal balance totaling $970,111 is outstanding.

 

On March 25, 2021, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.

 

On April 1, 2021, the Company received the first tranche of $1,142,857 from GS Capital, LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period.

 

The Company received the second tranche as follows; May 24, 2021, $796,000, July 15, 2021, $90,000, and July 21, 2021, $208,500. As of December 31, 2022, and through the date of this report, the principal balance totaling $2,141,632 is outstanding.

 

On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% promissory note in the aggregate principal of $251,625, with a maturity date of June 7, 2022. The note included a original issuance discount (“OID”) of $22,875, for a purchase price of $228,750. The interest was applied as a one- time interest charge upon the issuance date, in the amount of $20,130, recognized in accrued interest. The monthly payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company is required at have authorized and reserved four times the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business.  In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $03, with a 3-year term. The note was paid off by The Company on April 4, 2022.

 

On February 3, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $103,750. is due on February 3, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $131,096 is outstanding.

 

On March 25, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $258,638 is due on March 25, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 75% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $256,218 is outstanding.

 

On June 14, 2022, the Company and Diagonal Leasing entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $128,750 is due on June 14, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $162,685 is outstanding.

 

On August 18, 2022, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a 10% Convertible Note in the aggregate principal of $172,000, is due on August 18, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to 70% of the lowest trading price of the Company’s Common Stock for the 20 trading dates immediately preceding the delivery of a notice of conversion. As of December 31, 2022, and through the date of this report, the principal balance totaling $172,000 is outstanding.

 

On November 7, 2022, the Company and Gary Shover, entered into a security purchase agreement for a 12% Convertible Note in the aggregate principal of $75,000, is due on May 7, 2023. The note is convertible into shares of common stock of the Company at a fixed Conversion rate of $0.139 per share. The investor shall also receive warrants to purchase 500,000 common shares at $.0139 per share. As of December 31, 2022, and through the date of this report, the principal balance totaling $75,000 is outstanding.

 

On December 14, 2022, the Company and Ronal Minor entered into a security purchase agreement for a 12% Convertible Note in the aggregate principal of $25,000, is due on June 14, 2023. The note is convertible into shares of common stock of the Company at a fixed Conversion rate of $0.139 per share. The investor shall also receive warrants to purchase 500,000 common shares at $.0139 per share. As of December 2022, and through the date of this report, the principal balance totaling $25,000 is outstanding.

 

F-14

 

 

On August 17, 2020, the Company and Harbor Gates entered into a security purchase agreement for a 10% Convertible  Promissory Note in the aggregate principal of $165,000 due on May 17, 2021. The note is convertible into shares of common stock of the Company. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 60% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete. outstanding. The note was paid off on May 28, 2021, by the Company.

 

On May 20, 2020, the Company and GS Capital Partners, LLC entered into a 10% Convertible Note in the aggregate principal of $165,000 due on February 20, 2021. The note can be converted into shares of common stock of the Company. at any time after the issue date. The note was paid off by the Company in the first and second quarters of 2021.

 

On April 6, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a 10% Convertible Promissory Note in the aggregate principal of $53,000 due on April 6, 2021. The note is convertible into shares of common stock of the Company. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the conversion date. The note was paid off by the CEO of the Company see Note 9.

 

On May 10, 2019, the Company and GHS Investments LLC entered into a security agreement for a 10% Convertible Note in the aggregate principal of $335,000 due on February 10, 2020. The note carries original issue discount or $35,000. The note is convertible into shares of common stock of the Company. The “Conversion Price” shall mean 60% multiplied by the Market Price (as defined herein), representing a discount rate of 40%. “Market Price” means the lowest Traded Price for the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. The Company is required to maintain a common share reserve of not less than three times the number of shares that is actually issuable upon full conversion of the note. The purchaser will also receive warrants to purchase 5,000,000 shares of GDSI common stock at $.01/share. Warrants will have a three-year term to exercise. The Convertible Note is personally guaranteed by William Delgado, CEO.

 

On June 11, 2021, interest on the note in the amount of $115,200.00 was converted into 8,000,000 shares of the Company’s common stock. The outstanding balance of $761,005, as of October 21, 2021, was converted into 25,500,000 shares of the Company’s common stock. The lender also received the 23,000,000 warrants. The Company recognized a gain of $844,797.00 on the conversions of June 11, 2021, and October 21, 2021. The fair value of the 25,500,000 shares issued was approximately $729,300.00

 

Notes Payable

 

During August 2017, Dragon Acquisitions, a related entity owned by William Delgado, and an individual lender entered into a Promissory Note agreement for $20,000 as well as $2,000 in interest to accrue through maturity on August 31, 2018 for a total of $22,000 due on August 31, 2018. Dragon Acquisition assumed payment of a payable of the Company and the Company took on the note. The Company defaulted on the note at maturity in August 2018. The $20,000 note remained outstanding at December 31, 2022 through the date of this report.

 

On December 22, 2017, the Company entered into a financing agreement with Parabellum, an accredited investor, for $1.2 million, amended in 2019 and increased to $1,850,000. Under the terms of the agreement, the Company is to receive milestone payments based on the progress of the Company’s lawsuit (Note 6) for damages against Grupo Rontan Metalurgica, S.A (the “Lawsuit”). Such milestone payments consist of (i) an initial purchase price payment of $300,000, which the Company received on December 22, 2017, (ii) $150,000 within 30 days of the Lawsuit surviving a motion to dismiss on the primary claims, (iii) $100,000 within 30 days of the close of all discovery in the Lawsuit and (iv) $650,000 within 30 days of the Lawsuit surviving a motion for summary judgment and challenges on the primary claims. As part of the agreement, the Company shall pay the investor an investment return of 100% of the litigation proceeds to recoup all money invested, plus 27.5% of the total litigation proceeds received by the Company. $300,000 was received by the Company in December 2017. As of December 31, 2022, and through the date of this report, the $2,550,000 note remains outstanding. 

 

F-15

 

 

On December 23, 2017 (the “effective date”), the Company entered into a $485,000, 7% interest rate, demand promissory note with Vox Business Trust, LLC (Vox). The note was in settlement of the amounts accrued under a consulting agreement (Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to Vox when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, Vox may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –

 

  $1,000 on the effective date.

 

  $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss.

 

  $50,000 on the date on which discovery closes with respect to the lawsuit.

 

  $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims.

 

Under the terms of the Vox note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the years ended December 31, 2022, and 2021, consulting fees totaling $120,000 were added to the note principal and are included in the note balance. The note had a balance of $861,500 and $926,500 as of December 31, 2022, and 2021, respectively. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default.

 

On December 26, 2017 (the “effective date”), the Company entered into a $485,000, 7% interest rate, demand promissory note with RLT Consulting, Inc. (RLT), a related party. The note was in settlement of the amounts accrued under a consulting agreement (Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to RLT when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, RLT may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –

 

  $1,000 on the effective date.

 

  $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss.

 

  $50,000 on the date on which discovery closes with respect to the lawsuit.

 

  $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims.

 

Under the terms of the RLT note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the year ended December 31, 2022, and 2021, consulting fees totaling $120,000 were added to the note principal and are included in the note balance. The note had a balance of $861,500 and $919,500 as of December 31, 2022, and 2021, respectively. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default. RLT was granted a first priority security interest in the Litigation Proceeds and is pari passu to Parabellum and Vox. To that end, they share in the litigation in a priority position to proceed to repay the note.

 

F-16

 

 

During April 2018, the Company entered into a two-month $36,000 note payable with $31,000 in proceeds paid directly to a third-party vendor for expenses. The note did not bear interest and included a $5,000 original issue discount. During June 2018, the Company defaulted on the note. As of December 31, 2022, and through the date of this report, the $11,000 note remained outstanding.   

 

During May 2018, the Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default.  

 

During June 2018, the Company entered in to a one-year $300,000 non-convertible note with an accredited investor with $150,000 original issue discount (“OID”) for net proceeds of $150,000. As part of the note agreement, the Company also agreed to issue the investor 5,000,000 warrants at an exercise price of $0.01, exercisable for a period of three (3) years. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $35,000 of which $28,378 was recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.008 at issuance date; a risk-free interest rate of 2.62% and estimated volatility of the Company’s common stock of 218%. At December 31, 2019, the $300,000 note remained outstanding. The Company defaulted on the note at maturity in June 2019 and the note remained outstanding through the date of this report. The note contains a default interest rate of 10% plus a 5% penalty of the outstanding balance of the note. The note holder has voluntarily refrained from making demand for repayment under the default provisions of the note, which would require the Company to pay the holder 130% of the outstanding principal and interest accrued at the default rate. The Company paid off the note on March 10, 2021.  

 

The June 2018 note bears a personal guarantee by William Delgado, the Chief Executive Officer of the Company. As further security for the note, Mr. Delgado has also pledged the 1,000,000 Convertible Preferred Shares of the Company that he owns, as well as 5,000,000 common shares of SHMP, another public company in which Mr. Delgado is a director and Chief Financial Officer.

 

On May 12, 2020, the Company and BBVA USA entered into a 1% SBA PPP, Promissory Note, in the aggregate principal of $103,125. The note is payable in monthly payments of $5,805 beginning on December 12, 2020, ending on May 12, 2022. The Company has requested debt forgiveness from the SBA. As of December 31, 2022, and through the date of this report the SBA has not responded to the request and BBVA has waived the monthly payments.

 

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

Legal Proceedings

 

We may be involved in legal proceedings in the ordinary course of our business, and our management cannot predict the ultimate outcome of these legal proceedings with certainty. The Company is plaintiff or defendant in the following actions:

 

Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A.  

 

Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”) and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date.

 

The purchase price shall consist of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date.

 

Under the terms of a Finders Fees Agreement dated April 14, 2014, we have agreed to pay RLT Consulting Inc., a related party, a fee of 2% (two percent) of the Transaction Value, as defined in the agreement, of Rontan upon closing. The fee is payable one-half in cash and one-half in shares of our common stock.

 

F-17

 

 

Specific conditions to closing consist of:

 

  a) Purchaser’s receipt of written limited assurance of an unqualified opinion with respect to Rontan’s audited financial statements for the years ended December 31, 2013 and 2014 (the “Opinion”);

 

  b) The commitment of sufficient investment by General American Capital Partners LLC (the “Institutional Investor”), in the Purchaser following receipt of the Opinion;

 

  c) The accuracy of each Parties’ representations and warranties contained in the SPSA;

 

  d) The continued operation of Rontan’s business in the ordinary course;

 

  e) The maintenance of all of Rontan’s bank credit lines in the maximum amount of R$200 million (approximately US$52 million) under the same terms and conditions originally agreed with any such financial institutions, and the maintenance of all other types of funding arrangements. As of the date of the SPSA, Rontan’s financial institution debt consists of not more than R$200 million (approximately US$52 million), trade debt of not more than R$50 million (approximately US$13 million) and other fiscal contingencies of not more that R$95 million (approximately US$24.7 million);

 

  f) Rontan shall enter into employment or consulting service agreements with key employees and advisors identified by the Purchaser, including Rontan’s Chief Executive Officer; and

 

  g) The Sellers continued guarantee of Rontan’s bank debt for a period of 90 days following issuance of the Opinion, among other items.

 

The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, as well as the ability to acquire 100% of the outstanding stock of Rontan at a price of $200 million BR, and the Company can acquire 100% of all real estate held by Rontan.

 

Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion.

 

Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets.

 

Subsequent to December 31, 2015, on April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions to closing, which were waivable by us,) and advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA.

 

On January 31, 2018, we announced that we initiated a lawsuit for damages against Grupo Rontan Metalurgica, S. A, (“Rontan”) and that company’s controlling shareholders, Joao Alberto Bolzan and Jose Carlos Bolzan. The action has been filed in the United States District Court for the Southern District of Florida. The complaint alleges that Rontan is wholly owned by Joao Bolzan and Jose Bolzan. In the complaint, we further allege that Rontan and its shareholders improperly terminated a Share Purchase and Sale Agreement (the “SPA”) by which we were to acquire whole ownership of Rontan.

 

On February 5, 2018, United States District Court Southern District of Florida filed a Pretrial Scheduling Order and Order Referring Case to Mediation dated February 5, 2018, for the Company’s lawsuit against Grupo Rontan Electro Metalurgica, S.A., et al. The Case No. is 18-80106-Civ-Middlebrooks/Brannon. The court has issued a schedule outlining various documents and responses that are to be delivered by the parties as part of the discovery plan.

 

On April 25, 2018, the Note of Filing Proposed Summons was completed by the Company. On April 26, 2018, a summons was issued to Grupo Rontan Electro Metalurgica, S.A. Also, on May 15, 2018, the Company filed a motion for Issuance of Letters Rogatory.

 

F-18

 

 

Consulting agreements

 

The Company entered into two consulting agreements (See Note 5) in May 2016, for services to be provided in connection towards the resolution of the Rontan lawsuit (below). The consulting agreements includes a monthly retainer payment of $10,000 to each consultant. The agreement also includes consideration of 5,000,000 shares of restricted common stock of the Company, plus a 5% cash consideration of the Resolution Progress Funding, (defined as upon the retention of legal counsel and receipt of funding for the litigation), as of the Resolution Progress Funding date and 10,000,000 shares of restricted common stock of the Company and a 5% cash consideration of the Resolution Funding amount (defined as a settlement or judgement in favor of the Company by Rotan),at the Resolution Funding date. The Resolution Progress funding was met on December 22, 2017.

 

F-19

 

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

We are authorized to issue 35,000,000 shares of noncumulative, non-voting, convertible preferred stock, $0.001 par value per share. At December 31, 2022, and 2021, 1,000,000 shares of preferred stock were outstanding.

 

 On August 15, 2016, William J. Delgado, our current Chief Executive Officer, agreed to convert $231,565 of indebtedness owed to him by the Company into 1,000,000 shares of convertible preferred stock (the “Preferred Stock”). The Preferred Stock has voting rights as to one (1) preferred share to four hundred (400) shares of the common stock of the Company. The Preferred Stock is convertible into common stock at any time after issuance into 37% of the outstanding common stock of the Company at the time of the conversion. The conversion to common can only take place when there are an adequate number of shares that are available and is subject to normal stock adjustments (i.e. stock splits etc.) that are executed by the Company in its normal course of business.

 

Common Stock

 

We are authorized to issue 2,000,000,000 shares of common stock, $0.001 par value per share. At December 31, 2022 and 2021 there were 800,542,896 and 737,263,858 Issued, outstanding, or vested but unissued under stock compensation plans, respectively.

 

F-20

 

 

Common Stock Warrant

 

We have issued warrants, which are fully vested and available for exercise, as follows:

 

The following is a summary of outstanding and exercisable warrants at December 31, 2022:  

 

                     
Outstanding   Exercisable 
                      
    Weighted                 
    Average   Outstanding             
Range of   Number   Remaining   Weighted   Number   Weighted 
Exercise   Outstanding   Contractual   Average   Exercisable   Average 
Prices   at 12/31/2022   Life (in yrs)   Exercise Price   at 12/31/2022   Exercise Price 
$0.01    12,000,000    4   $0.01    12,000,000   $0.01 
$0.01    1,000,000    4.1   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.2   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.3   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.4   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.5   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.6   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.7   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.8   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.9   $0.01    1,000,000   $0.01 
$0.01    1,000,000    5   $0.01    1,000,000   $0.01 
$0.01    1,000,000    5.1   $0.01    1,000,000   $0.01 
$0.01    10,000,000    9   $0.01    10,000,000   $0.01 
$0.01    20,000,000    8   $0.01    20,000,000   $0.01 
$0.03    2,096,875    1   $0.01    2,096,875   $0.01 
$0.01    10,750,000    4.8   $0.01    10,750,000   $0.01 
$0.01    500,000    3   $0.01    500,000   $0.01 
$0.01    100,000    3   $0.01    100,000   $0.01 
      66,446,875              66,446,875      

 

All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis.

 

The following is a summary of outstanding and exercisable warrants at December 31, 2021:

 

Outstanding   Exercisable
                     
    Weighted                
    Average   Outstanding            
Range of   Number   Remaining   Weighted   Number   Weighted
Exercise   Outstanding   Contractual   Average   Exercisable   Average
Prices   at 12/31/2021   Life (in yrs)   Exercise Price   at 12/31/2021   Exercise Price
$ 0.01       5,000,000       0.5       0.004       5,000,000     $ 0.01  
$ 0.01       3,750,000       2.1       0.002       3,750,000     $ 0.01  
$ 0.01       12,000,000       2     $ 0.01       12,000,000     $ 0.01  
$ 0.01       2,500,000       2.8     $ 0.01       2,500,000     $ 0.01  
$ 0.01       10,000,000       8.2     $ 0.01       10,000,000     $ 0.01  
$ 0.01       20,000,000       8.3     $ 0.01       20,000,000     $ 0.01  
$ 0.01       2,096,875       3.6     $ 0.01       2,096,875     $ 0.01  
$ 0.01       12,000,000       5     $ 0.01       12,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.2     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.3     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.4     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.5     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.6     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.7     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.8     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.9     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
          78,346,875                       78,346,875          

 

F-21

 

 

The intrinsic value of warrants outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the warrant multiplied by the number of warrants outstanding or exercisable.

 

Stock Incentive Plans

 

2014 Global Digital Solutions Equity Incentive Plan

 

On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 shares of our common stock for issuance pursuant to awards thereunder, including options, stock appreciation right, restricted stock, restricted stock units, performance awards, dividend equivalents, or other stock-based awards. The Plan is intended as an incentive, to retain in the employ of the Company, our directors, officers, employees, consultants, and advisors, and to attract new officers, employees, directors, consultants and advisors whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries.

 

In accordance with the ACS 718, Compensation – Stock Compensation, awards granted are valued at fair value at the grant date. The Company recognizes compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. The Company recognizes the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. The Company has not capitalized any portion of its stock-based compensation.

 

Stock-based compensation expense for the years ended December 31, 2022, and 2021 was $0 and $5,075, respectively.

 

Awards Issued Under Stock Incentive Plans

 

Stock Option Activity

 

On December 31, 2022, and 2021we have outstanding stock options of 12,900,000 and 13,650,002 respectively - all of which are fully-vested stock options that were granted to directors, officers and consultants. The outstanding stock options are exercisable at prices ranging from $0.006 to $0.64 and expire between February 2024 and December 2025, for an average exercise price per share of $0.60 and an average remaining term of 3 years as of December 31, 2022.  In 2021 there were 750,000 options exercised.

 

During the years ended December 31, 2022, and 2021, we did not recognize any stock-based compensation cost related to the outstanding stock options. The intrinsic value of options outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the option multiplied by the number of options outstanding.

 

F-22

 

 

Restricted Stock Units

 

On October 10, 2014, we granted an employee 1 million RSU’s convertible into 1 million shares of the Company’s common stock, with a grant date fair market value of $100,000. The grant was made under our 2014 Equity Incentive Plan. 333,333 RSU’s will vest in respect of each calendar year (commencing January 1 and ending December 31) of the Company from 2015 through 2017 if the Company has achieved at least 90% of the total revenue and EBITDA midpoint targets set forth in the agreement. If less than 90% of the target is achieved in respect of any such fiscal year, then the number of RSU’s vesting for that fiscal year shall be 333,333 times the applicable percentage set forth in the agreement; provided that, if the company shall exceed 100% of the revenue and EBITDA midpoint target for the 2018 or 2017 calendar year, and shall have failed to reach 90% of the target for a prior calendar year, the excess over 100% shall be applied to reduce the deficiency in the prior year(s), and an additional number of RSU’s shall vest to reflect the increased revenue for such prior calendar year. Any such excess shall be applied first to reduce any deficiency for the 2015 calendar year and then for the 2016 calendar year. The vesting of the RSU’s shall be effective upon the issuance of the audited financial statements of the Company for the applicable calendar year and shall be based upon the total revenue and EBITDA of the acquired companies as reflected in such financial statements.

 

Awards Not Issued Under Stock Incentive Plans

 

Restricted Stock Grants Awarded to Advisors

 

In order to align our senior advisors with the interest of the stakeholders of the Company, the Board of Directors of the Company has granted the advisors restricted stock awards valued at $0.17 to $0.364 per share which vest over a period of 12 – 24 months, subject to remaining an advisor for a minimum of twelve months, and which are forfeited if the advisor is terminated or is no longer an advisor on the anniversary of the advisory award, as follows:

 

                                           
                      December 31, 2022  
Name   Date of
Grant
  Number of
Shares
    Vest from   Vest To   Vested     Unvested     Forfeited  
Mathew Kelley   4/17/13     1,250,000     4/30/13   3/31/14     1,250,000              
    4/17/13     1,250,000     2/28/14   1/31/15     1,250,000              
                                             
Richard J. Feldman   4/30/14     500,000     4/30/14   3/30/15     500,000              
          500,000     4/30/15   3/30/16     375,000             125,000  
                                             
Gary Gray   3/7/15     1,000,000     3/7/15   5/30/15     1,000,000              
                                             
Ross Trevino   3/7/15     500,000     3/7/15   5/30/15     500,000              
          5,000,000               4,875,000             125,000  

 

The aggregate intrinsic value of the restricted stock grant was $0 on December 31, 2022, and 2021.

 

F-23

 

 

NOTE 8 – INCOME TAXES 

 

     
Net (Income) Loss - book  $5,761,061 
Permanent  Differences:     
Loss on disposal of fixed assets   (97,555)
Change in warrant liability   (993,000)
Change in derivative   (2,090,500) 
Debt discount amortization   (1,089,902)
Estimate loss - tax basis   1,490,104 

 

Reconciliations between the statutory rate and the effective tax rate for the year ended December 31, 2022 consist as follows: 

 

          
   2022 
   Amounts   Rate 
Income tax expense at          
statutory federal rate of 21%   1,210,000    21%
Permanent Differences          
Loss on disposal of Fixed assets   (20,000)   0%
Change in warrant liability   (209,000)   -4%
Change in derivative   (439,000)    8%
Debt discount amortization   (229,000)   -4%
Increase (decrease) in valuation allowance   313,000   -21%
Income tax expense (benefit) at          
Company's effective tax rate  $    0%

 

                
   TOTAL   Activity   TOTAL 
   12/31/2021   2022   12/31/2022 
             
Net Operating Loss Carryforward  $21,774,808   $313,000   $22,087,808 
                
NOL tax benefit  $4,004,010   $313,000   $4,317,010 
                
Total Deferred Tax Assets   4,004,010    313,000    4,317,010 
Valuation allowance  $(4,004,010)  $(313,000)  $(4,317,010)
   $   $   $ 

  

As of December 31, 2022, the Company had $ 22,087,808 of federal net operating loss carry forwards. These carry forwards, if not used, will begin to expire in 2029. Current or future ownership changes, including issuances of common stock under the terms of the Company’s convertible notes payable that were entered into during 2015 and the closing of the Rontan Transaction may severely limit the future realization of these net operating losses.

 

The Company provides for a valuation allowance when it is more likely than not that they will not realize a portion of the deferred tax assets. The Company has established a valuation allowance against their net deferred tax asset due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, they have not reflected any benefit of such deferred tax assets in the accompanying financial statements. The Company’s net deferred tax asset and valuation allowance increased by $313,000 for the year ended December 31, 2022, related to the current year activity.

 

The Company has reviewed all income tax positions taken or that are expected to be taken for all open years and determined that their income tax positions are appropriately stated and supported for all open years. The Company is subject to U.S. federal income tax examinations by tax authorities for years after 2011 due to unexpired net operating loss carryforwards originating in and subsequent to that year. The Company may be subject to income tax examinations for the various taxing authorities which vary by jurisdiction. 

 

F-24

 

 

The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statements of operations. As of December 31, 2022, there were no unrecognized tax benefits, or any tax related interest or penalties.

 

The Company files income tax returns in the U.S. federal jurisdiction and the various states in which they operate. The former members of NACSV are required to file separate federal and state tax returns for NACSV for the periods prior to our acquisition of NACSV. The Company files consolidated tax returns for subsequent periods. The Company has not filed their U.S. federal and certain state tax returns since 2014 and currently do not have any examinations ongoing. Tax returns for the years 2012 onwards are subject to federal, state or local examinations.

 

NOTE 9 – RELATED PARTY TRANSACTIONS 

 

Due to officer

 

As of December 31, 2022, the Company owes Mr. Delgado $21,000 in accrued compensation.  

 

During 2021 Mr.Delgado paid off approximately $390,000 of the Company’s debt. The Company paid Mr. Delgado approximately $1,326,000 which included repayment for amounts paid for the notes and compensation. The Company owes Mr. Delgado $50,000 at December 31, 2021 for money advanced.

 

During 2022 Mr. Delgado advance The Company $9,000 for payment of operating expenses. The Company reimbursed Mr. Delgado  $55,000 for his outstanding balance at December 31, 2021, and the current year advance. The Company owes Mr. Delgado approximated $3,300 at December 31, 2022.Due from Related Party

 

During the year ended December 31, 2022, The Company advanced approximately $140,000 to Eco Growth Strategies for operating expenses. During 2022 Eco Growth repaid The Company approximately $270,000in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000.

 

During the year ended December 31, and 2021, the Company advanced Eco Growth Strategies, a related entity, $80,195 to cover administrative costs and legal expense.

 

Accounts Payable

 

          
   December 31,   December 31, 
   2022   2021 
Jerry Gomolski   25,000    25,000 
Charter 804CS   20,099    20,099 
Gary Gray   12,000    12,000 
   $57,099    $57,099 

 

Accrued Compensation

 

On December 31, 2022, and December 31, 2021, we had $ 21,163 and $0.00 payable to William J. Delgado and $120,834 and $90,834 to Jerome Gomolski, respectively.

               
,
       William   Jerome 
   Total   Delgado   Gomolski 
Balance 12/31/2021  $90,834   $0.00   $90,834 
                
2022 Salary   300,000    240,000    60,000 
Payments   (248,837)   (218,837)   (30,000
                
Balance 12/31/2022  $(141,997)  $(21,163)   $(120,834)

 

F-25

 

 

NOTE 10 – SUBSEQUENT EVENTS 

 

On January 4, 2023, Company and Leonite Capital,LLC, entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $41,666.67 less an original issue discount of $4,166.67. The note shall be paid in one or more tranches. The Company received the first tranche of $21,500, on January 12, 2023. The maturity of each tranche shall be 12 months after each Tranche is advanced. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the Advance Date of the first Tranche. 

 

On January 12, 2023, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $41,667, due on January 12, 2024. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the date of the First Tranche, Fixed Conversion Price. Upon the advance of the First Tranche the Company shall issue warrants to purchase 5,000,000 shares of the Company common stock. The exercise price is $0.024 per share with a term of 120 Months.

                   
 Date    Category    Description         Shares Issued
                   
1/26/2023   Settlemement Agreement   The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.            
                   
2/6/2023    Promissory Note    On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date.            
                     
2/7/2023    Notice of Conversion   On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.           6,736,045
                     
2/8/2023    Notice of Conversion   On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.           10,000,000
                     
2/21/2023    Notice of Conversion   On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.           15,000,000
                     
2/23/2023    Notice of Conversion   On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.           8,227,753
                     
3/1/2023    Notice of Conversion   On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common           20,000,000
                     
3/7/2023    Notice of Conversion   On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.           10,163,288
                     
3/17/2023    Notice of Conversion   On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.           10,831,096
                     
3/22/2023    Second Amendment to Senior Secured Convertible Promissory Note   Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC            
                     
4/18/2023    Notice of Conversion   On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common           15,000,000
                     
3/17/2023    Notice of Conversion   On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common           20,000,000
                  115,958,182
                     
                    798,168,896
                    115,958,182
                    914,127,078

 

F-26

EX-31.1 2 gdsi_20221231-10kex31z1.htm EX-31.1

Exhibit 31.1

 

GLOBAL DIGITAL SOLUTIONS, INC.

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, William Delgado, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Global Digital Solutions, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By:           

/s/ William Delgado

William Delgado

Principal Executive Officer

Date: April xx, 2023  

 

EX-31 3 gdsi_20221231-10kex31z2.htm EX-31

GLOBAL DIGITAL SOLUTIONS, INC.

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Jerome J. Gomolski, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Global Digital Solutions, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a–15(e) and 15d–15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a–15(f) and 15d–15(f)) for the registrant and have:

 

(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

By: 

/s/ Jerome J. Gomolski 

 

Jerome J. Gomolski

Principal Accounting Officer

Date: April xx, 2023

 

 

EX-32.1 4 gdsi_20221231-10kex32z1.htm EX-32.1

Exhibit 32.1

 

GLOBAL DIGITAL SOLUTIONS, INC.

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Annual Report on Form 10-K of Global Digital Solutions, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

By:           

/s/ William Delgado

William Delgado

Principal Executive Officer

Date: April xx, 2023

 

EX-32.2 5 gdsi_20221231-10kex32z2.htm EX-32.2

Exhibit 32.2

 

GLOBAL DIGITAL SOLUTIONS, INC.

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with this Annual Report on Form 10-K of Global Digital Solutions, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

By: /s/ Jerome J. Gomolski 

 

Jerome J. Gomolski 

Principal Accounting Officer 

Date: April xx, 2023

 

EX-101.SCH 6 gdsi-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - DESCRIPTION OF BUSINESS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - NOTE PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUBSEQUENT EVENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - FAIR VALUE MEASUREMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - NOTE PAYABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - STOCKHOLDERS' EQUITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - INCOME TAXES (Details) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - INCOME TAXES (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - INCOME TAXES (Details 2) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - RELATED PARTY TRANSACTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - RELATED PARTY TRANSACTIONS (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SUBSEQUENT EVENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 gdsi-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 gdsi-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 9 gdsi-20221231_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Shares Payable [Member] Retained Earnings [Member] Antidilutive Securities [Axis] Convertible Notes Payable [Member] Equity Option [Member] Warrant [Member] Financial Instrument [Axis] Derivative [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 3 [Member] Long-Term Debt, Type [Axis] Convertible Note Payable [Member] Related Party [Axis] L G Capital Funding [Member] J M J Financial [Member] Adar Alef L L C [Member] Leonite Capital [Member] GS Capital Partners [Member] Geneva Roth Remark Holdings [Member] Sixth Street Lending [Member] Gary Shover [Member] Ronal Minor [Member] Harbor Gates Capital [Member] First Fire Global Opportunity [Member] Power Up Lending Group [Member] G H S Investments [Member] William Delgado Member Parabellum [Member] Vox [Member] R L T [Member] Third Party Vendor [Member] Purchaser [Member] Accredited Investor [Member] P P P [Member] Exercise Price Range [Axis] Range 1 [Member] Range 2 [Member] Range 3 [Member] Range 4 [Member] Range 5 [Member] Range 6 [Member] Range 7 [Member] Range 8 [Member] Range 9 [Member] Range 10 [Member] Range 11 [Member] Range 12 [Member] Range 13 [Member] Range 14 [Member] Range 15 [Member] Range 16 [Member] Range 17 [Member] Range 18 [Member] Range 19 [Member] Counterparty Name [Axis] Mathew Kelley [Member] Mathew Kelley 1 [Member] Richard J Feldman [Member] Richard J Feldman 1 [Member] Gary Gray Ross Trevino [Member] Scenario [Axis] Activity [Member] Mr. Delgado [Member] Mr Delgado [Member] William J Delgado [Member] Jerome Gomolski [Member] Jerry Gomolski Charter 804CS Subsequent Event Type [Axis] Subsequent Event [Member] Leonite Capital L L C [Member] GS Capital Partners, LLC [Member] Fourth Man L L C [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Name Auditor Firm ID Auditor Location Statement of Financial Position [Abstract] Assets Current assets Cash Total current assets Other Assets Due from related entity, (Note 9) Prepaid Expense, (Note 9) Equipment net of accumulated depreciation of $ 17,773 Software Development costs Total other assets Total assets Liabilities and Stockholders’ Deficit Current liabilities Accounts payable Accrued expenses Due to related entity, (Note 9) Due to Officer (Note 9) Financed insurance policy Derivative liability Warrant Liability Convertible notes payable, net of discount of $246,470 and $652,178, respectively Notes Payable Total Current Liabilities Commitments and Contingencies (Note 6) Long term liabilities Notes payable Total Liabilities Stockholders’ deficit Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 shares issued and outstanding at December 31, 2022, and 2021 respectively Common stock, $0.001 par value, 2,000,000,000 shares authorized, 800,543,896 shares and 737,263,858 issued and outstanding at December 31, 2022, and 2021, respectively Additional paid-in capital Shares Issuable Accumulated deficit Total stockholders’ deficit Total liabilities and stockholders’ deficit Accumulated depreciation Debt Instrument, Unamortized Discount, Current Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost of revenues Gross profit Operating expenses Selling, general and administrative expenses Total operating expenses  Loss from operations Other expense (income) Change in fair value of derivative liability Change in warrant liability   Loss on disposal of fixed assets Loss on write off of prepaid expense Financing costs Interest expense Amortization of original issue discount Gain on settlement of accrued expenses Loss on conversion of notes payable Total other expense (income) Income tax expense Net (Loss) Income Net (Loss) per common share, basic and diluted Weighted average common shares outstanding, basic Weighted average common shares outstanding, basic and diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Shares Issued for conversion of debt Shares Issued for conversion of debt, shares Shares issued for financing fees Shares issued for financing fees, shares Shares issued for services Shares issued for services, shares Reduction in derivative liability Warrant Exercise Warrant exercise, shares Net (Loss) Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities: Net Income (Loss) Adjustments to reconcile net loss to net cash (used in) operating activities: Depreciation Amortization of debt discount Change in fair value of derivative liability Change in fair value of warrant liability Stock-based compensation Consulting fees added to note payable principal Interest expense from warrant liability Extension fees added to principal balance Penalty/other extension fees for notes payable Loss (gain) on Conversion of NP Loss on Disposal of Fixed assets Legal fees for note issuance Changes in operating assets and liabilities: Prepaid expenses Prepaid expense from related party Due from related entity Accounts payable Accrued expenses Due to Related Party Due to officer Net cash (used in) operating activities Cash flows from investing activities: Advances to related party Net cash (used in) investing activities Cash flows from financing activities: Proceeds from notes payable Payments of notes payable Proceeds from convertible notes payable Payments of convertible notes payable Repayment of advanced to officer Proceeds from Related Party Net cash provided by (used in) financing activities Net increase (decrease) in cash Cash at beginning of year Cash at end of year Non-Cash Items Convertible notes and interest paid by officer Debt discount from derivative on convertible notes payable Reduction in derivative liability from payments on convertible notes payable Debt discount from issuance of warrants with convertible note payable Discount on   convertible notes payable Conversion of Convertible notes payable Cashless exercise of warrants Settlement of derivative liability to APIC Convertible notes and interest paid by affiliate Convertible debt settled through issuance of common shares Reduction in accrued compensation due to officer Shares issued for accounts payable Warrant exercise shares Supplemental Disclosure: Loan Interest Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF BUSINESS Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Payables and Accruals [Abstract] ACCRUED EXPENSES Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Debt Disclosure [Abstract] NOTE PAYABLE Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] STOCKHOLDERS’ EQUITY Income Tax Disclosure [Abstract] INCOME TAXES Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Subsequent Events [Abstract] SUBSEQUENT EVENTS Going Concern Principles of Consolidation Use of Estimates Income Taxes Cash and Cash Equivalents Prepaid expenses Fair Value of Financial Instruments Derivative Financial Instruments Earnings (Loss) Per Share (“EPS”) Stock Based Compensation Convertible Instruments Convertible Securities Securities excluded from the diluted per share calculation Schedule of warranty liability Schedule of Accrued Expenses Schedule of Fair Value of Liabilities Schedule of summary of outstanding and warrants exercisable Schedule of intrinsic value of the restricted stock grant Schedule of deferred tax assets and liabilities Schedule of Reconciliations between the statutory rate and the effective tax rate Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Schedule of accounts payable Schedule of accrued liabilities Schedule of Subsequent Events Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities Warrant Liability balance at beginning of period Additions to warrant liability Change in fair value Balance at end of period Net loss Operating activities Accumulated deficit Working capital deficit Stockholders' deficit Share price Risk free interest rate Volatility Warrant issuance percentage Accrued compensation to executive officers Accrued professional fees and settlements Accrued interest Total accrued expenses Schedule of Fair Value, off-Balance-Sheet Risks [Table] Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items] Balance at beginning of period Additions Settlements Change in fair value Balance at end of year Risk free interest rate Term Volatility Dividend rate Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Principal amount Interest rate Common stock issuable upon conversion Convertible Notes Payable Maturity date Original issue discount Purchase price Notes payable Consulting fees Repayments of notes payable Investment return description Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise Price Weighted Average Number Outstanding Outstanding Remaining Contractual Life (in yrs) Weighted Average Exercise Price Number Exercisable Weighted Average Exercise Price Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Date of Grant Number of Shares Vest from Vest To Vested Unvested Forfeited Preferred stock, par or stated value per share Net (Income) Loss - book Permanent  Differences: Loss on disposal of fixed assets Change in warrant liability Change in derivative Debt discount amortization Estimate loss - tax basis Income tax expense at statutory federal rate of 21%, Amount Income tax expense at statutory federal rate of 21%, percent Impairments, Amount Impairments, percent Change in warrant liability, Amount Change in warrant liability, percent Change in derivative, Amount Change in derivative, percent Debt discount amortization, Amount Debt discount amortization, percent Increase (decrease) in valuation allowance, Amount Increase (decrease) in valuation allowance, percent Company's effective tax rate, Amount Company's effective tax rate, Percent Net Operating Loss Carryforward NOL tax benefit Total Deferred Tax Assets Valuation allowance Net Deferred Tax Assets Operating loss carry forward Deferred tax asset and valuation allowance Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Compensation owed to related parties Balance at Beginning 2022 Salary Payments Balance at Ending Accrued compensation Repayments of debt Employee-related liabilities, current Advance from related party for operating expenses Reimbursed amount Eco growth repayment Subsequent Event [Table] Subsequent Event [Line Items] 3/17/2023 Subsequent event category Subsequent event description Shares issued Share outstanding Total share issued Debt instrument, interest rate during period Long-Term Debt, Gross Number of warrant purchase Assets, Current Assets, Noncurrent Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Gross Profit Operating Expenses Operating Income (Loss) Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net Gain (Loss) on Sale of Assets and Asset Impairment Charges Interest Income (Expense), Net LossOnConversionOfNotesPayable Nonoperating Income (Expense) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Shares, Outstanding Gain (Loss) on Derivative Instruments, Net, Pretax ChangeInFairValueOfWarrantLiability LossGainOnConversionOfNp Increase (Decrease) in Prepaid Expense IncreaseDecreaseInPrepaidExpenseFromRelatedParty Increase (Decrease) in Due from Related Parties Increase (Decrease) in Accounts Payable Increase (Decrease) in Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Investing Activities Repayments of Convertible Debt Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Product Warranty Accrual, Current Extended Product Warranty Accrual, Additions from Business Acquisition Accrued Liabilities Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Notes Payable [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Other Real Estate, Disposals Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount ChangeInWarrantLiabilityAmount ChangeInDerivativeAmount DebtDiscountAmortizationAmount Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Deferred Tax Assets, Valuation Allowance AccountsPayableRelatedParties Payments to Employees EX-101.PRE 10 gdsi-20221231_pre.xml XBRL PRESENTATION FILE GRAPHIC 11 image_001.jpg GRAPHIC begin 644 image_001.jpg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end XML 12 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Sep. 30, 2022
Cover [Abstract]    
Document Type 10-K  
Amendment Flag false  
Document Annual Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2022  
Document Fiscal Period Focus FY  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 000-26361  
Entity Registrant Name GLOBAL DIGITAL SOLUTIONS, INC.  
Entity Central Index Key 0001011662  
Entity Tax Identification Number 22-3392051  
Entity Incorporation, State or Country Code NJ  
Entity Address, Address Line One 777 South Flagler Drive  
Entity Address, Address Line Two Suite 800 West Tower  
Entity Address, City or Town West Palm Beach  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33401  
City Area Code (561)  
Local Phone Number 515-6163  
Entity Well-known Seasoned Issuer No  
Entity Voluntary Filers No  
Entity Current Reporting Status Yes  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Public Float   $ 18,278,068
Entity Common Stock, Shares Outstanding 798,168,896  
Documents Incorporated by Reference [Text Block] None.  
Auditor Name Turner, Stone & Company, L.L.P  
Auditor Firm ID 76  
Auditor Location Dallas, Texas  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets    
Cash $ 1,043 $ 98,800
Total current assets 1,043 98,800
Other Assets    
Due from related entity, (Note 9) 80,914
Prepaid Expense, (Note 9) 22,500
Equipment net of accumulated depreciation of $ 17,773 33,009
Software Development costs 64,547
Total other assets 200,970
Total assets 1,043 299,770
Current liabilities    
Accounts payable 363,402 361,813
Accrued expenses 2,028,801 1,481,910
Due to related entity, (Note 9) 50,233
Due to Officer (Note 9) 3,281 50,000
Financed insurance policy 11,187 11,187
Derivative liability 3,421,000 809,000
Warrant Liability 1,599,000 606,000
Convertible notes payable, net of discount of $246,470 and $652,178, respectively 3,992,396 3,310,662
Notes Payable 4,607,125 4,627,000
Total Current Liabilities 16,076,425 11,257,572
Long term liabilities    
Notes payable 103,125
Total Liabilities 16,076,425 11,360,697
Stockholders’ deficit    
Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 shares issued and outstanding at December 31, 2022, and 2021 respectively 1,000 1,000
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 800,543,896 shares and 737,263,858 issued and outstanding at December 31, 2022, and 2021, respectively 800,544 737,264
Additional paid-in capital 38,233,710 37,370,384
Shares Issuable 180,000
Accumulated deficit (55,110,636) (49,349,575)
Total stockholders’ deficit (16,075,382) (11,060,927)
Total liabilities and stockholders’ deficit $ 1,043 $ 299,770
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Accumulated depreciation $ 17,773  
Debt Instrument, Unamortized Discount, Current $ 246,470 $ 652,178
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 35,000,000 35,000,000
Preferred stock, shares issued 1,000,000 1,000,000
Preferred stock, shares outstanding 1,000,000 1,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 2,000,000,000 2,000,000,000
Common stock, shares issued 800,543,896 737,263,858
Common stock, shares outstanding 800,543,896 737,263,858
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]    
Revenues
Cost of revenues
Gross profit
Operating expenses    
Selling, general and administrative expenses 427,132 2,240,437
Total operating expenses 427,132 2,240,437
 Loss from operations 427,132 2,240,437
Other expense (income)    
Change in fair value of derivative liability 2,090,500 (7,348,389)
Change in warrant liability   993,000 (1,782,000)
Loss on disposal of fixed assets 97,555
Loss on write off of prepaid expense   315,000
Financing costs 63,000
Interest expense 1,000,866 2,008,670
Amortization of original issue discount 1,089,902 2,303,973
Gain on settlement of accrued expenses (12,000)
Loss on conversion of notes payable 62,106
Total other expense (income) 5,333,929 (4,451,746)
Income tax expense
Net (Loss) Income $ (5,761,061) $ 2,211,309
Net (Loss) per common share, basic and diluted
Weighted average common shares outstanding, basic 800,543,896 737,263,858
Weighted average common shares outstanding, basic and diluted   1,420,563,361
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Shares Payable [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 668,338 $ 1,000 $ 34,086,086 $ (51,560,884) $ (16,805,460)
Beginning balance, shares at Dec. 31, 2020 668,338,264 1,000,000        
Shares Issued for conversion of debt $ 50,620 1,027,933 1,078,553
Shares Issued for conversion of debt, shares 50,619,573          
Shares issued for financing fees $ 8,000 384,000 392,000
Shares issued for financing fees, shares 8,000,000          
Shares issued for services $ 5,000 279,500 180,000 464,500
Shares issued for services, shares 5,000,000          
Reduction in derivative liability 1,602,171 1,602,171
Warrant Exercise $ 5,306 (9,306) (4,000)
Warrant exercise, shares 5,306,021          
Net (Loss) 2,211,309 2,211,309
Ending balance, value at Dec. 31, 2021 $ 737,264 $ 1,000 37,370,384 180,000 (49,349,575) (11,060,927)
Ending balance, shares at Dec. 31, 2021 737,263,858 1,000,000        
Shares Issued for conversion of debt $ 58,280 568,326 626,606
Shares Issued for conversion of debt, shares 58,280,038          
Shares issued for services $ 5,000 175,000 (180,000)  
Shares issued for services, shares 5,000,000          
Reduction in derivative liability 120,000 120,000
Net (Loss) (5,761,061) (5,761,061)
Ending balance, value at Dec. 31, 2022 $ 800,544 $ 1,000 $ 38,233,710 $ (55,110,636) $ (16,075,382)
Ending balance, shares at Dec. 31, 2022 800,543,896        
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net Income (Loss) $ (5,761,061) $ 2,211,309
Adjustments to reconcile net loss to net cash (used in) operating activities:    
Depreciation 12,695
Amortization of debt discount 1,089,901 2,303,945
Change in fair value of derivative liability 2,090,500 (7,348,389)
Change in fair value of warrant liability 993,000 (1,782,000)
Stock-based compensation 464,500
Consulting fees added to note payable principal (123,000) 240,000
Interest expense from warrant liability 881,000
Extension fees added to principal balance 176,536 250,000
Penalty/other extension fees for notes payable 251,169
Loss (gain) on Conversion of NP 62,105
Loss on Disposal of Fixed assets 97,556
Legal fees for note issuance 17,795
Changes in operating assets and liabilities:    
Prepaid expenses 22,500 (22,500)
Prepaid expense from related party 315,000
Due from related entity (10,204)
Accounts payable 1,588 (124,780)
Accrued expenses 576,081 203,356
Due to Related Party
Due to officer   (251,291)
Net cash (used in) operating activities (523,125) (2,639,564)
Cash flows from investing activities:    
Advances to related party (138,917)
Net cash (used in) investing activities (138,917)
Cash flows from financing activities:    
Proceeds from notes payable 100,000
Payments of notes payable (125,000)
Proceeds from convertible notes payable 575,000 3,403,750
Payments of convertible notes payable (306,981) (540,650)
Repayment of advanced to officer (46,719)
Proceeds from Related Party 242,985
Net cash provided by (used in) financing activities 564,285 2,738,100
Net increase (decrease) in cash (97,757) 98,536
Cash at beginning of year 98,800 264
Cash at end of year 1,043 98,800
Non-Cash Items    
Convertible notes and interest paid by officer (27,176) 253,000
Debt discount from derivative on convertible notes payable (641,500) 386,823
Reduction in derivative liability from payments on convertible notes payable (120,000) (4,000)
Debt discount from issuance of warrants with convertible note payable 1,507,000
Discount on   convertible notes payable (42,693) (490,214)
Conversion of Convertible notes payable (557,760) (743,583)
Cashless exercise of warrants 5,306
Settlement of derivative liability to APIC   1,743,908
Convertible notes and interest paid by affiliate (27,176) 53,000
Convertible debt settled through issuance of common shares 564,501 1,078,552
Reduction in accrued compensation due to officer 53,000
Shares issued for accounts payable (180,000)
Warrant exercise shares $ (4,000)
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)
12 Months Ended
Dec. 31, 2022
USD ($)
Statement of Cash Flows [Abstract]  
Loan Interest $ 29,449
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.23.1
DESCRIPTION OF BUSINESS
12 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS

NOTE 1 – DESCRIPTION OF BUSINESS

 

We were incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation (“Global”). The merger was treated as a recapitalization of Global, and Creative changed its name to Global Digital Solutions, Inc. (“the Company”, “we”), Global provided structured cabling design, installation and maintenance for leading information technology companies, federal, state and local government, major businesses, educational institutions, and telecommunication companies. On May 1, 2012, we made the decision to wind down our operations in the telecommunications area and to refocus our efforts in the area of cyber arms technology and complementary security and technology solutions. From August 2012 through November 2013, we were actively involved in managing Airtronic USA, Inc., and effective as of June 16, 2014, we acquired North American Custom Specialty Vehicles (“NACSV”). In July 2014, we announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead our efforts overseas. The Company had limited operations from the NACSV subsidiary from December 31, 2015, until May 13, 2016. During the interim, the Company was pursuing acquisition opportunities and responding to the litigation with the Securities and Exchange Commission. Subsequent to May 13, 2016, the Company has been seeking acquisitions and additional financing.

 

In March of 2019, the Company acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA is developing an updated version of the system known as Pilot Assisted Landing Systems (PALS).

 

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Going Concern

 

The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $5,761,061 used net cash of $523,125 to fund operating activities. On December 31, 2022, we had cash of $1,043 an accumulated deficit of $55,110,636 a working capital deficit of $16,076,425 and stockholders’ deficit of $16,075,382. We have funded our activities to date almost exclusively from equity and debt financings.

 

Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern.

 

We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all.

 

We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities.

 

While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. 

 

Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. 

 

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 

Income Taxes

 

Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period.

 

Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.

 

On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact.

 

Cash and Cash Equivalents

 

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits.

 

Prepaid expenses

  

In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing.

 

As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts.

 

Fair Value of Financial Instruments

 

The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

 

The three levels of the fair value hierarchy defined by ASC 820 are as follows:

 

  Level 1 – Quoted prices in active markets for identical assets or liabilities

 

  Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly

 

  Level 3 – Significant unobservable inputs that cannot be corroborated by market data.

 

Derivative Financial Instruments

 

We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging”. Subtopic ASC 815-15, Embedded Derivatives generally requires companies to bifurcate conversion options embedded in the convertible notes from their host instruments and to account for them as free standing derivative financial instruments. Derivative liabilities are recognized in the consolidated balance sheet at fair value as Derivative Liabilities and based on the criteria specified in FASB ASC 815-40, Derivatives and Hedging – Contracts in Entity’s own Equity. The estimated fair value of the derivative liabilities is calculated using various assumptions and such estimates are revalued at each balance sheet date, with changes recorded to other income or expense as Change in fair value of derivative liability in the consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the instrument origination date and reviewed at the end of each event date (i.e. conversions, payments, etc.) and the measurement period end date for financial reporting. See Note 4 Fair Value Measurement.

 

Earnings (Loss) Per Share (“EPS”)

 

Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.

 

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: 

 

        
   Year Ended 
   December 31,   December 31, 
   2022   2021 
         
Convertible notes and accrued interest   268,563,014     361,265,001 
Preferred Stock   296,201,242    227,787,627 
Stock options   12,900,000    12,900,000 
Warrants   66,446,875    81,346,875 
Potentially dilutive securities   644,111,131    683,299,503 

 

Stock Based Compensation

 

In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award.

 

The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the advisor, consultant or vendor is reached or (ii) the date at which the advisor, consultant or vendor’s performance is complete. In the case of equity instruments issued to advisors and consultants, the fair value of the equity instrument is recognized over the term of the advisor or consulting agreement. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable.

 

          
Warrant liability        
   2022   2021 
Warrant Liability balance at beginning of period   606,000    560,000 
Additions to warrant liability       (1,736,000)
Change in fair value   993,000    1,782,000 
           
Balance at end of period   1,599,000    606,000 

 

At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company's Common stock of $0.0249; a risk free interest rate of 3.0% and expected volatility of the Company's common stock of 173.54%. 185.9% to 205.9% and the remaining terms of each warrant issuance.  

 

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.”

 

Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

 

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Convertible Securities

 

Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first. 

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
ACCRUED EXPENSES

NOTE 3 – ACCRUED EXPENSES 

 

Accrued expenses consist of the following amounts:

 

          
   December 31,   December 31, 
   2022   2021 
Accrued compensation to executive officers  $141,997   $90,834 
Accrued professional fees and settlements   73,890    86,392 
Accrued interest   1,812,914    1,304,684 
Total accrued expenses  $2,028,801   $1,481,910 

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS

NOTE 4 – FAIR VALUE MEASUREMENTS 

 

We had no Level 1 or Level 2 assets and liabilities at December 31, 2022, and December 31, 2021. The Derivative liabilities are Level 3 fair value measurements.

 

The following is a summary of activity of Level 3 liabilities during the years ended December 31, 2022, and 2021: 

 

          
Balance at beginning of period  $809,000   $9,367,159 
Additions   641,500    266,000 
Settlements   (120,000   (1,580,000)
Change in fair value   2,090,500    (7,244,159)
Balance at end of year  $3,421,000   $809,000 

 

Embedded Derivative Liabilities of Convertible Notes

 

At December 31, 2022, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — 4.73%; term — 1 years; volatility — 173.74%; dividend rate — 0%. At December 31, 2021, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — 0.082.45%; term — 0.31.25 years; volatility — dividend rate — 173.74%.

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE PAYABLE
12 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
NOTE PAYABLE

NOTE 5 – NOTE PAYABLE  

 

Convertible Note Payable

 

During January 2015, the Company entered into a one-year $78,750 convertible note payable with LG Capital Funding (LG). The note bears interest at 8% per annum and is convertible at any time at the option of LG into shares of our common stock at a conversion price equal to a 40% discount of the lowest closing bid price for 20 prior trading days including the notice of conversion date. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve four times the potential number of shares of common stock issuable upon conversion, or 35,015,467 and 33,408,936 at December 31, 2022 and 2021, respectively. The Company defaulted on the note in January 2016. Additionally, as a result of declines in the fair value of the Company’s common stock, from time to time the Company did not have sufficient authorized shares to maintain this required four times share reserve. Accordingly, the note holder had the right to accelerate the repayment of the note and unpaid interest. In addition, LG has the right to require that additional shares and/or monies be paid in connection with the defaults. During December 2017, in settlement of default, the Company and LG entered into a Convertible Note Redemption Agreement under which the Company was to repay $68,110, $39,921 in unpaid principal outstanding at December 31, 2017, and $28,189 in accrued interest, in five payments through April 2018. Through April 2018, the Company repaid $6,500 of principal under the Convertible Note Redemption Agreement. The Company defaulted on the Convertible Note Redemption Agreement in April 2018 and the $28,189 in accrued interest was converted to principal. As of December 31, 2022, and through the date of this report, the principal balance totaling $48,610 is outstanding and remains in default.

 

During January 2015, the Company entered into a two-year convertible note payable for up to $250,000 with JMJ Financial (JMJ), of which $110,000 was funded between January and April 2015. The note was issued with an original issue discount of 10% of amounts funded, had a one-time 12% interest charge as it was not repaid within 90 days of the funding date, and is convertible at any time at the option of JMJ into shares of our common stock at the lesser of $0.075 per share or 60% of the average of the trading price in the 25 trading days prior to conversion. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve 26,650,000 shares of common stock. JMJ had the option to finance additional amounts up to the balance of the $250,000 during the term of the note. The Company defaulted on the note during January 2017. During December 2017, in settlement of default, the Company and JMJ entered into a Repayment Agreement under which the Company was to repay $84,514, $69,070 in unpaid principal outstanding at December 31, 2017, and $15,444 in accrued interest, in four payments through May 2018. Through May 2018, the Company repaid $25,000 of principal under the Repayment Agreement. The Company defaulted on the Repayment Agreement in May 2018 and the $15,444 in accrued interest was converted to principal. As of December 31, 2022, and through the date of this report, the principal balance totaling $59,514 is outstanding and remains in default. 

 

On April 7, 2020, the Company entered into a convertible promissory note arrangement with Actus Fund, LLC in the principal amount of $197,000. The principal amount of the note with interest at 12% is due on February 7, 2021. The note is convertible into shares of the Company’s common stock. The conversion price shall equal the lessor of (i) Current Market price or (ii) Variable Market price as defined as Market Price less a 50% discount price. As of December 31, 2022, and through the date of this report, the principal balance totaling $197,000 is outstanding.

 

On August 5, 2020, The Company and Adar Alef, LLC entered into a security purchase agreement in the aggregate principal  of $150,000. The notes shall contain a 5% OID such that the purchase price shall be $142,500. The note was paid off on May 12, 2021, by the CEO of the Company.   

 

On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.

 

On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of December 31, 2022, and through the date of this report, the principal balance totaling $970,111 is outstanding.

 

On March 25, 2021, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a prime rate plus 8% convertible note in the aggregate principal of $2,285,714. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.

 

On April 1, 2021, the Company received the first tranche of $1,142,857 from GS Capital, LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period.

 

The Company received the second tranche as follows; May 24, 2021, $796,000, July 15, 2021, $90,000, and July 21, 2021, $208,500. As of December 31, 2022, and through the date of this report, the principal balance totaling $2,141,632 is outstanding.

 

On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% promissory note in the aggregate principal of $251,625, with a maturity date of June 7, 2022. The note included a original issuance discount (“OID”) of $22,875, for a purchase price of $228,750. The interest was applied as a one- time interest charge upon the issuance date, in the amount of $20,130, recognized in accrued interest. The monthly payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company is required at have authorized and reserved four times the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business.  In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $03, with a 3-year term. The note was paid off by The Company on April 4, 2022.

 

On February 3, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $103,750. is due on February 3, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $131,096 is outstanding.

 

On March 25, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $258,638 is due on March 25, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 75% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $256,218 is outstanding.

 

On June 14, 2022, the Company and Diagonal Leasing entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $128,750 is due on June 14, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $162,685 is outstanding.

 

On August 18, 2022, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a 10% Convertible Note in the aggregate principal of $172,000, is due on August 18, 2023. The note is convertible into shares of common stock of the Company. The conversion price is equal to 70% of the lowest trading price of the Company’s Common Stock for the 20 trading dates immediately preceding the delivery of a notice of conversion. As of December 31, 2022, and through the date of this report, the principal balance totaling $172,000 is outstanding.

 

On November 7, 2022, the Company and Gary Shover, entered into a security purchase agreement for a 12% Convertible Note in the aggregate principal of $75,000, is due on May 7, 2023. The note is convertible into shares of common stock of the Company at a fixed Conversion rate of $0.139 per share. The investor shall also receive warrants to purchase 500,000 common shares at $.0139 per share. As of December 31, 2022, and through the date of this report, the principal balance totaling $75,000 is outstanding.

 

On December 14, 2022, the Company and Ronal Minor entered into a security purchase agreement for a 12% Convertible Note in the aggregate principal of $25,000, is due on June 14, 2023. The note is convertible into shares of common stock of the Company at a fixed Conversion rate of $0.139 per share. The investor shall also receive warrants to purchase 500,000 common shares at $.0139 per share. As of December 2022, and through the date of this report, the principal balance totaling $25,000 is outstanding.

 

On August 17, 2020, the Company and Harbor Gates entered into a security purchase agreement for a 10% Convertible  Promissory Note in the aggregate principal of $165,000 due on May 17, 2021. The note is convertible into shares of common stock of the Company. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 60% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete. outstanding. The note was paid off on May 28, 2021, by the Company.

 

On May 20, 2020, the Company and GS Capital Partners, LLC entered into a 10% Convertible Note in the aggregate principal of $165,000 due on February 20, 2021. The note can be converted into shares of common stock of the Company. at any time after the issue date. The note was paid off by the Company in the first and second quarters of 2021.

 

On April 6, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a 10% Convertible Promissory Note in the aggregate principal of $53,000 due on April 6, 2021. The note is convertible into shares of common stock of the Company. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the conversion date. The note was paid off by the CEO of the Company see Note 9.

 

On May 10, 2019, the Company and GHS Investments LLC entered into a security agreement for a 10% Convertible Note in the aggregate principal of $335,000 due on February 10, 2020. The note carries original issue discount or $35,000. The note is convertible into shares of common stock of the Company. The “Conversion Price” shall mean 60% multiplied by the Market Price (as defined herein), representing a discount rate of 40%. “Market Price” means the lowest Traded Price for the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. The Company is required to maintain a common share reserve of not less than three times the number of shares that is actually issuable upon full conversion of the note. The purchaser will also receive warrants to purchase 5,000,000 shares of GDSI common stock at $.01/share. Warrants will have a three-year term to exercise. The Convertible Note is personally guaranteed by William Delgado, CEO.

 

On June 11, 2021, interest on the note in the amount of $115,200.00 was converted into 8,000,000 shares of the Company’s common stock. The outstanding balance of $761,005, as of October 21, 2021, was converted into 25,500,000 shares of the Company’s common stock. The lender also received the 23,000,000 warrants. The Company recognized a gain of $844,797.00 on the conversions of June 11, 2021, and October 21, 2021. The fair value of the 25,500,000 shares issued was approximately $729,300.00

 

Notes Payable

 

During August 2017, Dragon Acquisitions, a related entity owned by William Delgado, and an individual lender entered into a Promissory Note agreement for $20,000 as well as $2,000 in interest to accrue through maturity on August 31, 2018 for a total of $22,000 due on August 31, 2018. Dragon Acquisition assumed payment of a payable of the Company and the Company took on the note. The Company defaulted on the note at maturity in August 2018. The $20,000 note remained outstanding at December 31, 2022 through the date of this report.

 

On December 22, 2017, the Company entered into a financing agreement with Parabellum, an accredited investor, for $1.2 million, amended in 2019 and increased to $1,850,000. Under the terms of the agreement, the Company is to receive milestone payments based on the progress of the Company’s lawsuit (Note 6) for damages against Grupo Rontan Metalurgica, S.A (the “Lawsuit”). Such milestone payments consist of (i) an initial purchase price payment of $300,000, which the Company received on December 22, 2017, (ii) $150,000 within 30 days of the Lawsuit surviving a motion to dismiss on the primary claims, (iii) $100,000 within 30 days of the close of all discovery in the Lawsuit and (iv) $650,000 within 30 days of the Lawsuit surviving a motion for summary judgment and challenges on the primary claims. As part of the agreement, the Company shall pay the investor an investment return of 100% of the litigation proceeds to recoup all money invested, plus 27.5% of the total litigation proceeds received by the Company. $300,000 was received by the Company in December 2017. As of December 31, 2022, and through the date of this report, the $2,550,000 note remains outstanding. 

 

On December 23, 2017 (the “effective date”), the Company entered into a $485,000, 7% interest rate, demand promissory note with Vox Business Trust, LLC (Vox). The note was in settlement of the amounts accrued under a consulting agreement (Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to Vox when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, Vox may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –

 

  $1,000 on the effective date.

 

  $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss.

 

  $50,000 on the date on which discovery closes with respect to the lawsuit.

 

  $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims.

 

Under the terms of the Vox note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the years ended December 31, 2022, and 2021, consulting fees totaling $120,000 were added to the note principal and are included in the note balance. The note had a balance of $861,500 and $926,500 as of December 31, 2022, and 2021, respectively. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default.

 

On December 26, 2017 (the “effective date”), the Company entered into a $485,000, 7% interest rate, demand promissory note with RLT Consulting, Inc. (RLT), a related party. The note was in settlement of the amounts accrued under a consulting agreement (Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to RLT when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, RLT may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –

 

  $1,000 on the effective date.

 

  $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss.

 

  $50,000 on the date on which discovery closes with respect to the lawsuit.

 

  $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims.

 

Under the terms of the RLT note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the year ended December 31, 2022, and 2021, consulting fees totaling $120,000 were added to the note principal and are included in the note balance. The note had a balance of $861,500 and $919,500 as of December 31, 2022, and 2021, respectively. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default. RLT was granted a first priority security interest in the Litigation Proceeds and is pari passu to Parabellum and Vox. To that end, they share in the litigation in a priority position to proceed to repay the note.

 

During April 2018, the Company entered into a two-month $36,000 note payable with $31,000 in proceeds paid directly to a third-party vendor for expenses. The note did not bear interest and included a $5,000 original issue discount. During June 2018, the Company defaulted on the note. As of December 31, 2022, and through the date of this report, the $11,000 note remained outstanding.   

 

During May 2018, the Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default.  

 

During June 2018, the Company entered in to a one-year $300,000 non-convertible note with an accredited investor with $150,000 original issue discount (“OID”) for net proceeds of $150,000. As part of the note agreement, the Company also agreed to issue the investor 5,000,000 warrants at an exercise price of $0.01, exercisable for a period of three (3) years. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $35,000 of which $28,378 was recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.008 at issuance date; a risk-free interest rate of 2.62% and estimated volatility of the Company’s common stock of 218%. At December 31, 2019, the $300,000 note remained outstanding. The Company defaulted on the note at maturity in June 2019 and the note remained outstanding through the date of this report. The note contains a default interest rate of 10% plus a 5% penalty of the outstanding balance of the note. The note holder has voluntarily refrained from making demand for repayment under the default provisions of the note, which would require the Company to pay the holder 130% of the outstanding principal and interest accrued at the default rate. The Company paid off the note on March 10, 2021.  

 

The June 2018 note bears a personal guarantee by William Delgado, the Chief Executive Officer of the Company. As further security for the note, Mr. Delgado has also pledged the 1,000,000 Convertible Preferred Shares of the Company that he owns, as well as 5,000,000 common shares of SHMP, another public company in which Mr. Delgado is a director and Chief Financial Officer.

 

On May 12, 2020, the Company and BBVA USA entered into a 1% SBA PPP, Promissory Note, in the aggregate principal of $103,125. The note is payable in monthly payments of $5,805 beginning on December 12, 2020, ending on May 12, 2022. The Company has requested debt forgiveness from the SBA. As of December 31, 2022, and through the date of this report the SBA has not responded to the request and BBVA has waived the monthly payments.

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.23.1
COMMITMENTS AND CONTINGENCIES
12 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 6 – COMMITMENTS AND CONTINGENCIES

 

Legal Proceedings

 

We may be involved in legal proceedings in the ordinary course of our business, and our management cannot predict the ultimate outcome of these legal proceedings with certainty. The Company is plaintiff or defendant in the following actions:

 

Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A.  

 

Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”) and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date.

 

The purchase price shall consist of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date.

 

Under the terms of a Finders Fees Agreement dated April 14, 2014, we have agreed to pay RLT Consulting Inc., a related party, a fee of 2% (two percent) of the Transaction Value, as defined in the agreement, of Rontan upon closing. The fee is payable one-half in cash and one-half in shares of our common stock.

 

Specific conditions to closing consist of:

 

  a) Purchaser’s receipt of written limited assurance of an unqualified opinion with respect to Rontan’s audited financial statements for the years ended December 31, 2013 and 2014 (the “Opinion”);

 

  b) The commitment of sufficient investment by General American Capital Partners LLC (the “Institutional Investor”), in the Purchaser following receipt of the Opinion;

 

  c) The accuracy of each Parties’ representations and warranties contained in the SPSA;

 

  d) The continued operation of Rontan’s business in the ordinary course;

 

  e) The maintenance of all of Rontan’s bank credit lines in the maximum amount of R$200 million (approximately US$52 million) under the same terms and conditions originally agreed with any such financial institutions, and the maintenance of all other types of funding arrangements. As of the date of the SPSA, Rontan’s financial institution debt consists of not more than R$200 million (approximately US$52 million), trade debt of not more than R$50 million (approximately US$13 million) and other fiscal contingencies of not more that R$95 million (approximately US$24.7 million);

 

  f) Rontan shall enter into employment or consulting service agreements with key employees and advisors identified by the Purchaser, including Rontan’s Chief Executive Officer; and

 

  g) The Sellers continued guarantee of Rontan’s bank debt for a period of 90 days following issuance of the Opinion, among other items.

 

The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, as well as the ability to acquire 100% of the outstanding stock of Rontan at a price of $200 million BR, and the Company can acquire 100% of all real estate held by Rontan.

 

Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion.

 

Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets.

 

Subsequent to December 31, 2015, on April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions to closing, which were waivable by us,) and advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA.

 

On January 31, 2018, we announced that we initiated a lawsuit for damages against Grupo Rontan Metalurgica, S. A, (“Rontan”) and that company’s controlling shareholders, Joao Alberto Bolzan and Jose Carlos Bolzan. The action has been filed in the United States District Court for the Southern District of Florida. The complaint alleges that Rontan is wholly owned by Joao Bolzan and Jose Bolzan. In the complaint, we further allege that Rontan and its shareholders improperly terminated a Share Purchase and Sale Agreement (the “SPA”) by which we were to acquire whole ownership of Rontan.

 

On February 5, 2018, United States District Court Southern District of Florida filed a Pretrial Scheduling Order and Order Referring Case to Mediation dated February 5, 2018, for the Company’s lawsuit against Grupo Rontan Electro Metalurgica, S.A., et al. The Case No. is 18-80106-Civ-Middlebrooks/Brannon. The court has issued a schedule outlining various documents and responses that are to be delivered by the parties as part of the discovery plan.

 

On April 25, 2018, the Note of Filing Proposed Summons was completed by the Company. On April 26, 2018, a summons was issued to Grupo Rontan Electro Metalurgica, S.A. Also, on May 15, 2018, the Company filed a motion for Issuance of Letters Rogatory.

 

Consulting agreements

 

The Company entered into two consulting agreements (See Note 5) in May 2016, for services to be provided in connection towards the resolution of the Rontan lawsuit (below). The consulting agreements includes a monthly retainer payment of $10,000 to each consultant. The agreement also includes consideration of 5,000,000 shares of restricted common stock of the Company, plus a 5% cash consideration of the Resolution Progress Funding, (defined as upon the retention of legal counsel and receipt of funding for the litigation), as of the Resolution Progress Funding date and 10,000,000 shares of restricted common stock of the Company and a 5% cash consideration of the Resolution Funding amount (defined as a settlement or judgement in favor of the Company by Rotan),at the Resolution Funding date. The Resolution Progress funding was met on December 22, 2017.

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Preferred Stock

 

We are authorized to issue 35,000,000 shares of noncumulative, non-voting, convertible preferred stock, $0.001 par value per share. At December 31, 2022, and 2021, 1,000,000 shares of preferred stock were outstanding.

 

 On August 15, 2016, William J. Delgado, our current Chief Executive Officer, agreed to convert $231,565 of indebtedness owed to him by the Company into 1,000,000 shares of convertible preferred stock (the “Preferred Stock”). The Preferred Stock has voting rights as to one (1) preferred share to four hundred (400) shares of the common stock of the Company. The Preferred Stock is convertible into common stock at any time after issuance into 37% of the outstanding common stock of the Company at the time of the conversion. The conversion to common can only take place when there are an adequate number of shares that are available and is subject to normal stock adjustments (i.e. stock splits etc.) that are executed by the Company in its normal course of business.

 

Common Stock

 

We are authorized to issue 2,000,000,000 shares of common stock, $0.001 par value per share. At December 31, 2022 and 2021 there were 800,542,896 and 737,263,858 Issued, outstanding, or vested but unissued under stock compensation plans, respectively.

 

Common Stock Warrant

 

We have issued warrants, which are fully vested and available for exercise, as follows:

 

The following is a summary of outstanding and exercisable warrants at December 31, 2022:  

 

                     
Outstanding   Exercisable 
                      
    Weighted                 
    Average   Outstanding             
Range of   Number   Remaining   Weighted   Number   Weighted 
Exercise   Outstanding   Contractual   Average   Exercisable   Average 
Prices   at 12/31/2022   Life (in yrs)   Exercise Price   at 12/31/2022   Exercise Price 
$0.01    12,000,000    4   $0.01    12,000,000   $0.01 
$0.01    1,000,000    4.1   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.2   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.3   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.4   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.5   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.6   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.7   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.8   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.9   $0.01    1,000,000   $0.01 
$0.01    1,000,000    5   $0.01    1,000,000   $0.01 
$0.01    1,000,000    5.1   $0.01    1,000,000   $0.01 
$0.01    10,000,000    9   $0.01    10,000,000   $0.01 
$0.01    20,000,000    8   $0.01    20,000,000   $0.01 
$0.03    2,096,875    1   $0.01    2,096,875   $0.01 
$0.01    10,750,000    4.8   $0.01    10,750,000   $0.01 
$0.01    500,000    3   $0.01    500,000   $0.01 
$0.01    100,000    3   $0.01    100,000   $0.01 
      66,446,875              66,446,875      

 

All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis.

 

The following is a summary of outstanding and exercisable warrants at December 31, 2021:

 

Outstanding   Exercisable
                     
    Weighted                
    Average   Outstanding            
Range of   Number   Remaining   Weighted   Number   Weighted
Exercise   Outstanding   Contractual   Average   Exercisable   Average
Prices   at 12/31/2021   Life (in yrs)   Exercise Price   at 12/31/2021   Exercise Price
$ 0.01       5,000,000       0.5       0.004       5,000,000     $ 0.01  
$ 0.01       3,750,000       2.1       0.002       3,750,000     $ 0.01  
$ 0.01       12,000,000       2     $ 0.01       12,000,000     $ 0.01  
$ 0.01       2,500,000       2.8     $ 0.01       2,500,000     $ 0.01  
$ 0.01       10,000,000       8.2     $ 0.01       10,000,000     $ 0.01  
$ 0.01       20,000,000       8.3     $ 0.01       20,000,000     $ 0.01  
$ 0.01       2,096,875       3.6     $ 0.01       2,096,875     $ 0.01  
$ 0.01       12,000,000       5     $ 0.01       12,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.2     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.3     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.4     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.5     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.6     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.7     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.8     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.9     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
          78,346,875                       78,346,875          

 

The intrinsic value of warrants outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the warrant multiplied by the number of warrants outstanding or exercisable.

 

Stock Incentive Plans

 

2014 Global Digital Solutions Equity Incentive Plan

 

On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 shares of our common stock for issuance pursuant to awards thereunder, including options, stock appreciation right, restricted stock, restricted stock units, performance awards, dividend equivalents, or other stock-based awards. The Plan is intended as an incentive, to retain in the employ of the Company, our directors, officers, employees, consultants, and advisors, and to attract new officers, employees, directors, consultants and advisors whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries.

 

In accordance with the ACS 718, Compensation – Stock Compensation, awards granted are valued at fair value at the grant date. The Company recognizes compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. The Company recognizes the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. The Company has not capitalized any portion of its stock-based compensation.

 

Stock-based compensation expense for the years ended December 31, 2022, and 2021 was $0 and $5,075, respectively.

 

Awards Issued Under Stock Incentive Plans

 

Stock Option Activity

 

On December 31, 2022, and 2021we have outstanding stock options of 12,900,000 and 13,650,002 respectively - all of which are fully-vested stock options that were granted to directors, officers and consultants. The outstanding stock options are exercisable at prices ranging from $0.006 to $0.64 and expire between February 2024 and December 2025, for an average exercise price per share of $0.60 and an average remaining term of 3 years as of December 31, 2022.  In 2021 there were 750,000 options exercised.

 

During the years ended December 31, 2022, and 2021, we did not recognize any stock-based compensation cost related to the outstanding stock options. The intrinsic value of options outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the option multiplied by the number of options outstanding.

 

Restricted Stock Units

 

On October 10, 2014, we granted an employee 1 million RSU’s convertible into 1 million shares of the Company’s common stock, with a grant date fair market value of $100,000. The grant was made under our 2014 Equity Incentive Plan. 333,333 RSU’s will vest in respect of each calendar year (commencing January 1 and ending December 31) of the Company from 2015 through 2017 if the Company has achieved at least 90% of the total revenue and EBITDA midpoint targets set forth in the agreement. If less than 90% of the target is achieved in respect of any such fiscal year, then the number of RSU’s vesting for that fiscal year shall be 333,333 times the applicable percentage set forth in the agreement; provided that, if the company shall exceed 100% of the revenue and EBITDA midpoint target for the 2018 or 2017 calendar year, and shall have failed to reach 90% of the target for a prior calendar year, the excess over 100% shall be applied to reduce the deficiency in the prior year(s), and an additional number of RSU’s shall vest to reflect the increased revenue for such prior calendar year. Any such excess shall be applied first to reduce any deficiency for the 2015 calendar year and then for the 2016 calendar year. The vesting of the RSU’s shall be effective upon the issuance of the audited financial statements of the Company for the applicable calendar year and shall be based upon the total revenue and EBITDA of the acquired companies as reflected in such financial statements.

 

Awards Not Issued Under Stock Incentive Plans

 

Restricted Stock Grants Awarded to Advisors

 

In order to align our senior advisors with the interest of the stakeholders of the Company, the Board of Directors of the Company has granted the advisors restricted stock awards valued at $0.17 to $0.364 per share which vest over a period of 12 – 24 months, subject to remaining an advisor for a minimum of twelve months, and which are forfeited if the advisor is terminated or is no longer an advisor on the anniversary of the advisory award, as follows:

 

                                           
                      December 31, 2022  
Name   Date of
Grant
  Number of
Shares
    Vest from   Vest To   Vested     Unvested     Forfeited  
Mathew Kelley   4/17/13     1,250,000     4/30/13   3/31/14     1,250,000              
    4/17/13     1,250,000     2/28/14   1/31/15     1,250,000              
                                             
Richard J. Feldman   4/30/14     500,000     4/30/14   3/30/15     500,000              
          500,000     4/30/15   3/30/16     375,000             125,000  
                                             
Gary Gray   3/7/15     1,000,000     3/7/15   5/30/15     1,000,000              
                                             
Ross Trevino   3/7/15     500,000     3/7/15   5/30/15     500,000              
          5,000,000               4,875,000             125,000  

 

The aggregate intrinsic value of the restricted stock grant was $0 on December 31, 2022, and 2021.

 

XML 26 R15.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 8 – INCOME TAXES 

 

     
Net (Income) Loss - book  $5,761,061 
Permanent  Differences:     
Loss on disposal of fixed assets   (97,555)
Change in warrant liability   (993,000)
Change in derivative   (2,090,500) 
Debt discount amortization   (1,089,902)
Estimate loss - tax basis   1,490,104 

 

Reconciliations between the statutory rate and the effective tax rate for the year ended December 31, 2022 consist as follows: 

 

          
   2022 
   Amounts   Rate 
Income tax expense at          
statutory federal rate of 21%   1,210,000    21%
Permanent Differences          
Loss on disposal of Fixed assets   (20,000)   0%
Change in warrant liability   (209,000)   -4%
Change in derivative   (439,000)    8%
Debt discount amortization   (229,000)   -4%
Increase (decrease) in valuation allowance   313,000   -21%
Income tax expense (benefit) at          
Company's effective tax rate  $    0%

 

                
   TOTAL   Activity   TOTAL 
   12/31/2021   2022   12/31/2022 
             
Net Operating Loss Carryforward  $21,774,808   $313,000   $22,087,808 
                
NOL tax benefit  $4,004,010   $313,000   $4,317,010 
                
Total Deferred Tax Assets   4,004,010    313,000    4,317,010 
Valuation allowance  $(4,004,010)  $(313,000)  $(4,317,010)
   $   $   $ 

  

As of December 31, 2022, the Company had $ 22,087,808 of federal net operating loss carry forwards. These carry forwards, if not used, will begin to expire in 2029. Current or future ownership changes, including issuances of common stock under the terms of the Company’s convertible notes payable that were entered into during 2015 and the closing of the Rontan Transaction may severely limit the future realization of these net operating losses.

 

The Company provides for a valuation allowance when it is more likely than not that they will not realize a portion of the deferred tax assets. The Company has established a valuation allowance against their net deferred tax asset due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, they have not reflected any benefit of such deferred tax assets in the accompanying financial statements. The Company’s net deferred tax asset and valuation allowance increased by $313,000 for the year ended December 31, 2022, related to the current year activity.

 

The Company has reviewed all income tax positions taken or that are expected to be taken for all open years and determined that their income tax positions are appropriately stated and supported for all open years. The Company is subject to U.S. federal income tax examinations by tax authorities for years after 2011 due to unexpired net operating loss carryforwards originating in and subsequent to that year. The Company may be subject to income tax examinations for the various taxing authorities which vary by jurisdiction. 

 

The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statements of operations. As of December 31, 2022, there were no unrecognized tax benefits, or any tax related interest or penalties.

 

The Company files income tax returns in the U.S. federal jurisdiction and the various states in which they operate. The former members of NACSV are required to file separate federal and state tax returns for NACSV for the periods prior to our acquisition of NACSV. The Company files consolidated tax returns for subsequent periods. The Company has not filed their U.S. federal and certain state tax returns since 2014 and currently do not have any examinations ongoing. Tax returns for the years 2012 onwards are subject to federal, state or local examinations.

 

XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 9 – RELATED PARTY TRANSACTIONS 

 

Due to officer

 

As of December 31, 2022, the Company owes Mr. Delgado $21,000 in accrued compensation.  

 

During 2021 Mr.Delgado paid off approximately $390,000 of the Company’s debt. The Company paid Mr. Delgado approximately $1,326,000 which included repayment for amounts paid for the notes and compensation. The Company owes Mr. Delgado $50,000 at December 31, 2021 for money advanced.

 

During 2022 Mr. Delgado advance The Company $9,000 for payment of operating expenses. The Company reimbursed Mr. Delgado  $55,000 for his outstanding balance at December 31, 2021, and the current year advance. The Company owes Mr. Delgado approximated $3,300 at December 31, 2022.Due from Related Party

 

During the year ended December 31, 2022, The Company advanced approximately $140,000 to Eco Growth Strategies for operating expenses. During 2022 Eco Growth repaid The Company approximately $270,000in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000.

 

During the year ended December 31, and 2021, the Company advanced Eco Growth Strategies, a related entity, $80,195 to cover administrative costs and legal expense.

 

Accounts Payable

 

          
   December 31,   December 31, 
   2022   2021 
Jerry Gomolski   25,000    25,000 
Charter 804CS   20,099    20,099 
Gary Gray   12,000    12,000 
   $57,099    $57,099 

 

Accrued Compensation

 

On December 31, 2022, and December 31, 2021, we had $ 21,163 and $0.00 payable to William J. Delgado and $120,834 and $90,834 to Jerome Gomolski, respectively.

               
,
       William   Jerome 
   Total   Delgado   Gomolski 
Balance 12/31/2021  $90,834   $0.00   $90,834 
                
2022 Salary   300,000    240,000    60,000 
Payments   (248,837)   (218,837)   (30,000
                
Balance 12/31/2022  $(141,997)  $(21,163)   $(120,834)

 

XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 10 – SUBSEQUENT EVENTS 

 

On January 4, 2023, Company and Leonite Capital,LLC, entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $41,666.67 less an original issue discount of $4,166.67. The note shall be paid in one or more tranches. The Company received the first tranche of $21,500, on January 12, 2023. The maturity of each tranche shall be 12 months after each Tranche is advanced. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the Advance Date of the first Tranche. 

 

On January 12, 2023, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $41,667, due on January 12, 2024. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the date of the First Tranche, Fixed Conversion Price. Upon the advance of the First Tranche the Company shall issue warrants to purchase 5,000,000 shares of the Company common stock. The exercise price is $0.024 per share with a term of 120 Months.

                   
 Date    Category    Description         Shares Issued
                   
1/26/2023   Settlemement Agreement   The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.            
                   
2/6/2023    Promissory Note    On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date.            
                     
2/7/2023    Notice of Conversion   On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.           6,736,045
                     
2/8/2023    Notice of Conversion   On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.           10,000,000
                     
2/21/2023    Notice of Conversion   On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.           15,000,000
                     
2/23/2023    Notice of Conversion   On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.           8,227,753
                     
3/1/2023    Notice of Conversion   On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common           20,000,000
                     
3/7/2023    Notice of Conversion   On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.           10,163,288
                     
3/17/2023    Notice of Conversion   On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.           10,831,096
                     
3/22/2023    Second Amendment to Senior Secured Convertible Promissory Note   Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC            
                     
4/18/2023    Notice of Conversion   On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common           15,000,000
                     
3/17/2023    Notice of Conversion   On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common           20,000,000
                  115,958,182
                     
                    798,168,896
                    115,958,182
                    914,127,078

 

XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Going Concern

Going Concern

 

The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $5,761,061 used net cash of $523,125 to fund operating activities. On December 31, 2022, we had cash of $1,043 an accumulated deficit of $55,110,636 a working capital deficit of $16,076,425 and stockholders’ deficit of $16,075,382. We have funded our activities to date almost exclusively from equity and debt financings.

 

Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern.

 

We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all.

 

We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities.

 

While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. 

 

Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. 

 

Principles of Consolidation

Principles of Consolidation

 

The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 

Income Taxes

Income Taxes

 

Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period.

 

Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.

 

On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits.

 

Prepaid expenses

Prepaid expenses

  

In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing.

 

As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.

 

The three levels of the fair value hierarchy defined by ASC 820 are as follows:

 

  Level 1 – Quoted prices in active markets for identical assets or liabilities

 

  Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly

 

  Level 3 – Significant unobservable inputs that cannot be corroborated by market data.

 

Derivative Financial Instruments

Derivative Financial Instruments

 

We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging”. Subtopic ASC 815-15, Embedded Derivatives generally requires companies to bifurcate conversion options embedded in the convertible notes from their host instruments and to account for them as free standing derivative financial instruments. Derivative liabilities are recognized in the consolidated balance sheet at fair value as Derivative Liabilities and based on the criteria specified in FASB ASC 815-40, Derivatives and Hedging – Contracts in Entity’s own Equity. The estimated fair value of the derivative liabilities is calculated using various assumptions and such estimates are revalued at each balance sheet date, with changes recorded to other income or expense as Change in fair value of derivative liability in the consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the instrument origination date and reviewed at the end of each event date (i.e. conversions, payments, etc.) and the measurement period end date for financial reporting. See Note 4 Fair Value Measurement.

 

Earnings (Loss) Per Share (“EPS”)

Earnings (Loss) Per Share (“EPS”)

 

Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.

 

The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: 

 

        
   Year Ended 
   December 31,   December 31, 
   2022   2021 
         
Convertible notes and accrued interest   268,563,014     361,265,001 
Preferred Stock   296,201,242    227,787,627 
Stock options   12,900,000    12,900,000 
Warrants   66,446,875    81,346,875 
Potentially dilutive securities   644,111,131    683,299,503 

 

Stock Based Compensation

Stock Based Compensation

 

In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award.

 

The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50. The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the advisor, consultant or vendor is reached or (ii) the date at which the advisor, consultant or vendor’s performance is complete. In the case of equity instruments issued to advisors and consultants, the fair value of the equity instrument is recognized over the term of the advisor or consulting agreement. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable.

 

          
Warrant liability        
   2022   2021 
Warrant Liability balance at beginning of period   606,000    560,000 
Additions to warrant liability       (1,736,000)
Change in fair value   993,000    1,782,000 
           
Balance at end of period   1,599,000    606,000 

 

At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company's Common stock of $0.0249; a risk free interest rate of 3.0% and expected volatility of the Company's common stock of 173.54%. 185.9% to 205.9% and the remaining terms of each warrant issuance.  

 

Convertible Instruments

Convertible Instruments

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.”

 

Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”

 

The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.

 

ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.

 

Convertible Securities

Convertible Securities

 

Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first. 

 

XML 30 R19.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Securities excluded from the diluted per share calculation
        
   Year Ended 
   December 31,   December 31, 
   2022   2021 
         
Convertible notes and accrued interest   268,563,014     361,265,001 
Preferred Stock   296,201,242    227,787,627 
Stock options   12,900,000    12,900,000 
Warrants   66,446,875    81,346,875 
Potentially dilutive securities   644,111,131    683,299,503 
Schedule of warranty liability
          
Warrant liability        
   2022   2021 
Warrant Liability balance at beginning of period   606,000    560,000 
Additions to warrant liability       (1,736,000)
Change in fair value   993,000    1,782,000 
           
Balance at end of period   1,599,000    606,000 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES (Tables)
12 Months Ended
Dec. 31, 2022
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses
          
   December 31,   December 31, 
   2022   2021 
Accrued compensation to executive officers  $141,997   $90,834 
Accrued professional fees and settlements   73,890    86,392 
Accrued interest   1,812,914    1,304,684 
Total accrued expenses  $2,028,801   $1,481,910 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Liabilities
          
Balance at beginning of period  $809,000   $9,367,159 
Additions   641,500    266,000 
Settlements   (120,000   (1,580,000)
Change in fair value   2,090,500    (7,244,159)
Balance at end of year  $3,421,000   $809,000 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Tables)
12 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of summary of outstanding and warrants exercisable
                     
Outstanding   Exercisable 
                      
    Weighted                 
    Average   Outstanding             
Range of   Number   Remaining   Weighted   Number   Weighted 
Exercise   Outstanding   Contractual   Average   Exercisable   Average 
Prices   at 12/31/2022   Life (in yrs)   Exercise Price   at 12/31/2022   Exercise Price 
$0.01    12,000,000    4   $0.01    12,000,000   $0.01 
$0.01    1,000,000    4.1   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.2   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.3   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.4   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.5   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.6   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.7   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.8   $0.01    1,000,000   $0.01 
$0.01    1,000,000    4.9   $0.01    1,000,000   $0.01 
$0.01    1,000,000    5   $0.01    1,000,000   $0.01 
$0.01    1,000,000    5.1   $0.01    1,000,000   $0.01 
$0.01    10,000,000    9   $0.01    10,000,000   $0.01 
$0.01    20,000,000    8   $0.01    20,000,000   $0.01 
$0.03    2,096,875    1   $0.01    2,096,875   $0.01 
$0.01    10,750,000    4.8   $0.01    10,750,000   $0.01 
$0.01    500,000    3   $0.01    500,000   $0.01 
$0.01    100,000    3   $0.01    100,000   $0.01 
      66,446,875              66,446,875      

 

All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis.

 

The following is a summary of outstanding and exercisable warrants at December 31, 2021:

 

Outstanding   Exercisable
                     
    Weighted                
    Average   Outstanding            
Range of   Number   Remaining   Weighted   Number   Weighted
Exercise   Outstanding   Contractual   Average   Exercisable   Average
Prices   at 12/31/2021   Life (in yrs)   Exercise Price   at 12/31/2021   Exercise Price
$ 0.01       5,000,000       0.5       0.004       5,000,000     $ 0.01  
$ 0.01       3,750,000       2.1       0.002       3,750,000     $ 0.01  
$ 0.01       12,000,000       2     $ 0.01       12,000,000     $ 0.01  
$ 0.01       2,500,000       2.8     $ 0.01       2,500,000     $ 0.01  
$ 0.01       10,000,000       8.2     $ 0.01       10,000,000     $ 0.01  
$ 0.01       20,000,000       8.3     $ 0.01       20,000,000     $ 0.01  
$ 0.01       2,096,875       3.6     $ 0.01       2,096,875     $ 0.01  
$ 0.01       12,000,000       5     $ 0.01       12,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.2     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.3     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.4     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.5     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.6     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.7     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.8     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.9     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
$ 0.01       1,000,000       5.1     $ 0.01       1,000,000     $ 0.01  
          78,346,875                       78,346,875          
Schedule of intrinsic value of the restricted stock grant
                                           
                      December 31, 2022  
Name   Date of
Grant
  Number of
Shares
    Vest from   Vest To   Vested     Unvested     Forfeited  
Mathew Kelley   4/17/13     1,250,000     4/30/13   3/31/14     1,250,000              
    4/17/13     1,250,000     2/28/14   1/31/15     1,250,000              
                                             
Richard J. Feldman   4/30/14     500,000     4/30/14   3/30/15     500,000              
          500,000     4/30/15   3/30/16     375,000             125,000  
                                             
Gary Gray   3/7/15     1,000,000     3/7/15   5/30/15     1,000,000              
                                             
Ross Trevino   3/7/15     500,000     3/7/15   5/30/15     500,000              
          5,000,000               4,875,000             125,000  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of deferred tax assets and liabilities
     
Net (Income) Loss - book  $5,761,061 
Permanent  Differences:     
Loss on disposal of fixed assets   (97,555)
Change in warrant liability   (993,000)
Change in derivative   (2,090,500) 
Debt discount amortization   (1,089,902)
Estimate loss - tax basis   1,490,104 
Schedule of Reconciliations between the statutory rate and the effective tax rate
          
   2022 
   Amounts   Rate 
Income tax expense at          
statutory federal rate of 21%   1,210,000    21%
Permanent Differences          
Loss on disposal of Fixed assets   (20,000)   0%
Change in warrant liability   (209,000)   -4%
Change in derivative   (439,000)    8%
Debt discount amortization   (229,000)   -4%
Increase (decrease) in valuation allowance   313,000   -21%
Income tax expense (benefit) at          
Company's effective tax rate  $    0%
Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
                
   TOTAL   Activity   TOTAL 
   12/31/2021   2022   12/31/2022 
             
Net Operating Loss Carryforward  $21,774,808   $313,000   $22,087,808 
                
NOL tax benefit  $4,004,010   $313,000   $4,317,010 
                
Total Deferred Tax Assets   4,004,010    313,000    4,317,010 
Valuation allowance  $(4,004,010)  $(313,000)  $(4,317,010)
   $   $   $ 
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Tables)
12 Months Ended
Dec. 31, 2022
Related Party Transactions [Abstract]  
Schedule of accounts payable
          
   December 31,   December 31, 
   2022   2021 
Jerry Gomolski   25,000    25,000 
Charter 804CS   20,099    20,099 
Gary Gray   12,000    12,000 
   $57,099    $57,099 
Schedule of accrued liabilities
               
,
       William   Jerome 
   Total   Delgado   Gomolski 
Balance 12/31/2021  $90,834   $0.00   $90,834 
                
2022 Salary   300,000    240,000    60,000 
Payments   (248,837)   (218,837)   (30,000
                
Balance 12/31/2022  $(141,997)  $(21,163)   $(120,834)
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Tables)
12 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Schedule of Subsequent Events
                   
 Date    Category    Description         Shares Issued
                   
1/26/2023   Settlemement Agreement   The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.            
                   
2/6/2023    Promissory Note    On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date.            
                     
2/7/2023    Notice of Conversion   On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.           6,736,045
                     
2/8/2023    Notice of Conversion   On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.           10,000,000
                     
2/21/2023    Notice of Conversion   On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.           15,000,000
                     
2/23/2023    Notice of Conversion   On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.           8,227,753
                     
3/1/2023    Notice of Conversion   On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common           20,000,000
                     
3/7/2023    Notice of Conversion   On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.           10,163,288
                     
3/17/2023    Notice of Conversion   On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.           10,831,096
                     
3/22/2023    Second Amendment to Senior Secured Convertible Promissory Note   Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC            
                     
4/18/2023    Notice of Conversion   On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common           15,000,000
                     
3/17/2023    Notice of Conversion   On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common           20,000,000
                  115,958,182
                     
                    798,168,896
                    115,958,182
                    914,127,078
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 644,111,131 683,299,503
Convertible Notes Payable [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 268,563,014 361,265,001
Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 296,201,242 227,787,627
Equity Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 12,900,000 12,900,000
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Potentially dilutive securities 66,446,875 81,346,875
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Accounting Policies [Abstract]    
Warrant Liability balance at beginning of period $ 606,000 $ 560,000
Additions to warrant liability (1,736,000)
Change in fair value 993,000 1,782,000
Balance at end of period $ 1,599,000 $ 606,000
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accounting Policies [Abstract]      
Net loss $ 5,761,061 $ (2,211,309)  
Operating activities 523,125    
Cash 1,043 98,800  
Accumulated deficit 55,110,636 49,349,575  
Working capital deficit 16,076,425    
Stockholders' deficit $ 16,075,382 $ 11,060,927 $ 16,805,460
Share price $ 0.0249    
Risk free interest rate 3.00%    
Volatility 173.54%    
Warrant issuance percentage 185.90% 205.90%  
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.23.1
ACCRUED EXPENSES (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Payables and Accruals [Abstract]    
Accrued compensation to executive officers $ 141,997 $ 90,834
Accrued professional fees and settlements 73,890 86,392
Accrued interest 1,812,914 1,304,684
Total accrued expenses $ 2,028,801 $ 1,481,910
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Balance at beginning of period $ 809,000  
Change in fair value (2,090,500) $ 7,348,389
Balance at end of year 3,421,000 809,000
Derivative [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]    
Balance at beginning of period 809,000 9,367,159
Additions 641,500 266,000
Settlements (120,000) (1,580,000)
Change in fair value 2,090,500 (7,244,159)
Balance at end of year $ 3,421,000 $ 809,000
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.23.1
FAIR VALUE MEASUREMENTS (Details Narrative)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
Risk free interest rate 4.73% 0.08%
Term 1 year 3 months 21 days
Volatility 173.74%  
Dividend rate 0.00% 173.74%
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE PAYABLE (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Dec. 14, 2022
Nov. 07, 2022
Jun. 14, 2022
Feb. 03, 2022
Jun. 07, 2021
Aug. 05, 2020
May 12, 2020
Apr. 06, 2020
May 10, 2019
Aug. 18, 2022
Mar. 25, 2022
Mar. 25, 2021
Feb. 25, 2021
Aug. 17, 2020
May 20, 2020
Jun. 30, 2018
May 31, 2018
Apr. 30, 2018
Dec. 26, 2017
Dec. 23, 2017
Jan. 31, 2015
Dec. 31, 2022
Dec. 31, 2021
Aug. 31, 2018
Dec. 22, 2017
Aug. 31, 2017
Debt Instrument [Line Items]                                                    
Accrued interest                                           $ 1,812,914 $ 1,304,684      
Repayments of notes payable                                           125,000      
William Delgado Member                                                    
Debt Instrument [Line Items]                                                    
Principal amount                                                   $ 20,000
Accrued interest                                                   $ 2,000
Notes payable                                             20,000 $ 22,000    
Parabellum [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                                                 $ 1,850,000  
Notes payable                                           2,550,000        
Vox [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                                       $ 485,000            
Interest rate                                       7.00%            
Notes payable                                           861,500 926,500      
Consulting fees                                           120,000        
R L T [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                                     $ 485,000              
Interest rate                                     7.00%              
Notes payable                                           861,500 $ 919,500      
Consulting fees                                           120,000        
Third Party Vendor [Member]                                                    
Debt Instrument [Line Items]                                                    
Original issue discount                                   $ 5,000                
Notes payable                                   36,000       $ 11,000        
Repayments of notes payable                                   $ 31,000                
Purchaser [Member]                                                    
Debt Instrument [Line Items]                                                    
Investment return description                                 Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default.                  
Accredited Investor [Member]                                                    
Debt Instrument [Line Items]                                                    
Original issue discount                               $ 150,000                    
Notes payable                               300,000                    
Repayments of notes payable                               $ 150,000                    
Convertible Note Payable [Member] | L G Capital Funding [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                                         $ 78,750          
Interest rate                                         8.00%          
Common stock issuable upon conversion                                           33,408,936 35,015,467      
Convertible Notes Payable                                             $ 48,610      
Convertible Note Payable [Member] | J M J Financial [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                                         $ 250,000          
Interest rate                                         10.00%          
Convertible Notes Payable                                             59,514      
Convertible Note Payable [Member] | Adar Alef L L C [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount           $ 150,000                                        
Interest rate           5.00%                                        
Convertible Note Payable [Member] | Leonite Capital [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                         $ 2,285,714                          
Interest rate                         8.00%                          
Convertible Notes Payable                                             $ 970,111      
Convertible Note Payable [Member] | GS Capital Partners [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                   $ 172,000   $ 2,285,714     $ 165,000                      
Interest rate                   10.00%   8.00%     10.00%                      
Maturity date                   Aug. 18, 2023         Feb. 20, 2021                      
Convertible Note Payable [Member] | Geneva Roth Remark Holdings [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount         $ 251,625                                          
Interest rate         8.00%                                          
Maturity date         Jun. 07, 2022                                          
Original issue discount         $ 22,875                                          
Purchase price         228,750                                          
Accrued interest         $ 20,130                                          
Convertible Note Payable [Member] | Sixth Street Lending [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount     $ 128,750 $ 103,750             $ 258,638                              
Interest rate     8.00% 8.00%             8.00%                              
Maturity date     Jun. 14, 2023 Feb. 03, 2023             Mar. 25, 2023                              
Convertible Note Payable [Member] | Gary Shover [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount   $ 75,000                                                
Interest rate   12.00%                                                
Maturity date   May 07, 2023                                                
Convertible Note Payable [Member] | Ronal Minor [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount $ 25,000                                                  
Interest rate 12.00%                                                  
Maturity date Jun. 14, 2023                                                  
Convertible Note Payable [Member] | Harbor Gates Capital [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                           $ 165,000                        
Interest rate                           10.00%                        
Maturity date                           May 17, 2021                        
Convertible Note Payable [Member] | First Fire Global Opportunity [Member]                                                    
Debt Instrument [Line Items]                                                    
Interest rate               10.00% 10.00%                                  
Maturity date               Apr. 06, 2021 Feb. 10, 2020                                  
Convertible Note Payable [Member] | Power Up Lending Group [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount               $ 53,000                                    
Convertible Note Payable [Member] | G H S Investments [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount                 $ 335,000                                  
P P P [Member]                                                    
Debt Instrument [Line Items]                                                    
Principal amount             $ 103,125                                      
Interest rate             1.00%                                      
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details) - $ / shares
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Weighted Average Number Outstanding 66,446,875 78,346,875
Number Exercisable 66,446,875 78,346,875
Range 1 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 12,000,000 5,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 6 months
Weighted Average Exercise Price $ 0.01 $ 0.004
Number Exercisable 12,000,000 5,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 2 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 3,750,000
Outstanding Remaining Contractual Life (in yrs) 4 years 1 month 6 days 2 years 1 month 6 days
Weighted Average Exercise Price $ 0.01 $ 0.002
Number Exercisable 1,000,000 3,750,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 3 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 12,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 2 months 12 days 2 years
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 12,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 4 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 2,500,000
Outstanding Remaining Contractual Life (in yrs) 4 years 3 months 18 days 2 years 9 months 18 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 2,500,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 5 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 10,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 4 months 24 days 8 years 2 months 12 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 10,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 6 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 20,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 6 months 8 years 3 months 18 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 20,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 7 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 2,096,875
Outstanding Remaining Contractual Life (in yrs) 4 years 7 months 6 days 3 years 7 months 6 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 2,096,875
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 8 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 12,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 8 months 12 days 5 years
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 12,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 9 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 9 months 18 days 5 years 1 month 6 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 10 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 10 months 24 days 5 years 2 months 12 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 11 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 5 years 5 years 3 months 18 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 12 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 1,000,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 5 years 1 month 6 days 5 years 4 months 24 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 1,000,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 13 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 10,000,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 9 years 5 years 6 months
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 10,000,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 14 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 20,000,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 8 years 5 years 7 months 6 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 20,000,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 15 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.03 $ 0.01
Weighted Average Number Outstanding 2,096,875 1,000,000
Outstanding Remaining Contractual Life (in yrs) 1 year 5 years 8 months 12 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 2,096,875 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 16 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 10,750,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 4 years 9 months 18 days 5 years 9 months 18 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 10,750,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 17 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 500,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 3 years 5 years 10 months 24 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 500,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 18 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price $ 0.01 $ 0.01
Weighted Average Number Outstanding 100,000 1,000,000
Outstanding Remaining Contractual Life (in yrs) 3 years 5 years 1 month 6 days
Weighted Average Exercise Price $ 0.01 $ 0.01
Number Exercisable 100,000 1,000,000
Weighted Average Exercise Price $ 0.01 $ 0.01
Range 19 [Member]    
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]    
Exercise Price   $ 0.01
Weighted Average Number Outstanding   1,000,000
Outstanding Remaining Contractual Life (in yrs)   5 years 1 month 6 days
Weighted Average Exercise Price   $ 0.01
Number Exercisable   1,000,000
Weighted Average Exercise Price   $ 0.01
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS' EQUITY (Details 1)
12 Months Ended
Dec. 31, 2022
shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Number of Shares 5,000,000
Vested 4,875,000
Unvested
Forfeited 125,000
Mathew Kelley [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Date of Grant Apr. 17, 2013
Number of Shares 1,250,000
Vest from Apr. 30, 2013
Vest To Mar. 31, 2001
Vested 1,250,000
Unvested
Forfeited
Mathew Kelley 1 [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Date of Grant Apr. 17, 2013
Number of Shares 1,250,000
Vest from Feb. 28, 2014
Vest To Jan. 31, 2015
Vested 1,250,000
Unvested
Forfeited
Richard J Feldman [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Date of Grant Apr. 30, 2014
Number of Shares 500,000
Vest from Apr. 30, 2014
Vest To Mar. 30, 2015
Vested 500,000
Unvested
Forfeited
Richard J Feldman 1 [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Number of Shares 500,000
Vest from Apr. 30, 2015
Vest To Mar. 30, 2016
Vested 375,000
Unvested
Forfeited 125,000
Gary Gray  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Date of Grant Mar. 07, 2015
Number of Shares 1,000,000
Vest from Mar. 07, 2015
Vest To May 30, 2015
Vested 1,000,000
Unvested
Forfeited
Ross Trevino [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Date of Grant Mar. 07, 2015
Number of Shares 500,000
Vest from Mar. 07, 2015
Vest To May 30, 2015
Vested 500,000
Unvested
Forfeited
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (Details Narrative) - $ / shares
Dec. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Preferred stock, shares authorized 35,000,000 35,000,000
Preferred stock, par or stated value per share $ 0.001 $ 0.001
Preferred stock, shares outstanding 1,000,000 1,000,000
Common stock, shares authorized 2,000,000,000 2,000,000,000
Common stock, par value $ 0.001 $ 0.001
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net (Income) Loss - book $ 5,761,061  
Loss on disposal of fixed assets (97,555)  
Change in warrant liability (993,000) $ 1,782,000
Change in derivative (2,090,500)  
Debt discount amortization (1,089,902) $ (2,303,973)
Estimate loss - tax basis $ 1,490,104  
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 1) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Income tax expense at statutory federal rate of 21%, Amount $ 1,210,000  
Income tax expense at statutory federal rate of 21%, percent 21.00%  
Impairments, Amount $ (20,000)  
Impairments, percent 0.00%  
Change in warrant liability, Amount $ (209,000)  
Change in warrant liability, percent (4.00%)  
Change in derivative, Amount $ (439,000)  
Change in derivative, percent 8.00%  
Debt discount amortization, Amount $ (229,000)  
Debt discount amortization, percent (4.00%)  
Increase (decrease) in valuation allowance, Amount $ 313,000  
Increase (decrease) in valuation allowance, percent (21.00%)  
Company's effective tax rate, Amount
Company's effective tax rate, Percent 0.00%  
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details 2) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Net Operating Loss Carryforward $ 22,087,808 $ 21,774,808
NOL tax benefit 4,317,010 4,004,010
Total Deferred Tax Assets 4,317,010 4,004,010
Valuation allowance (4,317,010) (4,004,010)
Net Deferred Tax Assets
Activity [Member]    
Net Operating Loss Carryforward 313,000  
NOL tax benefit 313,000  
Total Deferred Tax Assets 313,000  
Valuation allowance (313,000)  
Net Deferred Tax Assets  
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.23.1
INCOME TAXES (Details Narrative)
Dec. 31, 2022
USD ($)
Income Tax Disclosure [Abstract]  
Operating loss carry forward $ 22,087,808
Deferred tax asset and valuation allowance $ 313,000
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]    
Compensation owed to related parties $ 57,099 $ 57,099
Jerry Gomolski    
Related Party Transaction [Line Items]    
Compensation owed to related parties 25,000 25,000
Charter 804CS    
Related Party Transaction [Line Items]    
Compensation owed to related parties 20,099 20,099
Gary Gray    
Related Party Transaction [Line Items]    
Compensation owed to related parties $ 12,000 $ 12,000
XML 52 R41.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details 1)
12 Months Ended
Dec. 31, 2022
USD ($)
Related Party Transaction [Line Items]  
Balance at Beginning $ 90,834
2022 Salary 300,000
Payments (248,837)
Balance at Ending (141,997)
William Delgado Member  
Related Party Transaction [Line Items]  
Balance at Beginning 0.00
2022 Salary 240,000
Payments (218,837)
Balance at Ending (21,163)
Jerome Gomolski [Member]  
Related Party Transaction [Line Items]  
Balance at Beginning 90,834
2022 Salary 60,000
Payments (30,000)
Balance at Ending $ (120,834)
XML 53 R42.htm IDEA: XBRL DOCUMENT v3.23.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Related Party Transaction [Line Items]    
Employee-related liabilities, current $ 3,281 $ 50,000
Advance from related party for operating expenses $ 140,000  
Eco growth repayment Eco Growth repaid The Company approximately $270,000in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000.  
Mr Delgado [Member]    
Related Party Transaction [Line Items]    
Repayments of debt   390,000
Reimbursed amount   55,000
William J Delgado [Member]    
Related Party Transaction [Line Items]    
Accrued compensation $ 0  
Jerome Gomolski [Member]    
Related Party Transaction [Line Items]    
Accrued compensation   90,834
Mr. Delgado [Member]    
Related Party Transaction [Line Items]    
Accrued compensation 21,000  
Advance from related party for operating expenses 9,000  
William Delgado Member    
Related Party Transaction [Line Items]    
Employee-related liabilities, current $ 3,300 $ 50,000
XML 54 R43.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details) - shares
1 Months Ended 12 Months Ended
Mar. 07, 2023
Mar. 02, 2023
Feb. 08, 2023
Feb. 07, 2023
Feb. 06, 2023
Jun. 30, 2023
Apr. 18, 2023
Mar. 27, 2023
Mar. 17, 2023
Feb. 23, 2023
Feb. 21, 2023
Jan. 26, 2023
Dec. 31, 2022
Subsequent Event [Line Items]                          
Shares issued                         115,958,182
Share outstanding                         798,168,896
Total share issued                         914,127,078
Subsequent Event [Member] | Sixth Street Lending [Member]                          
Subsequent Event [Line Items]                          
Subsequent event category                       Settlemement Agreement  
Subsequent event description                       The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.    
Subsequent Event [Member] | Fourth Man L L C [Member]                          
Subsequent Event [Line Items]                          
Subsequent event category          Promissory Note                
Subsequent event description          On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date.                
Subsequent Event [Member] | GS Capital Partners, LLC [Member]                          
Subsequent Event [Line Items]                          
Subsequent event category  Notice of Conversion      Notice of Conversion        Notice of Conversion    Notice of Conversion      
Subsequent event description On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.     On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.       On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.   On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.      
Shares issued 10,163,288     6,736,045       10,831,096   8,227,753      
Subsequent Event [Member] | Leonite Capital L L C [Member]                          
Subsequent Event [Line Items]                          
Subsequent event category    Notice of Conversion  Notice of Conversion      Second Amendment to Senior Secured Convertible Promissory Note  Notice of Conversion    Notice of Conversion    Notice of Conversion    
Subsequent event description   On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.     Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common   On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common   On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.    
Shares issued   20,000,000 10,000,000       15,000,000   20,000,000   15,000,000    
XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.1
SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)
Jan. 12, 2023
Jan. 04, 2023
Leonite Capital L L C [Member]    
Subsequent Event [Line Items]    
Debt instrument, interest rate during period   8.00%
Long-Term Debt, Gross   $ 41,666
Original issue discount   $ 4,166
GS Capital Partners, LLC [Member]    
Subsequent Event [Line Items]    
Debt instrument, interest rate during period 8.00%  
Principal amount $ 41,667  
Maturity date Jan. 12, 2024  
Number of warrant purchase 5,000,000  
XML 56 gdsi-20221231_10k_htm.xml IDEA: XBRL DOCUMENT 0001011662 2022-01-01 2022-12-31 0001011662 2022-09-30 0001011662 2022-12-31 0001011662 2021-12-31 0001011662 2021-01-01 2021-12-31 0001011662 us-gaap:CommonStockMember 2020-12-31 0001011662 us-gaap:PreferredStockMember 2020-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001011662 gdsi:SharesPayableMember 2020-12-31 0001011662 us-gaap:RetainedEarningsMember 2020-12-31 0001011662 2020-12-31 0001011662 us-gaap:CommonStockMember 2021-12-31 0001011662 us-gaap:PreferredStockMember 2021-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001011662 gdsi:SharesPayableMember 2021-12-31 0001011662 us-gaap:RetainedEarningsMember 2021-12-31 0001011662 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001011662 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001011662 gdsi:SharesPayableMember 2021-01-01 2021-12-31 0001011662 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001011662 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001011662 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001011662 gdsi:SharesPayableMember 2022-01-01 2022-12-31 0001011662 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001011662 us-gaap:CommonStockMember 2022-12-31 0001011662 us-gaap:PreferredStockMember 2022-12-31 0001011662 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001011662 gdsi:SharesPayableMember 2022-12-31 0001011662 us-gaap:RetainedEarningsMember 2022-12-31 0001011662 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-12-31 0001011662 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001011662 us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001011662 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001011662 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001011662 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001011662 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001011662 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001011662 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2021-12-31 0001011662 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2020-12-31 0001011662 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2022-01-01 2022-12-31 0001011662 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2021-01-01 2021-12-31 0001011662 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeMember 2022-12-31 0001011662 2020-01-01 2020-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2015-01-01 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2021-01-01 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2022-01-01 2022-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LGCapitalFundingMember 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:JMJFinancialMember 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:JMJFinancialMember 2015-01-01 2015-01-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:JMJFinancialMember 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:AdarAlefLLCMember 2020-08-05 0001011662 gdsi:ConvertibleNotePayableMember gdsi:AdarAlefLLCMember 2020-08-01 2020-08-05 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LeoniteCapitalMember 2021-02-01 2021-02-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LeoniteCapitalMember 2021-02-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:LeoniteCapitalMember 2021-12-31 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2021-03-01 2021-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2021-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GenevaRothRemarkHoldingsMember 2021-06-01 2021-06-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GenevaRothRemarkHoldingsMember 2021-06-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-02-01 2022-02-03 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-02-03 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-03-01 2022-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-03-25 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-06-01 2022-06-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:SixthStreetLendingMember 2022-06-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2022-08-01 2022-08-18 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2022-08-18 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GaryShoverMember 2022-11-01 2022-11-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GaryShoverMember 2022-11-07 0001011662 gdsi:ConvertibleNotePayableMember gdsi:RonalMinorMember 2022-12-01 2022-12-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:RonalMinorMember 2022-12-14 0001011662 gdsi:ConvertibleNotePayableMember gdsi:HarborGatesCapitalMember 2020-08-01 2020-08-17 0001011662 gdsi:ConvertibleNotePayableMember gdsi:HarborGatesCapitalMember 2020-08-17 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2020-05-01 2020-05-20 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GSCapitalPartnersMember 2020-05-20 0001011662 gdsi:ConvertibleNotePayableMember gdsi:FirstFireGlobalOpportunityMember 2020-04-01 2020-04-06 0001011662 gdsi:ConvertibleNotePayableMember gdsi:PowerUpLendingGroupMember 2020-04-06 0001011662 gdsi:ConvertibleNotePayableMember gdsi:FirstFireGlobalOpportunityMember 2019-05-01 2019-05-10 0001011662 gdsi:ConvertibleNotePayableMember gdsi:GHSInvestmentsMember 2019-05-10 0001011662 gdsi:WilliamDelgadoMember 2017-08-31 0001011662 gdsi:WilliamDelgadoMember 2018-08-31 0001011662 gdsi:WilliamDelgadoMember 2021-12-31 0001011662 gdsi:ParabellumMember 2017-12-22 0001011662 gdsi:ParabellumMember 2022-12-31 0001011662 gdsi:VoxMember 2017-12-23 0001011662 gdsi:VoxMember 2017-12-01 2017-12-23 0001011662 gdsi:VoxMember 2022-01-01 2022-12-31 0001011662 gdsi:VoxMember 2022-12-31 0001011662 gdsi:VoxMember 2021-12-31 0001011662 gdsi:RLTMember 2017-12-26 0001011662 gdsi:RLTMember 2017-12-01 2017-12-26 0001011662 gdsi:RLTMember 2022-01-01 2022-12-31 0001011662 gdsi:RLTMember 2022-12-31 0001011662 gdsi:RLTMember 2021-12-31 0001011662 gdsi:ThirdPartyVendorMember 2018-04-30 0001011662 gdsi:ThirdPartyVendorMember 2018-04-01 2018-04-30 0001011662 gdsi:ThirdPartyVendorMember 2022-12-31 0001011662 gdsi:PurchaserMember 2018-05-01 2018-05-31 0001011662 gdsi:AccreditedInvestorMember 2018-06-30 0001011662 gdsi:AccreditedInvestorMember 2018-06-01 2018-06-30 0001011662 gdsi:PPPMember 2020-05-01 2020-05-12 0001011662 gdsi:PPPMember 2020-05-12 0001011662 gdsi:Range1Member 2022-12-31 0001011662 gdsi:Range1Member 2022-01-01 2022-12-31 0001011662 gdsi:Range2Member 2022-12-31 0001011662 gdsi:Range2Member 2022-01-01 2022-12-31 0001011662 gdsi:Range3Member 2022-12-31 0001011662 gdsi:Range3Member 2022-01-01 2022-12-31 0001011662 gdsi:Range4Member 2022-12-31 0001011662 gdsi:Range4Member 2022-01-01 2022-12-31 0001011662 gdsi:Range5Member 2022-12-31 0001011662 gdsi:Range5Member 2022-01-01 2022-12-31 0001011662 gdsi:Range6Member 2022-12-31 0001011662 gdsi:Range6Member 2022-01-01 2022-12-31 0001011662 gdsi:Range7Member 2022-12-31 0001011662 gdsi:Range7Member 2022-01-01 2022-12-31 0001011662 gdsi:Range8Member 2022-12-31 0001011662 gdsi:Range8Member 2022-01-01 2022-12-31 0001011662 gdsi:Range9Member 2022-12-31 0001011662 gdsi:Range9Member 2022-01-01 2022-12-31 0001011662 gdsi:Range10Member 2022-12-31 0001011662 gdsi:Range10Member 2022-01-01 2022-12-31 0001011662 gdsi:Range11Member 2022-12-31 0001011662 gdsi:Range11Member 2022-01-01 2022-12-31 0001011662 gdsi:Range12Member 2022-12-31 0001011662 gdsi:Range12Member 2022-01-01 2022-12-31 0001011662 gdsi:Range13Member 2022-12-31 0001011662 gdsi:Range13Member 2022-01-01 2022-12-31 0001011662 gdsi:Range14Member 2022-12-31 0001011662 gdsi:Range14Member 2022-01-01 2022-12-31 0001011662 gdsi:Range15Member 2022-12-31 0001011662 gdsi:Range15Member 2022-01-01 2022-12-31 0001011662 gdsi:Range16Member 2022-12-31 0001011662 gdsi:Range16Member 2022-01-01 2022-12-31 0001011662 gdsi:Range17Member 2022-12-31 0001011662 gdsi:Range17Member 2022-01-01 2022-12-31 0001011662 gdsi:Range18Member 2022-12-31 0001011662 gdsi:Range18Member 2022-01-01 2022-12-31 0001011662 gdsi:Range1Member 2021-12-31 0001011662 gdsi:Range1Member 2021-01-01 2021-12-31 0001011662 gdsi:Range2Member 2021-12-31 0001011662 gdsi:Range2Member 2021-01-01 2021-12-31 0001011662 gdsi:Range3Member 2021-12-31 0001011662 gdsi:Range3Member 2021-01-01 2021-12-31 0001011662 gdsi:Range4Member 2021-12-31 0001011662 gdsi:Range4Member 2021-01-01 2021-12-31 0001011662 gdsi:Range5Member 2021-12-31 0001011662 gdsi:Range5Member 2021-01-01 2021-12-31 0001011662 gdsi:Range6Member 2021-12-31 0001011662 gdsi:Range6Member 2021-01-01 2021-12-31 0001011662 gdsi:Range7Member 2021-12-31 0001011662 gdsi:Range7Member 2021-01-01 2021-12-31 0001011662 gdsi:Range8Member 2021-12-31 0001011662 gdsi:Range8Member 2021-01-01 2021-12-31 0001011662 gdsi:Range9Member 2021-12-31 0001011662 gdsi:Range9Member 2021-01-01 2021-12-31 0001011662 gdsi:Range10Member 2021-12-31 0001011662 gdsi:Range10Member 2021-01-01 2021-12-31 0001011662 gdsi:Range11Member 2021-12-31 0001011662 gdsi:Range11Member 2021-01-01 2021-12-31 0001011662 gdsi:Range12Member 2021-12-31 0001011662 gdsi:Range12Member 2021-01-01 2021-12-31 0001011662 gdsi:Range13Member 2021-12-31 0001011662 gdsi:Range13Member 2021-01-01 2021-12-31 0001011662 gdsi:Range14Member 2021-12-31 0001011662 gdsi:Range14Member 2021-01-01 2021-12-31 0001011662 gdsi:Range15Member 2021-12-31 0001011662 gdsi:Range15Member 2021-01-01 2021-12-31 0001011662 gdsi:Range16Member 2021-12-31 0001011662 gdsi:Range16Member 2021-01-01 2021-12-31 0001011662 gdsi:Range17Member 2021-12-31 0001011662 gdsi:Range17Member 2021-01-01 2021-12-31 0001011662 gdsi:Range18Member 2021-12-31 0001011662 gdsi:Range18Member 2021-01-01 2021-12-31 0001011662 gdsi:Range19Member 2021-12-31 0001011662 gdsi:Range19Member 2021-01-01 2021-12-31 0001011662 gdsi:MathewKelleyMember 2022-01-01 2022-12-31 0001011662 gdsi:MathewKelley1Member 2022-01-01 2022-12-31 0001011662 gdsi:RichardJFeldmanMember 2022-01-01 2022-12-31 0001011662 gdsi:RichardJFeldman1Member 2022-01-01 2022-12-31 0001011662 gdsi:GaryGrayMember 2022-01-01 2022-12-31 0001011662 gdsi:RossTrevinoMember 2022-01-01 2022-12-31 0001011662 gdsi:ActivityMember 2022-12-31 0001011662 gdsi:Mr.DelgadoMember 2022-12-31 0001011662 gdsi:MrDelgadoMember 2021-01-01 2021-12-31 0001011662 gdsi:WilliamDelgadoMember 2022-12-31 0001011662 gdsi:WilliamJDelgadoMember 2022-12-31 0001011662 gdsi:JeromeGomolskiMember 2021-12-31 0001011662 gdsi:JerryGomolskiMember 2022-12-31 0001011662 gdsi:JerryGomolskiMember 2021-12-31 0001011662 gdsi:Charter804CSMember 2022-12-31 0001011662 gdsi:Charter804CSMember 2021-12-31 0001011662 gdsi:GaryGrayMember 2022-12-31 0001011662 gdsi:GaryGrayMember 2021-12-31 0001011662 gdsi:JeromeGomolskiMember 2021-12-31 0001011662 gdsi:WilliamDelgadoMember 2022-01-01 2022-12-31 0001011662 gdsi:JeromeGomolskiMember 2022-01-01 2022-12-31 0001011662 gdsi:JeromeGomolskiMember 2022-12-31 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-04 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-01-04 0001011662 gdsi:GSCapitalPartnersLLCMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-12 0001011662 gdsi:GSCapitalPartnersLLCMember us-gaap:SubsequentEventMember 2023-01-12 0001011662 gdsi:SixthStreetLendingMember us-gaap:SubsequentEventMember 2023-01-01 2023-01-26 0001011662 gdsi:FourthManLLCMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-06 0001011662 gdsi:GSCapitalPartnersLLCMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-07 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-08 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-21 0001011662 gdsi:GSCapitalPartnersLLCMember us-gaap:SubsequentEventMember 2023-02-01 2023-02-23 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-02-27 2023-03-02 0001011662 gdsi:GSCapitalPartnersLLCMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-07 0001011662 gdsi:GSCapitalPartnersLLCMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-27 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-06-01 2023-06-30 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-04-01 2023-04-18 0001011662 gdsi:LeoniteCapitalLLCMember us-gaap:SubsequentEventMember 2023-03-01 2023-03-17 iso4217:USD shares iso4217:USD shares pure 0001011662 false 2022 FY 10-K true 2022-12-31 --12-31 false 000-26361 GLOBAL DIGITAL SOLUTIONS, INC. NJ 22-3392051 777 South Flagler Drive Suite 800 West Tower West Palm Beach FL 33401 (561) 515-6163 No No Yes No Non-accelerated Filer true false false 18278068 798168896 None. Turner, Stone & Company, L.L.P 76 Dallas, Texas 1043 98800 1043 98800 80914 22500 17773 33009 64547 200970 1043 299770 363402 361813 2028801 1481910 50233 3281 50000 11187 11187 3421000 809000 1599000 606000 246470 652178 3992396 3310662 4607125 4627000 16076425 11257572 103125 16076425 11360697 0.001 0.001 35000000 35000000 1000000 1000000 1000000 1000000 1000 1000 0.001 0.001 2000000000 800543896 800543896 737263858 737263858 800544 737264 38233710 37370384 180000 -55110636 -49349575 -16075382 -11060927 1043 299770 427132 2240437 427132 2240437 -427132 -2240437 -2090500 7348389 -993000 1782000 -97555 315000 63000 -1000866 -2008670 1089902 2303973 -12000 -62106 -5333929 4451746 -5761061 2211309 800543896 737263858 1420563361 668338264 668338 1000000 1000 34086086 -51560884 -16805460 50619573 50620 1027933 1078553 8000000 8000 384000 392000 5000000 5000 279500 180000 464500 1602171 1602171 5306021 5306 -9306 -4000 2211309 2211309 737263858 737264 1000000 1000 37370384 180000 -49349575 -11060927 58280038 58280 568326 626606 5000000 5000 175000 -180000 120000 120000 -5761061 -5761061 800543896 800544 1000 38233710 -55110636 -16075382 -5761061 2211309 12695 1089901 2303945 -2090500 7348389 -993000 1782000 464500 -123000 240000 881000 176536 250000 251169 -62105 97556 17795 -22500 22500 -315000 10204 1588 -124780 576081 203356 -251291 -523125 -2639564 -138917 -138917 100000 125000 575000 3403750 306981 540650 -46719 242985 564285 2738100 -97757 98536 98800 264 1043 98800 -27176 253000 -641500 386823 -120000 -4000 1507000 -42693 -490214 -557760 -743583 5306 1743908 -27176 53000 564501 1078552 53000 -180000 -4000 29449 <p id="xdx_800_eus-gaap--NatureOfOperations_zamRWtagGzg9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_829_zS7z7D2t9ew3">DESCRIPTION OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We were incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation (“Global”). The merger was treated as a recapitalization of Global, and Creative changed its name to Global Digital Solutions, Inc. (“the Company”, “we”), Global provided structured cabling design, installation and maintenance for leading information technology companies, federal, state and local government, major businesses, educational institutions, and telecommunication companies. On May 1, 2012, we made the decision to wind down our operations in the telecommunications area and to refocus our efforts in the area of cyber arms technology and complementary security and technology solutions. From August 2012 through November 2013, we were actively involved in managing Airtronic USA, Inc., and effective as of June 16, 2014, we acquired North American Custom Specialty Vehicles (“NACSV”). In July 2014, we announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead our efforts overseas. The Company had limited operations from the NACSV subsidiary from December 31, 2015, until May 13, 2016. During the interim, the Company was pursuing acquisition opportunities and responding to the litigation with the Securities and Exchange Commission. Subsequent to May 13, 2016, the Company has been seeking acquisitions and additional financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March of 2019, the Company acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA is developing an updated version of the system known as Pilot Assisted Landing Systems (PALS).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_80B_eus-gaap--SignificantAccountingPoliciesTextBlock_zeSqt7sAQ4pi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 - <span id="xdx_82C_zgONLajjARqa">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zdeyNzahzN12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zTZmYR47Y8b">Going Concern</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $<span id="xdx_909_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20220101__20221231_znA72Uw3VHv7" title="Net loss">5,761,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">used net cash of $<span id="xdx_907_ecustom--OperatingActivities_pp0p0_c20220101__20221231_zpYnXwu3Rzml" title="Operating activities">523,125 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to fund operating activities. On December 31, 2022, we had cash of $<span id="xdx_902_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20221231_zH5o95ca1fgd" title="Cash">1,043 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20221231_zDelQ1psTlhe" title="Accumulated deficit">55,110,636 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20221231_z7PvqDzGsyr9" title="Working capital deficit">16,076,425 </span> and stockholders’ deficit of $<span id="xdx_90B_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20221231_zNxbCzRZ8Bu8" title="Stockholders' deficit">16,075,382</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. We have funded our activities to date almost exclusively from equity and debt financings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zcSa719FHajf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zKPPyJRQrU16">Principles of Consolidation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zFnoJPi0tIQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zWonb74GOvXk">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zE0NVILI9XI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zn8mVrScBn5f">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zICLmz0JdRVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zOzyDPYHbyYk">Cash and Cash Equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.<i> </i>We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--PrepaidExpensesPolicyTextBlock_z3R8lDhPKzi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zHinlUzDguVh">Prepaid expenses</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z5Ho2AYtmAf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zHxiC7a6aQFb"><span id="xdx_86F_zGoSZNZn7zzd">Fair Value of Financial Instruments</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The three levels of the fair value hierarchy defined by ASC 820 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Level 1 – Quoted prices in active markets for identical assets or liabilities</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Level 3 – Significant unobservable inputs that cannot be corroborated by market data.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--DerivativesPolicyTextBlock_zXcOTE3cWC7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zAhGFwh7B1mg">Derivative Financial Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, <i>“Derivatives and Hedging”</i>. Subtopic ASC 815-15, <i>Embedded Derivatives</i> generally requires companies to bifurcate conversion options embedded in the convertible notes from their host instruments and to account for them as free standing derivative financial instruments. Derivative liabilities are recognized in the consolidated balance sheet at fair value as <i>Derivative Liabilities</i> and based on the criteria specified in FASB ASC 815-40, <i>Derivatives and Hedging – Contracts in Entity’s own Equity</i>. The estimated fair value of the derivative liabilities is calculated using various assumptions and such estimates are revalued at each balance sheet date, with changes recorded to other income or expense as <i>Change in fair value of derivative liability</i> in the consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the instrument origination date and reviewed at the end of each event date (i.e. conversions, payments, etc.) and the measurement period end date for financial reporting. See Note 4 Fair Value Measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zRJL7lpjzSBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_z88cC6NuyMQ3">Earnings (Loss) Per Share (“EPS”)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zHIzWt4zJnXj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_z0klchAFr5T9" style="display: none">Securities excluded from the diluted per share calculation</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Convertible notes and accrued interest</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zqUrZknQmkth" style="color: rgb(204,238,255); width: 10%; text-align: right" title="Potentially dilutive securities"><span style="color: Black">268,563,014 </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd" style="width: 10%; text-align: right" title="Potentially dilutive securities">361,265,001</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred Stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="text-align: right" title="Potentially dilutive securities">296,201,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="text-align: right" title="Potentially dilutive securities">227,787,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Potentially dilutive securities">12,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Potentially dilutive securities">12,900,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">66,446,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">81,346,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Potentially dilutive securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">644,111,131</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">683,299,503</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zbl1nJ6X85G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zgANhn2V6xqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zfrojIScrAi8">Stock Based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50<i>.</i> The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the advisor, consultant or vendor is reached or (ii) the date at which the advisor, consultant or vendor’s performance is complete. In the case of equity instruments issued to advisors and consultants, the fair value of the equity instrument is recognized over the term of the advisor or consulting agreement. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zmYBgI7mBEy7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_z7uC8UTicNM1" style="display: none">Schedule of warranty liability</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><i>Warrant liability</i></td><td><i> </i></td> <td colspan="2"><i> </i></td><td><i> </i></td><td><i> </i></td> <td colspan="2"><i> </i></td><td><i> </i></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Warrant Liability balance at beginning of period</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20221231_zvv7gVLPM7V4" style="width: 10%; text-align: right" title="Warrant Liability balance at beginning of period">606,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20210101__20211231_zfFgf4NEEir2" style="width: 10%; text-align: right" title="Warrant Liability balance at beginning of period">560,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions to warrant liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition_iN_pp0p0_di_c20220101__20221231_zkEQujXlVPo" style="text-align: right" title="Additions to warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl0588">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition_iN_pp0p0_di_c20210101__20211231_zTYxFmsYk385" style="text-align: right" title="Additions to warrant liability">(1,736,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantLiabilityChangeInFairValue_c20220101__20221231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">993,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--WarrantLiabilityChangeInFairValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">1,782,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 3pt">Balance at end of period</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20221231_zSzjTdVWFN08" style="border-bottom: Black 3pt double; text-align: right" title="Balance at end of period">1,599,000</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zEqirJJmdCAl" style="border-bottom: Black 3pt double; text-align: right" title="Balance at end of period">606,000</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zmzT17Z3RxHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company's Common stock of $<span id="xdx_90F_eus-gaap--SharePrice_c20221231_pdd" title="Share price">0.0249</span>; a risk free interest rate of <span id="xdx_903_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_c20220101__20221231_pdd" title="Risk free interest rate">3.0%</span> and expected volatility of the Company's common stock of <span id="xdx_90B_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_c20220101__20221231_pdd" title="Volatility">173.54%</span>. <span id="xdx_909_ecustom--WarrantIssuancePercentage_c20220101__20221231_pdd" title="Warrant issuance percentage">185.9%</span> to <span id="xdx_90B_ecustom--WarrantIssuancePercentage_c20210101__20211231_pdd" title="Warrant issuance percentage">205.9%</span> and the remaining terms of each warrant issuance.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--ConvertibleInstrumentsPolicyTextBlock_z9jdhcpJqaij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zLPq5Ktu9Cmk">Convertible Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--ConvertibleSecuritiesPolicyTextBlock_zLOldjIuwXD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zqSdZMVf0XEe">Convertible Securities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zdeyNzahzN12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zTZmYR47Y8b">Going Concern</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $<span id="xdx_909_eus-gaap--NetIncomeLoss_iN_pp0p0_di_c20220101__20221231_znA72Uw3VHv7" title="Net loss">5,761,061 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">used net cash of $<span id="xdx_907_ecustom--OperatingActivities_pp0p0_c20220101__20221231_zpYnXwu3Rzml" title="Operating activities">523,125 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">to fund operating activities. On December 31, 2022, we had cash of $<span id="xdx_902_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_pp0p0_c20221231_zH5o95ca1fgd" title="Cash">1,043 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an accumulated deficit of $<span id="xdx_907_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pp0p0_di_c20221231_zDelQ1psTlhe" title="Accumulated deficit">55,110,636 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a working capital deficit of $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20221231_z7PvqDzGsyr9" title="Working capital deficit">16,076,425 </span> and stockholders’ deficit of $<span id="xdx_90B_eus-gaap--StockholdersEquity_iNI_pp0p0_di_c20221231_zNxbCzRZ8Bu8" title="Stockholders' deficit">16,075,382</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. We have funded our activities to date almost exclusively from equity and debt financings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -5761061 523125 1043 -55110636 16076425 -16075382 <p id="xdx_848_eus-gaap--ConsolidationPolicyTextBlock_zcSa719FHajf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zKPPyJRQrU16">Principles of Consolidation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--UseOfEstimates_zFnoJPi0tIQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zWonb74GOvXk">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--IncomeTaxPolicyTextBlock_zE0NVILI9XI3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zn8mVrScBn5f">Income Taxes</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zICLmz0JdRVd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zOzyDPYHbyYk">Cash and Cash Equivalents</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.<i> </i>We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--PrepaidExpensesPolicyTextBlock_z3R8lDhPKzi4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zHinlUzDguVh">Prepaid expenses</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z5Ho2AYtmAf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_zHxiC7a6aQFb"><span id="xdx_86F_zGoSZNZn7zzd">Fair Value of Financial Instruments</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The three levels of the fair value hierarchy defined by ASC 820 are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Level 1 – Quoted prices in active markets for identical assets or liabilities</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Level 3 – Significant unobservable inputs that cannot be corroborated by market data.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84C_eus-gaap--DerivativesPolicyTextBlock_zXcOTE3cWC7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zAhGFwh7B1mg">Derivative Financial Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, <i>“Derivatives and Hedging”</i>. Subtopic ASC 815-15, <i>Embedded Derivatives</i> generally requires companies to bifurcate conversion options embedded in the convertible notes from their host instruments and to account for them as free standing derivative financial instruments. Derivative liabilities are recognized in the consolidated balance sheet at fair value as <i>Derivative Liabilities</i> and based on the criteria specified in FASB ASC 815-40, <i>Derivatives and Hedging – Contracts in Entity’s own Equity</i>. The estimated fair value of the derivative liabilities is calculated using various assumptions and such estimates are revalued at each balance sheet date, with changes recorded to other income or expense as <i>Change in fair value of derivative liability</i> in the consolidated statement of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or equity, is evaluated at the instrument origination date and reviewed at the end of each event date (i.e. conversions, payments, etc.) and the measurement period end date for financial reporting. See Note 4 Fair Value Measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zRJL7lpjzSBj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_z88cC6NuyMQ3">Earnings (Loss) Per Share (“EPS”)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zHIzWt4zJnXj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_z0klchAFr5T9" style="display: none">Securities excluded from the diluted per share calculation</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Convertible notes and accrued interest</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zqUrZknQmkth" style="color: rgb(204,238,255); width: 10%; text-align: right" title="Potentially dilutive securities"><span style="color: Black">268,563,014 </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd" style="width: 10%; text-align: right" title="Potentially dilutive securities">361,265,001</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred Stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="text-align: right" title="Potentially dilutive securities">296,201,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="text-align: right" title="Potentially dilutive securities">227,787,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Potentially dilutive securities">12,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Potentially dilutive securities">12,900,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">66,446,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">81,346,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Potentially dilutive securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">644,111,131</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">683,299,503</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zbl1nJ6X85G6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zHIzWt4zJnXj" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8B7_z0klchAFr5T9" style="display: none">Securities excluded from the diluted per share calculation</span></td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center">Year Ended</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Convertible notes and accrued interest</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_zqUrZknQmkth" style="color: rgb(204,238,255); width: 10%; text-align: right" title="Potentially dilutive securities"><span style="color: Black">268,563,014 </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--ConvertibleNotesPayableMember_pdd" style="width: 10%; text-align: right" title="Potentially dilutive securities">361,265,001</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Preferred Stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="text-align: right" title="Potentially dilutive securities">296,201,242</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--PreferredStockMember_pdd" style="text-align: right" title="Potentially dilutive securities">227,787,627</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Stock options</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Potentially dilutive securities">12,900,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_pdd" style="text-align: right" title="Potentially dilutive securities">12,900,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">66,446,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">81,346,875</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Potentially dilutive securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220101__20221231_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">644,111,131</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Potentially dilutive securities">683,299,503</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 268563014 361265001 296201242 227787627 12900000 12900000 66446875 81346875 644111131 683299503 <p id="xdx_841_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zgANhn2V6xqe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zfrojIScrAi8">Stock Based Compensation</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50<i>.</i> The measurement date for the fair value of the equity instruments issued is determined at the earlier of (i) the date at which a commitment for performance by the advisor, consultant or vendor is reached or (ii) the date at which the advisor, consultant or vendor’s performance is complete. In the case of equity instruments issued to advisors and consultants, the fair value of the equity instrument is recognized over the term of the advisor or consulting agreement. Stock-based compensation related to non-employees is accounted for based on the fair value of the related stock or options or the fair value of the services, whichever is more readily determinable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zmYBgI7mBEy7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_z7uC8UTicNM1" style="display: none">Schedule of warranty liability</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><i>Warrant liability</i></td><td><i> </i></td> <td colspan="2"><i> </i></td><td><i> </i></td><td><i> </i></td> <td colspan="2"><i> </i></td><td><i> </i></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Warrant Liability balance at beginning of period</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20221231_zvv7gVLPM7V4" style="width: 10%; text-align: right" title="Warrant Liability balance at beginning of period">606,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20210101__20211231_zfFgf4NEEir2" style="width: 10%; text-align: right" title="Warrant Liability balance at beginning of period">560,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions to warrant liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition_iN_pp0p0_di_c20220101__20221231_zkEQujXlVPo" style="text-align: right" title="Additions to warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl0588">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition_iN_pp0p0_di_c20210101__20211231_zTYxFmsYk385" style="text-align: right" title="Additions to warrant liability">(1,736,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantLiabilityChangeInFairValue_c20220101__20221231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">993,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--WarrantLiabilityChangeInFairValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">1,782,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 3pt">Balance at end of period</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20221231_zSzjTdVWFN08" style="border-bottom: Black 3pt double; text-align: right" title="Balance at end of period">1,599,000</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zEqirJJmdCAl" style="border-bottom: Black 3pt double; text-align: right" title="Balance at end of period">606,000</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zmzT17Z3RxHe" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company's Common stock of $<span id="xdx_90F_eus-gaap--SharePrice_c20221231_pdd" title="Share price">0.0249</span>; a risk free interest rate of <span id="xdx_903_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate_c20220101__20221231_pdd" title="Risk free interest rate">3.0%</span> and expected volatility of the Company's common stock of <span id="xdx_90B_eus-gaap--ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate_c20220101__20221231_pdd" title="Volatility">173.54%</span>. <span id="xdx_909_ecustom--WarrantIssuancePercentage_c20220101__20221231_pdd" title="Warrant issuance percentage">185.9%</span> to <span id="xdx_90B_ecustom--WarrantIssuancePercentage_c20210101__20211231_pdd" title="Warrant issuance percentage">205.9%</span> and the remaining terms of each warrant issuance.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zmYBgI7mBEy7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B4_z7uC8UTicNM1" style="display: none">Schedule of warranty liability</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td><i>Warrant liability</i></td><td><i> </i></td> <td colspan="2"><i> </i></td><td><i> </i></td><td><i> </i></td> <td colspan="2"><i> </i></td><td><i> </i></td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Warrant Liability balance at beginning of period</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20220101__20221231_zvv7gVLPM7V4" style="width: 10%; text-align: right" title="Warrant Liability balance at beginning of period">606,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iS_pp0p0_c20210101__20211231_zfFgf4NEEir2" style="width: 10%; text-align: right" title="Warrant Liability balance at beginning of period">560,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Additions to warrant liability</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition_iN_pp0p0_di_c20220101__20221231_zkEQujXlVPo" style="text-align: right" title="Additions to warrant liability"><span style="-sec-ix-hidden: xdx2ixbrl0588">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition_iN_pp0p0_di_c20210101__20211231_zTYxFmsYk385" style="text-align: right" title="Additions to warrant liability">(1,736,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantLiabilityChangeInFairValue_c20220101__20221231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">993,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--WarrantLiabilityChangeInFairValue_c20210101__20211231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">1,782,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 3pt">Balance at end of period</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20220101__20221231_zSzjTdVWFN08" style="border-bottom: Black 3pt double; text-align: right" title="Balance at end of period">1,599,000</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iE_pp0p0_c20210101__20211231_zEqirJJmdCAl" style="border-bottom: Black 3pt double; text-align: right" title="Balance at end of period">606,000</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> 606000 560000 1736000 993000 1782000 1599000 606000 0.0249 0.030 1.7354 1.859 2.059 <p id="xdx_84A_ecustom--ConvertibleInstrumentsPolicyTextBlock_z9jdhcpJqaij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zLPq5Ktu9Cmk">Convertible Instruments</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--ConvertibleSecuritiesPolicyTextBlock_zLOldjIuwXD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zqSdZMVf0XEe">Convertible Securities</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80F_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_zFrO9BbXiPxh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span id="xdx_82D_zAipjoE2iWie">ACCRUED EXPENSES</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following amounts:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zOpc82PGq1Vl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zDK3WaLt5Sgj" style="display: none">Schedule of Accrued Expenses</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zs1S9ZrkeRbg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20211231_zqXA2RuCxfia" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedSalariesCurrent_iI_maCzPEf_znoKCL8hDiC9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Accrued compensation to executive officers</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">141,997</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90,834</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCzPEf_zs9jbaPLp0x2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued professional fees and settlements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,392</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InterestPayableCurrent_iI_maCzPEf_maCzRg4_zY4gyyT81Nse" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,812,914</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,304,684</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_mtCzPEf_zgu0N1RLHNT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 3pt">Total accrued expenses</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">2,028,801</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">1,481,910</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zOpc82PGq1Vl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - ACCRUED EXPENSES (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span id="xdx_8B1_zDK3WaLt5Sgj" style="display: none">Schedule of Accrued Expenses</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20221231_zs1S9ZrkeRbg" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49C_20211231_zqXA2RuCxfia" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedSalariesCurrent_iI_maCzPEf_znoKCL8hDiC9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left">Accrued compensation to executive officers</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">141,997</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">90,834</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--AccruedProfessionalFeesCurrent_iI_maCzPEf_zs9jbaPLp0x2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued professional fees and settlements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,890</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">86,392</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--InterestPayableCurrent_iI_maCzPEf_maCzRg4_zY4gyyT81Nse" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Accrued interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,812,914</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,304,684</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_mtCzPEf_zgu0N1RLHNT" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 3pt">Total accrued expenses</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">2,028,801</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">1,481,910</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> 141997 90834 73890 86392 1812914 1304684 2028801 1481910 <p id="xdx_807_eus-gaap--FairValueDisclosuresTextBlock_zWy47Y7Za2Je" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_824_z9RJkfFz4AIk">FAIR VALUE MEASUREMENTS</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We had no Level 1 or Level 2 assets and liabilities at December 31, 2022, and December 31, 2021. The Derivative liabilities are Level 3 fair value measurements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of activity of Level 3 liabilities during the years ended December 31, 2022, and 2021: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zqTnoYOlHhbi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zkaJQH7X6Qcg" style="display: none">Schedule of Fair Value of Liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zouQfSBk9Qp8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20210101__20211231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdE9bYHYkBf8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DerivativeLiabilitiesCurrent_iS_pp0p0_zeF7yGeqFrO7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%">Balance at beginning of period</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">809,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">9,367,159</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DerivativeLiabilityAdditions_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td>Additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">641,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DerivativeLiabilitySettlements_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Settlements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(120,000</td><td style="text-align: left">) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,580,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,090,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,244,159</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DerivativeLiabilitiesCurrent_iE_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 3pt">Balance at end of year</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">3,421,000</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">809,000</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Embedded Derivative Liabilities of Convertible Notes</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2022, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20220101__20221231_z0a8oRAoOTfk" title="Risk free interest rate">4.73</span>%; term — <span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231_z99RgCTevXG5" title="Term">1</span> years; volatility — <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_c20220101__20221231_z41HCcjfkvxk" title="Volatility">173.74</span>%; dividend rate —<span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231_z4L4y90frDwh" title="Dividend rate"> 0</span>%. At December 31, 2021, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_c20200101__20201231_z0DwcTeSKwg1" title="Risk free interest rate">0.08</span>2.45%; term — <span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20200101__20201231_zhr6YG2ZZ2Kk" title="Term">0.31</span>.25 years; volatility — dividend rate — <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20200101__20201231_zrkABMK1BIg7" title="Dividend rate">173.74</span>%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_888_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zqTnoYOlHhbi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - FAIR VALUE MEASUREMENTS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B5_zkaJQH7X6Qcg" style="display: none">Schedule of Fair Value of Liabilities</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20220101__20221231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zouQfSBk9Qp8" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_490_20210101__20211231__us-gaap--FinancialInstrumentAxis__us-gaap--DerivativeMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdE9bYHYkBf8" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DerivativeLiabilitiesCurrent_iS_pp0p0_zeF7yGeqFrO7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%">Balance at beginning of period</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">809,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">9,367,159</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DerivativeLiabilityAdditions_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td>Additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">641,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">266,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DerivativeLiabilitySettlements_i_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Settlements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(120,000</td><td style="text-align: left">) </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,580,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_i_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,090,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,244,159</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_406_eus-gaap--DerivativeLiabilitiesCurrent_iE_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 3pt">Balance at end of year</td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">3,421,000</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td style="border-bottom: Black 3pt double; text-align: right">809,000</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> 809000 9367159 641500 266000 -120000 -1580000 2090500 -7244159 3421000 809000 0.0473 P1Y 1.7374 0 0.0008 P0Y3M21D 1.7374 <p id="xdx_801_eus-gaap--DebtDisclosureTextBlock_ztzwxzEfDglg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 – <span id="xdx_82F_zJOonl7BZzch">NOTE PAYABLE</span></b>  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Convertible Note Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During January 2015, the Company entered into a one-year $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_c20150131__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LGCapitalFundingMember_pp0p0" title="Principal amount">78,750</span> convertible note payable with LG Capital Funding (LG). The note bears interest at <span id="xdx_90E_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20150101__20150131__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LGCapitalFundingMember_zBKQTgLD10Vc" title="Interest rate">8</span>% per annum and is convertible at any time at the option of LG into shares of our common stock at a conversion price equal to a 40% discount of the lowest closing bid price for 20 prior trading days including the notice of conversion date. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve four times the potential number of shares of common stock issuable upon conversion, or <span id="xdx_901_ecustom--CommonStockIssuableUponConversion_c20210101__20211231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LGCapitalFundingMember_zTKd6lfQpfDj" title="Common stock issuable upon conversion">35,015,467</span> and <span id="xdx_90D_ecustom--CommonStockIssuableUponConversion_c20220101__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LGCapitalFundingMember_zGRZZAnEWUm" title="Common stock issuable upon conversion"> 33,408,936</span> at December 31, 2022 and 2021, respectively. The Company defaulted on the note in January 2016. Additionally, as a result of declines in the fair value of the Company’s common stock, from time to time the Company did not have sufficient authorized shares to maintain this required four times share reserve. Accordingly, the note holder had the right to accelerate the repayment of the note and unpaid interest. In addition, LG has the right to require that additional shares and/or monies be paid in connection with the defaults. During December 2017, in settlement of default, the Company and LG entered into a Convertible Note Redemption Agreement under which the Company was to repay $68,110, $39,921 in unpaid principal outstanding at December 31, 2017, and $28,189 in accrued interest, in five payments through April 2018. Through April 2018, the Company repaid $6,500 of principal under the Convertible Note Redemption Agreement. The Company defaulted on the Convertible Note Redemption Agreement in April 2018 and the $28,189 in accrued interest was converted to principal. As of December 31, 2022, and through the date of this report, the principal balance totaling $<span id="xdx_903_eus-gaap--ConvertibleNotesPayable_c20211231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LGCapitalFundingMember_pp0p0" title="Convertible Notes Payable">48,610</span> is outstanding and remains in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During January 2015, the Company entered into a two-year convertible note payable for up to $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20150131__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JMJFinancialMember_pp0p0" title="Principal amount">250,000</span> with JMJ Financial (JMJ), of which $110,000 was funded between January and April 2015. The note was issued with an original issue discount of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20150101__20150131__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JMJFinancialMember_zggTIfV718ig" title="Interest rate">10</span>% of amounts funded, had a one-time 12% interest charge as it was not repaid within 90 days of the funding date, and is convertible at any time at the option of JMJ into shares of our common stock at the lesser of $0.075 per share or 60% of the average of the trading price in the 25 trading days prior to conversion. The embedded derivative liability associated with the conversion option of the note was bifurcated from the note and recorded at its fair value on the date of issuance and at each reporting date. The note requires the Company to reserve 26,650,000 shares of common stock. JMJ had the option to finance additional amounts up to the balance of the $250,000 during the term of the note. The Company defaulted on the note during January 2017. During December 2017, in settlement of default, the Company and JMJ entered into a Repayment Agreement under which the Company was to repay $84,514, $69,070 in unpaid principal outstanding at December 31, 2017, and $15,444 in accrued interest, in four payments through May 2018. Through May 2018, the Company repaid $25,000 of principal under the Repayment Agreement. The Company defaulted on the Repayment Agreement in May 2018 and the $15,444 in accrued interest was converted to principal. As of December 31, 2022, and through the date of this report, the principal balance totaling $<span id="xdx_90C_eus-gaap--ConvertibleNotesPayable_c20211231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JMJFinancialMember_pp0p0" title="Convertible Notes Payable">59,514</span> is outstanding and remains in default. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 7, 2020, the Company entered into a convertible promissory note arrangement with Actus Fund, LLC in the principal amount of $197,000. The principal amount of the note with interest at 12% is due on February 7, 2021. The note is convertible into shares of the Company’s common stock. The conversion price shall equal the lessor of (i) Current Market price or (ii) Variable Market price as defined as Market Price less a 50% discount price. As of December 31, 2022, and through the date of this report, the principal balance totaling $197,000 is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 5, 2020, The Company and Adar Alef, LLC entered into a security purchase agreement in the aggregate principal  of $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20200805__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AdarAlefLLCMember_pp0p0" title="Principal amount">150,000</span>. The notes shall contain a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200801__20200805__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AdarAlefLLCMember_z76k6JJLhdij" title="Interest rate">5</span>% OID such that the purchase price shall be $142,500. The note was paid off on May 12, 2021, by the CEO of the Company.   </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210201__20210225__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeoniteCapitalMember_zkmcs2wt0Um1" title="Interest rate">8</span>% convertible note in the aggregate principal of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_c20210225__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeoniteCapitalMember_pp0p0" title="Principal amount">2,285,714</span>. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of December 31, 2022, and through the date of this report, the principal balance totaling $<span id="xdx_900_eus-gaap--ConvertibleNotesPayable_iI_pp0p0_c20211231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LeoniteCapitalMember_zpoRh4MMYmO2" title="Convertible Notes Payable">970,111</span> is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2021, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a prime rate plus <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210301__20210325__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_zWPrmp0gFRl9" title="Interest rate">8</span>% convertible note in the aggregate principal of $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_c20210325__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_pp0p0" title="Principal amount">2,285,714</span>. The note shall be paid in one or more tranches. The maturity for each tranche shall be twelve-month period from advance date. The holder has the right at any time to convert all or any part of the outstanding principal into shares of common stock of the Company. The conversion price shall be a fixed conversion price of $0.06, which upon a default event, shall be equal to the lesser of (i) the fixed conversion price; (ii) or 70% of the lowest intraday price during the 21 days preceding the conversion request.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 1, 2021, the Company received the first tranche of $1,142,857 from GS Capital, LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received the second tranche as follows; May 24, 2021, $796,000, July 15, 2021, $90,000, and July 21, 2021, $208,500. As of December 31, 2022, and through the date of this report, the principal balance totaling $2,141,632 is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an <span id="xdx_90F_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20210601__20210607__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GenevaRothRemarkHoldingsMember_zxTGLi6PRL56" title="Interest rate">8</span>% promissory note in the aggregate principal of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20210607__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GenevaRothRemarkHoldingsMember_pp0p0" title="Principal amount">251,625</span>, with a maturity date of <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_c20210601__20210607__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GenevaRothRemarkHoldingsMember" title="Maturity date">June 7, 2022</span>. The note included a original issuance discount (“OID”) of $<span id="xdx_903_ecustom--OriginalIssueDiscount_c20210607__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GenevaRothRemarkHoldingsMember_pp0p0" title="Original issue discount">22,875</span>, for a purchase price of $<span id="xdx_90B_ecustom--PurchasePrice_c20210607__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GenevaRothRemarkHoldingsMember_pp0p0" title="Purchase price">228,750</span>. The interest was applied as a one- time interest charge upon the issuance date, in the amount of $<span id="xdx_90C_eus-gaap--InterestPayableCurrent_c20210607__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GenevaRothRemarkHoldingsMember_pp0p0" title="Accrued interest">20,130</span>, recognized in accrued interest. The monthly payments will include the outstanding principal and accrued interest, in 10 monthly payments of $27,175, with the first payment on July 30, 2021. Upon an event of default, as set forth in the agreement, the holder shall have the right to convert the outstanding balance of the note into shares of common stock of the Company, with a conversion rate based on 75% of the lowest trading price of the common stock for the 5 trading days prior to the conversion date. In addition, upon default, the interest increases to 22%, and any outstanding principal and accrued interest shall be increased by 150%. The Company is required at have authorized and reserved four times the number of shares that is actually issuable upon full conversion of the note, which was initially 29,494,505 shares. While the note is still outstanding the Company shall not, without written consent of the holder, issue any variable convertible instruments with a convertible price that varies with the market price of the Company’s common stock, nor shall the Company without the holder’s written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business.  In connection with the note, the Company issued 2,096,875 warrants, exercisable each at $03, with a 3-year term. The note was paid off by The Company on April 4, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220201__20220203__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zy0popck9T05">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% Convertible Note in the aggregate principal of $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220203__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_z93jIY4OJxZ6">103,750</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. is due on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20220201__20220203__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zul8hyC4xtVj">February 3, 2023</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $131,096 is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 25, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220301__20220325__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zZVnmofMoMid" title="Interest rate">8</span>% Convertible Note in the aggregate principal of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220325__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zK2GLPh6j1a9" title="Principal amount">258,638</span> is due on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20220301__20220325__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zQaY1jtUqJsj" title="Maturity date">March 25, 2023</span>. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 75% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $256,218 is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 14, 2022, the Company and Diagonal Leasing entered into a security purchase agreement for a <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20220601__20220614__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zbgm64CfTmNg" title="Interest rate">8</span>% Convertible Note in the aggregate principal of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220614__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zKxMUSwKZbE2" title="Principal amount">128,750</span> is due on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20220601__20220614__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SixthStreetLendingMember_zTcUcXmKcvWk" title="Maturity date">June 14, 2023</span>. The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $162,685 is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 18, 2022, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20220801__20220818__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_zWRs9IvGiYa4" title="Interest rate">10%</span> Convertible Note in the aggregate principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_iI_c20220818__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_zsjVHdDXO429" title="Principal amount">172,000</span>, is due on <span id="xdx_901_eus-gaap--DebtInstrumentMaturityDate_c20220801__20220818__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_zO2rVIV8oU7j" title="Maturity date">August 18, 2023</span>. The note is convertible into shares of common stock of the Company. The conversion price is equal to 70% of the lowest trading price of the Company’s Common Stock for the 20 trading dates immediately preceding the delivery of a notice of conversion. As of December 31, 2022, and through the date of this report, the principal balance totaling $172,000 is outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 7, 2022, the Company and Gary Shover, entered into a security purchase agreement for a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20221101__20221107__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryShoverMember_pdd" title="Interest rate">12%</span> Convertible Note in the aggregate principal of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_c20221107__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryShoverMember_pp0p0" title="Principal amount">75,000</span>, is due on <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20221101__20221107__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryShoverMember_zcIdGRyz9UVb" title="Maturity date">May 7, 2023</span>. The note is convertible into shares of common stock of the Company at a fixed Conversion rate of $0.139 per share. </span>The investor shall also receive warrants to purchase 500,000 common shares at $.0139 per share. As of December 31, 2022, and through the date of this report, the principal balance totaling $75,000 is outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On December 14, 2022, the Company and Ronal Minor entered into a security purchase agreement for a <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20221201__20221214__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RonalMinorMember_pdd" title="Interest rate">12%</span> Convertible Note in the aggregate principal of $<span id="xdx_90F_eus-gaap--DebtInstrumentFaceAmount_c20221214__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RonalMinorMember_pp0p0" title="Principal amount">25,000</span>, is due on <span id="xdx_905_eus-gaap--DebtInstrumentMaturityDate_c20221201__20221214__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RonalMinorMember" title="Maturity date">June 14, 2023</span>. The note is convertible into shares of common stock of the Company at a fixed Conversion rate of $0.139 per share. The investor shall also receive warrants to purchase 500,000 common shares at $.0139 per share. As of December 2022, and through the date of this report, the principal balance totaling $25,000 is outstanding.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 17, 2020, the Company and Harbor Gates entered into a security purchase agreement for a <span id="xdx_905_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200801__20200817__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HarborGatesCapitalMember_zQhGKgzjxfdg" title="Interest rate">10</span>% Convertible  Promissory Note in the aggregate principal of $<span id="xdx_90A_eus-gaap--DebtInstrumentFaceAmount_c20200817__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HarborGatesCapitalMember_pp0p0" title="Principal amount">165,000</span> due on <span id="xdx_90F_eus-gaap--DebtInstrumentMaturityDate_c20200801__20200817__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HarborGatesCapitalMember" title="Maturity date">May 17, 2021</span>. The note is convertible into shares of common stock of the Company. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 60% of the Market Price for the lowest two trading dates during a fifteen-day trading period ending on the latest complete. outstanding. The note was paid off on May 28, 2021, by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 20, 2020, the Company and GS Capital Partners, LLC entered into a <span id="xdx_90A_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200501__20200520__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_zP04sRNOpYKi" title="Interest rate">10</span>% Convertible Note in the aggregate principal of $<span id="xdx_903_eus-gaap--DebtInstrumentFaceAmount_c20200520__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember_pp0p0" title="Principal amount">165,000</span> due on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20200501__20200520__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GSCapitalPartnersMember" title="Maturity date">February 20, 2021</span>. The note can be converted into shares of common stock of the Company. at any time after the issue date. The note was paid off by the Company in the first and second quarters of 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 6, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a <span id="xdx_90C_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200401__20200406__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FirstFireGlobalOpportunityMember_zBqDdb0P8AU5" title="Interest rate">10</span>% Convertible Promissory Note in the aggregate principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20200406__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PowerUpLendingGroupMember_pp0p0" title="Principal amount">53,000</span> due on <span id="xdx_902_eus-gaap--DebtInstrumentMaturityDate_c20200401__20200406__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FirstFireGlobalOpportunityMember" title="Maturity date">April 6, 2021</span>. The note is convertible into shares of common stock of the Company. The note can be converted (180) days following the date of the note. The conversion price is equal to the Variable Conversion price which is defined as 61% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the conversion date. The note was paid off by the CEO of the Company see Note 9.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 10, 2019, the Company and GHS Investments LLC entered into a security agreement for a <span id="xdx_907_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20190501__20190510__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FirstFireGlobalOpportunityMember_zxeiNw7dmXy9" title="Interest rate">10</span>% Convertible Note in the aggregate principal of $<span id="xdx_90D_eus-gaap--DebtInstrumentFaceAmount_c20190510__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GHSInvestmentsMember_pp0p0" title="Principal amount">335,000</span> due on <span id="xdx_90E_eus-gaap--DebtInstrumentMaturityDate_c20190501__20190510__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleNotePayableMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--FirstFireGlobalOpportunityMember" title="Maturity date">February 10, 2020</span>. The note carries original issue discount or $35,000. The note is convertible into shares of common stock of the Company. The “Conversion Price” shall mean 60% multiplied by the Market Price (as defined herein), representing a discount rate of 40%. “Market Price” means the lowest Traded Price for the Common Stock during the twenty (20) Trading Day period ending on the latest complete Trading Day prior to the Conversion Date. The Company is required to maintain a common share reserve of not less than three times the number of shares that is actually issuable upon full conversion of the note. The purchaser will also receive warrants to purchase 5,000,000 shares of GDSI common stock at $.01/share. Warrants will have a three-year term to exercise. The Convertible Note is personally guaranteed by William Delgado, CEO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 11, 2021, interest on the note in the amount of $115,200.00 was converted into 8,000,000 shares of the Company’s common stock. The outstanding balance of $761,005, as of October 21, 2021, was converted into 25,500,000 shares of the Company’s common stock. The lender also received the 23,000,000 warrants. The Company recognized a gain of $844,797.00 on the conversions of June 11, 2021, and October 21, 2021. The fair value of the 25,500,000 shares issued was approximately $729,300.00</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Notes Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During August 2017, Dragon Acquisitions, a related entity owned by William Delgado, and an individual lender entered into a Promissory Note agreement for $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_c20170831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" title="Principal amount">20,000</span> as well as $<span id="xdx_908_eus-gaap--InterestPayableCurrent_c20170831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" title="Accrued interest">2,000</span> in interest to accrue through maturity on August 31, 2018 for a total of $<span id="xdx_900_eus-gaap--NotesPayable_c20180831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" title="Notes payable">22,000</span> due on August 31, 2018. Dragon Acquisition assumed payment of a payable of the Company and the Company took on the note. The Company defaulted on the note at maturity in August 2018. The $<span id="xdx_904_eus-gaap--NotesPayable_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" title="Notes payable">20,000</span> note remained outstanding at December 31, 2022 through the date of this report.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 22, 2017, the Company entered into a financing agreement with Parabellum, an accredited investor, for $1.2 million, amended in 2019 and increased to $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_c20171222__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ParabellumMember_pp0p0" title="Principal amount">1,850,000</span>. Under the terms of the agreement, the Company is to receive milestone payments based on the progress of the Company’s lawsuit (Note 6) for damages against Grupo Rontan Metalurgica, S.A (the “Lawsuit”). Such milestone payments consist of (i) an initial purchase price payment of $300,000, which the Company received on December 22, 2017, (ii) $150,000 within 30 days of the Lawsuit surviving a motion to dismiss on the primary claims, (iii) $100,000 within 30 days of the close of all discovery in the Lawsuit and (iv) $650,000 within 30 days of the Lawsuit surviving a motion for summary judgment and challenges on the primary claims. As part of the agreement, the Company shall pay the investor an investment return of 100% of the litigation proceeds to recoup all money invested, plus 27.5% of the total litigation proceeds received by the Company. $300,000 was received by the Company in December 2017. As of December 31, 2022, and through the date of this report, the $<span id="xdx_904_eus-gaap--NotesPayable_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ParabellumMember_pp0p0" title="Notes payable">2,550,000</span> note remains outstanding. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 23, 2017 (the “effective date”), the Company entered into a $<span id="xdx_90B_eus-gaap--DebtInstrumentFaceAmount_c20171223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VoxMember_pp0p0" title="Principal amount">485,000</span>, <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20171201__20171223__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VoxMember_z3iTkHLOVkZ2" title="Interest rate">7</span>% interest rate, demand promissory note with Vox Business Trust, LLC (Vox). The note was in settlement of the amounts accrued under a consulting agreement (Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to Vox when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, Vox may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$1,000 on the effective date.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$50,000 on the date on which discovery closes with respect to the lawsuit.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the Vox note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the years ended December 31, 2022, and 2021, consulting fees totaling $<span id="xdx_90C_ecustom--ConsultingFees_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VoxMember_pp0p0" title="Consulting fees">120,000</span> were added to the note principal and are included in the note balance. The note had a balance of $<span id="xdx_905_eus-gaap--NotesPayable_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VoxMember_pp0p0" title="Notes payable">861,500</span> and $<span id="xdx_902_eus-gaap--NotesPayable_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--VoxMember_pp0p0" title="Notes payable">926,500</span> as of December 31, 2022, and 2021, respectively. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 26, 2017 (the “effective date”), the Company entered into a $<span id="xdx_907_eus-gaap--DebtInstrumentFaceAmount_c20171226__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RLTMember_pp0p0" title="Principal amount">485,000</span>, <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20171201__20171226__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RLTMember_zWYKMHZJ5yw7" title="Interest rate">7</span>% interest rate, demand promissory note with RLT Consulting, Inc. (RLT), a related party. The note was in settlement of the amounts accrued under a consulting agreement (Note 6), consisting of $200,000 owed for retainer payments through December 2017, as well as $285,000 owed to RLT when the Resolution Progress Funding was met on December 22, 2017. As part of the agreement, RLT may not demand payment prior to the date of the Resolution Funding Date. The Company also agreed to grant 5,000,000 shares within 90 days of the Resolution Progress Funding Date and 10,000,000 shares within 90 days of the Resolution Funding Date. The 5,000,000 shares were issued on March 13, 2018. The Company shall make mandatory prepayment in the following amounts and at the following times –</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$1,000 on the effective date.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$50,000 on the date on which discovery closes with respect to the lawsuit.</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the RLT note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the year ended December 31, 2022, and 2021, consulting fees totaling $<span id="xdx_906_ecustom--ConsultingFees_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RLTMember_pp0p0" title="Consulting fees">120,000</span> were added to the note principal and are included in the note balance. The note had a balance of $<span id="xdx_903_eus-gaap--NotesPayable_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RLTMember_pp0p0" title="Notes payable">861,500</span> and $<span id="xdx_902_eus-gaap--NotesPayable_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RLTMember_pp0p0" title="Notes payable">919,500</span> as of December 31, 2022, and 2021, respectively. Through the date of this report, monthly consulting fees have not been repaid and continue to be added to the principal balance of the note. The note remains in default. RLT was granted a first priority security interest in the Litigation Proceeds and is pari passu to Parabellum and Vox. To that end, they share in the litigation in a priority position to proceed to repay the note.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During April 2018, the Company entered into a two-month $<span id="xdx_90A_eus-gaap--NotesPayable_c20180430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyVendorMember_pp0p0" title="Notes payable">36,000</span> note payable with $<span id="xdx_90B_eus-gaap--RepaymentsOfNotesPayable_c20180401__20180430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyVendorMember_pp0p0" title="Repayments of notes payable">31,000</span> in proceeds paid directly to a third-party vendor for expenses. The note did not bear interest and included a $<span id="xdx_902_ecustom--OriginalIssueDiscount_c20180430__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyVendorMember_pp0p0" title="Original issue discount">5,000</span> original issue discount. During June 2018, the Company defaulted on the note. As of December 31, 2022, and through the date of this report, the $<span id="xdx_90F_eus-gaap--NotesPayable_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--ThirdPartyVendorMember_pp0p0" title="Notes payable">11,000</span> note remained outstanding.   </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During May 2018, the <span id="xdx_90C_ecustom--InvestmentReturnDescription_c20180501__20180531__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--PurchaserMember" title="Investment return description">Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default.</span>  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During June 2018, the Company entered in to a one-year $<span id="xdx_90B_eus-gaap--NotesPayable_c20180630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_pp0p0" title="Notes payable">300,000</span> non-convertible note with an accredited investor with $<span id="xdx_908_ecustom--OriginalIssueDiscount_c20180630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_pp0p0" title="Original issue discount">150,000</span> original issue discount (“OID”) for net proceeds of $<span id="xdx_90D_eus-gaap--RepaymentsOfNotesPayable_c20180601__20180630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AccreditedInvestorMember_pp0p0" title="Repayments of notes payable">150,000</span>. As part of the note agreement, the Company also agreed to issue the investor 5,000,000 warrants at an exercise price of $0.01, exercisable for a period of three (3) years. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $35,000 of which $28,378 was recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.008 at issuance date; a risk-free interest rate of 2.62% and estimated volatility of the Company’s common stock of 218%. At December 31, 2019, the $300,000 note remained outstanding. The Company defaulted on the note at maturity in June 2019 and the note remained outstanding through the date of this report. The note contains a default interest rate of 10% plus a 5% penalty of the outstanding balance of the note. The note holder has voluntarily refrained from making demand for repayment under the default provisions of the note, which would require the Company to pay the holder 130% of the outstanding principal and interest accrued at the default rate. The Company paid off the note on March 10, 2021.  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The June 2018 note bears a personal guarantee by William Delgado, the Chief Executive Officer of the Company. As further security for the note, Mr. Delgado has also pledged the 1,000,000 Convertible Preferred Shares of the Company that he owns, as well as 5,000,000 common shares of SHMP, another public company in which Mr. Delgado is a director and Chief Financial Officer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 12, 2020, the Company and BBVA USA entered into a <span id="xdx_90B_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20200501__20200512__us-gaap--LongtermDebtTypeAxis__custom--PPPMember_zbgQxRk1FPgi" title="Interest rate">1</span>% SBA PPP, Promissory Note, in the aggregate principal of $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20200512__us-gaap--LongtermDebtTypeAxis__custom--PPPMember_pp0p0" title="Principal amount">103,125</span>. The note is payable in monthly payments of $5,805 beginning on December 12, 2020, ending on May 12, 2022. The Company has requested debt forgiveness from the SBA. As of December 31, 2022, and through the date of this report the SBA has not responded to the request and BBVA has waived the monthly payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 78750 0.08 35015467 33408936 48610 250000 0.10 59514 150000 0.05 0.08 2285714 970111 0.08 2285714 0.08 251625 2022-06-07 22875 228750 20130 0.08 103750 2023-02-03 0.08 258638 2023-03-25 0.08 128750 2023-06-14 0.10 172000 2023-08-18 0.12 75000 2023-05-07 0.12 25000 2023-06-14 0.10 165000 2021-05-17 0.10 165000 2021-02-20 0.10 53000 2021-04-06 0.10 335000 2020-02-10 20000 2000 22000 20000 1850000 2550000 485000 0.07 120000 861500 926500 485000 0.07 120000 861500 919500 36000 31000 5000 11000 Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default. 300000 150000 150000 0.01 103125 <p id="xdx_80A_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zb1XpdUnUom3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_824_zuqajlEs9A7k">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Proceedings</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may be involved in legal proceedings in the ordinary course of our business, and our management cannot predict the ultimate outcome of these legal proceedings with certainty. The Company is plaintiff or defendant in the following actions:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A.</i>  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”) and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price shall consist of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of a Finders Fees Agreement dated April 14, 2014, we have agreed to pay RLT Consulting Inc., a related party, a fee of 2% (two percent) of the Transaction Value, as defined in the agreement, of Rontan upon closing. The fee is payable one-half in cash and one-half in shares of our common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific conditions to closing consist of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">a)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Purchaser’s receipt of written limited assurance of an unqualified opinion with respect to Rontan’s audited financial statements for the years ended December 31, 2013 and 2014 (the “Opinion”);</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">b)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">The commitment of sufficient investment by General American Capital Partners LLC (the “Institutional Investor”), in the Purchaser following receipt of the Opinion;</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">c)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">The accuracy of each Parties’ representations and warranties contained in the SPSA;</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">d)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">The continued operation of Rontan’s business in the ordinary course;</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">e)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">The maintenance of all of Rontan’s bank credit lines in the maximum amount of R$200 million (approximately US$52 million) under the same terms and conditions originally agreed with any such financial institutions, and the maintenance of all other types of funding arrangements. As of the date of the SPSA, Rontan’s financial institution debt consists of not more than R$200 million (approximately US$52 million), trade debt of not more than R$50 million (approximately US$13 million) and other fiscal contingencies of not more that R$95 million (approximately US$24.7 million);</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">f)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Rontan shall enter into employment or consulting service agreements with key employees and advisors identified by the Purchaser, including Rontan’s Chief Executive Officer; and</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">g)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">The Sellers continued guarantee of Rontan’s bank debt for a period of 90 days following issuance of the Opinion, among other items.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, as well as the ability to acquire 100% of the outstanding stock of Rontan at a price of $200 million BR, and the Company can acquire 100% of all real estate held by Rontan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to December 31, 2015, on April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions to closing, which were waivable by us,) and advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 31, 2018, we announced that we initiated a lawsuit for damages against Grupo Rontan Metalurgica, S. A, (“Rontan”) and that company’s controlling shareholders, Joao Alberto Bolzan and Jose Carlos Bolzan. The action has been filed in the United States District Court for the Southern District of Florida. The complaint alleges that Rontan is wholly owned by Joao Bolzan and Jose Bolzan. In the complaint, we further allege that Rontan and its shareholders improperly terminated a Share Purchase and Sale Agreement (the “SPA”) by which we were to acquire whole ownership of Rontan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 5, 2018, United States District Court Southern District of Florida filed a Pretrial Scheduling Order and Order Referring Case to Mediation dated February 5, 2018, for the Company’s lawsuit against Grupo Rontan Electro Metalurgica, S.A., et al. The Case No. is 18-80106-Civ-Middlebrooks/Brannon. The court has issued a schedule outlining various documents and responses that are to be delivered by the parties as part of the discovery plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 25, 2018, the Note of Filing Proposed Summons was completed by the Company. On April 26, 2018, a summons was issued to Grupo Rontan Electro Metalurgica, S.A. Also, on May 15, 2018, the Company filed a motion for Issuance of Letters Rogatory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Consulting agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into two consulting agreements (See Note 5) in May 2016, for services to be provided in connection towards the resolution of the Rontan lawsuit (below). The consulting agreements includes a monthly retainer payment of $10,000 to each consultant. The agreement also includes consideration of 5,000,000 shares of restricted common stock of the Company, plus a 5% cash consideration of the Resolution Progress Funding, (defined as upon the retention of legal counsel and receipt of funding for the litigation), as of the Resolution Progress Funding date and 10,000,000 shares of restricted common stock of the Company and a 5% cash consideration of the Resolution Funding amount (defined as a settlement or judgement in favor of the Company by Rotan),at the Resolution Funding date. The Resolution Progress funding was met on December 22, 2017.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z8dcYxQIp7V5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_828_zkGA3tYmk4Ch">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_c20221231_zj5keEtzhJ8i" title="Preferred stock, shares authorized">35,000,000</span> shares of noncumulative, non-voting, convertible preferred stock, $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221231_z7PVYR3YE0Ad" title="Preferred stock, par or stated value per share">0.001</span> par value per share. At December 31, 2022, and 2021, <span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_c20221231_z5a5KQ4seEJ1" title="Preferred stock, shares outstanding"><span id="xdx_90D_eus-gaap--PreferredStockSharesOutstanding_iI_c20211231_zpQTVWex5Prg" title="Preferred stock, shares outstanding">1,000,000</span></span> shares of preferred stock were outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> On August 15, 2016, William J. Delgado, our current Chief Executive Officer, agreed to convert $231,565 of indebtedness owed to him by the Company into 1,000,000 shares of convertible preferred stock (the “Preferred Stock”). The Preferred Stock has voting rights as to one (1) preferred share to four hundred (400) shares of the common stock of the Company. The Preferred Stock is convertible into common stock at any time after issuance into 37% of the outstanding common stock of the Company at the time of the conversion. The conversion to common can only take place when there are an adequate number of shares that are available and is subject to normal stock adjustments (i.e. stock splits etc.) that are executed by the Company in its normal course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue <span id="xdx_90A_eus-gaap--CommonStockSharesAuthorized_iI_c20221231_zreqMrxzD2S7" title="Common stock, shares authorized">2,000,000,000</span> shares of common stock, $<span id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221231_zyFgwc5Y1SC4" title="Common stock, par value">0.001</span> par value per share. At December 31, 2022 and 2021 there were 800,542,896 and 737,263,858 <span title="Common Stock, Shares, Issued"><span style="display: none" title="Common Stock, Shares, Outstanding"/></span> Issued, outstanding, or vested but unissued under stock compensation plans, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock Warrant</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have issued warrants, which are fully vested and available for exercise, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -40pt; text-indent: 0.5in">The following is a summary of outstanding and exercisable warrants at December 31, 2022:  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt -40pt; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryofOutstandingAndWarrantsExercisableTableTextBlock_zoutDuDgYSwf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8BA_z7d6SSTsE1Bh" style="display: none">Schedule of summary of outstanding and warrants exercisable</span></td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">Range of</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Number</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Remaining</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Number</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Contractual</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercisable</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">at 12/31/2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Life (in yrs)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">at 12/31/2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 1%">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 13%" title="Exercise Price">0.01</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Weighted Average Number Outstanding">12,000,000</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_zB62DIdj2cT2" title="Outstanding Remaining Contractual Life (in yrs)">4</span></td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%">$</td><td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Number Exercisable">12,000,000</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_zqhP71i7ZKN3" title="Outstanding Remaining Contractual Life (in yrs)">4.1</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_zW1VimRK5ho3" title="Outstanding Remaining Contractual Life (in yrs)">4.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_zISBtws754Hd" title="Outstanding Remaining Contractual Life (in yrs)">4.3</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_zvTCeTnaP3k5" title="Outstanding Remaining Contractual Life (in yrs)">4.4</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_zKUPRor19pJf" title="Outstanding Remaining Contractual Life (in yrs)">4.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_zsUc5vVWeyBl" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_zEhf33REWIFg" title="Outstanding Remaining Contractual Life (in yrs)">4.6</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_z6p22sUDLjGk" title="Outstanding Remaining Contractual Life (in yrs)">4.7</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_zOrmgNJQpDO4" title="Outstanding Remaining Contractual Life (in yrs)">4.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_zka9dTpfG01g" title="Outstanding Remaining Contractual Life (in yrs)">4.9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_zQDFHQFvZ7Rg" title="Outstanding Remaining Contractual Life (in yrs)">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_zCyDEZefpimi" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_z5APLCfsKhWk" title="Outstanding Remaining Contractual Life (in yrs)">9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Number Exercisable">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_zk13Vz1FEBsf" title="Outstanding Remaining Contractual Life (in yrs)">8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Number Exercisable">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Exercise Price">0.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">2,096,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_z8i6k1GJWn74" title="Outstanding Remaining Contractual Life (in yrs)">1</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Number Exercisable">2,096,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">10,750,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_zkxfcWJ6JUUf" title="Outstanding Remaining Contractual Life (in yrs)">4.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Number Exercisable">10,750,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_zhON5Ev3hWo2" title="Outstanding Remaining Contractual Life (in yrs)">3</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Number Exercisable">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Number Outstanding">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_zhjn9WB1BKxf" title="Outstanding Remaining Contractual Life (in yrs)">3</span></td><td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98B_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Exercisable">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231_pdd" style="border-bottom: Black 3pt double; text-align: right" title="Weighted Average Number Outstanding">66,446,875</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231_pdd" style="border-bottom: Black 3pt double; text-align: right" title="Number Exercisable">66,446,875</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of outstanding and exercisable warrants at December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="11" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercisable</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Weighted</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Average</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Range of</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Number</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Remaining</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Weighted</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Number</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Weighted</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercise</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Contractual</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Average</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercisable</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Average</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Prices</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>at 12/31/2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Life (in yrs)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercise Price</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>at 12/31/2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercise Price</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">5,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_zmVzWNMGB887" title="Outstanding Remaining Contractual Life (in yrs)">0.5</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.004</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">5,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">3,750,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_zDxzSNyh3qW7" title="Outstanding Remaining Contractual Life (in yrs)">2.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.002</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">3,750,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_zfMPT65mmZEc" title="Outstanding Remaining Contractual Life (in yrs)">2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_z9Z8CbmXUdQj" title="Outstanding Remaining Contractual Life (in yrs)">2.8</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">10,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_znRA2kUJdZsc" title="Outstanding Remaining Contractual Life (in yrs)">8.2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">10,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">20,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_zaG33PKJzk1l" title="Outstanding Remaining Contractual Life (in yrs)">8.3</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">20,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,096,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_zesUJJwCVqul" title="Outstanding Remaining Contractual Life (in yrs)">3.6</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,096,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_zSAvc4T3v5u2" title="Outstanding Remaining Contractual Life (in yrs)">5</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_zvtikTp847Jb" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_987_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_zA5rmxVAPq3b" title="Outstanding Remaining Contractual Life (in yrs)">5.2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_zeM8DVnmmVqj" title="Outstanding Remaining Contractual Life (in yrs)">5.3</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_zQNfGalQU7d9" title="Outstanding Remaining Contractual Life (in yrs)">5.4</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_z0FQju6vbP42" title="Outstanding Remaining Contractual Life (in yrs)">5.5</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98D_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_zthf4SmbVad8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_z2yjQQaCIfO2" title="Outstanding Remaining Contractual Life (in yrs)">5.6</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98E_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_zP7kK37BH5r9" title="Outstanding Remaining Contractual Life (in yrs)">5.7</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_z7pvWyV5yAUi" title="Outstanding Remaining Contractual Life (in yrs)">5.8</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_988_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_z6IRJgMQCSCk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_z4aTrKj8Xwc5" title="Outstanding Remaining Contractual Life (in yrs)">5.9</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_989_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_zQSHp5GMJje2" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_zkADCbW3fmS7" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231_zi7wVZv2Ri9k" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">78,346,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zmnsN5kySCMi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">78,346,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_z1UjRQG56D8d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The intrinsic value of warrants outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the warrant multiplied by the number of warrants outstanding or exercisable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock Incentive Plans</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2014 Global Digital Solutions Equity Incentive Plan</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 shares of our common stock for issuance pursuant to awards thereunder, including options, stock appreciation right, restricted stock, restricted stock units, performance awards, dividend equivalents, or other stock-based awards. The Plan is intended as an incentive, to retain in the employ of the Company, our directors, officers, employees, consultants, and advisors, and to attract new officers, employees, directors, consultants and advisors whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with the ACS 718, <i>Compensation – Stock Compensation</i>, awards granted are valued at fair value at the grant date. The Company recognizes compensation expense on a pro rata straight-line basis over the requisite service period for stock-based compensation awards with both graded and cliff vesting terms. The Company recognizes the cumulative effect of a change in the number of awards expected to vest in compensation expense in the period of change. The Company has not capitalized any portion of its stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stock-based compensation expense for the years ended December 31, 2022, and 2021 was $0 and $5,075, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards Issued Under Stock Incentive Plans</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Stock Option Activity</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021we have outstanding stock options of 12,900,000 and 13,650,002 respectively - all of which are fully-vested stock options that were granted to directors, officers and consultants. The outstanding stock options are exercisable at prices ranging from $0.006 to $0.64 and expire between February 2024 and December 2025, for an average exercise price per share of $0.60 and an average remaining term of 3 years as of December 31, 2022.<i> </i> In 2021 there were 750,000 options exercised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022, and 2021, we did not recognize any stock-based compensation cost related to the outstanding stock options. The intrinsic value of options outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the option multiplied by the number of options outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Restricted Stock Units</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 10, 2014, we granted an employee 1 million RSU’s convertible into 1 million shares of the Company’s common stock, with a grant date fair market value of $100,000. The grant was made under our 2014 Equity Incentive Plan. 333,333 RSU’s will vest in respect of each calendar year (commencing January 1 and ending December 31) of the Company from 2015 through 2017 if the Company has achieved at least 90% of the total revenue and EBITDA midpoint targets set forth in the agreement. If less than 90% of the target is achieved in respect of any such fiscal year, then the number of RSU’s vesting for that fiscal year shall be 333,333 times the applicable percentage set forth in the agreement; <i>provided that,</i> if the company shall exceed 100% of the revenue and EBITDA midpoint target for the 2018 or 2017 calendar year, and shall have failed to reach 90% of the target for a prior calendar year, the excess over 100% shall be applied to reduce the deficiency in the prior year(s), and an additional number of RSU’s shall vest to reflect the increased revenue for such prior calendar year. Any such excess shall be applied first to reduce any deficiency for the 2015 calendar year and then for the 2016 calendar year. The vesting of the RSU’s shall be effective upon the issuance of the audited financial statements of the Company for the applicable calendar year and shall be based upon the total revenue and EBITDA of the acquired companies as reflected in such financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards Not Issued Under Stock Incentive Plans</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Restricted Stock Grants Awarded to Advisors</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to align our senior advisors with the interest of the stakeholders of the Company, the Board of Directors of the Company has granted the advisors restricted stock awards valued at $0.17 to $0.364 per share which vest over a period of 12 – 24 months, subject to remaining an advisor for a minimum of twelve months, and which are forfeited if the advisor is terminated or is no longer an advisor on the anniversary of the advisory award, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfIntrinsicValueOfTheRestrictedStockGrantTableTextBlock_zr4B4XEtyC5a" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span id="xdx_8BF_zfwNXcXxY4Oi" style="display: none">Schedule of intrinsic value of the restricted stock grant</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>December 31, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Name</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Date of<br/> Grant</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Number of<br/> Shares</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Vest from</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Vest To</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Vested</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Unvested</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Forfeited</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Mathew Kelley</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember" title="Date of Grant">4/17/13</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_905_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember" title="Vest from">4/30/13</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_900_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember" title="Vest To">3/31/1</span>4</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1312">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member" title="Date of Grant">4/17/13</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member" title="Vest from">2/28/14</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_902_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member" title="Vest To">1/31/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1324">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1326">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Richard J. Feldman</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember" title="Date of Grant">4/30/14</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90F_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember" title="Vest from">4/30/14</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_906_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember" title="Vest To">3/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1338">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_zVBd12T9JZ0g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1340">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_903_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member" title="Vest from">4/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_902_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member" title="Vest To">3/30/16</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">375,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1350">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Gary Gray</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_902_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember" title="Date of Grant">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember" title="Vest from">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember" title="Vest To">5/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1364">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1366">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Ross Trevino</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_905_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember" title="Date of Grant">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember" title="Vest from">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90A_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember" title="Vest To">5/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1378">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1380">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--NumberOfShares_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">5,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">4,875,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--Unvested_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1386">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A5_zraCotOJL4d8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate intrinsic value of the restricted stock grant was $0 on December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 35000000 0.001 1000000 1000000 2000000000 0.001 <table cellpadding="0" cellspacing="0" id="xdx_891_ecustom--SummaryofOutstandingAndWarrantsExercisableTableTextBlock_zoutDuDgYSwf" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details)"> <tr style="vertical-align: bottom"> <td colspan="2"><span id="xdx_8BA_z7d6SSTsE1Bh" style="display: none">Schedule of summary of outstanding and warrants exercisable</span></td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Outstanding</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; text-align: center">Exercisable</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">Range of</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Number</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Remaining</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Number</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted</td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Outstanding</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Contractual</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercisable</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Average</td><td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Prices</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">at 12/31/2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Life (in yrs)</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">at 12/31/2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 1%">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 13%" title="Exercise Price">0.01</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Weighted Average Number Outstanding">12,000,000</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 12%"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_zB62DIdj2cT2" title="Outstanding Remaining Contractual Life (in yrs)">4</span></td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%">$</td><td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Number Exercisable">12,000,000</td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="text-align: right; width: 12%" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_zqhP71i7ZKN3" title="Outstanding Remaining Contractual Life (in yrs)">4.1</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_zW1VimRK5ho3" title="Outstanding Remaining Contractual Life (in yrs)">4.2</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_zISBtws754Hd" title="Outstanding Remaining Contractual Life (in yrs)">4.3</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_zvTCeTnaP3k5" title="Outstanding Remaining Contractual Life (in yrs)">4.4</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_905_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_zKUPRor19pJf" title="Outstanding Remaining Contractual Life (in yrs)">4.5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_zsUc5vVWeyBl" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_zEhf33REWIFg" title="Outstanding Remaining Contractual Life (in yrs)">4.6</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_z6p22sUDLjGk" title="Outstanding Remaining Contractual Life (in yrs)">4.7</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_zOrmgNJQpDO4" title="Outstanding Remaining Contractual Life (in yrs)">4.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_zka9dTpfG01g" title="Outstanding Remaining Contractual Life (in yrs)">4.9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_zQDFHQFvZ7Rg" title="Outstanding Remaining Contractual Life (in yrs)">5</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98C_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_zCyDEZefpimi" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Number Exercisable">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_z5APLCfsKhWk" title="Outstanding Remaining Contractual Life (in yrs)">9</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98E_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Number Exercisable">10,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_zk13Vz1FEBsf" title="Outstanding Remaining Contractual Life (in yrs)">8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Number Exercisable">20,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Exercise Price">0.03</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">2,096,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_z8i6k1GJWn74" title="Outstanding Remaining Contractual Life (in yrs)">1</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_988_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Number Exercisable">2,096,875</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">10,750,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_zkxfcWJ6JUUf" title="Outstanding Remaining Contractual Life (in yrs)">4.8</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_989_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Number Exercisable">10,750,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Weighted Average Number Outstanding">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_zhON5Ev3hWo2" title="Outstanding Remaining Contractual Life (in yrs)">3</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98A_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Number Exercisable">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="padding-bottom: 1.5pt; text-align: right" title="Exercise Price">0.01</td><td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Weighted Average Number Outstanding">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_zhjn9WB1BKxf" title="Outstanding Remaining Contractual Life (in yrs)">3</span></td><td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_98B_ecustom--WeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Number Exercisable">100,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20221231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="padding-bottom: 1.5pt; text-align: right" title="Weighted Average Exercise Price">0.01</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20221231_pdd" style="border-bottom: Black 3pt double; text-align: right" title="Weighted Average Number Outstanding">66,446,875</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20221231_pdd" style="border-bottom: Black 3pt double; text-align: right" title="Number Exercisable">66,446,875</td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt; text-align: right"> </td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following is a summary of outstanding and exercisable warrants at December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="11" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="11" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercisable</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Weighted</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Average</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Range of</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Number</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Remaining</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Weighted</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Number</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Weighted</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercise</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Outstanding</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Contractual</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Average</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercisable</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Average</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Prices</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>at 12/31/2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Life (in yrs)</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercise Price</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>at 12/31/2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Exercise Price</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">5,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_zmVzWNMGB887" title="Outstanding Remaining Contractual Life (in yrs)">0.5</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.004</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">5,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">3,750,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_zDxzSNyh3qW7" title="Outstanding Remaining Contractual Life (in yrs)">2.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.002</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">3,750,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range2Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_zfMPT65mmZEc" title="Outstanding Remaining Contractual Life (in yrs)">2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range3Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_z9Z8CbmXUdQj" title="Outstanding Remaining Contractual Life (in yrs)">2.8</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range4Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">10,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_znRA2kUJdZsc" title="Outstanding Remaining Contractual Life (in yrs)">8.2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">10,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range5Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98D_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">20,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_zaG33PKJzk1l" title="Outstanding Remaining Contractual Life (in yrs)">8.3</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">20,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range6Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,096,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_zesUJJwCVqul" title="Outstanding Remaining Contractual Life (in yrs)">3.6</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">2,096,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range7Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_zSAvc4T3v5u2" title="Outstanding Remaining Contractual Life (in yrs)">5</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">12,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range8Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_zvtikTp847Jb" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_987_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range9Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_zA5rmxVAPq3b" title="Outstanding Remaining Contractual Life (in yrs)">5.2</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range10Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_zeM8DVnmmVqj" title="Outstanding Remaining Contractual Life (in yrs)">5.3</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_980_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range11Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_909_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_zQNfGalQU7d9" title="Outstanding Remaining Contractual Life (in yrs)">5.4</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98C_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range12Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_980_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90C_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_z0FQju6vbP42" title="Outstanding Remaining Contractual Life (in yrs)">5.5</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98D_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_zthf4SmbVad8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range13Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_981_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_908_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_z2yjQQaCIfO2" title="Outstanding Remaining Contractual Life (in yrs)">5.6</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98E_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range14Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_zP7kK37BH5r9" title="Outstanding Remaining Contractual Life (in yrs)">5.7</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98F_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range15Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_z7pvWyV5yAUi" title="Outstanding Remaining Contractual Life (in yrs)">5.8</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_988_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_z6IRJgMQCSCk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range16Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90A_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_z4aTrKj8Xwc5" title="Outstanding Remaining Contractual Life (in yrs)">5.9</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_989_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range17Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_zQSHp5GMJje2" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98A_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range18Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_986_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_zkADCbW3fmS7" title="Outstanding Remaining Contractual Life (in yrs)">5.1</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_98B_ecustom--WeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">$</span></td> <td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_c20211231__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--Range19Member_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">0.01</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iI_c20211231_zi7wVZv2Ri9k" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Number Outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">78,346,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20211231_zmnsN5kySCMi" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number Exercisable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">78,346,875</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 0.01 12000000 P4Y 0.01 12000000 0.01 0.01 1000000 P4Y1M6D 0.01 1000000 0.01 0.01 1000000 P4Y2M12D 0.01 1000000 0.01 0.01 1000000 P4Y3M18D 0.01 1000000 0.01 0.01 1000000 P4Y4M24D 0.01 1000000 0.01 0.01 1000000 P4Y6M 0.01 1000000 0.01 0.01 1000000 P4Y7M6D 0.01 1000000 0.01 0.01 1000000 P4Y8M12D 0.01 1000000 0.01 0.01 1000000 P4Y9M18D 0.01 1000000 0.01 0.01 1000000 P4Y10M24D 0.01 1000000 0.01 0.01 1000000 P5Y 0.01 1000000 0.01 0.01 1000000 P5Y1M6D 0.01 1000000 0.01 0.01 10000000 P9Y 0.01 10000000 0.01 0.01 20000000 P8Y 0.01 20000000 0.01 0.03 2096875 P1Y 0.01 2096875 0.01 0.01 10750000 P4Y9M18D 0.01 10750000 0.01 0.01 500000 P3Y 0.01 500000 0.01 0.01 100000 P3Y 0.01 100000 0.01 66446875 66446875 0.01 5000000 P0Y6M 0.004 5000000 0.01 0.01 3750000 P2Y1M6D 0.002 3750000 0.01 0.01 12000000 P2Y 0.01 12000000 0.01 0.01 2500000 P2Y9M18D 0.01 2500000 0.01 0.01 10000000 P8Y2M12D 0.01 10000000 0.01 0.01 20000000 P8Y3M18D 0.01 20000000 0.01 0.01 2096875 P3Y7M6D 0.01 2096875 0.01 0.01 12000000 P5Y 0.01 12000000 0.01 0.01 1000000 P5Y1M6D 0.01 1000000 0.01 0.01 1000000 P5Y2M12D 0.01 1000000 0.01 0.01 1000000 P5Y3M18D 0.01 1000000 0.01 0.01 1000000 P5Y4M24D 0.01 1000000 0.01 0.01 1000000 P5Y6M 0.01 1000000 0.01 0.01 1000000 P5Y7M6D 0.01 1000000 0.01 0.01 1000000 P5Y8M12D 0.01 1000000 0.01 0.01 1000000 P5Y9M18D 0.01 1000000 0.01 0.01 1000000 P5Y10M24D 0.01 1000000 0.01 0.01 1000000 P5Y1M6D 0.01 1000000 0.01 0.01 1000000 P5Y1M6D 0.01 1000000 0.01 78346875 78346875 <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfIntrinsicValueOfTheRestrictedStockGrantTableTextBlock_zr4B4XEtyC5a" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - STOCKHOLDERS' EQUITY (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span id="xdx_8BF_zfwNXcXxY4Oi" style="display: none">Schedule of intrinsic value of the restricted stock grant</span></td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="10" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>December 31, 2022</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Name</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Date of<br/> Grant</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Number of<br/> Shares</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Vest from</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Vest To</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Vested</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Unvested</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><b>Forfeited</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Mathew Kelley</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember" title="Date of Grant">4/17/13</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_905_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember" title="Vest from">4/30/13</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_900_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember" title="Vest To">3/31/1</span>4</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelleyMember_pdd" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1312">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member" title="Date of Grant">4/17/13</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member" title="Vest from">2/28/14</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_902_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member" title="Vest To">1/31/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,250,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1324">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--MathewKelley1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1326">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Richard J. Feldman</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember" title="Date of Grant">4/30/14</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90F_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember" title="Vest from">4/30/14</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_906_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember" title="Vest To">3/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1338">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldmanMember_zVBd12T9JZ0g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1340">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_903_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member" title="Vest from">4/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_902_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member" title="Vest To">3/30/16</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">375,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1350">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--RichardJFeldman1Member_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Gary Gray</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_902_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember" title="Date of Grant">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember" title="Vest from">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_907_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember" title="Vest To">5/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">1,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1364">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--GaryGrayMember_pdd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1366">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">Ross Trevino</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_905_ecustom--DateOfGrant_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember" title="Date of Grant">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--NumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90B_ecustom--VestFrom_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember" title="Vest from">3/7/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span id="xdx_90A_ecustom--VestTo_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember" title="Vest To">5/30/15</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">500,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--Unvested_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1378">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231__srt--CounterpartyNameAxis__custom--RossTrevinoMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1380">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--NumberOfShares_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">5,000,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">4,875,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--Unvested_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Unvested"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%"><span style="-sec-ix-hidden: xdx2ixbrl1386">—</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_c20220101__20221231_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Forfeited"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; line-height: 107%">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 2013-04-17 1250000 2013-04-30 2001-03-31 1250000 2013-04-17 1250000 2014-02-28 2015-01-31 1250000 2014-04-30 500000 2014-04-30 2015-03-30 500000 500000 2015-04-30 2016-03-30 375000 125000 2015-03-07 1000000 2015-03-07 2015-05-30 1000000 2015-03-07 500000 2015-03-07 2015-05-30 500000 5000000 4875000 125000 <p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zvAp4tAMVAFk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_82B_z0fJFJN6ngOf">INCOME TAXES</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zZoeZuEpBRgh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span id="xdx_8B1_z9eqw3Fl6AK8" style="display: none">Schedule of deferred tax assets and liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20220101__20221231_zJ6ekIuirFd2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--NetIncomeLossBook_zAq8j6g1YXKg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 85%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (Income) Loss - book</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,761,061</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--Permanentdifferences_zyR2vJtN8JN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permanent  Differences:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--OtherRealEstateDisposals_iN_di_zFlraP66ELu8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on disposal of fixed assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_ecustom--ChangeInWarrantLiability_zVEuty2BsiXd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in warrant liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(993,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--ChangeInDerivative_z7WNOFiXg0Og" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,090,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AmortizationOfDebtDiscountPremium_iN_di_ztCFymfd7Au3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,089,902</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_ecustom--EstimateLossTaxBasis_z1nEnr9X7oK1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimate loss - tax basis</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,490,104</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zrSlknQQoPYi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/>Reconciliations between the statutory rate and the effective tax rate for the year ended December 31, 2022 consist as follows: </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_znAS7azSkVHl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span id="xdx_8BD_zR5gGfUQTDG2" style="display: none">Schedule of Reconciliations between the statutory rate and the effective tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense at</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">statutory federal rate of 21%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Income tax expense at statutory federal rate of 21%, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,210,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zqJBiVZ68Er1" title="Income tax expense at statutory federal rate of 21%, percent">21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permanent Differences</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on disposal of Fixed assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_iN_pp0p0_di_c20220101__20221231_zPksRCyN6ZD6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairments, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_dp_c20220101__20221231_zt2GaQwC06Ta" title="Impairments, percent">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in warrant liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ChangeInWarrantLiabilityAmount_iN_pp0p0_di_c20220101__20221231_zpUoHCGRTwR7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in warrant liability, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(209,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ChangeInWarrantLiabilityPercent_dp_c20220101__20221231_zVAssfmBDKh7" title="Change in warrant liability, percent">-4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ChangeInDerivativeAmount_iN_pp0p0_di_c20220101__20221231_z42S5loTupBc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in derivative, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(439,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ChangeInDerivativePercent_dp_c20220101__20221231_zGBrSP0gzIu1" title="Change in derivative, percent">8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtDiscountAmortizationAmount_iN_pp0p0_di_c20220101__20221231_zIeMDvlGP363" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount amortization, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(229,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DebtDiscountAmortizationPercent_dp_c20220101__20221231_zDohAzj1w1xd" title="Debt discount amortization, percent">-4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase (decrease) in valuation allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pp0p0_di_c20220101__20221231_zHLR9RMtHCpd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Increase (decrease) in valuation allowance, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zBqKwS4P10Ml" title="Increase (decrease) in valuation allowance, percent">-21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense (benefit) at</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: red; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: red; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: red; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company's effective tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Company's effective tax rate, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1435">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_zpN7ebZbZ3yj" title="Company's effective tax rate, Percent">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> <p id="xdx_8AF_zWo6B3BERVra" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationTableTextBlock_zcTfYGj5IsY9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z7UfQWiEHyEc" style="display: none">Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 55%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Operating Loss Carryforward</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Net Operating Loss Carryforward"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,774,808</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Net Operating Loss Carryforward"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20221231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Net Operating Loss Carryforward"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,087,808</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOL tax benefit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--DeferredTaxAssetsNetOperatingLossTaxBenefit_c20211231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="NOL tax benefit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,004,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--DeferredTaxAssetsNetOperatingLossTaxBenefit_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="NOL tax benefit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--DeferredTaxAssetsNetOperatingLossTaxBenefit_c20221231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="NOL tax benefit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,317,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--DeferredTaxAssetsGross_c20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,004,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--DeferredTaxAssetsGross_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsGross_c20221231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,317,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20211231_zZs2YN4OK8Pk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,004,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_zdxtUUJMuXV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20221231_zbRmpGlzeiib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,317,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_c20211231_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1465">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsNet_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsNet_c20221231_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AC_zA8bX99FSWHf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company had $ <span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_c20221231_z3XQI2BPd4jd" title="Operating loss carry forward">22,087,808</span> of federal net operating loss carry forwards. These carry forwards, if not used, will begin to expire in 2029. Current or future ownership changes, including issuances of common stock under the terms of the Company’s convertible notes payable that were entered into during 2015 and the closing of the Rontan Transaction may severely limit the future realization of these net operating losses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company provides for a valuation allowance when it is more likely than not that they will not realize a portion of the deferred tax assets. The Company has established a valuation allowance against their net deferred tax asset due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, they have not reflected any benefit of such deferred tax assets in the accompanying financial statements. The Company’s net deferred tax asset and valuation allowance increased by $<span id="xdx_904_ecustom--DeferredTaxAssetAndValuationAllowance_iI_c20221231_z2CqVz8986Z7" title="Deferred tax asset and valuation allowance">313,000</span> for the year ended December 31, 2022, related to the current year activity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has reviewed all income tax positions taken or that are expected to be taken for all open years and determined that their income tax positions are appropriately stated and supported for all open years. The Company is subject to U.S. federal income tax examinations by tax authorities for years after 2011 due to unexpired net operating loss carryforwards originating in and subsequent to that year. The Company may be subject to income tax examinations for the various taxing authorities which vary by jurisdiction. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statements of operations. As of December 31, 2022, there were no unrecognized tax benefits, or any tax related interest or penalties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files income tax returns in the U.S. federal jurisdiction and the various states in which they operate. The former members of NACSV are required to file separate federal and state tax returns for NACSV for the periods prior to our acquisition of NACSV. The Company files consolidated tax returns for subsequent periods. The Company has not filed their U.S. federal and certain state tax returns since 2014 and currently do not have any examinations ongoing. Tax returns for the years 2012 onwards are subject to federal, state or local examinations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zZoeZuEpBRgh" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span id="xdx_8B1_z9eqw3Fl6AK8" style="display: none">Schedule of deferred tax assets and liabilities</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20220101__20221231_zJ6ekIuirFd2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--NetIncomeLossBook_zAq8j6g1YXKg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 85%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net (Income) Loss - book</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,761,061</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_408_ecustom--Permanentdifferences_zyR2vJtN8JN8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permanent  Differences:</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--OtherRealEstateDisposals_iN_di_zFlraP66ELu8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on disposal of fixed assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(97,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_ecustom--ChangeInWarrantLiability_zVEuty2BsiXd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in warrant liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(993,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40D_ecustom--ChangeInDerivative_z7WNOFiXg0Og" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2,090,500</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--AmortizationOfDebtDiscountPremium_iN_di_ztCFymfd7Au3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,089,902</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_ecustom--EstimateLossTaxBasis_z1nEnr9X7oK1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimate loss - tax basis</span></td><td style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,490,104</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 5761061 97555 -993000 -2090500 1089902 1490104 <table cellpadding="0" cellspacing="0" id="xdx_898_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_znAS7azSkVHl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 1)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span id="xdx_8BD_zR5gGfUQTDG2" style="display: none">Schedule of Reconciliations between the statutory rate and the effective tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rate</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense at</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">statutory federal rate of 21%</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c20220101__20221231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Income tax expense at statutory federal rate of 21%, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,210,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_dp_c20220101__20221231_zqJBiVZ68Er1" title="Income tax expense at statutory federal rate of 21%, percent">21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permanent Differences</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Loss on disposal of Fixed assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses_iN_pp0p0_di_c20220101__20221231_zPksRCyN6ZD6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Impairments, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses_dp_c20220101__20221231_zt2GaQwC06Ta" title="Impairments, percent">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in warrant liability</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--ChangeInWarrantLiabilityAmount_iN_pp0p0_di_c20220101__20221231_zpUoHCGRTwR7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in warrant liability, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(209,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--ChangeInWarrantLiabilityPercent_dp_c20220101__20221231_zVAssfmBDKh7" title="Change in warrant liability, percent">-4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Change in derivative</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--ChangeInDerivativeAmount_iN_pp0p0_di_c20220101__20221231_z42S5loTupBc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in derivative, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(439,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ChangeInDerivativePercent_dp_c20220101__20221231_zGBrSP0gzIu1" title="Change in derivative, percent">8</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt discount amortization</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--DebtDiscountAmortizationAmount_iN_pp0p0_di_c20220101__20221231_zIeMDvlGP363" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount amortization, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(229,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--DebtDiscountAmortizationPercent_dp_c20220101__20221231_zDohAzj1w1xd" title="Debt discount amortization, percent">-4</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase (decrease) in valuation allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pp0p0_di_c20220101__20221231_zHLR9RMtHCpd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Increase (decrease) in valuation allowance, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_dp_c20220101__20221231_zBqKwS4P10Ml" title="Increase (decrease) in valuation allowance, percent">-21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense (benefit) at</span></td><td style="font: 10pt Times New Roman, Times, Serif; color: red"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; color: red; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: red; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; color: red; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company's effective tax rate</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--IncomeTaxExpenseBenefit_c20220101__20221231_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Company's effective tax rate, Amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1435">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20221231_zpN7ebZbZ3yj" title="Company's effective tax rate, Percent">0</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%</span></td></tr> </table> 1210000 0.21 20000 0 209000 -0.04 439000 0.08 229000 -0.04 -313000 -0.21 0 <table cellpadding="0" cellspacing="0" id="xdx_89E_ecustom--DeferredTaxAssetsTaxDeferredExpenseCompensationTableTextBlock_zcTfYGj5IsY9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAXES (Details 2)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_z7UfQWiEHyEc" style="display: none">Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Activity</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">TOTAL</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12/31/2022</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 55%; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net Operating Loss Carryforward</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Net Operating Loss Carryforward"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21,774,808</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Net Operating Loss Carryforward"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20221231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Net Operating Loss Carryforward"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,087,808</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOL tax benefit</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_ecustom--DeferredTaxAssetsNetOperatingLossTaxBenefit_c20211231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="NOL tax benefit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,004,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98E_ecustom--DeferredTaxAssetsNetOperatingLossTaxBenefit_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="NOL tax benefit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--DeferredTaxAssetsNetOperatingLossTaxBenefit_c20221231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="NOL tax benefit"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,317,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Deferred Tax Assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--DeferredTaxAssetsGross_c20211231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,004,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_989_eus-gaap--DeferredTaxAssetsGross_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsGross_c20221231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,317,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Valuation allowance</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20211231_zZs2YN4OK8Pk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,004,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_zdxtUUJMuXV1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(313,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_c20221231_zbRmpGlzeiib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,317,010</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--DeferredTaxAssetsNet_c20211231_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1465">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--DeferredTaxAssetsNet_c20221231__srt--StatementScenarioAxis__custom--ActivityMember_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsNet_c20221231_pp0p0" style="border-bottom: Black 3pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net Deferred Tax Assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 3pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 21774808 313000 22087808 4004010 313000 4317010 4004010 313000 4317010 4004010 313000 4317010 22087808 313000 <p id="xdx_808_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zyHZQ01NLRpc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_823_zSqNazCskTe8">RELATED PARTY TRANSACTIONS</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to officer</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2022, the Company owes Mr. Delgado $<span id="xdx_90E_ecustom--AccruedCompensation_iI_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Mr.DelgadoMember_zofLH6WE5vza" title="Accrued compensation">21,000</span> in accrued compensation. <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2021 Mr.Delgado paid off approximately $<span id="xdx_90F_eus-gaap--RepaymentsOfDebt_c20210101__20211231__srt--CounterpartyNameAxis__custom--MrDelgadoMember_zJGhiG8lcsii" title="Repayments of debt">390,000</span> of the Company’s debt. The Company paid Mr. Delgado approximately $1,326,000 which included repayment for amounts paid for the notes and compensation. The Company owes Mr. Delgado $<span id="xdx_905_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_zAZvNKH2UqSb" title="Employee-related Liabilities, Current">50,000</span> at December 31, 2021 for money advanced.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Calibri, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2022 Mr. Delgado advance The Company $<span id="xdx_906_ecustom--AdvanceFromRelatedPartyForOperatingExpenses_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Mr.DelgadoMember_pp0p0" title="Advance from related party for operating expenses">9,000</span> for payment of operating expenses. The Company reimbursed Mr. Delgado  $<span id="xdx_901_ecustom--ReimbursedAmount_c20210101__20211231__srt--CounterpartyNameAxis__custom--MrDelgadoMember_pp0p0" title="Reimbursed amount">55,000</span> for his outstanding balance at December 31, 2021, and the current year advance. The Company owes Mr. Delgado approximated $<span id="xdx_901_eus-gaap--EmployeeRelatedLiabilitiesCurrent_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" title="Employee-related liabilities, current">3,300</span> at December 31, 2022.Due from Related Party</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the year ended December 31, 2022, The Company advanced approximately $<span id="xdx_90D_ecustom--AdvanceFromRelatedPartyForOperatingExpenses_iI_c20221231_zg6BxgXnqRBb" title="Advance from related party for operating expenses">140,000</span> to Eco Growth Strategies for operating expenses<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. During 2022 <span id="xdx_906_ecustom--EcoGrowthRepayment_c20220101__20221231_zpsERrfoIM77" title="Eco growth repayment">Eco Growth repaid The Company approximately $270,000in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_ff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, and 2021, the Company advanced Eco Growth Strategies, a related entity, $80,195 to cover administrative costs and legal expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts Payable</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfAccountsPayableTableTextBlock_zkxjYrq2R4Bl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY TRANSACTIONS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 70%"><span id="xdx_8B7_zIvWhANR0AGe" style="display: none">Schedule of accounts payable</span></td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Jerry Gomolski</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JerryGomolskiMember_zAlnjeaqYVJ8" style="text-align: right" title="Compensation owed to related parties">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JerryGomolskiMember_za2X8ugO3W68" style="text-align: right">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Charter 804CS</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Charter804CSMember_zVjJIEB1Ecm7" style="text-align: right">20,099</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Charter804CSMember_zsRkOncZnwbh" style="text-align: right">20,099</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Gary Gray</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryGrayMember_zS5n0E1FZ3Ia" style="border-bottom: Black 1.5pt solid; text-align: right">12,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryGrayMember_z2Rmh35Z1zhb" style="border-bottom: Black 1.5pt solid; text-align: right">12,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 3pt"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98A_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231_zUzQXXruXUHd" style="border-bottom: Black 3pt double; text-align: right">57,099 </td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98F_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231_z8ZMdhziqekl" style="border-bottom: Black 3pt double; text-align: right">57,099</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zc7ZW4xYG5v2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accrued Compensation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and December 31, 2021, we had $ 21,163 and $<span id="xdx_908_ecustom--AccruedCompensation_iI_c20221231__srt--CounterpartyNameAxis__custom--WilliamJDelgadoMember_z3kWQqB1Npxh" title="Accrued compensation">0</span>.00 payable to William J. Delgado and $120,834 and $<span id="xdx_90B_ecustom--AccruedCompensation_iI_c20211231__srt--CounterpartyNameAxis__custom--JeromeGomolskiMember_z5OTJAExALTc" title="Accrued compensation">90,834 </span> to Jerome Gomolski, respectively.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zvwWIpIF3vU2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY TRANSACTIONS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B0_zvowE31qoO76" style="display: none"> Schedule of accrued liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="13">,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">William</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Jerome</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Delgado</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Gomolski</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%">Balance 12/31/2021</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AccountsPayableRelatedParties_iS_pp0p0_c20220101__20221231_zBBgf3pEQwn9" style="width: 10%; text-align: right" title="Balance at Beginning">90,834</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--AccountsPayableRelatedParties_iS_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_zUEuDKpl0Aqk" style="width: 10%; text-align: right" title="Balance at Beginning">0.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--AccountsPayableRelatedParties_iS_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_zJPAnu3Wwl68" style="width: 10%; text-align: right" title="Balance at Beginning">90,834</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>2022 Salary</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SalariesAndWages_c20220101__20221231_pp0p0" style="text-align: right" title="2022 Salary">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SalariesAndWages_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" style="text-align: right" title="2022 Salary">240,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--SalariesAndWages_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_pp0p0" style="text-align: right" title="2022 Salary">60,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--PaymentsToEmployees_iN_pp0p0_di_c20220101__20221231_z0fDRzhst8ck" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payments">(248,837</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PaymentsToEmployees_iN_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_z5g8v5vkKeO5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payments">(218,837</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--PaymentsToEmployees_iN_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_zxeavsT48qB1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payments">(30,000</td><td style="padding-bottom: 1.5pt; text-align: left">) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 3pt"><span style="color: Black">Balance 12/31/2022</span></td><td style="padding-bottom: 3pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 3pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_ecustom--AccountsPayableRelatedParties_iNE_pp0p0_di_c20220101__20221231_z1zBSHJAXDx9" style="border-bottom: Black 3pt double; color: White; text-align: right" title="Balance at Ending"><span style="color: Black">(141,997</span></td><td style="padding-bottom: 3pt; text-align: left">)<span style="color: Black"> </span></td><td style="padding-bottom: 3pt"/> <td style="border-bottom: Black 3pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--AccountsPayableRelatedParties_iNE_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_zeplVOtYpFK9" style="border-bottom: Black 3pt double; color: White; text-align: right" title="Balance at Ending"><span style="color: Black">(21,163</span></td><td style="padding-bottom: 3pt; text-align: left">)<span style="color: Black"> </span></td><td style="padding-bottom: 3pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 3pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--AccountsPayableRelatedParties_iNE_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_zHM4IWroAOU4" style="border-bottom: Black 3pt double; color: White; text-align: right" title="Balance at Ending"><span style="color: Black">(120,834</span></td><td style="padding-bottom: 3pt; text-align: left">)</td></tr> </table> <p id="xdx_8AD_zneDDDJkpzjh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 21000 390000 50000 9000 55000 3300 140000 Eco Growth repaid The Company approximately $270,000in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000. <table cellpadding="0" cellspacing="0" id="xdx_897_ecustom--ScheduleOfAccountsPayableTableTextBlock_zkxjYrq2R4Bl" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY TRANSACTIONS (Details)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; width: 70%"><span id="xdx_8B7_zIvWhANR0AGe" style="display: none">Schedule of accounts payable</span></td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td><td style="width: 3%"> </td> <td style="text-align: left; width: 1%"> </td><td style="text-align: right; width: 10%"> </td><td style="text-align: left; width: 1%"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td><td> </td> <td colspan="2" style="text-align: center">December 31,</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2022</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">2021</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Jerry Gomolski</td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JerryGomolskiMember_zAlnjeaqYVJ8" style="text-align: right" title="Compensation owed to related parties">25,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JerryGomolskiMember_za2X8ugO3W68" style="text-align: right">25,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Charter 804CS</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Charter804CSMember_zVjJIEB1Ecm7" style="text-align: right">20,099</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--Charter804CSMember_zsRkOncZnwbh" style="text-align: right">20,099</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Gary Gray</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryGrayMember_zS5n0E1FZ3Ia" style="border-bottom: Black 1.5pt solid; text-align: right">12,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--GaryGrayMember_z2Rmh35Z1zhb" style="border-bottom: Black 1.5pt solid; text-align: right">12,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 3pt"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98A_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20221231_zUzQXXruXUHd" style="border-bottom: Black 3pt double; text-align: right">57,099 </td><td style="padding-bottom: 3pt; text-align: left"> </td><td style="padding-bottom: 3pt"> </td> <td style="border-bottom: Black 3pt double; text-align: left">$</td><td id="xdx_98F_ecustom--CompensationOwedToRelatedParties_iI_pp0p0_c20211231_z8ZMdhziqekl" style="border-bottom: Black 3pt double; text-align: right">57,099</td><td style="padding-bottom: 3pt; text-align: left"> </td></tr> </table> 25000 25000 20099 20099 12000 12000 57099 57099 0 90834 <table cellpadding="0" cellspacing="0" id="xdx_892_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zvwWIpIF3vU2" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - RELATED PARTY TRANSACTIONS (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td><span id="xdx_8B0_zvowE31qoO76" style="display: none"> Schedule of accrued liabilities</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td colspan="13">,</td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center">William</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Jerome</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Total</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Delgado</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Gomolski</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 55%">Balance 12/31/2021</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--AccountsPayableRelatedParties_iS_pp0p0_c20220101__20221231_zBBgf3pEQwn9" style="width: 10%; text-align: right" title="Balance at Beginning">90,834</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--AccountsPayableRelatedParties_iS_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_zUEuDKpl0Aqk" style="width: 10%; text-align: right" title="Balance at Beginning">0.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--AccountsPayableRelatedParties_iS_pp0p0_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_zJPAnu3Wwl68" style="width: 10%; text-align: right" title="Balance at Beginning">90,834</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>2022 Salary</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--SalariesAndWages_c20220101__20221231_pp0p0" style="text-align: right" title="2022 Salary">300,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--SalariesAndWages_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_pp0p0" style="text-align: right" title="2022 Salary">240,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--SalariesAndWages_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_pp0p0" style="text-align: right" title="2022 Salary">60,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Payments</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--PaymentsToEmployees_iN_pp0p0_di_c20220101__20221231_z0fDRzhst8ck" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payments">(248,837</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--PaymentsToEmployees_iN_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_z5g8v5vkKeO5" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payments">(218,837</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--PaymentsToEmployees_iN_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_zxeavsT48qB1" style="border-bottom: Black 1.5pt solid; text-align: right" title="Payments">(30,000</td><td style="padding-bottom: 1.5pt; text-align: left">) </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 3pt"><span style="color: Black">Balance 12/31/2022</span></td><td style="padding-bottom: 3pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 3pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98D_ecustom--AccountsPayableRelatedParties_iNE_pp0p0_di_c20220101__20221231_z1zBSHJAXDx9" style="border-bottom: Black 3pt double; color: White; text-align: right" title="Balance at Ending"><span style="color: Black">(141,997</span></td><td style="padding-bottom: 3pt; text-align: left">)<span style="color: Black"> </span></td><td style="padding-bottom: 3pt"/> <td style="border-bottom: Black 3pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--AccountsPayableRelatedParties_iNE_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--WilliamDelgadoMember_zeplVOtYpFK9" style="border-bottom: Black 3pt double; color: White; text-align: right" title="Balance at Ending"><span style="color: Black">(21,163</span></td><td style="padding-bottom: 3pt; text-align: left">)<span style="color: Black"> </span></td><td style="padding-bottom: 3pt"><span style="color: Black"> </span></td> <td style="border-bottom: Black 3pt double; text-align: left"><span style="color: Black">$</span></td><td id="xdx_98B_ecustom--AccountsPayableRelatedParties_iNE_pp0p0_di_c20220101__20221231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--JeromeGomolskiMember_zHM4IWroAOU4" style="border-bottom: Black 3pt double; color: White; text-align: right" title="Balance at Ending"><span style="color: Black">(120,834</span></td><td style="padding-bottom: 3pt; text-align: left">)</td></tr> </table> 90834 0.00 90834 300000 240000 60000 248837 218837 30000 141997 21163 120834 <p id="xdx_808_eus-gaap--SubsequentEventsTextBlock_z3CmpKl7fP9j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_82C_zKGmWzQcWkHk">SUBSEQUENT EVENTS</span></b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 4, 2023, Company and Leonite Capital,LLC, entered into a security purchase agreement for a <span id="xdx_902_eus-gaap--DebtInstrumentInterestRateDuringPeriod_dp_c20230101__20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_zuQm7QgLjyHc">8</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% Convertible Note in the aggregate principal of $<span id="xdx_90F_eus-gaap--DebtInstrumentCarryingAmount_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pp0p0">41,666</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.67 less an original issue discount of $<span id="xdx_901_ecustom--OriginalIssueDiscount_iI_pp0p0_c20230104__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_zgUIFoeNJBA" title="Original issue discount">4,166</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.67. The note shall be paid in one or more tranches. The Company received the first tranche of $21,500, on January 12, 2023. The maturity of each tranche shall be 12 months after each Tranche is advanced. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the Advance Date of the first Tranche. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 12, 2023, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a <span id="xdx_908_eus-gaap--DebtInstrumentInterestRateDuringPeriod_c20230101__20230112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zHRk1SzuSfyg" title="Debt instrument, interest rate during period">8%</span> Convertible Note in the aggregate principal of $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20230112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zL378pY0fYo3" title="Principal amount">41,667</span>, due on <span id="xdx_90A_eus-gaap--DebtInstrumentMaturityDate_c20230101__20230112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z2a3L0Zao4Nl" title="Maturity date">January 12, 2024</span>. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the date of the First Tranche, Fixed Conversion Price. Upon the advance of the First Tranche the Company shall issue warrants to purchase <span id="xdx_908_ecustom--NumberOfWarrantPurchase_c20230101__20230112__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zO8eYWfW1OV2" title="Number of warrant purchase">5,000,000</span> shares of the Company common stock. The exercise price is $0.024 per share with a term of 120 Months.</span></p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfSubsequentEventsTextBlock_zLC3pVCKoZ35" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUBSEQUENT EVENTS (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zc3KWpvMujah" style="display: none">Schedule of Subsequent Events</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>Date</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>Category</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>Description</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares Issued</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--SubsequentEventsDate_i" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/26/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--SubsequentEventCategory_c20230101__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--SixthStreetLendingMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlemement Agreement </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--SubsequentEventDescription_c20230101__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--SixthStreetLendingMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.  </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--SubsequentEventsDate_zxRWDdks1BJf" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--SubsequentEventCategory_c20230201__20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--FourthManLLCMember_zLWV6WUEHd5b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Promissory Note</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--SubsequentEventDescription_c20230201__20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--FourthManLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date. </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--SubsequentEventsDate_zyfgSMCgHha9" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/7/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--SubsequentEventCategory_c20230201__20230207__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z9LpUYwerelg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 15%; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--SubsequentEventDescription_c20230201__20230207__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zFrOxJI0hwvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 47%" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230207__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zbGDOgQS2Kq5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,736,045</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--SubsequentEventsDate_zxVCwd40zMHi" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/8/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--SubsequentEventCategory_c20230201__20230208__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--SubsequentEventDescription_c20230201__20230208__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230208__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--SubsequentEventsDate_ztThvtUcaIgh" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/21/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--SubsequentEventCategory_c20230201__20230221__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--SubsequentEventDescription_c20230201__20230221__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230221__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--SubsequentEventsDate_zXlahlUvGBY2" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/23/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_ecustom--SubsequentEventCategory_c20230201__20230223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zPuoZ1ABTPMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SubsequentEventDescription_c20230201__20230223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zEpOAnh0z8mh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zVrSC9Ejsgic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,227,753</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--SubsequentEventsDate_zOPSBKZL0xte" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/1/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--SubsequentEventCategory_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SubsequentEventDescription_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--SubsequentEventsDate_zIdpUWe6KV4d" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/7/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--SubsequentEventCategory_c20230301__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zqcHkjcotXuk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--SubsequentEventDescription_c20230301__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z9P5hRIVKhKa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z10L3TvNETj4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,163,288</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--SubsequentEventsDate_zw9IwQHTkII9" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/17/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--SubsequentEventCategory_c20230301__20230327__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zCHAhI3ohRxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--SubsequentEventDescription_c20230301__20230327__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zptqFa8ba3Rb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20230327__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zKDgTU36jQL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,831,096</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--SubsequentEventsDate_z9QAJPncitEf" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/22/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--SubsequentEventCategory_c20230601__20230630__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Second Amendment to Senior Secured Convertible Promissory Note</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SubsequentEventDescription_c20230601__20230630__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--SubsequentEventsDate_zKlQ5zqHZ0ff" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/18/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--SubsequentEventCategory_c20230401__20230418__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--SubsequentEventDescription_c20230401__20230418__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230401__20230418__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--SubsequentEventsDate_zpSkZ5V7Zflb" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/17/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--SubsequentEventCategory_c20230301__20230317__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--SubsequentEventDescription_c20230301__20230317__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20230317__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231_pdd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,958,182</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20221231_zo2do6uXP6Ke" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Share outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798,168,896</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231_zPC9sK7B2oBl" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,958,182</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220101__20221231_pdd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Total share issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">914,127,078</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.08 41666 4166 0.08 41667 2024-01-12 5000000 <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfSubsequentEventsTextBlock_zLC3pVCKoZ35" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - SUBSEQUENT EVENTS (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zc3KWpvMujah" style="display: none">Schedule of Subsequent Events</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>Date</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>Category</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b>Description</b></span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Shares Issued</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--SubsequentEventsDate_i" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1/26/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--SubsequentEventCategory_c20230101__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--SixthStreetLendingMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Settlemement Agreement </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--SubsequentEventDescription_c20230101__20230126__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--SixthStreetLendingMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.  </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--SubsequentEventsDate_zxRWDdks1BJf" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/6/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--SubsequentEventCategory_c20230201__20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--FourthManLLCMember_zLWV6WUEHd5b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Promissory Note</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--SubsequentEventDescription_c20230201__20230206__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--FourthManLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date. </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--SubsequentEventsDate_zyfgSMCgHha9" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/7/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--SubsequentEventCategory_c20230201__20230207__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z9LpUYwerelg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; width: 15%; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--SubsequentEventDescription_c20230201__20230207__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zFrOxJI0hwvd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 47%" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230207__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zbGDOgQS2Kq5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 11%; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,736,045</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_eus-gaap--SubsequentEventsDate_zxVCwd40zMHi" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/8/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_ecustom--SubsequentEventCategory_c20230201__20230208__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--SubsequentEventDescription_c20230201__20230208__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230208__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--SubsequentEventsDate_ztThvtUcaIgh" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/21/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--SubsequentEventCategory_c20230201__20230221__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--SubsequentEventDescription_c20230201__20230221__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230221__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--SubsequentEventsDate_zXlahlUvGBY2" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2/23/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_ecustom--SubsequentEventCategory_c20230201__20230223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zPuoZ1ABTPMa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SubsequentEventDescription_c20230201__20230223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zEpOAnh0z8mh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230201__20230223__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zVrSC9Ejsgic" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,227,753</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--SubsequentEventsDate_zOPSBKZL0xte" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/1/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--SubsequentEventCategory_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SubsequentEventDescription_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230227__20230302__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--SubsequentEventsDate_zIdpUWe6KV4d" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/7/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--SubsequentEventCategory_c20230301__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zqcHkjcotXuk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98A_eus-gaap--SubsequentEventDescription_c20230301__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z9P5hRIVKhKa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20230307__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_z10L3TvNETj4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,163,288</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--SubsequentEventsDate_zw9IwQHTkII9" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/17/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--SubsequentEventCategory_c20230301__20230327__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zCHAhI3ohRxe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_980_eus-gaap--SubsequentEventDescription_c20230301__20230327__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zptqFa8ba3Rb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20230327__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--GSCapitalPartnersLLCMember_zKDgTU36jQL" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,831,096</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--SubsequentEventsDate_z9QAJPncitEf" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/22/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_ecustom--SubsequentEventCategory_c20230601__20230630__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Second Amendment to Senior Secured Convertible Promissory Note</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--SubsequentEventDescription_c20230601__20230630__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--SubsequentEventsDate_zKlQ5zqHZ0ff" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4/18/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_ecustom--SubsequentEventCategory_c20230401__20230418__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98D_eus-gaap--SubsequentEventDescription_c20230401__20230418__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_989_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230401__20230418__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--SubsequentEventsDate_zpSkZ5V7Zflb" style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3/17/2023</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--SubsequentEventCategory_c20230301__20230317__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center" title="Subsequent event category"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Notice of Conversion</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--SubsequentEventDescription_c20230301__20230317__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top" title="Subsequent event description"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230301__20230317__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--CounterpartyNameAxis__custom--LeoniteCapitalLLCMember_pdd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000,000</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231_pdd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,958,182</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_eus-gaap--CommonStockOtherSharesOutstanding_iI_c20221231_zo2do6uXP6Ke" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Share outstanding"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">798,168,896</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20220101__20221231_zPC9sK7B2oBl" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Shares issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">115,958,182</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_eus-gaap--StockIssuedDuringPeriodSharesOther_c20220101__20221231_pdd" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: right" title="Total share issued"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">914,127,078</span></td></tr> </table> Settlemement Agreement The Company entered into a Settlement Agreement  on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000.  The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments  were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.    Promissory Note  On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date.  Notice of Conversion On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock. 6736045  Notice of Conversion On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock. 10000000  Notice of Conversion On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock. 15000000  Notice of Conversion On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock. 8227753  Notice of Conversion On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common 20000000  Notice of Conversion On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock. 10163288  Notice of Conversion On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock. 10831096  Second Amendment to Senior Secured Convertible Promissory Note Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC  Notice of Conversion On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common 15000000  Notice of Conversion On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common 20000000 115958182 798168896 115958182 914127078 EXCEL 57 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 59 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 60 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 217 265 1 false 72 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://gdsi/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://gdsi/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://gdsi/role/ConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://gdsi/role/ConsolidatedStatementsOfOperations CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Sheet http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT Statements 5 false false R6.htm 00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://gdsi/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Sheet http://gdsi/role/ConsolidatedStatementsOfCashFlowsParenthetical CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) Statements 7 false false R8.htm 00000008 - Disclosure - DESCRIPTION OF BUSINESS Sheet http://gdsi/role/DescriptionOfBusiness DESCRIPTION OF BUSINESS Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://gdsi/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - ACCRUED EXPENSES Sheet http://gdsi/role/AccruedExpenses ACCRUED EXPENSES Notes 10 false false R11.htm 00000011 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://gdsi/role/FairValueMeasurements FAIR VALUE MEASUREMENTS Notes 11 false false R12.htm 00000012 - Disclosure - NOTE PAYABLE Sheet http://gdsi/role/NotePayable NOTE PAYABLE Notes 12 false false R13.htm 00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://gdsi/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 13 false false R14.htm 00000014 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://gdsi/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 14 false false R15.htm 00000015 - Disclosure - INCOME TAXES Sheet http://gdsi/role/IncomeTaxes INCOME TAXES Notes 15 false false R16.htm 00000016 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://gdsi/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 16 false false R17.htm 00000017 - Disclosure - SUBSEQUENT EVENTS Sheet http://gdsi/role/SubsequentEvents SUBSEQUENT EVENTS Notes 17 false false R18.htm 00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 18 false false R19.htm 00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://gdsi/role/SummaryOfSignificantAccountingPolicies 19 false false R20.htm 00000020 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://gdsi/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://gdsi/role/AccruedExpenses 20 false false R21.htm 00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://gdsi/role/FairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://gdsi/role/FairValueMeasurements 21 false false R22.htm 00000022 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://gdsi/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://gdsi/role/StockholdersEquity 22 false false R23.htm 00000023 - Disclosure - INCOME TAXES (Tables) Sheet http://gdsi/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://gdsi/role/IncomeTaxes 23 false false R24.htm 00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables) Sheet http://gdsi/role/RelatedPartyTransactionsTables RELATED PARTY TRANSACTIONS (Tables) Tables http://gdsi/role/RelatedPartyTransactions 24 false false R25.htm 00000025 - Disclosure - SUBSEQUENT EVENTS (Tables) Sheet http://gdsi/role/SubsequentEventsTables SUBSEQUENT EVENTS (Tables) Tables http://gdsi/role/SubsequentEvents 25 false false R26.htm 00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Sheet http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) Details http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables 26 false false R27.htm 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Sheet http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) Details http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables 27 false false R28.htm 00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables 28 false false R29.htm 00000029 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://gdsi/role/AccruedExpensesDetails ACCRUED EXPENSES (Details) Details http://gdsi/role/AccruedExpensesTables 29 false false R30.htm 00000030 - Disclosure - FAIR VALUE MEASUREMENTS (Details) Sheet http://gdsi/role/FairValueMeasurementsDetails FAIR VALUE MEASUREMENTS (Details) Details http://gdsi/role/FairValueMeasurementsTables 30 false false R31.htm 00000031 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative) Sheet http://gdsi/role/FairValueMeasurementsDetailsNarrative FAIR VALUE MEASUREMENTS (Details Narrative) Details http://gdsi/role/FairValueMeasurementsTables 31 false false R32.htm 00000032 - Disclosure - NOTE PAYABLE (Details Narrative) Sheet http://gdsi/role/NotePayableDetailsNarrative NOTE PAYABLE (Details Narrative) Details http://gdsi/role/NotePayable 32 false false R33.htm 00000033 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://gdsi/role/StockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details 33 false false R34.htm 00000034 - Disclosure - STOCKHOLDERS' EQUITY (Details 1) Sheet http://gdsi/role/StockholdersEquityDetails1 STOCKHOLDERS' EQUITY (Details 1) Details 34 false false R35.htm 00000035 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://gdsi/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://gdsi/role/StockholdersEquityTables 35 false false R36.htm 00000036 - Disclosure - INCOME TAXES (Details) Sheet http://gdsi/role/IncomeTaxesDetails INCOME TAXES (Details) Details http://gdsi/role/IncomeTaxesTables 36 false false R37.htm 00000037 - Disclosure - INCOME TAXES (Details 1) Sheet http://gdsi/role/IncomeTaxesDetails1 INCOME TAXES (Details 1) Details http://gdsi/role/IncomeTaxesTables 37 false false R38.htm 00000038 - Disclosure - INCOME TAXES (Details 2) Sheet http://gdsi/role/IncomeTaxesDetails2 INCOME TAXES (Details 2) Details http://gdsi/role/IncomeTaxesTables 38 false false R39.htm 00000039 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://gdsi/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://gdsi/role/IncomeTaxesTables 39 false false R40.htm 00000040 - Disclosure - RELATED PARTY TRANSACTIONS (Details) Sheet http://gdsi/role/RelatedPartyTransactionsDetails RELATED PARTY TRANSACTIONS (Details) Details http://gdsi/role/RelatedPartyTransactionsTables 40 false false R41.htm 00000041 - Disclosure - RELATED PARTY TRANSACTIONS (Details 1) Sheet http://gdsi/role/RelatedPartyTransactionsDetails1 RELATED PARTY TRANSACTIONS (Details 1) Details http://gdsi/role/RelatedPartyTransactionsTables 41 false false R42.htm 00000042 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://gdsi/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://gdsi/role/RelatedPartyTransactionsTables 42 false false R43.htm 00000043 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://gdsi/role/SubsequentEventsDetails SUBSEQUENT EVENTS (Details) Details http://gdsi/role/SubsequentEventsTables 43 false false R44.htm 00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://gdsi/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://gdsi/role/SubsequentEventsTables 44 false false All Reports Book All Reports gdsi-20221231_10k.htm gdsi-20221231.xsd gdsi-20221231_cal.xml gdsi-20221231_def.xml gdsi-20221231_lab.xml gdsi-20221231_pre.xml image_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 62 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "gdsi-20221231_10k.htm": { "axisCustom": 0, "axisStandard": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 611, "http://xbrl.sec.gov/dei/2022": 34 }, "contextCount": 217, "dts": { "calculationLink": { "local": [ "gdsi-20221231_cal.xml" ] }, "definitionLink": { "local": [ "gdsi-20221231_def.xml" ] }, "inline": { "local": [ "gdsi-20221231_10k.htm" ] }, "labelLink": { "local": [ "gdsi-20221231_lab.xml" ] }, "presentationLink": { "local": [ "gdsi-20221231_pre.xml" ] }, "schema": { "local": [ "gdsi-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 430, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 60, "http://gdsi/20221231": 36, "http://xbrl.sec.gov/dei/2022": 4, "total": 100 }, "keyCustom": 83, "keyStandard": 182, "memberCustom": 58, "memberStandard": 10, "nsprefix": "gdsi", "nsuri": "http://gdsi/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://gdsi/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - ACCRUED EXPENSES", "menuCat": "Notes", "order": "10", "role": "http://gdsi/role/AccruedExpenses", "shortName": "ACCRUED EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - FAIR VALUE MEASUREMENTS", "menuCat": "Notes", "order": "11", "role": "http://gdsi/role/FairValueMeasurements", "shortName": "FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - NOTE PAYABLE", "menuCat": "Notes", "order": "12", "role": "http://gdsi/role/NotePayable", "shortName": "NOTE PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "13", "role": "http://gdsi/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "14", "role": "http://gdsi/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "15", "role": "http://gdsi/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - RELATED PARTY TRANSACTIONS", "menuCat": "Notes", "order": "16", "role": "http://gdsi/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "17", "role": "http://gdsi/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "18", "role": "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "19", "role": "http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - CONSOLIDATED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://gdsi/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - ACCRUED EXPENSES (Tables)", "menuCat": "Tables", "order": "20", "role": "http://gdsi/role/AccruedExpensesTables", "shortName": "ACCRUED EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)", "menuCat": "Tables", "order": "21", "role": "http://gdsi/role/FairValueMeasurementsTables", "shortName": "FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "gdsi:SummaryofOutstandingAndWarrantsExercisableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "22", "role": "http://gdsi/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "gdsi:SummaryofOutstandingAndWarrantsExercisableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "23", "role": "http://gdsi/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "gdsi:ScheduleOfAccountsPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)", "menuCat": "Tables", "order": "24", "role": "http://gdsi/role/RelatedPartyTransactionsTables", "shortName": "RELATED PARTY TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "gdsi:ScheduleOfAccountsPayableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUBSEQUENT EVENTS (Tables)", "menuCat": "Tables", "order": "25", "role": "http://gdsi/role/SubsequentEventsTables", "shortName": "SUBSEQUENT EVENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "menuCat": "Details", "order": "26", "role": "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "menuCat": "Details", "order": "27", "role": "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails1", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:CompensationRelatedCostsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ProductWarrantyAccrualClassifiedCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "28", "role": "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "gdsi:OperatingActivities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - ACCRUED EXPENSES (Details)", "menuCat": "Details", "order": "29", "role": "http://gdsi/role/AccruedExpensesDetails", "shortName": "ACCRUED EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedSalariesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - FAIR VALUE MEASUREMENTS (Details)", "menuCat": "Details", "order": "30", "role": "http://gdsi/role/FairValueMeasurementsDetails", "shortName": "FAIR VALUE MEASUREMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_DerivativeMember_us-gaap_FairValueInputsLevel3Member", "decimals": "0", "lang": null, "name": "us-gaap:DerivativeLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - FAIR VALUE MEASUREMENTS (Details Narrative)", "menuCat": "Details", "order": "31", "role": "http://gdsi/role/FairValueMeasurementsDetailsNarrative", "shortName": "FAIR VALUE MEASUREMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - NOTE PAYABLE (Details Narrative)", "menuCat": "Details", "order": "32", "role": "http://gdsi/role/NotePayableDetailsNarrative", "shortName": "NOTE PAYABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2017-08-31_custom_WilliamDelgadoMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "gdsi:SummaryofOutstandingAndWarrantsExercisableTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - STOCKHOLDERS' EQUITY (Details)", "menuCat": "Details", "order": "33", "role": "http://gdsi/role/StockholdersEquityDetails", "shortName": "STOCKHOLDERS' EQUITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "gdsi:SummaryofOutstandingAndWarrantsExercisableTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "gdsi:ScheduleOfIntrinsicValueOfTheRestrictedStockGrantTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "gdsi:NumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - STOCKHOLDERS' EQUITY (Details 1)", "menuCat": "Details", "order": "34", "role": "http://gdsi/role/StockholdersEquityDetails1", "shortName": "STOCKHOLDERS' EQUITY (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "gdsi:ScheduleOfIntrinsicValueOfTheRestrictedStockGrantTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "gdsi:NumberOfShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "35", "role": "http://gdsi/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:NetIncomeLossBook", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - INCOME TAXES (Details)", "menuCat": "Details", "order": "36", "role": "http://gdsi/role/IncomeTaxesDetails", "shortName": "INCOME TAXES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:NetIncomeLossBook", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - INCOME TAXES (Details 1)", "menuCat": "Details", "order": "37", "role": "http://gdsi/role/IncomeTaxesDetails1", "shortName": "INCOME TAXES (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "gdsi:DeferredTaxAssetsTaxDeferredExpenseCompensationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - INCOME TAXES (Details 2)", "menuCat": "Details", "order": "38", "role": "http://gdsi/role/IncomeTaxesDetails2", "shortName": "INCOME TAXES (Details 2)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "gdsi:DeferredTaxAssetsTaxDeferredExpenseCompensationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "39", "role": "http://gdsi/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://gdsi/role/ConsolidatedStatementsOfOperations", "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "gdsi:ScheduleOfAccountsPayableTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:CompensationOwedToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - RELATED PARTY TRANSACTIONS (Details)", "menuCat": "Details", "order": "40", "role": "http://gdsi/role/RelatedPartyTransactionsDetails", "shortName": "RELATED PARTY TRANSACTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "gdsi:ScheduleOfAccountsPayableTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:CompensationOwedToRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:AccountsPayableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - RELATED PARTY TRANSACTIONS (Details 1)", "menuCat": "Details", "order": "41", "role": "http://gdsi/role/RelatedPartyTransactionsDetails1", "shortName": "RELATED PARTY TRANSACTIONS (Details 1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:AccountsPayableRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "menuCat": "Details", "order": "42", "role": "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "gdsi:AdvanceFromRelatedPartyForOperatingExpenses", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSubsequentEventsTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SUBSEQUENT EVENTS (Details)", "menuCat": "Details", "order": "43", "role": "http://gdsi/role/SubsequentEventsDetails", "shortName": "SUBSEQUENT EVENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfSubsequentEventsTextBlock", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2023-01-012023-01-04_us-gaap_SubsequentEventMember_custom_LeoniteCapitalLLCMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "menuCat": "Details", "order": "44", "role": "http://gdsi/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2023-01-012023-01-04_us-gaap_SubsequentEventMember_custom_LeoniteCapitalLLCMember", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateDuringPeriod", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit", "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://gdsi/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:LoanInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "menuCat": "Statements", "order": "7", "role": "http://gdsi/role/ConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "gdsi:LoanInterest", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - DESCRIPTION OF BUSINESS", "menuCat": "Notes", "order": "8", "role": "http://gdsi/role/DescriptionOfBusiness", "shortName": "DESCRIPTION OF BUSINESS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://gdsi/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "gdsi-20221231_10k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 72, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r404", "r406", "r407" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r404", "r406", "r407" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r404", "r406", "r407" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r404", "r406", "r407" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r393" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r401" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://gdsi/role/Cover" ], "xbrltype": "booleanItemType" }, "gdsi_AccountsPayableRelatedParties": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "AccountsPayableRelatedParties", "negatedPeriodEndLabel": "Balance at Ending", "periodStartLabel": "Balance at Beginning" } } }, "localname": "AccountsPayableRelatedParties", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails1" ], "xbrltype": "monetaryItemType" }, "gdsi_AccreditedInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accredited Investor [Member]" } } }, "localname": "AccreditedInvestorMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_AccruedCompensation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Accrued compensation" } } }, "localname": "AccruedCompensation", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_ActivityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Activity [Member]" } } }, "localname": "ActivityMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "gdsi_AdarAlefLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adar Alef L L C [Member]" } } }, "localname": "AdarAlefLLCMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_AdvanceFromRelatedPartyForOperatingExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Advance from related party for operating expenses" } } }, "localname": "AdvanceFromRelatedPartyForOperatingExpenses", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_AdvancesToRelatedParty": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Advances to related party" } } }, "localname": "AdvancesToRelatedParty", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_CashlessExerciseOfWarrants": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Cashless exercise of warrants" } } }, "localname": "CashlessExerciseOfWarrants", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ChangeInDerivative": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in derivative" } } }, "localname": "ChangeInDerivative", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_ChangeInDerivativeAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInDerivativeAmount", "negatedLabel": "Change in derivative, Amount" } } }, "localname": "ChangeInDerivativeAmount", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "gdsi_ChangeInDerivativePercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in derivative, percent" } } }, "localname": "ChangeInDerivativePercent", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "gdsi_ChangeInFairValueOfWarrantLiability": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInFairValueOfWarrantLiability", "negatedLabel": "Change in fair value of warrant liability" } } }, "localname": "ChangeInFairValueOfWarrantLiability", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ChangeInWarrantLiability": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in warrant liability", "negatedLabel": "Change in warrant liability" } } }, "localname": "ChangeInWarrantLiability", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations", "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_ChangeInWarrantLiabilityAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "ChangeInWarrantLiabilityAmount", "negatedLabel": "Change in warrant liability, Amount" } } }, "localname": "ChangeInWarrantLiabilityAmount", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "gdsi_ChangeInWarrantLiabilityPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in warrant liability, percent" } } }, "localname": "ChangeInWarrantLiabilityPercent", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "gdsi_Charter804CSMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Charter 804CS" } } }, "localname": "Charter804CSMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "gdsi_CommonStockIssuableUponConversion": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common stock issuable upon conversion" } } }, "localname": "CommonStockIssuableUponConversion", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "gdsi_CompensationOwedToRelatedParties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Compensation owed to related parties" } } }, "localname": "CompensationOwedToRelatedParties", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_ConsultingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consulting fees" } } }, "localname": "ConsultingFees", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_ConsultingFeesAddedToNotePayablePrincipal": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consulting fees added to note payable principal" } } }, "localname": "ConsultingFeesAddedToNotePayablePrincipal", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ConversionOfConvertibleNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Conversion of Convertible notes payable" } } }, "localname": "ConversionOfConvertibleNotesPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ConvertibleDebtSettledThriughIssuanceOfCommonShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Convertible debt settled through issuance of common shares" } } }, "localname": "ConvertibleDebtSettledThriughIssuanceOfCommonShares", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ConvertibleInstrumentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Instruments" } } }, "localname": "ConvertibleInstrumentsPolicyTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "gdsi_ConvertibleNotePayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Note Payable [Member]" } } }, "localname": "ConvertibleNotePayableMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_ConvertibleNotesAndInterestPaidByAffiliate": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Convertible notes and interest paid by affiliate" } } }, "localname": "ConvertibleNotesAndInterestPaidByAffiliate", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ConvertibleNotesAndInterestPaidByOfficer": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Convertible notes and interest paid by officer" } } }, "localname": "ConvertibleNotesAndInterestPaidByOfficer", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ConvertibleNotesPaidByOfficer": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Repayment of advanced to officer" } } }, "localname": "ConvertibleNotesPaidByOfficer", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ConvertibleSecuritiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Securities" } } }, "localname": "ConvertibleSecuritiesPolicyTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "gdsi_DateOfGrant": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Date of Grant" } } }, "localname": "DateOfGrant", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "dateItemType" }, "gdsi_DebtDiscountAmortizationAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "DebtDiscountAmortizationAmount", "negatedLabel": "Debt discount amortization, Amount" } } }, "localname": "DebtDiscountAmortizationAmount", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "gdsi_DebtDiscountAmortizationPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt discount amortization, percent" } } }, "localname": "DebtDiscountAmortizationPercent", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "gdsi_DebtDiscountFromIssuanceOfWarrantsWithConvertibleNotePayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt discount from issuance of warrants with convertible note payable" } } }, "localname": "DebtDiscountFromIssuanceOfWarrantsWithConvertibleNotePayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_DeferredTaxAssetAndValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Deferred tax asset and valuation allowance" } } }, "localname": "DeferredTaxAssetAndValuationAllowance", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_DeferredTaxAssetsNetOperatingLossTaxBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "NOL tax benefit" } } }, "localname": "DeferredTaxAssetsNetOperatingLossTaxBenefit", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "gdsi_DeferredTaxAssetsTaxDeferredExpenseCompensationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationTableTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "gdsi_DerivativeLiabilityAdditions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Additions" } } }, "localname": "DerivativeLiabilityAdditions", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_DerivativeLiabilitySettlements": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Settlements" } } }, "localname": "DerivativeLiabilitySettlements", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_DiscountFromDerivativeOnConvertibleNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Debt discount from derivative on convertible notes payable" } } }, "localname": "DiscountFromDerivativeOnConvertibleNotesPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_DiscountOnNotesPayable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Discount on\u00a0\u00a0\u00a0convertible notes payable" } } }, "localname": "DiscountOnNotesPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_DueToRelatedEntity": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Due to related entity, (Note 9)" } } }, "localname": "DueToRelatedEntity", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gdsi_EarningsPerShareBasicAndDiluted1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net (Loss) per common share, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted1", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "gdsi_EcoGrowthRepayment": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Eco growth repayment" } } }, "localname": "EcoGrowthRepayment", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "gdsi_EstimateLossTaxBasis": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Estimate loss - tax basis" } } }, "localname": "EstimateLossTaxBasis", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_ExtensionFeesAddedToPrincipalBalance": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Extension fees added to principal balance" } } }, "localname": "ExtensionFeesAddedToPrincipalBalance", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_FinancedInsurancePolicy": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Financed insurance policy" } } }, "localname": "FinancedInsurancePolicy", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gdsi_FinancingCosts": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Financing costs" } } }, "localname": "FinancingCosts", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "gdsi_FirstFireGlobalOpportunityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "First Fire Global Opportunity [Member]" } } }, "localname": "FirstFireGlobalOpportunityMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_FourthManLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fourth Man L L C [Member]" } } }, "localname": "FourthManLLCMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "gdsi_GHSInvestmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "G H S Investments [Member]" } } }, "localname": "GHSInvestmentsMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_GSCapitalPartnersLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GS Capital Partners, LLC [Member]" } } }, "localname": "GSCapitalPartnersLLCMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_GSCapitalPartnersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GS Capital Partners [Member]" } } }, "localname": "GSCapitalPartnersMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_GainOnSettlementOfAccruedExpenses": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Gain on settlement of accrued expenses" } } }, "localname": "GainOnSettlementOfAccruedExpenses", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "gdsi_GaryGrayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gary Gray" } } }, "localname": "GaryGrayMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails", "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "gdsi_GaryShoverMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gary Shover [Member]" } } }, "localname": "GaryShoverMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_GenevaRothRemarkHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Geneva Roth Remark Holdings [Member]" } } }, "localname": "GenevaRothRemarkHoldingsMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_HarborGatesCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Harbor Gates Capital [Member]" } } }, "localname": "HarborGatesCapitalMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_IncreaseDecreaseInPrepaidExpenseFromRelatedParty": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "IncreaseDecreaseInPrepaidExpenseFromRelatedParty", "negatedLabel": "Prepaid expense from related party" } } }, "localname": "IncreaseDecreaseInPrepaidExpenseFromRelatedParty", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_InterestExpenseFromWarrantLiability": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Interest expense from warrant liability" } } }, "localname": "InterestExpenseFromWarrantLiability", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_InvestmentReturnDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment return description" } } }, "localname": "InvestmentReturnDescription", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "gdsi_JMJFinancialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "J M J Financial [Member]" } } }, "localname": "JMJFinancialMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_JeromeGomolskiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Jerome Gomolski [Member]" } } }, "localname": "JeromeGomolskiMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails1", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_JerryGomolskiMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Jerry Gomolski" } } }, "localname": "JerryGomolskiMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "gdsi_LGCapitalFundingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "L G Capital Funding [Member]" } } }, "localname": "LGCapitalFundingMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_LeoniteCapitalLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leonite Capital L L C [Member]" } } }, "localname": "LeoniteCapitalLLCMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_LeoniteCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leonite Capital [Member]" } } }, "localname": "LeoniteCapitalMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_LoanInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Loan Interest" } } }, "localname": "LoanInterest", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "gdsi_LossGainOnConversionOfNp": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "LossGainOnConversionOfNp", "negatedLabel": "Loss (gain) on Conversion of NP" } } }, "localname": "LossGainOnConversionOfNp", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_LossOnConversionOfNotesPayable": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "LossOnConversionOfNotesPayable", "negatedLabel": "Loss on conversion of notes payable" } } }, "localname": "LossOnConversionOfNotesPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "gdsi_LossOnDisposalOfFixedAssets": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss on Disposal of Fixed assets" } } }, "localname": "LossOnDisposalOfFixedAssets", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_LossOnWriteOffOfPrepaidExpense": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Loss on write off of prepaid expense" } } }, "localname": "LossOnWriteOffOfPrepaidExpense", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "gdsi_MathewKelley1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mathew Kelley 1 [Member]" } } }, "localname": "MathewKelley1Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "gdsi_MathewKelleyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mathew Kelley [Member]" } } }, "localname": "MathewKelleyMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "gdsi_Mr.DelgadoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mr. Delgado [Member]" } } }, "localname": "Mr.DelgadoMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_MrDelgadoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mr Delgado [Member]" } } }, "localname": "MrDelgadoMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_NetIncomeLossBook": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net (Income) Loss - book" } } }, "localname": "NetIncomeLossBook", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "gdsi_NumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of Shares" } } }, "localname": "NumberOfShares", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "gdsi_NumberOfWarrantPurchase": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Number of warrant purchase" } } }, "localname": "NumberOfWarrantPurchase", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "gdsi_OperatingActivities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Operating activities" } } }, "localname": "OperatingActivities", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_OriginalIssueDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Original issue discount" } } }, "localname": "OriginalIssueDiscount", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_PPPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "P P P [Member]" } } }, "localname": "PPPMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_ParabellumMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Parabellum [Member]" } } }, "localname": "ParabellumMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_PenaltyotherExtensionFeesForNotesPayable": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Penalty/other extension fees for notes payable" } } }, "localname": "PenaltyotherExtensionFeesForNotesPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_Permanentdifferences": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Permanent\u00a0\u00a0Differences:" } } }, "localname": "Permanentdifferences", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "gdsi_PowerUpLendingGroupMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Power Up Lending Group [Member]" } } }, "localname": "PowerUpLendingGroupMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_PrepaidExpensesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Prepaid expenses" } } }, "localname": "PrepaidExpensesPolicyTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "gdsi_PurchasePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Purchase price" } } }, "localname": "PurchasePrice", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_PurchaserMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Purchaser [Member]" } } }, "localname": "PurchaserMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_RLTMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "R L T [Member]" } } }, "localname": "RLTMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_Range10Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 10 [Member]" } } }, "localname": "Range10Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range11Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 11 [Member]" } } }, "localname": "Range11Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range12Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 12 [Member]" } } }, "localname": "Range12Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range13Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 13 [Member]" } } }, "localname": "Range13Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range14Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 14 [Member]" } } }, "localname": "Range14Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range15Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 15 [Member]" } } }, "localname": "Range15Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range16Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 16 [Member]" } } }, "localname": "Range16Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range17Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 17 [Member]" } } }, "localname": "Range17Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range18Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 18 [Member]" } } }, "localname": "Range18Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range19Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 19 [Member]" } } }, "localname": "Range19Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 1 [Member]" } } }, "localname": "Range1Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range2Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 2 [Member]" } } }, "localname": "Range2Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range3Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 3 [Member]" } } }, "localname": "Range3Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range4Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 4 [Member]" } } }, "localname": "Range4Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range5Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 5 [Member]" } } }, "localname": "Range5Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range6Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 6 [Member]" } } }, "localname": "Range6Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range7Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 7 [Member]" } } }, "localname": "Range7Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range8Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 8 [Member]" } } }, "localname": "Range8Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_Range9Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Range 9 [Member]" } } }, "localname": "Range9Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "gdsi_ReductionInAcruedCompensationDueToOfficer": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reduction in accrued compensation due to officer" } } }, "localname": "ReductionInAcruedCompensationDueToOfficer", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ReductionInDerivativeLiabilityFromPaymentsOnConvertibleNotesPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Reduction in derivative liability from payments on convertible notes payable" } } }, "localname": "ReductionInDerivativeLiabilityFromPaymentsOnConvertibleNotesPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_ReimbursedAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Reimbursed amount" } } }, "localname": "ReimbursedAmount", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "gdsi_RichardJFeldman1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Richard J Feldman 1 [Member]" } } }, "localname": "RichardJFeldman1Member", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "gdsi_RichardJFeldmanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Richard J Feldman [Member]" } } }, "localname": "RichardJFeldmanMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "gdsi_RonalMinorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ronal Minor [Member]" } } }, "localname": "RonalMinorMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_RossTrevinoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Ross Trevino [Member]" } } }, "localname": "RossTrevinoMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "domainItemType" }, "gdsi_ScheduleOfAccountsPayableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of accounts payable" } } }, "localname": "ScheduleOfAccountsPayableTableTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "gdsi_ScheduleOfIntrinsicValueOfTheRestrictedStockGrantTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of intrinsic value of the restricted stock grant" } } }, "localname": "ScheduleOfIntrinsicValueOfTheRestrictedStockGrantTableTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "gdsi_SettlementOfDerivativeLiabilityToApic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Settlement of derivative liability to APIC" } } }, "localname": "SettlementOfDerivativeLiabilityToApic", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_SharesIssuable": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares Issuable" } } }, "localname": "SharesIssuable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gdsi_SharesIssuedForAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for accounts payable" } } }, "localname": "SharesIssuedForAccountsPayable", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_SharesIssuedForFinancingFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Shares issued for financing fees" } } }, "localname": "SharesIssuedForFinancingFees", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "gdsi_SharesIssuedForFinancingFeesinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares issued for financing fees, shares" } } }, "localname": "SharesIssuedForFinancingFeesinShares", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "gdsi_SharesIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Shares issued for services" } } }, "localname": "SharesIssuedForServices", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "gdsi_SharesPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shares Payable [Member]" } } }, "localname": "SharesPayableMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "gdsi_SixthStreetLendingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Sixth Street Lending [Member]" } } }, "localname": "SixthStreetLendingMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "gdsi_StockIssuedDuringPeriodValueWarrantExercised": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Warrant Exercise" } } }, "localname": "StockIssuedDuringPeriodValueWarrantExercised", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "gdsi_StockIssuedDuringPeriodValueWarrantExercisedInShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercise, shares" } } }, "localname": "StockIssuedDuringPeriodValueWarrantExercisedInShares", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "gdsi_SubsequentEventCategory": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent event category" } } }, "localname": "SubsequentEventCategory", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "gdsi_SummaryofOutstandingAndWarrantsExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of summary of outstanding and warrants exercisable" } } }, "localname": "SummaryofOutstandingAndWarrantsExercisableTableTextBlock", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "gdsi_ThirdPartyVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Third Party Vendor [Member]" } } }, "localname": "ThirdPartyVendorMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_Unvested": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unvested" } } }, "localname": "Unvested", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "gdsi_VestFrom": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vest from" } } }, "localname": "VestFrom", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "dateItemType" }, "gdsi_VestTo": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vest To" } } }, "localname": "VestTo", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "dateItemType" }, "gdsi_VoxMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Vox [Member]" } } }, "localname": "VoxMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_WarrantExerciseShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Warrant exercise shares" } } }, "localname": "WarrantExerciseShares", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "gdsi_WarrantIssuancePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant issuance percentage" } } }, "localname": "WarrantIssuancePercentage", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "gdsi_WarrantLiability": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Warrant Liability" } } }, "localname": "WarrantLiability", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "gdsi_WarrantLiabilityChangeInFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Change in fair value" } } }, "localname": "WarrantLiabilityChangeInFairValue", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "gdsi_WeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Exercise Price" } } }, "localname": "WeightedAverageExercisePrice", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "gdsi_WeightedAverageNumberOfShareOutstandingBasicAndDiluted1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted1", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "gdsi_WilliamDelgadoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "William Delgado Member" } } }, "localname": "WilliamDelgadoMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/RelatedPartyTransactionsDetails1", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_WilliamJDelgadoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "William J Delgado [Member]" } } }, "localname": "WilliamJDelgadoMember", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "gdsi_WorkingCapitalDeficit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Working capital deficit" } } }, "localname": "WorkingCapitalDeficit", "nsuri": "http://gdsi/20221231", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r138", "r139", "r207", "r234", "r375", "r377" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative", "http://gdsi/role/StockholdersEquityDetails1", "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r138", "r139", "r207", "r234", "r376", "r377" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative", "http://gdsi/role/StockholdersEquityDetails1", "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r154", "r255", "r413", "r426" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r154", "r255", "r413", "r414", "r426" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.", "label": "ACCRUED EXPENSES" } } }, "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r10", "r392" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r97", "r110" ], "calculation": { "http://gdsi/role/AccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities.", "label": "Accrued Liabilities", "totalLabel": "Total accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://gdsi/role/AccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued professional fees and settlements" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalariesCurrent": { "auth_ref": [ "r13", "r374" ], "calculation": { "http://gdsi/role/AccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation to executive officers" } } }, "localname": "AccruedSalariesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/AccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r45", "r118" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r5", "r392" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r263", "r264", "r265", "r423", "r424", "r425", "r440" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Reduction in derivative liability" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r26", "r32", "r87", "r226" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of original issue discount", "negatedLabel": "Debt discount amortization" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations", "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r226", "r309", "r385", "r386", "r420" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of debt discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potentially dilutive securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r93", "r103", "r119", "r135", "r169", "r172", "r176", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r289", "r293", "r301", "r392", "r432", "r433", "r444" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r115", "r120", "r135", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r289", "r293", "r301", "r392", "r432", "r433", "r444" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r135", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r289", "r293", "r301", "r432", "r433", "r444" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total other assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Assets" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r448" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Software Development costs" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r34", "r117", "r373" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets", "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r35" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r29", "r34", "r36" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash at end of year", "periodStartLabel": "Cash at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r29", "r86" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r17", "r98", "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r47", "r193", "r194", "r372", "r431" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r423", "r424", "r440" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockOtherSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Total number of shares of other common stock instruments held by shareholders, such as exchangeable shares. May be all or portion of the number of common shares authorized.", "label": "Share outstanding" } } }, "localname": "CommonStockOtherSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical", "http://gdsi/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical", "http://gdsi/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r4", "r54" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r4", "r392" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 2,000,000,000 shares authorized, 800,543,896 shares and 737,263,858 issued and outstanding at December 31, 2022, and 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock Based Compensation" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r73", "r378" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r2", "r95", "r104", "r112" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable, net of discount of $246,470 and $652,178, respectively" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r1", "r94", "r102", "r112" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r22", "r135", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r301", "r432" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenues" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r53", "r133", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r220", "r227", "r228", "r230" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTE PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r2", "r95", "r102", "r231" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r88", "r89", "r204", "r310", "r383", "r384" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateDuringPeriod": { "auth_ref": [ "r15", "r88", "r223" ], "lang": { "en-us": { "role": { "documentation": "The average effective interest rate during the reporting period.", "label": "Interest rate", "verboseLabel": "Debt instrument, interest rate during period" } } }, "localname": "DebtInstrumentInterestRateDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r121", "r382", "r441" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r16", "r55", "r56", "r57", "r58", "r87", "r88", "r89", "r101", "r141", "r204", "r205", "r206", "r207", "r208", "r210", "r216", "r217", "r218", "r219", "r221", "r222", "r223", "r224", "r225", "r226", "r229", "r310", "r382", "r383", "r384", "r385", "r386", "r421" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": { "auth_ref": [ "r87", "r89" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.", "label": "Debt Instrument, Unamortized Discount, Current" } } }, "localname": "DebtInstrumentUnamortizedDiscountCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r273" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Total Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r435" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r72", "r436" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net Operating Loss Carryforward" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r274" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r32", "r44" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": { "auth_ref": [ "r80", "r439" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.", "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net", "negatedLabel": "Change in fair value of derivative liability", "verboseLabel": "Change in fair value" } } }, "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations", "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilitiesCurrent": { "auth_ref": [ "r122" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative liability", "periodEndLabel": "Balance at end of year", "periodStartLabel": "Balance at beginning of period" } } }, "localname": "DerivativeLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets", "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeMember": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "This element represents types of derivative financial instruments which are financial instruments or other contractual arrangements with all three of the following characteristics: (a) it has (1) one or more underlyings and (2) one or more notional amounts or payment provisions or both. Those terms determine the amount of the settlement or settlements, and, in some cases, whether or not a settlement is required; (b) it requires no initial net investment or an initial net investment that is smaller than would be required for other types of contracts that would be expected to have a similar response to changes in market factors; and (c) its terms require or permit net settlement, it can readily be settled net by a means outside the contract, or it provides for delivery of an asset that puts the recipient in a position not substantially different from net settlement. Notwithstanding the above characteristics, loan commitments that relate to the origination of mortgage loans that will be held for sale are accounted for as derivative instruments by the issuer of the loan commitment (that is, the potential lender).", "label": "Derivative [Member]" } } }, "localname": "DerivativeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r75", "r76", "r77", "r78", "r81", "r140" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivative Financial Instruments" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r38", "r39" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings (Loss) Per Share (\u201cEPS\u201d)" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Company's effective tax rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r136", "r269", "r282" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Income tax expense at statutory federal rate of 21%, percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r434", "r437" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Increase (decrease) in valuation allowance, percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses": { "auth_ref": [ "r434", "r437" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to impairment loss.", "label": "Impairments, percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Officer (Note 9)", "verboseLabel": "Employee-related liabilities, current" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r54", "r113", "r126", "r127", "r128", "r142", "r143", "r144", "r146", "r151", "r153", "r159", "r184", "r247", "r263", "r264", "r265", "r278", "r279", "r297", "r302", "r303", "r304", "r305", "r306", "r307", "r311", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition": { "auth_ref": [ "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liability for an extended product warranty acquired in a business acquisition. Does not include any liability for a standard warranty acquired in a business acquisition.", "label": "Extended Product Warranty Accrual, Additions from Business Acquisition", "negatedLabel": "Additions to warrant liability" } } }, "localname": "ExtendedProductWarrantyAccrualAdditionsFromBusinessAcquisition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r218", "r248", "r249", "r250", "r251", "r252", "r253", "r299", "r324", "r325", "r326", "r383", "r384", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "FAIR VALUE MEASUREMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r218", "r248", "r249", "r250", "r251", "r252", "r253", "r299", "r326", "r383", "r384", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r218", "r248", "r249", "r250", "r251", "r252", "r253", "r324", "r325", "r326", "r383", "r384", "r387", "r388", "r389" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r82", "r83" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]" } } }, "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r181", "r182", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r192", "r229", "r245", "r295", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r381", "r427", "r428", "r429", "r449", "r450", "r451", "r452", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": { "auth_ref": [ "r79" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.", "label": "Gain (Loss) on Derivative Instruments, Net, Pretax", "negatedLabel": "Change in fair value of derivative liability" } } }, "localname": "GainLossOnDerivativeInstrumentsNetPretax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": { "auth_ref": [ "r420" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.", "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges", "negatedLabel": "Loss on disposal of fixed assets" } } }, "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r21", "r135", "r169", "r171", "r175", "r177", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r301", "r380", "r432" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r136", "r270", "r271", "r276", "r280", "r283", "r285", "r286", "r287" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r152", "r153", "r168", "r268", "r281", "r284", "r366" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Company's effective tax rate, Amount", "negatedLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations", "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r125", "r266", "r267", "r271", "r272", "r275", "r277" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r434" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount", "negatedLabel": "Increase (decrease) in valuation allowance, Amount" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income tax expense at statutory federal rate of 21%, Amount" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses": { "auth_ref": [ "r434" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible impairment loss.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Impairment Losses, Amount", "negatedLabel": "Impairments, Amount" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromRelatedParties": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in receivables to be collected from other entities that could exert significant influence over the reporting entity.", "label": "Increase (Decrease) in Due from Related Parties", "negatedLabel": "Due from related entity" } } }, "localname": "IncreaseDecreaseInDueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToOfficersAndStockholders": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease), during an accounting period, in total obligations owed to the reporting entity's executives and owners.", "label": "Due to officer" } } }, "localname": "IncreaseDecreaseInDueToOfficersAndStockholders", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueToRelatedParties": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations to be paid to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management; an entity and its principal owners, management, or member of their immediate families; affiliates; or other parties with the ability to exert significant influence.", "label": "Due to Related Party" } } }, "localname": "IncreaseDecreaseInDueToRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r100" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income (Expense), Net", "negatedLabel": "Interest expense" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://gdsi/role/AccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrentAndNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/AccruedExpensesDetails", "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r23" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal fees for note issuance" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r12", "r135", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r290", "r293", "r294", "r301", "r379", "r432", "r444", "r445" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r9", "r96", "r107", "r392", "r422", "r430", "r442" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u0092 deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders\u0092 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r14", "r116", "r135", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r290", "r293", "r294", "r301", "r392", "r432", "r444", "r445" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Long term liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermNotesPayable": { "auth_ref": [ "r16" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Notes payable" } } }, "localname": "LongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r16", "r52" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r160", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "DESCRIPTION OF BUSINESS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/DescriptionOfBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r131" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r131" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r29", "r30", "r33" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r20", "r33", "r99", "r111", "r114", "r123", "r124", "r128", "r135", "r145", "r147", "r148", "r149", "r150", "r152", "r153", "r156", "r169", "r171", "r175", "r177", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r298", "r301", "r380", "r432" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net (Loss)", "negatedLabel": "Net loss", "verboseLabel": "Net Income (Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows", "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit", "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-Cash Items" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r25" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "negatedTotalLabel": "Total other expense (income)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other expense (income)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r2", "r95", "r105" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable [Default Label]", "verboseLabel": "Notes payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r11" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r169", "r171", "r175", "r177", "r380" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "negatedTotalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r71" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carry forward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherRealEstateDisposals": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposals of other real estate not separately disclosed, including, but not limited to, real estate investments, real estate loans that qualify as investments in real estate, and premises that are no longer used in operations may also be included in real estate owned. This excludes real estate assets taken in settlement of troubled loans through surrender or foreclosure.", "label": "Other Real Estate, Disposals", "negatedLabel": "Loss on disposal of fixed assets" } } }, "localname": "OtherRealEstateDisposals", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToEmployees": { "auth_ref": [ "r419" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments of cash to employees, including wages and salaries, during the current period.", "label": "Payments to Employees", "negatedLabel": "Payments" } } }, "localname": "PaymentsToEmployees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit", "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r3", "r232" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value", "verboseLabel": "Preferred stock, par or stated value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical", "http://gdsi/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical", "http://gdsi/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r3", "r232" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheetsParenthetical", "http://gdsi/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r3", "r392" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 shares issued and outstanding at December 31, 2022, and 2021 respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseNoncurrent": { "auth_ref": [ "r415" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of amounts paid in advance for expenses which will be charged against earnings in periods after one year or beyond the operating cycle, if longer.", "label": "Prepaid Expense, (Note 9)" } } }, "localname": "PrepaidExpenseNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r27" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible notes payable" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r27" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r27" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r13", "r48", "r49" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Product Warranty Accrual, Current", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Warrant Liability balance at beginning of period" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r114", "r123", "r124", "r130", "r135", "r145", "r152", "r153", "r169", "r171", "r175", "r177", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r288", "r291", "r292", "r298", "r301", "r364", "r380", "r390", "r391", "r416", "r432" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Net (Loss) Income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r46", "r108", "r365", "r392" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Equipment net of accumulated depreciation of $ 17,773" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesFromCustomers": { "auth_ref": [ "r447" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers for fees and charges arising from transactions related to the entity's brokerage activities and operations.", "label": "Due from related entity, (Note 9)" } } }, "localname": "ReceivablesFromCustomers", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r254", "r314", "r315" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/RelatedPartyTransactionsDetails", "http://gdsi/role/RelatedPartyTransactionsDetails1", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails", "http://gdsi/role/RelatedPartyTransactionsDetails1", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r254", "r314", "r352", "r353", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r443" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/NotePayableDetailsNarrative", "http://gdsi/role/RelatedPartyTransactionsDetails", "http://gdsi/role/RelatedPartyTransactionsDetails1", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r312", "r313", "r315", "r316", "r317" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r28" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments of Convertible Debt", "negatedLabel": "Payments of convertible notes payable" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r418" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Repayments of debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r28" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayments of notes payable", "negatedLabel": "Payments of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows", "http://gdsi/role/NotePayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r6", "r59", "r106", "r370", "r371", "r392" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets", "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r113", "r142", "r143", "r144", "r146", "r151", "r153", "r184", "r263", "r264", "r265", "r278", "r279", "r297", "r367", "r369" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r129", "r135", "r166", "r167", "r170", "r173", "r174", "r178", "r179", "r180", "r183", "r195", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r203", "r301", "r364", "r432" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalariesAndWages": { "auth_ref": [ "r417" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by nonofficer employee. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "2022 Salary" } } }, "localname": "SalariesAndWages", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails1" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule of Accrued Expenses" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule of accrued liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r38" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Securities excluded from the diluted per share calculation" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule of deferred tax assets and liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative liabilities at fair value.", "label": "Schedule of Fair Value of Liabilities" } } }, "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule of Reconciliations between the statutory rate and the effective tax rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": { "auth_ref": [ "r84", "r85" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.", "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table]" } } }, "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of warranty liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r90", "r91" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/RelatedPartyTransactionsDetails", "http://gdsi/role/RelatedPartyTransactionsDetails1", "http://gdsi/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSubsequentEventsTextBlock": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.", "label": "Schedule of Subsequent Events" } } }, "localname": "ScheduleOfSubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r24" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r31" ], "calculation": { "http://gdsi/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r261" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Dividend rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "verboseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r262" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "verboseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "verboseLabel": "Weighted Average Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r256", "r257" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Weighted Average Number Outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage amount by which a share price is expected to fluctuate during the expected term of a nonvested share or option award issued to other than an employee.", "label": "Volatility" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing a nonvested share or option award issued to other than an employee.", "label": "Risk free interest rate" } } }, "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r259" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r62" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r63" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Outstanding Remaining Contractual Life (in yrs)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r37", "r132" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r19", "r54", "r113", "r126", "r127", "r128", "r142", "r143", "r144", "r146", "r151", "r153", "r159", "r184", "r247", "r263", "r264", "r265", "r278", "r279", "r297", "r302", "r303", "r304", "r305", "r306", "r307", "r311", "r367", "r368", "r369" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit", "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r142", "r143", "r144", "r159", "r351" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit", "http://gdsi/role/IncomeTaxesDetails2" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r18", "r54", "r55", "r59", "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Shares Issued for conversion of debt, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Shares issued for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r3", "r4", "r54", "r59" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Total share issued" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r3", "r4", "r54", "r59" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Forfeited" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquityDetails1" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r19", "r54", "r59" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Shares Issued for conversion of debt" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r4", "r7", "r8", "r43", "r392", "r422", "r430", "r442" ], "calculation": { "http://gdsi/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "negatedLabel": "Stockholders' deficit", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders\u0092 deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets", "http://gdsi/role/ConsolidatedStatementsOfStockholdersDeficit", "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u0092 deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r60", "r134", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r246", "r247", "r296" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventDescription": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Describes the event or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.", "label": "Subsequent event description" } } }, "localname": "SubsequentEventDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r308", "r319" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r308", "r319" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r308", "r319" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r308", "r319" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails", "http://gdsi/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsDate": { "auth_ref": [ "r92" ], "lang": { "en-us": { "role": { "documentation": "Date the event occurred after the balance sheet date but before financial statements are issues or available to be issued, in YYYY-MM-DD format.", "label": "3/17/2023" } } }, "localname": "SubsequentEventsDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEventsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r318", "r320" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Going Concern" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r181", "r182", "r229", "r245", "r295", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r427", "r428", "r429", "r449", "r450", "r451", "r452", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r40", "r41", "r42", "r161", "r162", "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/SummaryOfSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r155", "r157" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average common shares outstanding, basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://gdsi/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r393": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r394": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r395": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r396": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r397": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r398": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r399": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r401": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r402": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r403": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r404": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r405": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r406": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r407": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r408": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r409": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r411": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r412": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r431": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r447": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "310", "Topic": "940", "URI": "https://asc.fasb.org/subtopic&trid=2176284", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r449": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r451": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r452": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r453": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r454": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r455": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(4)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "83", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126929950&loc=d3e34841-113949", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 63 0001520138-23-000260-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001520138-23-000260-xbrl.zip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͌[UQVBW)/@NG0J^5$,M9YJ"?V%IH,M3'BV1CX@)5,14O^A6#T/FO,U* M6<5\8(%'_\"' "(5(E':*7DE^VZE S^,DF,N_ MPZ6SVKL0R(; $>5^.A!_?R#:Z82V+*YX:#,>I2"!N@8PP?XT_ BV%3Z%GP,X M.>+".:I47X$!4]6990>IT_P-KYE+K""D&ULN-][D/YA8X#=B_Y_LGW8&F2^- MJQ^-3;3_M=O!Q:!_^K-AE$,T'7O5$83E<4,J@#+M'-: >>$BGC>VVR&_DEK@Z7E MM+A9=.:@K]MLZ0T[?KH]/GP0F7#O9T:]FMD'TZ8Z5Z9(=2[=#JXZ5UK5^OKG M2[_\GTMUKLR:ZER]'93V+'WOFV$\_;G;T%3GP[M!KK7?>?K"[K:ISD-V\9%N M.$0]%\TCJ:6?!%6 7,D;T@FUD%T\U?.W@\)G.UO][76JS;E[X[]0 N#G)V._ MI!?U;T>U-R/?']T.CNWK/^=_K-)@T J!:BD4P07Y/H^9)00:(;Z4&RN5ODJ M+#%*@*J+WDF4M<,3ZL"<58.D8QDL%2$-DLM^BAR%U9]X' 8$O^%@6P6> 03? M\K"\T GC MO= /LUQ5GJMN/8-3YB@4)00?9GSPI^OZM4K_>5=>KO/'=P "PRO$61Y]W+:$F6-40&X3KF:P[<2K-(R9.8= MNE PP"26I+K!GL6+]- 8^=NS\;X1^A3.$JWLQ1E%% W)A2?M\5!\Z&;0]_/> MQ,)V4)S$QA#I/@1M$NW'T0T$X!&'2Z?$*KG(*G@PT*Y#H I]JS0=$$/8%XJW MN$;R\7!R*3J/#"K"IZ9'0SD4ZCT?#:^-/, MNX^*L&KJ $V]Z\*&Y%]O%C=D&-3\N:8'BPT7,]VGM9W@*?:86^@>/P+_M=@. MZ >M-NVC] ZW72F6*LN8/+IPK2]V_Z=(]7S'P92I;_/+IPFC.8>M26$[CUK. M80MS2X9;,GS]9)A-($,D.M> -^I.@DHX0JBJ\G=DB8!N)ZW'MT,SE3C9^WD@ MF%;'WQ2JEY"ZOOQ16'EG!OVD83BLCEFVE"4F_[5E%5M6L645L["*G,\JPJ55 M,88>I\J@ TW8BD9M/N1)V)V:'!?KVQJBW>7[3P_\6K,)@?3]D-,T^:';P:_Z MQA!W)1^K7N^+O,L/2ADG"U*J$GT5HCC> M8H(U<+ZC> DB'TWW QD)?(&\$EIA1RQQ*,Z-.<'^*OA(R&OH5T;X S8I?F$G@).WZAT&J2RS,AREC1VC0WYA'CZFWF?!G<%/.^1&04<,-K-L\&FE M?C5L- _+=S$'QQJJ]6(Q]0WAA-9T2F1O*6X;.UN"= AY?& G +W0XJ=AP\[@ M;\6[D_.)OVBSD/P^=0'BQ8NJ)25%&3[-9%Z, J.HLG9*)SQ%/MVR9 M')0K<]C26RCSA.GP=128"&&5$Y#(P0Y*'C#L+]1EWB;.\;,4.-3WZ0D:T1H] M3UQM-%U&S/6&ZGBPYVG0%I$')48ZN(76#C<2Q5W( ,!CF]&^"1RA'\G.;C46 M[B$7 3>>D2Y-1<@S'@;@T...=KF83'*D;37D.%V9Y^,W0\#J:=@T01Y;'G"( M*^^-7;8;HE?@F;)[-U@@7GTW<(^'_=FB,@X7I660'@-R\ULF )#MA9D MM:>[1CV=@HLA^0/:1D]87]02 GDLCIT2@1H"88)KV+WLW;;8@2&%%+3?I*%W@;[Z(MFTZ/MJ26 M'3#X2^AWJ/50)U6=M].A99]P"BX?OR;V$Y*HC[KCZ** AF^#9"YK1)2MYJA> M]9KYZT8>A<*'09TN=[C!5<+._#BZ&XSG%BV(/(O A069('9F=@:GE8']>;?5P3\E4UJK;=9HV>R MBV8U!,E@ZOJAN$M>";#?MBAWVUO@BLA'O4+7Y#MX// M)X.?7G[PQ?J%&@)A<)_>_2]P3[]1UXXR_1!@Y?T!#@\SW0\SJ!R);N6(^WG$ MQSSL.>:^\9#S>%BUV"O=#C+W9KU=/7(*-T&&7\-PNZ8.2 FXQ-Y\"F#[7,J- M>!/A_R321KRN<#C\U?]]$TSFC4M<#CT[M-025^8>T&?!.+J:?$[@N1^OT'8+ M82J.WW9Q?,(SK2%3GN,.]AM'D![B3*OG;R=P_LY^^+EN)3S9<1FW/G']!0!@ MKMO/SGG[R.%GN/>7W[6V@=CZ@MQIBD.#2 '@MQR[9S50K-C.OXK3JKW/9O)J M-E=6LX7"AY@@HQ V)0QUAK=FLB: ?W_$\1E.KY5]-H;O4H;ZWB4@4O1G6NR; MA]#5'YY8SH?TA#FU@RJE[,9.\KU=U#OV^O$+5)\,-_26$*#1 ^5>^M;Y]YK^Z,?+Z4JC#/MQ/HA7=Q'N 1<".D90Q?@H"DZI,>*18C M)TV67,BMC)MX'.BU$H"W8^$WY?#*D_.CT*Q*VHL+S*I85@O%G)K1\B/S*CE* M3_O_AC2E6)N])67CNR*1Q-QQ\OSQ%42J:GP*L65#S2"V1Q$ MM$:$DRQY2S>;CAB%'"6<2TBT*8ZNODO^_1HQ- M9O5+Q-AL22V52VHQ6YH38Y=MV8R^_3H4X:E]: MW/S'2")9&"V.),J:FELF2:S:T/BH))#>! Q9-P(NKD2FO7H2BDW'F4>"Y/.J MIFFJEIOL;-V*D"E$R*O'P!$F/A_^E7-JME)1"YGRA2O'MT. M:J9F?2G^*A>.BXO-_UZ[GHJ%S!0]%;7;P9U9/CJH_,SFS=I_KJ>BEIFUJ6+N M=O#-N:_]^7-Y>%.K;&)3Q3VX^N)-X;)K?L^4ZMNFBB/SXX-6K5=\N,V^[4X: M-Z!%1LE/M<+MH%4];UO9'\6GOVP3:U+V;P=-Q[X[N:X[5:,LO.?IU!Y5!8:! ML"T_68ML<6S%/5S>BZ69)9PP(XJ&PM<6M!:@L$CX*U%8%&FA+"KJQ$PYK'G% M"KU.U[3[6-+*G ?J0")'+E%](] V'SY'K4U0?Q"SDB,-D\7*?KE@"^U*4:HW M4O"I/^K.=B3=NATE/*/8K^4=GD7<)S3@A:*1 E.L,A+=,1L/AFL[\"8L=NV9 MGDZUG30"F%D-^$891JN6;3=$':_ 05FPXL;,#/(+E@N9PDXA VQOETIL;X9J M1OU"T:%6>0(+DP]AN)&!E[*@57=,@Y=SO3<^! ._L5JF;6#%%95A&1YOP CO M[3*'='0D95$C)H 3A@U6WG+ X(L=+)AE-!/SO1%Z#6V#OV?B.O[MA3<@RME, M.!C.K^0L0.?57U/=)R\$B]SIE(#EY_(KW>T'QN^$&K1*GL#?HO#>"/@*:FC: MW$6(]\CY=K!74#1V)#^C"O*XV:VB&GYTXW(A40SG^/5P23B4 M3DE\5?G=,#R:(69TRP:I$I>HY>FK8!4OS_5644AUZ=@XB%$X2?NRO4+_!B_R M^652BZU74K0/XX?]TDN70:+.]ZI[T7RVRQUE/2 3H[]\U_OWZX,WGXJ9XE3).NM6 M3Y*=%S&&XS6#YE&KF3\_/#2<[ 8C1F91B%$H3I?%M6Z5%U5@M]Q& NOK<522 M+R_[\?#)8U@R'7]]_K[0#-C#YF',=:MUL$SYI/5;XUQ@9\.(YUSWA]]Z=[_, M'Y>VCY_C#SLV#S%L>NVXK+YC/.VTC088-?\J<+:L\51SS$RA7'Y#+?6T[,>$ M2K-5)9J6EP?J$5YP\_OIJ./^OL^5"PN ]?OQY#[?818:FQW##S2UE)M.5(S> MZ8T[#\76T;2538-6Y;#XLK9Y6'+0A6@-7:ZK-=N MEBUTAE$AQYOV^5:"Z#H:;SO'/OQLI@%/*0V[5S/9\FWKPW&V]?7@[J;QX^?1 M>:;LLY(D4(QG)TE'6KK]M##!HZF%2F4F9I*;1_"L%(,R\V+0B.)]^-=POGSI M-/:KYJ9BT,I=,S/@3UPRY.1TR,[@1BO]R5T]?9XK]>AUQ?T6=I1TJNHIX=YB MR(V"*.^/<%QXQ/RDCI5!2W/J3:[H@A2NZVW;Q,&?=H.908?^H &G[!.[(_K$ MR@F<_XI9MB.E5 MDX@S6&L!'#R:C0QT=RDSDC.[F6R^$D-]A&L? ;HTRI1Z[\N>50J.1D%@#,,B M-PP+2G@[QBR3JM4XMRV9(W MPOF>5&&XZT_:>@7W\XI0+;C3 M=,J_]=!<,TIL;U!!!EH+_H NG,&@*D93Z3#XKYA^]HSA9Q-'FR7--=MYQERS M&QSG,+QS,;E$J1M.O=?!U<1T:IZ[_E[G*>T,-FUW<-1*'11DD/3P,-Q(G2,X MFGK^D'N?YF+G7_FC;NLF)NCWZ7G,K&4T-L[/# ^_5(EY9SH5>2E!K2Z&G*G* M^QK?=KM?(-!R[&Z*)?(C+R+#K C,_1DH4_ MHC@940->"(9:O=YS>"''^_H'L,A=UM7)! ^=S/=WN*!$" 6-+S ))H]R0AGF M_P-1.%1[$?_C7>72L9O,1:3'.2(^:8&::4NJ@IUBF0DCFN X@(4(F.C[V&96 M< '12H4&5AP0SM0$;5D>O09V@]\VL2I$W$0W81>N9.I8DW+&=)FWM!]:3@DW MYCY@-2_$Y[?\?#V/$E$=8I2%44W@/:&:X2EM/5Q5Q/E&A"IBV+B8VB?F ?L< MGX_UH*%,,0S^0YSVD8"HM+EX_2.,G:')(K3:'O":ID$28=_?=3IUQ'0/RPM5 M67M(A ^L..GU8)QZND&T*8L;Q2?AMX?4'TD7-.7403EE]M5(B2,?;XA3$>EL M%@/QX^H._*IAN.*^X'4QTT!%D8\!S!B@"5+"K_29H @VD';#=\[+C'I=A F? MO=)L CLC25ACWB-C215(Q%7,/MY!Q DF<"547]80KD_\& ^@>($/R1,7ERV$KUJR<%I M8ANS&C%WBX-$I[OA,*"X@'9LKAL%IW&2]JE;<)_ M490 (4AK N<8UG6W#6J]-DW0A/R"KT, V' C(J.Q4 M#T)CKQG-5N=K"P3N>%=;,=;5EOCT[>#TPFS?QUDUZFM2+Q3[>]UX\_9 MCV;FUR$;Y?X(UI3^@)7<-K<^@;%0SQX* MCG>!Q:&3WF$MW9'3(*7]*B==L% Q9CT^2'IV[':SL]FIW.-42-A=L=2=;("[L:YKI5 .D M/LX0[^$$<9DS !^ *F.CGHCB78++[351E<9-" U#[X'2[)#JA+*^9_%:?-4? MEVEP?@QLV>;F@#@I'-P@#X8\*>PDF'*># O1\(,T?\.!;\7*XOS\M0"P)D;A M8P"$=!NRXQG5OI.0@4T;'JCB)'M@D9[I29TD8G13KP'4!UVT=' CP7O0W,%= M[:Z"AM:O59@V1:NPRNW ^_N[==C0KZM?S/]>JS!MUE9A![>#W/7G+X>M8_,Z M;VQBJ["CV\'1]ZZ=N[%_FGN%=9+I,[0*6W[K,.'DD'.3JGP*GDR&QU;!5N," M]>[01T&K!I&(F*"-15*P%OLBN&3GHK)7^V57A^?7CM8TAM25K2QNAQRPQ# M(?:E4YA_9;G,Y3YVWO\KFIRH4PM2]]]-.V+\Q2QUSO80A5N-42*?L56,3SR1 MB33SO/IV<-&ME[.7QW^U'^;87C3#Y+D^$[(7VQH&[,N#K[F?^JE7N&[=3=,: M1L!8.11$M-"^,')C^4HI5.+A:M>5/\X]NZJUQI6\OD3=4+#A_5!%P=]?U>Q5 M;_^I:>B+WO#<,[ZW8ZZW/69>H,>,3RC#^B$RDVO=U!W@UGZ]SLEM1]\?7!XV M;P>6_77_M-P^,/:#)L8K[%0CV5VDUYYG*^R)U7E/=1L]%\P9&7JPB%8D;Y,Z M7TPSZ7@.3>*C8AH6VVE3C09^5'HWL>E[[%4NIMYMJ,HMKZF52MS0OG6:2OSL MJUL4=)]="S94O)Y1R[G1//>%M& )F,#>*!,(Y[(TA7%LXS< MJ- -N4K$:7EM7EVRD!O@(9Z0OJU>YER[.OU\?K-$X3O*+ZB]P(WM@0C6!<]@ MOO-A]9T)1A2[Q;<"F.YREL$ZLFHF6U;+F>WVQC4RNH M+/S)TJFVCEGNRBE[8*:B84HA_S/+4P4)@9>F#'^L\;SA M4#E=9!V'B5?ETJE0SFYHCHB[FI3&+2;PZHH@%(GC.V2DBM*,>+DC_2WN+'*7 MC9XC\\KZ3'=FN:Z.51I*U1",9+ M"F-6;V,:? 0SN(]D36E0W3,TI3M "#&H^W94+=GK^W]^-IBC._5VGUC#T%K^ MKTZHTQ+])">6'=B];\WKO?O*MVYY?8.LF=NQ@]/7")R-PTKM]^??]WO-A8,S M" $'IGUXOG L#QGI1S]@1Z7^,?M[Y%R4EAU8BS2G7-%XA\7&7\;!=)Q]YP^9 M'T$\^<48+)J_G5\Y,UT[R%<1(WOV'676XHXJ:JY84K5"7-NWA<;7V#[B[Y,X(<*BL:==5PWK$!G7!&"#'7BS&MJ8:;.]R\9:IL- MXB.=M%X$XMGBK+,&)M->9BSM70O4=MUSYBU0A#X[K+Z^=^\+6BO.,1.0JF:DT M@?]<,'_"C*/E8,6:,<22FLWGI[(>ID:/L7RR.+6CX7 9BLPSLP9&V_BC3_R5 M1J.?;?^N6*%*L']S:CZKO8ZA%>MXR9OEB-J8;(5UBH[]S_AT*'H=I5.A$&\( M0_RV>Z*3Q#EV^]JV"UE=FR,/;V8D!!O?(RO4XBZN6Z09O=;1)FYQ"9)T+9EED5S"&) DHLMKG_?K=\W[ MAZ?[N4:"+&WGJQ\04HK+YY:T)CLQ1ACJ\.46EGVY!V(7XZ_V--^O9)K.P6/; MO]J#\/;1)'N!^PUO?K6W&Z>Z\HO=5:JC:7C:BF5[.&-L8;(]?H#4DF5[QL?% MC)#M!X_U&W;]];&E;:9LS_@>H\Q",7(W4TY"RNQNOC!)NH]PFN5*]Y%[;3O% MW\?9/W^R7^^?+=W'@_2E9'MF-YSA3$2/E8RC%Q8_B5$P\BU.??5O;.O MVMY)JY0D&M91,"R)""<(_24G3:]?G[[L%'WZ"K>#NT+)+51_E+R&,;XUQ6OL MTY>=M4]?$4RBXZ-T^&O>]UJ&NM4+3-#G[[%IY_C M_(L@;3NI-$F+A&!BG[@=>(/'I\%A\Z!EMM8)S'Y14B&Q*.GH=O#EPK;,TMZ? M0;W]AGZO7%9_5_=.#T9U5J>8@ZGU;( M:)&T^E/;:J$I@0^A;.-Y\#$MUQ%)!(Z,I-=?\4D7E[KC]4.37MV]?OB;Z-*G MQ_MZU_!T\ZA'X[C$HB*N+)3/2S[4":O#Z0B3(VCQ1X^+GFD%9.$ #+ZCV[%G M%;^)W_3\(;1262T5$MT0(ZX"4 1H<[SM]>FQ(G:EB&TI[T^//_"J0/IYC8K% MI#E-\SC&^8.C4 S;P!QC+RFQ7U@1B%'!FJOCKF/$LT=(=/> ?[Z,0?/6:PR]\>X#%QNWSF73HEY_-('YMI/^)EH5*$ MB%XS&N)!G("3Q3DC!H["<70^XD_ONV)@GPR4 4&(\?.A=_-^^3<)(]S\T1\X M'\VUZP;YY_R6\R/S=2*#;="I-S37*OB21@'2B!\^" \G;H;]BF("CQB6$S2] MIP&''A\*S$?:\=/*4]#BHD.]&Y$H'LX4W/D<93\.5,H0I,8FV4\$TY39:ROE,#Y;(0^/^^93KJ"B0I,O M)K;S(_P?1I>#YZ)+<@GFVJ'+\=6?/U7K\.?WSG.Q15DXNHRFP+XPNN34?*:L M5G+%9'2)Z8G@E[KC%%FWRP>&F?WH++4&:^H],S1(A!BD82E"]4ZG (F*NXHL M9>%3J' &E)SI 2P0#H"=,UTYWV,T "1>%YI,%=RM*E@_BDL8N$P926/XL^$1D[2SMT7,3:=27G^/=%H^]'$X MYRP6/!/H<*HU\%#!5OWQ@ (.-,IW&! $?:&M\E&W_A& %DBC2>B:(>$55KP$ MD:&>Q0$5P*,FLI ][&%&UOR(;1X.M0[Q5MG?GJL]:RZ]HJ;Y2,:A]"!-LJ$2 M0# VP74-3/1\62W&MN3BH@G'4H7)EQ1[Y-(N'Z!*>+_ML[.NGC7OT>:>M417 M"]J7O2YRDA$"KVR<\^W+V1>_G\9&.-Y&-SP_16<+2=6&G*1)R8 7*_Z;E??P MSP\JB@0N[]^B3(M6.20W(E\B$O\,57(62@XS-B,AR]"Y#*CI]. MC&\2>W))/@Q#^EUX\[!(65 MEBU$O8'D("0;)S"OIW#]*4OT_)%#?CK7G[(0SU^VJ!8Y\QOQ\,']X%7LTH5) MNU <#E9H$EZSL-TFT8X+1SZED^O$ AAO!:,-MZ^C[+40L!+,A'0J;*^+YT-" MO32_W8?G'%(&KGQKUS=!TJGIS+QR7BUH>3#SBA4U4\K,9N;1OMZBZRR?C[7R MR.0A6W_$S#O3^T-&GOPDWL3+%NAJ1FT\^G4,)"(WE4Z-6'0QC^ 9Y"X"ZRWY M?#,9;]PVGM-Z&]7M]C?->)NHVJVKX;8,%:]007*]<1N^ )G) MU?L2L:+,6$,SK#!U02, P6Z#+.,Z09 GRW6,:MWKN1345Y73TWVITG2'C#-@ M^:)1^#K]P9\^4-W M##+/^;?I%/\:Y =0KV%A5-653U[25[@XW$,!M$C?NJ*'%N 7I-L'27:+=7@M>IA0D\=X,*8C5ANXH59,U.0T.T;/+ZJ" @GW0!3V_K;N M>V&UAZR4%GS20I3QL8.#D"R<885C;TIG4C:3*6<*ZZ!Q(( 0/@"=E?N2,/>_ MO -P>(:B,;+?^?4,;;PK:3>=DBS4%=P.CX+Q.WW$K[,_JU^',$+4\=;>7L2MO)9&5&%_R5?1:[BCO.TC-&Z^&< M"9EDDZ $Q:H_A6G5G_5&FQ5J0*M%C7'Q-#5;+JBE9']+2#CY@DLF]]@6&74= MVR$_OE5O,Y?_'O;$-6QD2>3W%M_[BX#X>F3F ]L!0Q,L6]YWGOO;]<8#66&! M@]Q/>0JG)85#%WYD #Z#Y9$/PE==N'AI1(=]1@$V#T.)!E,/_4*$1(JJ<$13FJ N/54*>P!T4?DZE#KE9U-'PRIH5E-()_8M'[EI M#0?(WVO]M^KF\W-6C>[=SOXS$YSF:^=\U\WE4VLFX43%$K7CR>' ME5RE5UZG@LXIZF8W5H<^P]$OBA:G/R,#,QY80[!(!]B>E#C(?ZF?)3GR2,(, M:=J4 !N7J8IB+_H>GOJ!J8.**6P5Y1HGK'3,,R>QUD[;* N_WPPD">[_HH8>4ZG_&3F MMX5,R)GL&Q:F:\N$E;R_YP2)IW/7K^&1.1%D+DM8<#DMO M0(+%#QZ.KLS3M,FZ(8%8\R+),\&M2='Y: A9V\$8^B#23(\UFSR/' .M0M7O M,*\-6H7]($*CIM'T(]S#26.JOU$@%O0WTPXRM >*^KJ,>%.7)L;=4!22" M_='#8V,_4(X8 DD7<5'8?]W47==H&GPY//HOC:P$V"37)-7Y>.IUNIG5T959>PMN5\[U=N6>Z-!).M/X.K]+T#J\U M1Y[5^KQ6BR!;M]?6[;76;J^M?C%[WM9L7@",N)8+)4YP@2)"62);+\#6"[#U M BS "_ J.,TK8IHWF.08RR+!QK(1W06/Q'(XZEKM?N2Y_WG)9-^6*D5.@E]Z M9E_1?./N;460)I5EX'=9GS,#)RCS_):H6RB=6FCU-KP'^+JF%G/9K7M@O8^" MXOM+#]3G4J)S@%G )F$YX&17#'9\KWP&<0.7"6/5=]3G)G.\QHSF;^7A] M6:6_M(\?N.< ]K%(7T'1]Q44P39;XU.C>'EU6BB^ MA,N@Z+L,X*_2LRS"L0=;?G.UH>S_9_H-DG%LQ&^P&8BT6O?!BR#+V&)TD#K9 MQ%Q07T/VW0)2NDV?/WXF'CW %O ;R6Q\[#@+0V&:H0(K8Q2X(?+'-/0^6F?, MBFL$'7\I;SZ%!%HV:=I J!J'&ALRJO(.]PW@/0)]PT=*KHN3 U]RQ7&47-!X M[4(LA^W$V(%8:(.YR45\6X6Q3?AB8; Q["2KEDMCN(F(>42SR1/*423$+\6O MJ8YJ@Y'A,G+JL3@0.?+FW/W8;L*<@41JK?5NU_1=!]@P@KN$AYM%H-N5EPKX M[0AX,PBINOBEAF/+J*6&)X CAPIO+D)5A^K7)^DJ\0#8&/3*J%HN$;O4L&&$/$L.-HC&MW%-[[3,Z*+D02RI6JF@!AY8[LKUVQE: MW-.0R\A:U^\46[!X4"'2.0*HPV44+O;:U(&!J^O"0.3VIPBS\) &=7(,HBVA M",OP"8 E?J,-@>N8.SV7?WR<*>[F@]"17*V! MA4U:(?-.E-P%7O:@2:8N>FR&7)*\\I^:HT2::-)E#'=#IF(L6! 0OX>-0H>Z MMJ+W/1( "EVJ[W8FGZ^!W9;1S551\Y6\6L@4Q"MVE9]MPV0A7 #4\Y!$PK ) M^SLX(."W'-/A9\HCJ)4>HS"$2QU,Q#ZDRYVK0OCPD)M7UG9+%=55(M@E:]<1 M;0@4^#AS PKK1 JU8SNCIE/1UJB6+6DFTEI%G"38M5]5/G0X%2C3-%7%1!S M$)Z-3NA'PR5=KVN[M!$"E &\J6G4=2S[1I^_N"%LOZ.[0-_=(J"O13MR?EF7RX(]225^ 'B MAS'>ECTSN>,UNW5@KME1(I5\N?#4Z+ 3\QK$=%NY]D#*>,HIXY3_S#ITKNQ/ M7VDUR4F9]6OW\*_<.NAK!"8.)0$DZ9[L9[IVMWY?NOROW',T MMJ3-+]D%*?^S,(Q^AZ&AH7Z^S_1JEJ?Q:D;2<#< !2NYNY/?^8LO3W^*"W5C MKA[5QK5 &DUQNI<.+*!@A>TK)F^(^N($W2CF%G/++?[^_DG[\?=E(/2E\V5 MYO-W2OF73G$!F$MP>BX>>Z;I:42*X?/SV6#!2 *:WZ-H?_B7W!@P(LV*BH&E M)GL:7?H#;HB51IM>2G/NT0Z9:9C-(;(J,*FNZ3%F[6#^FF_U\61!H4^(S!#$ M1_3VP.E,YK'(>A&S3_+YT.R<9?945]YJL!YHS0 JN)-M4'YMCS*2L[]2C399 M>9BLT>9\(; F6=;)0N#/#ZMC-\_L,Z.Q\H![UL_1SSX_!?N%]-QWHU,FN%:: M3DVKEF9G4$O7'H^^9H]/+]O%.TVOK";LOGJ4&1MP+ZO%7"+2*,G*9?4YRN4& M\95O^F_MSOO^]XM[-WN@?04,8CZ5,R*>DO3-:5M>/D<[E+TIYU,/2\/JH3*? M=IA.+5X]5&;2#GED<;:DS4)1S6KE;A_%3]G4\DG*X8&AMZBK_"G3*1'_ M1=V<19]Y%[7\>C/O6JM3S.\W;SKG*Q^6@9R^Z//\X@Z :@.4POE]E?D9E,*U MQZ.O3V??KQ^__JD=9E>F%*X89<8Y,<>GSHQS.29/8(_1"C>(L=S4O]=_=;[6 M'W[>SZ45+IM#S)]XF4X)N;1*K7""SS#B:7N&TW!.K7",SS"=6JE6..(SQ(+: M*9V&Q:Q:+!>V6N%Z'R74@QV'U,3KA3&-/D2A[4MX#3D3+_M,O*R5UX&))W?U MN'(K)P_'QF\]_Q+*8=EG_>4=@-2Z=/6(&:?V3GI_0IL3LW^?J1P>3*D;$8^G$YQ;<_H M=%@#1QIBTG2D?TF#F0;LJD]9DWA.\;)@L\O7WCC];;6W]3X*:F_G]@/'@5*B M^H8YCM=M;)OQK*+K>(UMA@DIQ&LU3?):^&L]RDP +APLLK"D\1(Q74V3+!G_ M>EZUR= )%J2:9:=2S988S*VO-YJLKE9Z=3@QQB]7*LRJBSTG$W #^,.@?M(X MONH/*M]_U.91PI9&\?,&9^74P67ZX*CO'>\"%_&O.4)1P39;N4HP=7I7$2_G MA9,/P%C]>A7JAB4:X00=JG!DK91F!=$A2VY(=#_RE+>[&?$:T3]OZ3H5)Z-1 ME6KU"DC03W_5;[ZP OAJ>14;K\5I+%<4A3PSL#+I)6*0G"'YJ$:.PK#U_ MF$M'61:1+Z!'RPHBA<_74E:MGBQ4-\FNC6ZR/I.C\E-,CBK=#C[?776_=O:/ M[W7MOS7):?'O*;.#DJ259'LHDY8G5L$%N9W?I8 4N8WU,J1)"V]'1%BYA)'3"FYC<) M IGV7BMG/O"F4+S7MQ\^]BT _NS""Z73*4QZS(Q/>EQ>9?1NQ$;AG:9&&_+ ML]3YO"P;5-?Z$="^BOCO*PMETX5EDC2[I"S$82UO>KDZ68*Z;#BH.UX=$ M[VM=ZF-F7=/-BR[&,I"% M]Z72L_?WH%'+7):KWPLOH?3D?;8'?Q6?P_8F'6VEVL^P^VJ)-1?U=<(O(L+O M74&"1($OHA ]%WD2]SV_2E3(S>*_2L[IC%&(-H[-S*49K8I%S%EW$9)62W5H MA;PU+^W0XN7DH2I>;>HJWA=K_3?2\3VY&S5!_?!B.*W!9<+8K6S5QC4[BO2 M:62F:)48#]CG:^6$4DQX9_AQ??LF:8K)D\\G:(I:1=JT^)>V%C;M9$WQB1GG MCZ5&YU>_LFI-4:M( YG_I3W+0%XK37&2GXS/#9Y5,UP?? )""]'9RI7"6? D M;LOSZX.YW$P!S>D]9)O(3696"%?)"1;D,]-$.&8:GYE#DTCL^&EO.!?D+<>F M9VJ2Z51R;%0,UPMI>*2TB4E[(@VSPP Y,5[9Z9F>P8=M"0TIHNF]UP.%$*=H M&]8''*C4Q=DTED>ENWIP'ID)FL^\VY7[""\G]X!O=\,:(Z AC@V,:I>1HN'0 M2&[O$5[=5]YG036^D07$!Z E3*5(BB<4>B"A&\R!KT?&C>N!WW=T@T^VUR-I MJIA<2C-[$ @XBMS$*>M>6\>M@.ZQN"$^H[J_](*'"P;"X%O$ !GFCST:%I@N7I>+:=%PUA80 M%JS*.!;^A*4-O:,<,+.E-VP5E?:M:KYF1PEZ)_HST?TI6(+T(E.$@U%\FE90 ML\#R /'00AN**)1CL#*NI4 82062)0PP>ULJ:K!@@0:FP;\OZIZ-M!<,4UH7EUNM)"+H.'*.?S:JE20J@) M\ ;<@#87O0P^F6[XJ/Q%3=UPE ?,XY:'&CVMF TEAC$Z]A,H1M27X6TI6U%S M='VO H]72)*+W/;_C$_(1]UT2BA&H(U\VKA3;"CPN7GK9UZ#[EI2E0,'.\4J MU3JH"2Z-&X05=*!FTJG1*8%JL?UH)0@Y/FT0N$_#># :Z+03?&3(G3&24QMU M:XR8FLF&QY"I65/'9V55>QO#FQ*[J(L?=@6(%&@I1#A_4+P_RY]4BSG(YY=;M6%NY! M*@6+C>ME0K=(7%@ A.ZNO)J[H_?BV%A\\:2+"V\R]KK**[FN\?1N[,9P5)V,".V@$8W.Q+90 QDC9HM6(_-NS[?NPBAK5OL1P6#ZEEJJB28T% M,\C'&,/'&+X_?'QL,^9A',EJ6G;C<"2K8=GK"_-6N@N'H?V--Q12^.&"1MI4 M3)KSM!JC.UB__J!U?\PX+_*V81G7]0=.#YOPIO[H]@Q/>4^>J>('PI^& MWM%;6'B.%CBP^F.GU[6Q"PLP'.6,@6K0 PJJZX#TNU7EO1=X7D_Y[5V\$NTRE_FW 9KN&2]'IO?.#:/\W@#IQT/#H?$G-O<]Q0EY.[O:CG@#L; M[%!/F8#- MCP"TE?GKG._ MUP'=I(P\P;6 XD!>' !,T#\3;KJE>SP%PZXSU@ ,Y6B->8_DI0=TZ8N56$-5 MNF;/5;*EW:"Y.M=18Y8*<&&HR,='(/+M)/R*^&2 08 ]BQBH^#P=*;L '6D" M6UVL?I2-ZD>+YZ-9M3">CX;5HVC;BE7H#;RYPCJUJRA,T:XB?SNX:O8+SF'9 M//A=_^^UJRC,VJ[BX';PXV\Y=_3MVV$FT]C$=A75V\'^>5'7SZSSXIVY;5>Q M3)T_QY60B*+$FDT&_.N!BPRI+XTU"T9$R-YSM/3T<3,M%* MR8EH1OBH*BS906VL&X0(>"(L*,[I%.Q*V>NYAH5)"3<.;)77"K^'+SX,I)9SW+DY:L ;\#3/;89MR&N&(CIGL>37[CUIQSU MN*,(C]?!*>9Q1M(XO1_?T-$)I#Z@A5T6220)YV:'-B+?/Y)<(G(UZ$UTE!8& MA4?3,X3Y4XF:/^..BJ\B]5S+3%R,3[L_!WL==J1[B)Q=L X$!&5EG\QR!Z!(;,.XF!?]5B32D 6O;9X[+%X;]\AY M70<$A\_1]44L&__=U1L-^>]G'^W1:'CM?\GT_*@(M;8.@-2[+FQ(_O6&%*O_ M><[S7T")/<"\),! S7LCU32O,?.&BYGNTQ*![C46L,?<0O?X$0QYB^VTF=%J MTSY*[W#;E6*ILJA]+Q6Q8_?_5N/>)MRR\!I%];[=\-'@?QR.B?\0.7P*DW/$ M#!HU@D::.&\):DM0KY"@I/\V1%%PFL>UB M@DJ/^IVBRQL44DHN-<(KF1'_*CTRX@_>TO"6AKT- 1I;JEO2WU;ZGN.2II9%Q':M!V^BW"84CA=1)8WCT=.3>*+M7E7,19E MD11%>03^Y M=*TB>RR:.T:L.V%56*K&%&"FW/43;4H?*?(Y""J@L-(&.SGC0PD!65[8$+PM MG1*OD^WM8]KDA.H(Q5-'\(P8"QJ,HIH_+)OD1]^/ B?)==MJN,:_T4TF3?K5 M0A,;@M#L GWHVH2$-7*11:Z74"*X8W)OH1O-HN!.0WK"Z&>BBB7DG&WK6!42 MKFX9UY][*4'UI-M;:C1]@5=6+FI8[9)T9;QR9NR0OJ7D! ME4L2?5P2">=90L<%.6E21>N$Q!(JZ#7[(XR52A.!9-*I&F,6_AS9+R7_V%BY MBJG@XWAOB,2BB<*1' L@5L'RM[FD+Q)7+BXIKIS<"R0FKER*J[L M]U_R]_ "<>7D9EG/BRLO[AX&/W]_/?O\YTNA_UAZ\;CRS'>TFK@R[$H)M#%5 M.;'JN\I[^/1#N/X-@ZK]Y469TZE(F%E94I09SSHNRIQ.#8698U-QQT69\0WS M1YFQ(<)P9A<0!#[83_!IFS>H1CD 052^]P[+QM)QSO.;F)C@OW;P<7I0?'N;-_[E6]N&Q,LJ7LK37C"(.+8U!#OT=XA M_C^J!57']X',YS)S2NJ;MN'PSW\ X[6=U72"S._D_"D,\3M8P!2-XN1&-K*? M(UDV8SL_7,D(+YPA[B)$CLC*KB38CY@$,/T%)1TE-E.D+*>IK>S:M$DM5_T& M5&2(-@P'U"RSKW!2PEWM4":(\D#[ HO1!B/SJK#C[!=6$#4TP MW=!M2[4&Y^4%%#>FS".8C75%#0H/F%MWC"[>L>"3!5]N%N9OQ2?GTPP-C#H9 MZ9/8"/8QS0"ILC] BOX*-> ;?F.(S8XY^YM/?E^6J"9HA08-*OPQ1;Y#J4:[ MU,9WIHUD*?O;DPG*E*7HB\](JYSPHTF-%*->VAHF**?&"@L\W3* MWR'GK'(S@83'=I0ZH-\[<74J3;3*CMTS!YQ_9I$@R,/AGO8=)ADV1AQCXK@N9:)]4F<,H M=Z9,WMB)A8X?\G\D 9O+3>$8"@">E4F0\/JXV4UC!LIB&B.@GQS )#K(HA,W MLYO1<.H2=]VH\B>D8_.6]V*"%BV(%T*%9MRA!3H:3;_B[$6.DO$W1RYHFBG3 M4+#'% \A<._$=;UMFP#C,^9XL.F.W6 FN>"$*XT\1M&A-&^U'.]12M$M7!QG M:]71]T&3:4-#QT8ZN=^S/BVD!YWBB;!=V!AKR'94*BFK.NH- GX^H$+ '!KS M$YJ[AM#,E!2=!^C(BX<(\1$#=89[O]-$^$72J/&I[&ZI\(ZT&?B41NHTE <; M>*9ATBR"R3.&B#$ 3;U;B+84T'0X5"!)>)2FI+A/IR*]UU$M'RJ&B9V-M]4+ M7DXO2%#% QG';33;$I/B[:A,(\!'VWRX S!M!* MF-,9$P$'A$1S%DP>!#I@C^Z #H2F0-/A9R!KK*/?XUJB7(X7^\FBN9YO$,O- M M=],/RQF?*M G/8+X$"F(.ZOW7<=-M>:X'(O4C3;$,*F(#:>5;Q/X"UY_/ M+M'XM&G'W5[-)(^=F-DC4U7#.S:X9, 8$4U-:0C0'/'I3P!, 9IM=X45=E= M%X^6Y4/NA]09N*&]O1]5Y?MU=3A./GUG_@E%_=F,=#SC7UIXM-:I;;70KXGK M8?K(D(OY\E*6[]=:WYZN[K6CRY:QZO+];$8ZI/E?6C!92^YO,>7[6G+Y_O5> M58&WJ85A6^IM02UG"B!6@.HM2O@/=1 (R))Q38/T I]C8^"H]1H1' +1(Y%O0I\5S;@RWSN1+D*O1+C]IA@:5NAI$>QCX"% MX"\?=1P^Q2/ P[!X+2Q_V!,Z*: E,\H].XCTO@'KHZYW88. ZNS-$!7 =7<, MKY@;)_<7YS+Y_&"P_\!%ZNBYJSNFZAB.BB_Z[.10>ZF#HD5GH>6 Q, M#B2!%4=?38YO, K0"R%["H5&@W9-_-P ZYE*Y9H@*?68"2.*<(;^^RKN;4/- MC?\9G\@ #9(-"&&N0<\*I52@S1N>_@U(%AG'>FB" >G8(V-9,0RYC3FN"88> MRGXLZ=0%F/NDS?(F3H6HD?E>=Y-S9")&)RF=EV"*-L@O*Y(:T^'G-@=S30Z&,)(I^!]->Y2E@Z31@^48=#6=0N MR#M7LB?1X"QP:F+1+]+#$8-/=/(F73'A>H&/^5G\(!3?DK_7T5.E4Q+RNN.! MVA^_IO"PUJ#D6IP^%.%QT%(7GW(K.75P.!"[2P&TDX#2< T,#NGAM MLDVABF@;GTTFA5=$U>01'9I6S1.O0L.M=1#Y;EO8](CV/##"_\V+4RU,T+)V M $/\CUTAJ]U_:3IV0)973 ^AM$31= HK[N7(=^ B7= 9GDBK $+Z?OTV6Y1? M?A!5>>1F%Y./@]PK4!3 5M5-WR+%^=]P(F&A/[!HQ V$$U ME?XK[_-EV(=, M80OZR UA\4<^BALYD>^'04)XQ@$,*T1!D?W+(!1V1 RB4*H,^^D>+J7M8M*/ M3 7[*(9MBTWY-Q$NP$#UB5F^8B=RX?PCTB!IP,)A:-+0]8#M4'1,[_%,AJ;O MY07X>HS#5_BW%;![!1QC2]"Q42/YX'E-IU;A:J"_=3_YCZZ2!FOSD*'=Z-7] MB>M#&\.G2)M!V[?&/ /)$H>[IW<'%0C MT7[.JC&PJ&5%BJ,J@0[8^ A'[^-]U.6$#H5O]JTT"_L*B<8216Q[/_'WK=V)XI\_;[/ M6OD./#G3SYE>8Q+!>_=,G^4M][LFZMO[]H%),,*S!"7L?/ 503XBRE]'TIX9V!Q=W\/",S$ >!CH5#? M) /-AP2R@6"KJ6ZSJ9ODJ6<@="EN0S)X6-D18, YRDX(GP6P:B1CX M[U#$)ZRG>Y.GY\VB<;-S@V;A+UHBKN!_8_XVABKP4EB]OEO2X^B(P:=Q4:$+ M)(RHL&P#Y79?QR140>IH"A^V._!=DMT!@YKH@ %JP:=@UP>C'_.7: KIQ'C# MY-AIJ7?N,'3.PV'H\NNX*IL'N'H7,;'(;^>$F^Y6I*9=SCHW@8 MFGL=9^Z3SR7Q]NR^\$8/0P=ON6L]$..TI"::J8V/+Z#3!Y:[G43V<<;.Z%2Z M*8*31URP;/=E+IW?5+I.=N._1W8HG4N6"*FWLC?8QZE)!DST3&0*G9_1K!8] M&/LH,*$"Y@$V$/8D!49/LU,CU\CW,!U++K9B4U:JEYXZ6G:+:;"RK2EYHE,J MJ3W8@CUH1-<>U"W-:]JE?ZCG>A^VW4DB*IO99\! JGXJ*J(&%+B(NA< 766^ M)QG@%Q O5F!B=W55GCGZZ4SFK5[]":YLYED.P B2,P\LF4F;J>Y4S:F:;UO- MFS%0<[[9!-Z\B5KQ1;[981QU'N"K(0 '_#A0=AY'_=#EFJ='(*!GMOY/X!%8 M?:.Z2'5QV[HHQ$ 7K1&1,(Y&M5L,H,\$SW;!Q;WAABH?5;YM*Y\8 ^6#1^! MFFLGMK+LIGN\\L[@8Z;H8;82=OE/J0O'H^**%JK=" ^CG<8^>;K6#SPXZ@0X_,57/.W]9% M;0";C>P"K=D7#$^3XR_!"C/JT1 &DJYJP'C#^@%&+F?;5!+F6$G;%LY8N 4G M-E'C#-5VJNU;UO9V=+7=CL"LUM%)&C0Y.+T@%+-.L$WUW]ESV6S(T![P,(T9 M)F"X!H_,(=\O&6)8%]ZXUS.W<0G.5KI!W1%?=-X/H\R&.0P%_<6)-3=-,!G\ ML04,GBS!,A$>9CCIU4G .W+>S$J3.SH,&WGV]ZPCZZB-QVRNAB>5FWBT@[-' M>:HQV1K:83;[P&$LCA$LSJ"U]#")M:WN]2::UC1Y!6J A$Y-@UVK(JI\,1U1 M1CX(OX*VKA&VE!H6,-0UJO.&I+?,-C$X=0L>6;5'-3B2-=@9*@KXGFYU( GF MM>,.H#0QU[1H/<8AWF8(9, [K'LRWQ3M 91L^3_(WDS8K:,1]L["3UFH]-Y\H3@Z%(?U!(Z'0\ -90A>=6E?U8>=>PV-U M).ON ?/Y"::C#@'K0%ZHJ&;*V)_TL^/+E10\VT#4NI("##!N=89O/F*>;>9/ M>N MTN$F*"!R00=&G ^8IAQ]#[[<-.?FI^!2S>35>N#0'+G0@Q\QC.G=F9H" MC8B+A4;$2+GAQ)T+8/9A3<=4Z#Q27WA*N@^\^41_@31@$2#J MP+AKPC(-,#6*AR/><)17:W9$ =\=? O!/B1C^%\/: H<_$N9AQ)OP&/*@GF^ M#9_)F2?-TL/9H9>617*U0DM.08M03 UZ[Y&,UPP#Z@YS[3QT\-?)S>H ]M E8NTI4#E,N]YL^47;ANZ MBADJC83TX@Z89AC7,K4^/(B%8RID[T5C4BVPYS+>6M$VE[4>RJ.[M:VOFI(( M9,FI!/M["[4 N%!=3=C3O*9HM9 E2[$GEWHSYXZ$_TH$L1]P- ]JFS=4;;1S MY\CR'LZ195_'YQ?%P>^RT'NJ\+MWCBR_VCFRZ)T6R[^.?Z;MCCKRQ_?BJ4+WE-"/+E]EFQ.*IX$?O MUJ Q-"&^Z@?P<2/H4+^>NIMT3-WU_(S7<5YH_OF\/^_EGH@*;>W9NKF%LW5! M7/Y^6DP9?[KOZ7+GX%>M?EN^/+N]JE0?:M;AH^K]XWG]3X"#=2,://H^;W14#0U[M*^*!3M9[Q*YXXK MKL=OF7>Q:HP[%WG),6W?N@3$'!%GAGT30KZ:O[^Y.Z>_CRD_E2316'Q'O1X#8:]J$],,&_:L@?UK;8?B\CR M?5\>:Y4[:V_@-5L+;Z9 JYM9T]2]6/M[T]<.P)N.$G-:D/U""VXG[7PS6Y#A M,Y?W:5VL7K!?JH&C*=!2=_?;^3R2P&(2>O?UIV?Q,W,'X^652%A9%1U$!*:+ M_E/%^D 5N\1 N(OFO.&8L0BXQ.J\D2T6WB>B<0PF&Y5W^NT^'&R9L3J?K"NW M+HXFMVZA(7M]L)F*L>@L1\(Q9M!T#,Q?0&,3F6P&-5 A&0RU%\+IN!-JI MBLC\S7YWOJEC%CA;D!V=OB+ W_Z=3B:_SPR370+UN%.!QY7:JX,LF)X_B^^T M!)P"V\KP+72^QRI>(8:EQJXY=?DDETLY@>\)*.&-7-F MJZ/M38'62[96+T =0!#G_M[?TA'P>O@/>D^&K2*BT3SZ/GFNB(1SKO(((3#X M:?/1DRL7K+[@N-R90SS9J!""[[^C.10!7FR5'&KVQB-5\9) :>+'M?8YKG"U MG!VVE:<&;*^6#A&F?Y)8_9T_0,\:4YD6,Y'A.BT4E[V,S\86OE] *> MVOG""KR,8-IC7[9F)SVF*T(Q9Q[L5B;-)?*%+(.;-'.I7(++IA+Y3)XQY7N: M?37,/DQ= O6)('G\^J-3T;FIFH($W!0/U!*L#>[$=,2,'YYPNNT$3&$'^-JY M1A]>PFMVQ.#&9.SZ8'^-J.BX2 2[I_2$-40074BQ:P47\-VO"RY :YXNA_H? M_>HQE\SO7,&%2\:]X%)]'==[P]9)NGWVS@DDH?RQ:6!QQ&W,,QYN1N.W\.,W M-.K?]!/FS#G=.AT$8[M6'_;LFUX%-1S8V1?L?P YD]:4=#S%W[HY)A;,B=$^ M^[T(]-_#-/(R;I37IV[\0]>-PSY='A\$F.*((09YN*T'XS/ MQ_6_6LC,Z_RK9+<%7?I1PSQ16X[HKZ@(IG'4JQ.VU-%_'%5MCT-*\ N0D_O! M3&K;S"$S50GF>ZIN%8*9ORNP\TO6OQ],"LD%]E6T;I%>E^K7,=CX2K_2_E,; MM@(=H.(8GS([% 6'&V@M$'/G0$_=*>Y3@S# _[?D;?Y'5X(M@MP"[,6/\O+DV'X=3QM93T+8Y/+( MGSW*3&)_MSUQ:(Q%G/5 4VWM)Z)GS:[$^X>#H+[JE-N5J=^$\20+5*2_'NJF M++->SVAZD2@0R#.Z8ZX[5@2$@.0[B$>[F$V"=B34#5W&M@__K+)MWPY_3+9=NVN.IKY3$MJ3 "*C$R[!3BW44[U^G"2RM16!I M-$]B\5/27U\MC _]BKU&Z.MK3Y@T3D]ON:NK0?UP$UZGOGW51$ 2JY=U*YC< M>74RQX\.!K<&AFE56BK)[@;!_$#JVP(CL,:3)XI2GE64.3DL3BXU*(TF'[G# M9XF+\/BRN3V.#<,1-$'2;HD.8\H.@RET[=98H@*<-Q7PDXE;D6.[[9M;TMI$ MHB1[W+(EYQ^V:[/LG-B1U]1%KR7.5<>..:=N#]N.@* GVHB\T?0E^#%YW.G24E8R<0EQT8083#A+) M"";F>$:#B2\M8288F:56-1"QCK&-W@!2>>Y(AN@!1W'7@!0%3YQJPFT GL02 M,.'"5)=E%5@/\KXP5*G$$ AQD]R-@!!RP8]-9-++F?=M"N42[L_@&'.Q2OC9 M+Q$XAB7XXX_.78Z5V\U S1458@L<;,78D0H6$&0ZM]MTL;!P M0,&"B6JD*%@PK2XI#*&8(&;7,4#+(BT MQW8S4'/..+9@P5:,':E@ 4&F,[1V@KEDB9 4-B1]2%.$8%I'TN3HB'_AQ1PL M%@.$P$UR8XH0;"*3H<<;:R,$>51" $EN"/SVLE8ZCG,NDS(3R$P$TV M(X(0I,A!"%)$(P2>3"TY"$$L7?A<&VP,$ (WN8H'0A!IC^UFH/([@Q!LQ=B1 MBA 09#I):"<(+P0E$BS(4+!@6ETRY*B+?Y&&GZ:>%+# 37)C"A9L(I.AAQYK M@P7A-7Z1#198@C\>U,MB7>'O4N^9\, "-]F,"%BP[A2% &)QCFBPP).I)08FUA&2PH:D M#UF*$$SK2)8<'?$OO/#3OI."$+A);DP1@DUD,O1X@TXG"$CPQY>/=P^JQA9Z M%ZWP$ (WV8P(0I A!R'($(T0>#*UY" $L73A Q=.'I& (';G(5#^ @TA[;4]H4V]:"K1@[4L$"@DQG M:*T%<\D2(2EL2/J0IPC!M([DR=$1_\(+/^T[*0B!F^3&%"'81"9#CS<"X\' M0A!IC^VI(SNV",%6C!VI" %!II.$=H*YEFQ"LMF05*- P8)I=2F0HRYDUB)( M 0O<)#>F8,$F,AEZZ+$V6# W7B/\%),(L, 2_/&MUFW?7-SW*K?I\, "-]F, M"%B0)P2 !;%TX0%=4T><"X\'6!!IC^UIP%MLP8*M&#M2P0*" M3&=H[03T:L0I?6"3%"*85A*+(R1HB7\!AI]P,"D8@:OLQA0DV$@J0X\YUD8) MPCL>1C9*8(O^^)TO"/5>ZS3)AGCJP%4Z(X(3%,C!"<@]A @=NTAD)X("@ M,8=ELF$#3\:6(-@@EFX\CO,*7"4K)K!!I+WV;E^&L!V#1RQL0)#Y#*W)($FQ M@BF-X"A6,*,E'#E:XE^0,0>1Q0$K<)/=N&(%FTAEZ%$'/8H0E.B/RZ-*]45L M]:2N%")6X":=T< *CEART((*V6B!)W-+$%H02T<>QVL17"4K)FA!I/VVFY'R M\_)MPM&"K1@\8M$"@LPG"4T&+ 4.II0C18&#&85)D:,P_L4;<]7:. ';K(; M5^!@$ZFT Y!DY) #VF7PA>R/,\6[JW)+O^P\ASCRT%4\(X$<$'0XH4HV;N#) MVA*$&\32C\=QC(&K9,4$-XBVVUXPEW57@(.M6#QB@0."[&=H;09SUX<2DLV& MI1%IBA;,:$F:'"WQ+\KP$QPF!BUPD]VXH@6;2*4ED5STT(*Y&1SA9YADH 66 M[(_?V=33F#VIEO16B&B!FWA& BT@:.3A"=EH@2=K2Q!:$$L_'L<;$EPE*R9H M0;3=]H+!K+N"%FS%XA&+%A!D/TEH,PCOIBXR@8,,!0YF%";CG\*DB DX_#R# M1@QPX":[<04.-I%*.P))) O91#Z7B0QN$-ZE-H3C!I;HC_-2]IT]O7A6 ME> JG9' #0@ZG9 G&S?P9&P)P@U\=./DX 9SIVOC@!NX259,<(-(>VTW(Q70 M\9B=-7C$P@8$F<_0F@SF)L<0DLN&I1%9BA7,:$F6'"WQ+\CP<\PM,5B!F^S& M%2O81"H=O8VY#&TRB 58D+6;##Y;S>>+[,7C8YA-!F[B&0FP@*B;%0MDPP6> M["U!<$$L/?GNT,$F4FE)9"9BAQ/F\*[P=VYM,=9#J/*M'(2 052/L(L-*K97IY,7E2S M!*8A,(C9 ,BA08SW>7_Q!87"M-G$8D4$>8!@VTMF=S"UB5;.?=G<_*]+I2N^ M90VW![[%"&H?2,A*7J^RI5S>U[1ZT5K)RZHW\CW9;"*=]G94T6\Q7\WUQ$&I MXK@F/PW%MJJ8FT2JH=J%E0)5:A>VJD-FC'%LP-T!_X+_]V_/^FX+;!.([9) M>NI25]29&W'(/*A=7DG@7R28FJA)K9],E]?:$G@#_&ARFKHW$%Y)K9'Y2PE$ MK/"AR:.,I$QHZ?W:]ILQ NEXW6&+[TKRZ,=7+T2?U4'TC>D[^%64Y?T](.] M'PR= 9+(B!.)9WB#X9414-RNR!@=$*6U.^!_14;@#9%16^"S/4E#&G7$@"+!D)\*,&_J2!8'[FU^AQ@))F!ZHT UZG@N=H4$WAYZ%) +^S M_XZ?+RG,L",U.TP3Z/TT?4YV* +ZFVCE$3T8CT/BX&_MCP$*P-J=BP'OY"$' M>JH&F<.#O_*ZI!_9N%V41<82^T"6$AC5]8ZXO]=295D=0IQ9TJ'H]+N AA'< M4-6!1L-M=VK!1!X,IB(V48[%I-@$ RP_^R-JC(CF]LW2BVP^TQ1E&?R^"7;M MOX/D ?K9]#CH9W.#4;3S@ZE(>E-6]3XP%X=,K7Y;OCR[O:I4'VK_R_=4_2=3 MO7\\K_]A_JZ(!B_).L-^/UB=*T-),#KPH\EO(+G%\0Q(;&6^IX/%6/\ZF$Z. MO3_>/8UVILC@%9!5_QVP[**XJC&/ 'JGP&EQFF"S04CDVS[_9&1)$0\[*)6$ MO\I] P]O_')D9_\>-Z;*'W/A"ADKF=.S*5+CN$>.2'EVC\Q(#:X]6)%/K:RP MV]IQ0LFBG N!G*/NDE2RB#7ZBX(RJRCC6]2\\YS>-;FE MG*.G"/8^89CV5#G)J9? M;>V2;0N'W;B)A_(Y<+&V3C-15E.,)RZ@ M*;,IAA431B]ID*+,WI)4AQ!!1+VO#YU!U>,@L5'?"=[ RV.YXQ1[#)O/Z:Z$ MORMP2@U>H#6JANY*^+MB949XDE0M(>DLF[#9(*= M)>.#P0]$OWVM]ML4IHBG<'L\G%C%9.!3:L@P;:M,QEE]XS@R[5W@LWC\-EKV MD'\X&6[!=+AH:ARU6B%2&(IZHH=/!A17"1Y0S-H#BL,SUN/NT_CYYOJTE,_G M@IQ/S-KSB;T:KTB,)TX>918.*-XM;:<6TRW.JZXP_IG0B,VW[)2<:&V]R=,! MIXK)-(VZB*%9-&X("J4!!HM0G;9LV7C MB+=LA,9%.T[6Q-#-7=87@Z*CF[4*INA(H D+I="XB1VR;% JD#M4J!#:M%NUZ'M")XP#-M I6C1SFG%4K1H1V31+K7CEHV2M6D^ M&/Q]]F18*UJT"[)HMXD=LFP0RP7; [KC*A\/LL*OVI5HU6ZIT1VWKN_JV4RW M^U)MAE>U[0-P14\3T%63')$_RIX-&&C9&V6L,UU#<6@ M@.=F2V@!S\<"'LW/*%G^!B?9G:G@[5*@0VH%;]?#)GK6SIM5FIME0$A!)R33 ME:9E.R++=ND=-V>4+)+:.$DIV[E9*UJV"[)LMXD=LFP0E\C0K)"219K&S53M MYLXFAU_K(:)J9]G<<>$E7VYT?S\*]V_A5>W<[%$TJG9'>5JWBQ]9ZR6A2:+K M=IZBK)@DB?[5[6C&1LG:+&/S\TH&4NIV;K:$UNU\K-O1!(V2Y6MLDMN9LMTN MQ3FDENUV/6JB!^]6-E#A7:A"9 4O0RMX1%;P,CMNV2A9/LQGBET%S\U:T0I> MD!6\3>R0W=B9I(V=E"SR5&ZFA)>G);RE1G>L/!2Y]\<+X44/\>"=FT&*1 DO M?T2/WL60K+7'OQ!'Y6,*C M&1HER]_@9"X1BFT-;Y<"'5)K>+L>-M&C=]ZLTMP@.4)*.B&9KBPMW!%9N,ON MN#FC9&V:!?H9?I%2N'.S5K1P%V3A;A,[9'=VTK20DD6@RLT4[N9Z3L,O]Q!1 MN+.,[I@_3:7N+B_&[ZP<7N'.S2!%I'"7HH6[^)&U]F7K!!?N/(59,E"0B:W@Y6L,CLH:7VW'+1LG:-"'T,Q(CI8;G9JUH#2_(&MXF=F@RG259 MR";RN0PU1)0LG93LBRW;Y'3=GE*Q-DT _PR]2 MRG9NUHJ6[8(LVVUBA^R)+/0R=$H6@2HW4[<+;YHZV74[R^B.:\5!,UU/#3)] M+KRZG9M!BD3=+D.K=O$C:[T<-$UTU&[V*!H%O".6EO#B1]9Z26B.Z!*>IR@K)DFB?R4\ MFK%1LC;+V.:F=\>@A.=F2V@)S\<2'DW0*%F^QB9S>5!L*WB[%.>06L';]:B) M'KRC\S+7,%ULDM;MB*S;61NSLP:-DK5I&NCG%0JD%.Y<[16MW 59N=O($M', MD))%L,K1LW>K6=UQ,:-U/Y^*=Q^I$&MWKA8I(L4[CA;OXD?6>JDH2W3QSEND M%9-4T;_J'@AO M91-U0JMY4W:,I=4\,JMY[([;-DK6IEFAG^U4Q%3SW.P5K>8%6LW;Q!+1-)&2 M1;#*S53SLK2:M]SJCL7K?.5)Z7:?/MY"K.:Y6:2(5/-2M)H7/[+62T639%?S M/$5:,4D5?:SFT;R-DD7.^!1BJGENUH16\_RLYM$TC9+E:WRR._?@[52L0VPU M;]&26\+@=-VB4K$U3P4H<2WAN]HJ6\ (MX6UB MB6AN2,DB6.5F2G@%6L);;G7']S>M4UZ^?\P)A1!+>&X6*2(EO#0MX<6/K+5G MPY!UZY$0/Y*W3!4FK>0X[EJ+5/#*K>:D=MVV4K$VSPKG&A3A4\]SL M%:WF!5K-V\02T321DD6PRLU4\^C->%]8W7'RY/ZMGQTT[M) MAE;SXD?6>JEHA>QJGJ=(*R:IHH_5/)JW4;+(&:0R7\V3SL,V*&.CTTK7NHTG M7LC3REX@E3V:LE&R?(U5\KM3V=NEN(?8RMZN1U'T<)[G*PIH.<]AO-*TG$=F M.2^]XP:-DK5I6C@W2C@.Y3PW>T7+>8&6\S:Q1#0WI&01K'(SY;RYI#7\$A 9 MY3S+ZHZYT=O]/5\^;]V&6=E:3DO?F2M/2>&Y'*>IT@K)JFBC^4\ MFK=1LC;+V^:F?,?A<)Z;-:$E/#]+>#1-HV3Y&I_D=J>$MTNQ#K$EO%V/G.CA MO)5-%$>K>5-V+$.K>616\S([;MLH69MFA7XV5!%3S7.S5[2:%V@U;Q-+1--$ M2A;!*C=3S0MO<@/AU3S+ZH[OWD:K>7Y6\VB:1LGR-3X)J*N QCJQ M,U4T%M8HEH;DC)(ECE9DIXX5VE3'@)S[*ZXUQO\#QZRHR*CU*()3PWBQ21$EZ> MEO#B1];:,ZM(+N%YBK1BDBKZ6,*C>1LEB^027GCS->T@(GO^<-&^OB_7RN^T MG!=(.8^F;)0L7V.5S.Z4\W8I[B&VG+?K410]G+>RB9J[9)B0DD]8=BQ'*WMD M5O9R.V[;*%F;9HC%.%;VW.P5K>P%6MG;Q!+1-)&21;#*S53VYBQF^-4@,BI[ MEM4=I_FZ=OF6_SUL9D*L[+E9I(A4]@JTLA<_LM9+10MD5_8\15HQ215]K.S1 MO(V2M5G>-G<;3!P.Y[E9$UK-\[.:1],T2E:P4'E\JWF[%.L06\W;]8JT M8I(J^EC"HWD;)6NSO&WN"I@XE/#0U5 ]ITB)\!GB6#AS#L40:0H:NR).#U1,&(S0T))J00%):E M*WBO]_DG!$2:/D($P;M]+.RX?8P*620:3Z^YIY]M6\34#-ULWBHUPY@;PG"J MBIM8,YJN4G.V3<+#KTR&%\827IFT;/OXO5@I-YY3K6XM%V)ETLVJT<]" Z@[DY:!+ZI_Q,T($5$AI MRAD1LDBT7NO%20'U>@9'2:]*/LLP@EBT172L8!MJE; M"L92;OCT,N >I,([K1&%5R/:*#;/Y1.I=#:1SV6BZ)@H6=2!18&!E"PJ;O$E M*\KQTMSQU>!N=1IW%?TF\SZJE:\EBF=N#<^DX1$EB_JK[<)$QP;43?#O_;VY M#HF>;7WSQ?3KF'U\>[@_S60K>6&-XR%=7FM+@.GPHTES'R1%$.'WDT<920EP MQ3VT/K!"L$#QLRGW!?'7O_]S>,B<2*(L_&#N0/K[$SSLHR\J3?"0+/N3>>+E M/GP> M]\:E=R$I;7C^I@G8*FK39"1=R$#,.CET\L+BPD^F/NH!!A0UOB$U?S(WP"]@ M3MVHD"<)_/MA0P26'CRNAQCOE5GF(QR2--GI MF3NOKAM0:!:VV]8ZXOR8"IB$\'] M3(I-,"".X!(,^"/\%_AYR.O,7\DCIMAN:V*;-T1F]LF:V .A@P@?;'3$R>L, M2 :,=WAE]+__)\^QN9\ZTY15';Y6AP4DI@?+$@P(E^ 795XW&$/C$5D"/S*? MP;0DON1T*0?S5B_:$J$JR$/9BE^DOVO] L5&O?WSA5HBZ6!R*!R(U#4 M7Y%;350WH?&+2[+I_;U366T /:Q(;]? B!:@26?3"6#C-$:'65Y'E4'0I3-\KZ>I U% 1A%^AEEMAYF_ MH57GDC_A#^B?[,_OR'- =Z#!)W-)JQ-F?P^]&UEM2$E3[795Q70#((IA)%WO MP[-N3*^OP7\!5Z R/,R!D5O1Q#[L.T@ ^P_=,S+4.#=.F ^!RP')+KMLLSO2;>-$$"ZS)4#;ZZU0(^#OX+?UZ$$M $3 !>CD?$0?;SPD#2T>?A M3Y"-!FKD9A0@/6Z/V-]SO,/QN*FG,<.."KPLW%GP / W342?!1S2P!JAVX<. M,P%?"$)80#D,&.%J0&R@(\<,Y TX:1&^IR/U+.J .@ O#2(+P!;P:8@V#%"4 M(<*]@M_3^\T.W" =RJ+),$$E!+4L#>24!LP:>=\8')2_0AL-/@ MSPU L\0#0G3JW0E;RCFP6GRS"=)"I(A#R>B@32R6:TR.S2<8$!(X(30&!98@ MST1Q N/\$XP1$I8%:<,X#VJB9@:H @Q\6[RDF?$J^ F^!WT.!)^&>+2_5W=( M#U /M:T 2G5HNB;O%S][6+H5AH?RS6B\P0-6:#RT0(<0*62 A0#6 )A:#;U# M@]9$EPQ;EZS0%II!ITUQO@BP!:\$L02D=!U(*S(N0*Z;LM1J,0.@+M P L7I MFJ;(A7Q(0K./- [JF=AJ 'T2!_:QOC?!)ZEP",NH:T[@>#HF/H;0ZLE!F7 MCI@B5" 0O,\>U(O*LF,4W,"4;(D)'(K )0+- MFTID,_!';LI:,H<,+\N8=1#GZD@@@(:Q3ZLORZ-#Z+NAX9Y^NM$!0= 0!-UV MM 3&T%^X0_8_ 2_ 2X#>AVP6[S9BS>##?9$ M,P6&G(0OP4RDSJ:^EU_)B[X=3& ML*G<-VG5U?:@]3OR9JJ 37#!6!8Y1=7QL4L-P=82.FD9B?P\A=;P#4L1X(^#1 MNVA,//A?+([GL8O'GX8>NLL+(D[K4!4 %6A^X!448;,X_L81A2.<^#Z+JZ/8 M'5"7 ;_5U'Z[ W_(,=+TISJ\#I'=CB0.,/8JBS V*"2_6<\S5%ASTL#?%8C' M@I=72^?U2A$P7^BI$BP( >D2(2((V =,,."NB3/R((Y!;91'S'D+/%E'R8PR M]73T749R4C'-%T@E*C28P0GD3 )^=Q8-=7+9@EPQV@4AYV4^(?,-ZG22@BAUO)%"^8;*Y:;(9OQ)& M4^!30+#L]7_-5Y"%F9 =V+\\K'*A?9R2%!Q%XI>@7!5(M(SC5PW)U3S'448& M SGPOS//PJ$>#OP&2%^3WU"=$',-\ MHJ0)K)UFYDV\(HDH!S=)I;DU&1CR#4B+*8Y,$MF><>3Y"/<4 M=\NAO<6&N6@V!U!T.71; 4OG*'U''1_PU;CE1U2@QYIT<5@E=6>#!>K2,/AW MNS=HM@\%_E!2P;8C#-3"A&=#05C1->-LLY?#>NMCB6JHLJT/]1RS$TEW#OARAR>$1FH:* M_FV>:Q)!;-V#5DOKBP?.N76U9@<$5K)XVSJWD$P$@=VV0&0TL6/(BB$C5H>Q M2AV\LR2#7X'U&CAX$649$ H3H?\.D@?HYQZ,),V?[8,U6I/M3^E^^I^D^F M>O]X7O_#_%V!S62RSK#?UX!ZAI)@='Z@\/LG8T* 32"#?$\'VVC]ZR * U%^ M0K4UQ$.XB8!V11UJ?&]V4FZ^=/(Z;@UO?C=_?_Y)WTY.B0B2WI/Y$?P>*J2: M&XLZ4>:A=YQ6S=@U9/Y\.KIDJ8Y_1[4LL-J/)Y/T%-<#:?X\V%6>2%TY>?M+ M.GU4_DAX"N5?9/EGGH'U,2X(ROWOU-%DRD(?R0+!*?SU?P?<.M'U/#NWW$$0 M!1;'@RRJ/)2%0=H?-AG(L)RMFRCW$3J-7U:=&2_=ZEV;J@Z0NU]!#(T-]-K- M@%5MT2;#9JR(;.FVF1^2UJ&SEW"E:NO?AL845NX\@F*Y8R](3ZP^!*81=75"4FYEM35R.W,;MB@Y_00:K(;0^A9.V* MU#PJ RHW5&Y6EIL3JP\E(H*SK5M4M';C;RZ93G"I?(++9+[[74"P.R3RWP+> MY&O>Z(A#3/VE*,OBR"],S6SQ\'$!?J-^F$(N\RT,Y9KJ#RDD'3>7PN3XMH52 M833:FK,O,N;P]5FZ9AP>EH$\ C)[O&:,(+XQ??<5WE:\H=;-2N8X;/AXV$R" M7G#@X6YASKY;F)N^N M]1LAB=P>A:XWY^(T_[:%DWH?1=#MEDD@B.8@\+79E?_F6HP.ZT;;:?8=^*I1 M*]\*R64"O!5RN>NB>N8#A4D2?%-F8AM@^@F%. C'!)^-4*'PG)*U/.B14DGJ MD,4>\PN$,#TSDE@"#'1R>S%->@XX?+[5-!' M7.Y3P;C==D(K_*XX!%13M]GXS'T:F5%MCP*%4Q=I61; G2#,B'6\R-F1)P/ M/]3%YJ'T>=B1!$$$! >WW8GP7"BVZC,'[Y#_N1&-VY:)HO<#=/DV4!]3A>5BJ+!1N?*=]L?Z M?'U=W H,[%8J#"SQ)09"A6_[+C,3:#&!#:::0$;&ZVL)P55E(I"I[K@B1<^Y MY *J$,QZ%O]+!*M[E4F-@#OF\L=L>@=="@$BQP52#' 5.!^K >N)&R2 1>6 MS X*V_;CETH4@'^W,&AMY)^,X(=,N)]&49%49T+)FEB9=$!POIMAV #/)Q43 MY-+;PP1W7&8))6NB2GGB,'HW)=P$I"=6"[-QT<*XG!W8<:- R=H]L@(UCW36 M#"6+DD7)HO:-VK<=)HO*X YM-J%D41DD('\EO)W,%=N8J"K3Q M;%VU6;%HFDG2DBG)&DZ BSGQL?%LN7_QI_5L4]\R>T!]%QT+ 6*7]:WYS(/0 M;=A^YH?(F>?1D[0!;3N1#+$GS[\.B&@+FD\M:#2>BKQ"$TK6Q,YP/K:@?6T: M8MB$ELK'I?V%>*DEE*PI^(& )C1W-1P_E026JQCI;>#[M M1Z-D4;)6R,R"Q9CIZ>85DB(_CN;0K(AL'2< [DL%AS('<\+9BYJLA#/O(NQ' M@.#Y=\C9B]CY"S2O?]09(\W9'12Y[<+EE&G+>W1- M&25K]\BBYW=V:+,I692L'2.+VK<=VFQ"R:(RN$.;32A95 8)2%JCT]?EBL6< M\MH($WRJ\?Y<2DZL#))49_;CI#;<.[AK@1W1GGW!>F>S4\>YW>QLV#Y<7?"] M;6Y:!&B[W,IZLO($ZR1ME"-:JPGP(R4?&^46.!%_&N36=B"3QKB=]1X$R%G. MM[ZX95*V83_<1C(&WYW9V=9+V@?G)I3C>O"DBO]Z"]8J$; 4K6[I%%:X@[M-F4 M+$K6CI%%[=L.;3:A9%$9W*'-)I0L*H,$)*T1[Q5[4'4=$US7Q(&DJ+NC,*&4 M7S,^7^P!ML_(7,9'3ST9# MKSB$7E&V4;Y>+++4K,QUO47:L'ALR\G1:T>H,D:L17@LTI .XE"S/421ZV6;I%3Q!12T/)BAE94787E3 1PH= M;@$Z],UII1-Y>N$#-2PK&I:<1Y1PY_&^?&R.X5&U"EZMRH'C?3%&[L*[ L(W M9QS?:QZ.#;XAB^#?W&5%O)KG,;N\EI; @('/YJ< MEL$WX*^DULC\I:0 2PT>FCS*2,J$]!Z@$-#8V]Z;_6-_O2/N[_'MMB:V8?.M MI "95G2IR0QXN8^:<8V.R&BVK(.7 F%GVK [EAGR.O-7D@%Z4Q&;".1G4FR" M@7*=8'A%@/]BC^R]#81/?G<#S4DDIAK0#410_&S*?4'\]>__'!XR)Y(H"S^8 M.[XM_@0/^^B+"E21;.HG\P29!Y[''!Y:JB=( UMFN=3)Z[AVU=7&=[S$L9E% MIK2$3"DW,:28#X>&V@/O@2;-_(7UA2RD?QT&SW-T^F5)EY$G M4Q_U .*&M^0FC\96!["G+I1(4^XE/-;Q];7X)\@P_\]!MQR,LYBCR;R[X<- M$1A+\+@>8OR*+'%(DE.!I][H) W2C,ER;#\6B#FAZ#DV./D\^JK95]['0^*O;11O'XJGKP'X@7\W(5_&[]N;NO5_;T\ M@R)]]B7Y3OKVN,O7B[VK-WKZ&N[D*QAGY MR@"?"0[< Q!%X2QM_FMHK=D1A;XLWK8J8DO4-%$ :E?4=='0BXIP)0'#+DN& M).IU&*,YE1<%;<"+R'*/%P00-?]WD#Q /\,@TOK9EO-"WIF_K/?6U_&+*K[T MJ[W20[L#=+_?!9P?H1?\8":V@CEDG$K$_%T1#5Z2]>]KF O353=56>9[.M@8 MZU\@8I8$HP.?DOQV$'Z1O*'*PEHO!"YUV@K(8LO.Q^SM*[&OXX+X,4R=R-GB MY23\%B2])_,CF#(H@#AK8V%$*9A;RQC\)\.CS471HCS9WJE\8,T53?1X<0+D MF3GS?' \W)F/IPNI5Y<4>GR1%=_/^Y)V(G '/M!@)L!+YK:)L;.T3YS)P*&*2 _%J06 M\&$P9]5?QZ,';G!AW.0O;M9!G\CV\WYPVN8:9CG^;V7"P1_^>'N2S=J6!=D7 M.K3EJF[PA@B2CIZJ P/Z*MV\"M+K^$36^+ML MMGK5#]9(!!\4!)*NO1[G3G'VVSTW[JMPDS#%$L*,\2\LU&,$353.V6F4#*V2)'\MU$Z6-Q_ M!X=SQJJ0^K(9@+A=]V*M*O/6J@(>-^ -:2"^CG//-[[X*-V0E7H1@,I3A';S>6)0" M)G_UMM227ZV56S6%02UBV_GGEWH<="+*)I+Y0J*0Y/RWFBZB'G[(YTA00=_RSQNJ2_CEFEJFB%WSGUDB4CZ",7@[<8B F7<741UM\;D)44@"<1 MU]YF%=%-P8*W9VD0!;+)=$"%Q+!J!';;^A>-Z^77L5:3WY7[>_7NCT1TCRBI M#7 /(A#1IB1+R"OK^WL-T1B*HH*ZUB%,W#=4;<1HL+<=MAC!7XNMEMB$Z0ZR M?^A/0'[1G^!(1$94!%&8[VB'R@"4 L28.OB\+*M#_8?/)P!\/U(0U9;#JK5% M=L/O ]BFZL^]PU=Y AOW^=;/BZO2^CI5B+<>/:^]/9W*%AY'3]DVJ>MQ_MZY93STG@X8RV8M8S%QE#9UUV)OC0D^@%$^?E(/XBD MS'-IR_1)M3?08 )1U;F$%N(-VTI1@&&$O_[O(+O\9)T#*;[[9Z VF MOR6"9(N7,92CMAB._;;QMH=[@&X%"D,X.#4UCRKI-K!A&GJS?UW%7K\D*F)+ M,HK&"=ZXFK6=4WBJ^VRJ7K*7M*=3X<_/!!0.;,]%,!(,3@O6B&E#/OXW-TS# M#R8'T ,&[(_H6O[CV*\G'T=/$ZAE(8.?6U#+J8I$(>FLOFJQFYF^7JB!G/QKPR,#VL)8A*>:5@..8=EN>MK((KAEIQ-CH9I M^4;!@R7?)PP8! M;E38:-<'X5E#%LT<];S;XR4-WG, -TU$TQ-0A@\/R+C&PG?O^D-Y=)-]J60G ML;#]%'V#[#[,LP8;L&Q["3P74/:^O7,'5-ECXY]GW0CYF&B'8 .^R+:7F ""+0'-L)=QAPZWV'[,5/YZ( L.9KZ.BGJ/ MZEGY]*$^?,C9!@D_TW4W(Q8E+1VU8:UD>U%0@89!.ZR_9&G,;!B4_]JFW.'8 M9&%P\U34]5:W5+GL>+0E=K!SN(;ZFM0$',',SZ7 H1J.Q Y9"79J%35V M+O&)P[ XQS8Y!SIYC5+.Q>O*0#Z]2V53MIF!SW3?S"C&*LLYM$5: MFLCK)M[R-Q 0].-W&'K#BX21"#(\')K$*\U-,9B0ISN8SX_V;$[WZ^,7M)U, MLJ&9.QF?K+TM6EO[=01U=O50>+@VSLH]P=F\C@3F:]&9BZ@B,UUTK8:?%3@? M9&2V8(QSB@UHV+RK?KNJ"34A80=HT5' #4_KK&(%%\5\I8_+82U]QR:OY;6, MWU+Q;F&B'DY&!Q1;- _F[@8^M?M]\,LA/QF***!"; M:$](C$32O8A<4L]?1(J]Q HI\9R+AC#2PT#+G?.R>;#S+CSE;_Q>5KO@4:/_ M:]Y'Z?L@V, 7L&X" LA@!+7?D$52\H^YV[HGZ$71#;V8'GCA86R(N=?_R_=4 M_:?NLM?>8(?-.1=0TF,^Z5 7FX?2YV%'$@01O VPD),^&YK,IE,9*#!YP)R? M0878J: #[(!&QU*U] T6(%9!IAIFOT %RN 1DM('(G(+TG&4*"\^&=2[R8F- ME\9+:O2VBK6YV^2\D!N!<3D1M'6CLB!K]WK'Q\GK^%G-EE*EZL.3QM,[/E92 MSGE9@JPE0S>5/1/:UL9197^DB%TJ*UY;8M:ZR32 :W$@A/35 M3 ^2-R-2Q%(K$ZZL[/0U823O3)Q,*LL=I]AC+@D[V"*Z'9$B-DZR\^4%C"1O M1*2(C9/4V!8GPK*STZXY;()\N>=QQWA&'$%T$V- $-U$,GQ'X.4T;M51MR&N"7_?EI+[%[\C=EJX"6M+]RCJ: MU>;:0^Q=A9OJW%,=M:JQ+GVP0"*6"4,@AVX)N41O!?9-]](5]=L69*=O'\!8X$0ZDKX%4E]T]XX*8"0Y1P60"B!!FTL%,+)( M>9 LNKF]FHP=,J<-48WU-7E++3G%"!*QJ?P#_,$YN,$5IKZ]. Y80PEQC*O)4Y(D3'"KR5.2IR,IXMF:0EQVLBEEQDYU[M@SZO[E&,4)84I,!]IUKJJY;F-M72];.7/=_ M/[%4LR.;TE!M)XQI'B] VT#;QXV';N]4'HN2U*":&XG\8WM:&L5"S]9O<8L& ME5&]:VZ)!2PMLX WXI)C!**Q.NQ"[!5VYI.6W/&8I7<\4KWS3^^60IZ6WODY M$V:G=#5'=97JJF^ZNG2LT[2N[KC>%6*I=RO?6UI^'1?SC=^%PDGM^:Q%WKVE MP=Q>.KTO;\ Q2:V1^4M) ;("'IH\RDB*GPLJZOM[:@MH61,Y/B;%)ABHC0G& MZ.";'WEEQ'1X@?F+P6^=W%;,.?1ZR1 DZ=R9ZJ=^WY]SI3LA_2;8>CX9A23# M44A-^'7&FH7T15TOZ/%!JPX-@A=JMD1@EGB948#]4I>L33]BZAU1%_?WIG^= M8*06HZ@&T]=%(<$,)5EF&B*0%,90&?&S)VDB WX RRD<,>4^,(\*>)'&M/H& MO-Q5'2JBIG>D'M/L\$H;;K^D-.4^- 2,I.M]B#SHD-"FVNVJ4)!48#A!,BQJ M^WMPWPU1ZZ(/.(0 &:;<3QUR%:75\ ):0"1X4H\?H>MHC0YO,$,1D( FS .C M+2F 8J&OP3=S23;#\(J '@HOHH6_--_Q '8*R%9=XQ4=\W-_K\N/&%T$KQ+E M$2-+7( -4VHPEX>I!'T<31_EY]RM3IC*A#1R7I'?!!=YKX-B\I.GJMI"&QFW\R MD'L1*BQ\;Q]\23/ =XP1IE=4U'Z[ S^,-$="5ZCO[YFJSK1%!4HQTB#P!55' M][-#H7X#RJ0+$M(1'3Z^;TAHK? UYHJ@5=%$P%$Q@1G3X0>BR9B6+#;A<^%: MS>.3D#EZO]FQUP",@,T>3 !X=+.).02):$D*8(,$3)QNI57XK7/&8@%KH!EP MXRO@ ]@[>)UP8[2_]]>LQTDO/D9:5 0WP'G*]W#ECZ=QOI#/ON1LWU/Q3-Q* MYSI=R0G"(WU1AT%Z!?=O)/(:D#H!K-3%V0,;BZ3-%->FZ5/0EW@S-::&E+"E M3!E2:+@T=?[C3= (B3P\:AV9$=7C@6*GX"%"E(V$,\V1EB9 M^\!P:H .IAS"48RD MVW4I8#' SHF?,)H5?_W[/X>'S(DDRL(/YHYO@X2_AK:B"1Z23?]DH 6&SV,. M#RU<19 &MC_A4OG7'$YKL!-&AXQ Q-J\Q?6%[(H MZ5^#Z_.W-$V_+.GR,L2LDT,G+RPN_&3JHQY@0%'C&U+S)W,#_!7FU(T*><*E MG=\ZMKX&_P09_N\QX):3<19[@(M^/VR@ .,'"/XAXU=DB4.\)CL]\T8G:9!F M3)9C^[% S E%S['!R=>Q^*8]7&B_^ZWR&WE(@D.\YY863;5U.B4["NP!O6DB M8PXLGR8V@7[!U! $J3H.MX#UYV5DW$ (IC8EY"F&DM$!UAE^OJV 5PC.F1_P MDPP$MZ#=F_(&HA6S@K0:6%2HLNAQDU 5!KRFG0WO@3_:ZZ-!%&%+F0JB6I*,I,=VS9IH]#7%3H*FX@^G MX[5Q#&J5A6.9$'.' CV .^9(I.&#W@IUAQ!'BEI(+0!81A\#CR,U M*/GH&U-QU_X>9L64 LV^R!'ZF&^9CMU@2 J33O@HP0P6IS@(UV#FQ2YKT<$^ M@+T!H5H:?Q(G)2"2%%3T7)35PA=-!5"JTE9!Q'2$"@9.:)IG91OIEDP?\S5&?N M*>I-O@?(-[0^"(.F$=8';-#N>,T8.0 ZO2+I$,7K:V(=O*($V/1^,(7C)_,. M@'B%I[R.1V_'JI7Q7JUPMP5'^I_F/I#\:96+-?/;V]JMEPUMFECR7<- M?E)8Z<-D%1C"5DL"UH=D4LEGYI;DN7MJLTJO71_SU*S=OV+70HV0DS$945'S"ZI1$0-=P55Z6"\ MQ;',1%Y ?B\)T%9B-.\32 9"\^94ZV3*V??X$4JU;EL5L6%V02;!_[V^VOV0 MN"^KK/9AHM2#&@3QB5DMFE&BB]..=)J7F[HDV4HT>1LT$@)XWU=%XUGZ#MP" M)18'2I-#4A-E\D674H7D4F5:4'Z%ZYN.L]$..S$ZQB127A:_"N):4N=&\^9& S'*9XXTY)\LB4>BJB@BR0EX8P$*6L)T$B%IE M3_%5&;R^H4D)YDR4!R(\[P">!Q3C,&P_PDU;)2P[4Y9CSE!D'0$:_CRTQD[- M/E$UN^>G^@DMDJ@'%[5--R2:)#$M0),-]"'7A91D4CL23<*6QW+>%QALC+?( M6!2^K"Q;[F,"J#H6/^TD-%'J-OH:K.T[I *KY;P+"_6$0.RK=@8GIO M)Z\Q'>'2O9LE:DL1Q$*SGOERJSH2;/7K&[H!G#G?2J2\>?[]/2N_ M/JKT36-GKH=!K(V<%]VJ\[<I&;"TTK8:1>:7ZI\D'NWO5:QV6! ? M+0E_ 'V8/#M9Q3MH.SYS+WMZ]4%KJ>?7N4E3&UQ;&Z_-3O$.UJT-.'9UGJ:# M7PX^PG>!U'%*K*>EFQ*BJ3#+TD#(*.J;NA8 M$&6QSC %=,49=D\"(9\)?P9$-BT?K8KE87\',RGN,H?,XJHG\W=%-'A)UK^O88W,9KVF M*LM\3P<;8?W+<>5Y\MO![ R)S:?/S4_S-M^7@Z^;J0&7 M3EH-!4GOR3P0-" ?X"46TZ%3XTVV6\=K%IP%-%^:^C81/K=CI NI9:>_N. K MZ$RD\Q)Y+U_R^)ZHK@"?:_Q2IARB,_-&]^4"L8,;_=\!=^!&$NX+!7[1X0#= M'ACX\UT&LZS* .M["X;!>B7_ZQ&E;@N$IG9U0@B@FEV#:L^;M>9LG/DCQ1=E)/\ )/0TJR5 MV=4D67D3^8\_3Q=Y.P]SD@8S#P'WOTYR:TG47970.H*^.,'^:M5><":7=6P. M,W&+H,CE5G9VK_T2%&Y=0?&C[N@J*#SW.]]OWZ:>L_EM[CT;E;W?R%3-!FN_ MRAW $^#%\LETN>:W<)7#M$+FRM#"+-EZ>KLXKY;8:K.;"]&NS%/F@V@E$\E" M@1BS4@S3K+CMO/[P?JLT7Y1AHQ.B52%VY[<=_RR\X. 4'ML[U?C1)M'D6A'D M%Q*="].60:Y IEC27,LHR2I[\I(ZY]>,E[=CZ:;IWES66X_C^]V^M__OQ3/ ^Y&Q[5L^'/I6WE.?_XYS0RXS0^&SYS*(ZDDA9V?K!Y1<25JW^V=AW\]1,CD95J&]+O1 UM2O.HH29V_I%L?I9O*HW@]^,>6QPCJ)U M]Z* 6.GF\>U.+/PZNU0 IU'I<"B1-!#E^:E3_A]PGJIT0WXYNC8WKJ@[AV1Z M?]'K>#!\/N^=GZ0&C]RF576&C41=?:YDG@1<4(?5%/NAWN:RBTKFV$W,%,Z1 MFCCZ=V=JYYNA@(O1-6\%97\QR3A3LWJ%?5)H95,'OQ*^5:HW*J4O?M2F3S8] M6!"/QE8YEI5_=.EI]$K_9HP2/<)GFP (ZELP75DF SQ9R6PH9KGC%'OLUFCA ML5/)[A?RBAQ,CR5P-MO-P@8U)V@TVPI>*K5;J5[U?J@4[)BQ-#GE4X(CI!7 M\(-90I/?5@42EI(9+(JP(*)\9Z<5=4^JGGH9S-$R]+;BO(YM.95++ $6BB M_&V)(3?>I]1LOX,!]<$R-:"HVLB?=;O?!HS> -2SJ C/?-LZLS]CEZ9/Y#HH M6[VGQ49W9M[K>E+;%3/:^,!M[]:X! G%;OQG,O6CKLW[L_%8:*,QT^\X[- MS%W2L^EPLE5Y&'=T(]^<)#?6@S9K]?GBXF<7:K?G=;AT'@2?.?\:>[Z3)ABY M#04CB$0ZT\X/,H/W2_$V0[2L;3^<_2FS$I# 8 M7YSRYHN]"^%6$C)R6_&=.[FUW<*3R]X@85=$^_T M+9QDTVRB4'!SY%[ERMV;KR)J7\IMN/)8\DT>@XA,Q9[\=&O\Z9U*]-W[KK-'ZN*1AW&II(>>>P\S">PZ7">L:MQE.;M6KOHX+GV\O]8O:DS MU2?PW^ OH(KH":&@KR&$IX8N>*4/IP.DT>&@5&(RR%(1F"M1!2Y79,I\3S)X M.7%U54XPR'3BNR95AF=T$&%IDC%B>GVMV>%U>$^])HJ3"S[FYLTZ3R? BU#. M%1TH$/S"N7E]Y0,(,/ (SCMTQ]^KT$-!6S,B873"8 'ECQ6_^^F[MO7[V-SII?%0V]K=,5ODS9\"7^5]I:TZO[DLR@ M:P'5'N.N\YL3._(ZY!RAUUU?$P]^Y1='7?A_?)/1;_#\H() +7@&YD8%XFA> MC,FW@:"UX86)/<#"IM3C9327=]DE0=/[4(87;0/N.V;\DR!8N&B]DD1-K\0U M*-^B]"R)VM-L(IO-;DU\CK*Y_3U9U.%M0M9-ZC(CZ7I?9 1)1XF-J] X9KW= MFE\[A]^JF%^:/DQ-@M2,VX_G)ZIXW=D'XSA@:2.4[\W>2-$5I@"^G95J2IAO6 M!Y$@S'';.^#F 6"5#75+G@@8""(16?N"#.Y M@;^L0UD"UKCI( 9^5E:'@ RXO.11DF7,:[[@;_'J!='\EHI-NW4O0 5=A]MR ML,IRA ;A(,L A'F\>6^=5CR[G MDN6V9,E/:R8;+"XXC/G9PSM;&_=KK5';MN9P08 UUHH2D^OLT2W= K[C 5^+ MO;V %+#+DP-8O-J@8M)OUGGO!1'D_I[7$+*Z4*Q.^*9HAH_F(7Q2).@JE)>&J,Q"98O9 M?O!KQINDYY [<\B&ET@&14S+0AG&_TA&<$0P)\X()K&_=R)] E]7GKSO#G[S MB'GLF5^V;B]T^_Z45\4DXB!_"%)!'H[P!^NV_>:2Z2Z DV#/;EO/^'MWYE<( ME?C;O/CGN?7,WCYQML3C%4 NF6NWU[TTT5FP*-A<&H81^"G,4()7%H'(4>O"!P(F,-/ID/HIS'LKLO!0;D>C+$'?K\JIWE/Y4GU)998.1IF#MC>Z M9<0Q\F3):)2Y:2@KC%N9ZPD;+N@)\_[,V?ZSKB0(LR7]P J:,\-<"J_C9NKR MN3>X[K_QDYKADOM/)C+ 8"&8O83+K9UA?>98$RL"2R;])7>K>TDY#L@UU%YD M:-TN:UT&A6Q*.A5L2FZ(Y,Y/GO)*KXO#GFG :'O:[TWO[]2BSZ"KP[NXJ M7624Q!48I)J)_<*UH9X&8=8NN1VCVR#THOEU=.)ZRG&*:)#"6HIH1%JP*;F+ M$ WL6"U8/IU,+CGR@(KMTCJCX^=J&?^G7*Y63TY\]=# >@6M4^PQEX6GZ%,1 MWO@)N:YW_R62LXUZ=/HU Q-%(TK$9V[M,JT9HW941@2X;.9 MIDFT#[9Z"T*U+T!@3M"YA%L( M,*"/H>8E ;9-_3],QUU?T_NPF<=0G>_"C5#PNPBV 4P _\ MV=Y,(R5B#9M,)7* />8[88O_'.EZOXL_FV(3R4+V*,DEF)[]O+R!UJ3A MQC%,1_X;TP)"RA3[;?!@)F]=\ 7>+,GH[,$1;FPUJ7>^-7O,IIV+<*<=/C"1 MRW%'F9SSRXZ58$J<:^ RV03'YL%7EJ^!R3,KTL]<]!618=/6YTSV8Q+F]P Q ME,M#YL/;MAQ$(S+<-RO+);+YS%&:8Q90[THXI >3X:3=,OFNO8G1]E@T*Z5I M7KS(W03NC6'/7'0WDG(\PARG.##UN"1RGY*[-1PX^Q4.//Y\>*X([SI;NF@1 M"PEOQW5PQ[$$A06'.1L"XY+80L!.UKQF=:UYQGJI\?LH^/U;/A$QC*]CP M=J3+$SC&V> 8^)='<&R>A=Z 82P]=^#=DJZ#WV#9@1!!+)/LJ5L9O"Q2,Q>36Q+I.Q(:&8%T;U:W/#%/ ;V.NX8HAK#N''*,1"A)@S<(A M"BSW;?$1>4C%HF/R;!:=1(28FY<9.VP6CC8!GW:D@8B P]$SZX5+S.>]:_=)/?K:;RDKX"2 M&ROYH! H%47*\;#)I1 H)9>&"91<8N5C 6Z;^Q*W';7:M>MR^ZS#%XC';1?= M"!\$AIL+'L.=+.C;]M&K_#IP;HZ L5*%J][C']@3)K>W"NM:>Y4)7/A6A[MR MF\^X\@[UWJB&B9M,YJ%M%>H-56\*ZZ*^).C.B7;[>7&>[ P'PA:A8'N_TCE? M-RQ$/?$"#\\!P[D$QH47#]4U,5)18/[*I!+I7/HHFX**YFB+5 38D9K(YS-' M>0[^S>Z%A AQ-I%+91/)=&8.736!4#1.+N[:2BFW*6>_13]5B<,^A."I4DY/ M!?4>'ZEW#HW&!^[!B]&?=$*]5N.T]NO1?-/_?9Y&\P_M1W2\LO_*,A-@13*<0IRQY6UD20W^I$C)3=6\K$ Y$Y_ MW9S\5!X*Z>3X^HS<>17;:D[.Q[$Y.;4.FIT/]QJXG6Y*SF]X%=VJ<#46FO P MZ^VKQ)+1/=+.CLW2[L'+%8*F+DTM0@IN0N.-ZR+GP.0X3D%B2BZ-!"FYQ,K' I#XY$N0V*AW!L9C MDS]O=W8>).;8.*+$V3508HXE%0Z+/TH,>$]1XL!'?:^%$I.K%O%"B7U2@;50 M8H[U"!-GYF%BA U/M2:S&8H/[PRY-"N(*;D+IN*OB0^'[44H/NP5'][8#VV" M#VNAR*E5QEY,QA2[C+W();A<[BB3FAM[D8=_2.3 7VQH M&5-!\>5XDDNSBIB2.W$S)3_P91)J;WI;:E*LV1/6[(/#V@!N!LZ$ M0\Z$HLV[97LHQR/'<8HV4W)I7$C))58^%J#-2PYGFVCS[5VM=/ERE?P$4<%N MH\VIXU@V(Y]X!INYG)G/@'^3VG495W"9R^%_P1]H,S)1R'(4U"(.2++O*K * MC'S-:\T.<^ZM$9ESF5_F47BWIFK\[K_O&D:-@]&*U9'CE>[S$R:ZV&35ZGZX*9: M?TM3R'D1Y.RWX]IL+K+I6"CJO%O&AW(\=19S:6L+/G5F1'1L.1D-&4SXJ=\Y3:>?@4=QEVYBCLO 4M M6>E"/=(TI6=\G/#Y!I]Z:.P*[.R?5JP..[,YW+'L%7C.N/D&*31X6L M&^J<3[&)9"&;F&MCQI10K#EFY-*4(J;D^HLU$^%O+BOM^F,J^W9_1:%F+U"S M'\YJ,ZC9]"84:MXMVT,Y'CF.4ZB9DDOC0DHNL?*Q &HN? DU%^Z+%W<@_S6J MK9V'FCENIZ'FK)W09%-)4H_WQQ-:SMIY2?80\'Y;4R]J(B!'P$)3[(J*T(4L M-E2P&$52-? _S;XF"B;@;$@-663N -$@H01/86Y40XPEV+7F?(Q(*%#T$>< ME,4+W(P41#2UY:*OB$PJ:4'.1D<$2M(%;!@QR(*(: *&RO",CG2,X9WJI6/U MTDWU:CK4JS=1+P6H5X(92D;'V>5LK@23X9C*$4M%W$UR:79!R25*/B@(2461 M(<6(Z$6T8<6 U"!53I9BSU-DADV;\&* M7PS?93->AN].[G*GPW?C2RY-!F)*[M1=N>MUJA+D/.CPW67MJ;ZZGTUZ4S-T M^.YN6AO*\W M;SXT'K[GU@E(G^^D'(\.QVD@2,DE"WC<,89'C%QZ#IXZK=#)I1RG84)L M6!M)TEU&/ H(9;HV.J.%L_[9OZ :O")+2?I7.,3B#()FQR@EJ MMO_[+GLI3F,SC#KY3CQ.GWS)FFG8I:C?MGR"6G*%?(+-YA/Y+8\SIU + 7I* M.1XYCM,8BI)+8Z@=('?!*-OU2USCNW)!O\R5.+4DTU:I':]T40 K= 6G'(\< MQVGP15D*O IA,LETLDQP0/N_YH]7;6_]V]O=<'N\EI; LR''TU.[\=;7S>DULC\I:0((GQH\B@C M*0$*?@\L!/X?W#SQLRGW!;#4_SD\9$XD419^,'=\&TA>#1T#:(*'9+,_F2=> M[L/G,8>'EM8(TF"!))>P)$^2!\R"0^!-P=-ZAOT+ZPM9)$MK\'8^$II^6=+E M98@E)X?.%5MK_1L'\N%'ARKFL\UO'UM?@GR!;_ST& M/#'98S+)^7'X'/Q1!^/-K9@[Q]=0A1$4N...T97A/Z;(-2S:@,WZR9Q7T#]> MD_G2*V"(J,##MSK>*O0]\6)DG!K&B'M[2Y:/U;O37CIW]9BK-WIZ*B<]717; MUTGNI2NT'BIUXJC9_/KZNY]DVY<,T?ISXK>>7Z]O2RENRQ M_W0'I>>+N_-BNCTVA+O4H/ET]]XI"7XUGN M@6./>VUET*S^SET7^Z=_DA<7]V3JY*L7LKY4?F]GSUA/ZM7HZY6RI0O MR[\SE4'UV,C=G1YG+C7C]\M)3N?O[N[?TKWKGI)\[N3_Z0WR_QC5E]K%U4GG M?=0VSM_.S\\?+\3+]^M"Z_)9^J>L7(]?2I]27SW]DTW7^-]97GJI9!XZ;X/1 M^XV8$_M7'^>%Q]./F^O3$^[S_?1=4RZZU>[515L__Z=TR19?]-%O7:@W'X][ MMYWD5:9^B?MR@6P9O*KU_'E7N\Y]26KC5TH-J_UK_9W#.-9.?Q>8EWWG@;KO\'ZG3&K8> MRMW:!=>56P\7[*6AG]Q7\L+EA5!2+GN_JQ?=BS,I,Q;>JMK-=>U4:]P89XUJ M\^I=OZT5!]);[:DR>DDWAD_#5.9Y7$^.DIWJN?QPESL_SU[>#WOMVUY9_#/0 M[\\R@]_'S><3[NW]O%P[^7BZKM]_MM^RMX_EOB)?C^]NL[=ZI?Q^NM0_I7.IS=7.SY\NM/>;^]O69ZM9R)Z^7U<_;E\:HY=R M]_?;H*@VV5K^KL0/I;.WC^.7BMH76F*=O6^<"TW#*#W7WG/WS=+U]<=[LGB9 M_S@K'A=[Y_?=I]_%JVQ[ML=2=>-<5/Y_R66 M-[:#2!1$%T2 0$!#, $@O =A,TSC/0BW^OES)J\*Z@7O7EKJ[=Z7?%ZVN*6: M@V.38UM+3-)(CUT5X6'=ZAH)\3F%D[\ZV'4M)3U)5]I)KM>WW:I,*&OV?[!T MWYL<.1^&Z-0*Z:D*=F+O9,X<-,OF'*\PJ:I=S"7OV._"W9W;%8/'YP>2!QYE MQ[_7Q@_SK#NU'3N.)%>QQ>N0$NH5=$_&*TB#]]-T'[C,W5)O@-V@O7Q!35\@ M1RYJ#.H:&'$6-4NOL-DN1\H[F]>8QMW,K8Q#"&AB4T**KMR$EOXJ(D7RD3+$7.<.5< ME0U?_]U3_/>CWAW7]485N,I/:C5HAZ]@PD073 06)X!(&*WIJL)(A!=\AVPP>1YVTOD.PM/ \[$-0LLH03'_[7F#7[-\L M7=2+M4*(&<8S>A2K;[XY\ZBAP."IM-N+%9+&Y)208R5V.3=;T(U/M<\ DX&? M/>)WF/H+WXIN[IM(K6*$__O2/&+1)K1HD2Z(C";/ QUX&RV$DI(7@/['OY]\ M)'D$;Q+9ZZ?(])$:(AO+<;B0-!.\"O"9"40J)!U.1)L\R;BO[RA!ZMNBK[<= MIF\I/T>/@+S>,V6/[PX]A#V M2^"E;^(8F#+UK<[\(**(KTF M6D+GVYR2WCG13*4]ST.$ \&VLW) MED^O2=490QZ0M="E=6B*I[05/#4YX!T6 U&/W?HTD?7@M07:D\2U_-.6L_W+ MV%Y8J',4?@V\+GG[0BW:UOKD,V2-:>\QR:K] M$JI_6QBOI_*G2<.JXLC^=N@H=8LVS2SW.82^T5"M.@ESO?6\J%UOB6@G-OXV MYO2?*5-@M40<8COS>.#GC,P[]H%Q8X3]G?X,OL:_R%H ?V#/BZ[2\9U)47SV+7>U%8]Q MS+.EB$VINMBLAK<_(SE]B_+3ND)O,3%4?7FREK:ZG\3].G1?Z9P%@G@2+=%-;=80)^EM[[F$4TX:Q2[SCS MW)-_YC?#%I#+2Q^V_'F=-E"II<*0U^;+BD=PSWLXII;%%/XG"#1>JB+B?OJ; M-RL*12WS!/+:0_+*&B++*JL/8_<*LA/,RIR0-=2#J?=#,=";)XF<;=&]G^28 M4I2/&;;F-^<%JIY#4*OXTSKO#Q&%0'P&F WL>,@R-'X^"$DCCZ?-9Y M]?K,PI$?!R2:?3Z[]5JVUW7=,XNF* I0&$?X\UD4G_WGWW__F\6^/OVCU;*N M"0Z#2ZL7^RTWFL8?K0&:XTOK"XYP@M(X^6A]0^&2?Q)?DQ G5C>>+T*<8O:/ MU8,OK;>O.N_OK%8+T.\W' 5QI^F"7K;;CX^/KZ+X 3W&R1_TE1_/ M81UZ*4J7=-O;ZZ?7ZZ\5^:>01']<\F]WB&*+R2NBET^4?#[CSUT_]O'B59S, MVN>O7W?:O]WT/?\>SU&+1%QN/C[;4/%>JN@Z'SY\:&?_W30MM7RZ2\+-,R[: M&SC;GME_B:1]#@DEES2#UX]]E&9J5S[&$K;@?[4VS5K\HU;GO'71>?5$@[.- M\#,))G&(QWAJ\9],>]NGS@)*VOS#=C=FAL@09LWO$SS]?,;_R7H]/^^1&-0Q*@% =7*.3R\>XQ3JD:@X*P(5PCE. HO<12!PWCW-N.X;T=QD$/4S\A"VYWP^G5DI((4Z5T MI42'X?&6\SE*GIEMD5E$F$FA*+5]/UY&*0O4(R8>GV EP'J]'(:8]9LL<> \ M+7!$U= $S0_#<(U(D@7U&XSH,ED9C@J)E.@P/(,XQ2/TC.XXL1Q%1=-#Q^1\ M3M*,&3L*V)CB*F/<8A=W',FZ7/DP1%%/F@R*FB.]3SW%'\YY(IWWF #!]1^U/XO^/ZP>/Z M0]@S)WS 'PG_;E]']>8PF%*B!CP[#!6 ]-C>#*A5!=W1/!L,CI"@&2\' P6C M/J['@XY)&=4I?$AT4K)&,-68Y<'H92A]%/K+,%L'Z;._=RCP4XJC >;?CAHU>): M2E+>:+W.V;%:?%%TR:C^'-1QXP[[;LR=.S[JR M^_:@ZUC>5\>9>)N%Q@W8,/9W (9\I3,N+"UN5HVS]2'DFJFJNZ0IFSXD5(Q<3&&&:96E7[ N%B]_I$ $X!)*JNEIP.4\T&_3X 66P1B5_ M&?)"X<+ODXFDUP,L\; MBD0%E:T-RO-$NI!P:9(VQ.=(RKJH:JMMX6:*F84'&23%TFUE8]VC67)^I[1@ M(V+5)#OB1Z3B"**.JMA(=V%&+=XJU.89_)CO)HMPX* D(M&,VKZ_ MG"^S&E+A['G5;@LUK>XJ#G@8P 5ADOIR4RD["NI,1]24NH,\E#?Q/-[LYP'=L6C_O]/>OAK>;*FX4V>'BC8P+ M;\)^W#@#QL'PVAJ.G+$]<5D#/3M0LYT5HR2>RKS\3B-=0>H!1TM9K>&EA6ZO M52'34J39Y<:D>-*-:3J8E*5? MT513^0.'K+O9ZJ:VD 4Q.YB3B-!T=3)A#4]2$@'2ZQ[30MT40W,M>9@T[K<< MKHYH]:6;#BL;&Z.C,@<%+55Y"R,GB'"6Q 9JDHL;Q%&\RY+20TA(="^BNQ$; MU]F9)SJ(TQZF9!;QN:)-O^)@EN'=-OC"4DNN/NG6ZR-TK7L0*C4L7)4_4)K- M5ZFZ]RB:,9C )7QQ<]U>!:PC.1OFQ;"-60PC#X6896JK+<$\#/-?W/D"D80; M$&,JFK7A+$[G$Z'T]TC-X+1IB+272VN->9@ M$CAF9)=NY&.0>?94-5Q>-L"]--)=\*TEZFH.C9HTN5&*$TS3'5ZD\P@QA>[= M>G6]E(IWDZ*//8^3E/R%5M>W]O!=VB,T.T? QN^<+.=BA0%(=>__JZLYL#1. MX,9XK&-Q#J=IF-5D6;"KOBVVX-D =+HW_=5R=F YG$ GJQBWVHI(,QM1;&AZ M"8QB(MV[_/:(\BH)F.3A5B43>6DHWT9W,EK&*ZJ:5-17C"P(*3E26Z!!]K2] M#6J-\0I'6+H2)230G7TI]:)@5>%P3[]R"WT=P<["YUOXPJ6W%NRP\PN&0&"*?77J(];*35%53SNMM4_]@9093::[<' MZ:N&<)K7E,,3<5[$S-G.UF#6N\ %JH*1:J_L'J2K.N)I7EDC'*$P?8[3>YSL M(+N.$T 1'DX.S+Q?&ZJUNG(ZS=:(U2+.SK+!0K)<4MT/K95%%00E4G<$%"ZAT3N#R5%#X%#3_M@_AW+QN M-T MFEK#V%=N1A4TRDSTED7DTN4E< = ;1M<\Z@I*\/U7+@,MXZ&2Z1 W9I8 M(X$S^2.$V/(%NC7U6J(&JM;$8O[MW/,9?)@?HUL013C]$?1L'# MZ93X+/DMW!U16]/"?H!K]";6;_;DV#S="T3@1@^8'KBSI[*/8R8,=O# *YMT M9XR)T@)18T.W[T@4D)_[RT7P QC:=B_$ 896V8>V+T,I[@OP,$>X=RU2&[AG;SSV*A&*2$CFWA=V7?[G-P[P8VR/4S]A"Q6ITRN MEI1$.'>B:X>%]PPV/W82QG298/Z'XW7'[HA?%LMQ7]UZ[L#QO 90>MS&$S9K M\L@L(FSJQ-^AO%KD8E:3O=XL;S,[L#\487NW-S?V^'MVYM/],G"OW:X]F%AV MMSN\'4S[?CE3$W@#*W^[L:VWD1VV X<:R1_=V^ MZCN-'.2=STF:"8LY4.8IN$'B2&B.G8LBP.[PYL:=K$:_/>AQS\"-T!DT9(&2 MN[IW@+XIC9O\ >F?WI]WWGVTG/_=NI/O#:#2&:7S M(![&[\J.\B=4B"">W064===-Q%,8LG;5.-6\5 ;8V;U9'.W<#?H:/GTJOYO*@:+SA$K-!Y*$0)Y$W@HO:ZZ\#UM%2\^D,J M!).6&=9(^5UCF/(C;ZLS/5"U">ET5YZ/H3Z%4$Q2X^;@-O1]UJ+VNFOM/@5$H&6SZWN("G9R>92.2JCS#\TFKDB4"7TTNI MR90RMHI[$3?I99/S;Q'JZKGVA;Q:60F[H:FU"+C"5,J9G"2O/XGAY%)\J<64 M4KC='+]!(RDC%%A'*1.KA-B,091!GE>#+"52U2#/3P-28:ZE/*D:;*,&*JKQ MR*SU32DDRHH\#=JN GRU(;\I!40 ^F;,6H%?;CYO2H$1PD>S8;)0=9,:43E( MELMNC1:G*K$J9%X.D4+0)5&O)[C\VQVBF'WR?U!+ P04 " CA-A'7_=\O/?/__G/_RC1?[__U_Y^J>$B;_2E=(F'^TW_ M'O]6:CL3]*5TA7Q$G!"3WTK?'6_*/L$-UT.D5,.31P^%B'XQ>_"7TLFG\ME= M:7]?HM[OR!]A@3)@\'E<(PFSK[K,[L-T=ZB%*LEJUSY_/S\(/IV(9J2?+DCWN(91P<+.,N:Z;>C M<%D@+GQR,/LR+NIRJHZ!#MPO0:1)"P^=,&HA0D0E4(+]M;\0VVOG4AU'@'K /#VJ8MEF*,!(?$W3_=8]]26NM M5,J569V_)(3"UT?:=@.7-;V]TD'NY_D!]MR1$Z+1A>,Q^_3&"(6!&(.@H"9< M-PY!?CA&H3MTO+5!9M:B#C%[\]"$/B'HW'<>66]!VU@ND_)KT(.T%^+ASS'V M1K3SND3W[M -UX7,J4H/]IH3C!L>?E[;R*D*-.-=#)QR"MM6^Z#[](FY?AA=3C$4S^D/OV&FF?H(B' M?+5LAIC62Z9H5']Y1'X@A@:(;X:AX;@D\O_7R FF9-9P1$BXA3;#T\8ANG%> MG3M6F(\B0W33=W(R<<-(F:H_HN\4HYP."B6:C431#5MWK,.L_SUUPU=A2P9+ M;(:D24?)$]1W7L16R1#=[-E=Y+$NCO9FX6N?.'[@#*4\IZC5@<@MIZ-GE4$D45=V;2;(J M**>L9Y.# Q;0T\O)@9(KK;;'DWTG>:6*Z#LN4>BXGJ+.8Z6R O&7E2I0-J!! MVR%LROHD'.1M5JO2'EVR\?!+:>C3)7')E-6'3IKP7)4HFVOD12E15+6'E.V[ M1 4UX1+W2<*2FI#)]S72-2@;9TB2"I=0C41((Z>(:BR5_%@JNK!(-R*)HGI& MAY)-2;*X5HS"1B9;7BM*:85D&&TSNT/W+I0(2E;/=*\P?%+;&LQ?7# RIZ,).*X.4&G2Q> .'K2_@1-[ECJ,A?<9%']6!W/RXQ$P_=GV7=;PM^F<"-WH)D3]"HP5R5J$HMQZZ(1.: MKX@HE_;9\HDIFXW07^>2Z@&(K?:;5* X^+P,>T*/$WD]>OU.[5_?.JW+>K?WW\XC#GXK7=8;S5JSOUC& MLM#+P\.$,AY;1X-)NNL(%N_\O1/<12_^--A_<)S' S9 .$!>&"P^B88,45.J2@W@NMXKVK>U4R0+WO+>4 M=$FS+OK+$/LA;6UU+WH:[>;1 _ME@>R>X(G0E'.S8:X&<=M2('LE3&CS_+I7 M/GS#XN$ C;[NA62:H7+!!,V" &S5'O:CU.Z+*]/"LHLII2]S7"FB*\D"0!5/ MYPSF3'&T O-R/E"%N '$E7*2'C:+".':&LLH /%2.=QF8@;E#/BJN%F,'C?M M_#8E+U(2XN_(&']L)0OVH]'#]7Q&!7&7$ATHIRTYM0,HX;\;6(S9NM[MAE:# M"&$C.@D>LJ0UO$+*N0!Q@WP8(Z0Z&D5V<[P;QQTU_9KSZ(:.)V*&6VR0U4E; M1I%8 = #K&,QS;J#=F6B&Y""K/[7%U#S,H'\P]B9T66C6 M1Z.Z0WS7?PA$KT"V_.#88D+$R"%:CHW1 J_VS)JHK,H.3LW0D6,FF0G9.L<] M>X\[TS#:-T9;#8>%55'[2+.D#.$_<%6DOEA_061H1N\)=57 M>\@<5=A+TEJ:\'*SIEAJ"L83:U3U?EAKRHPWS$7,VRB<+85NX8#CZ1)B]I(# MH@4-'PM__'ZPH@A]S,^"E@&ECZU(+/[Y++_XIU;M?2LU6IT?!2YB$IQ?D5#E M=!U5]"\OXY]XD=#@C"TR= .V!&9*$/NCWJMUFS=LY1B#?7';:[;K/0WVSWGJ M10+U^2KJWNWU=;7[5[1@K'G5;C::M6J[7ZK6:IW;=K_9OBK=4%YJS;H&1: S M,N*(RX>KB"FT[BUM)?4_;^KMG@Y<_!,S$NC*J^@:U6:W]+W:NJV7KNO5WFUW MUI#5@\PZ4",!K;(*K=WIUTLWU;^J%ZVZCEY!?*A& M_1*KY:Y_JZV9^]]]7V M)>L36 .LM_6T/LZ1&PFS2OGTMU+]W[?-_E_J068=RI% =[** MKMFF=JR7^M4_=1A->#9' MSG57#=>BOJX6^JW?Y?I7ZWVNY5:YK6VH('=R0@ MGJ8[Q(L>99.VPE+]NYY7=\WC.A*X4^Y'OB.G;G1>M08/NM91'@G--G!1I7_, M*M:@%__LC[@"%:''T@A3YC"0!%A9!Z81L_"KIYS;^: MVS"<(Q&4P]U[C?41+3Q1/%SK-FXHKJ)K:8YM/!C_7:9#96]>,VN@+_9 M1NM#S6W5T=."<'&F ]NL7:V3'8 NVIHB+FEF^U 1_,FTF+0-;=J'I(]WFWPHT%R^U#G&*&MC])OYVK.Z$$JEC7E2O8%65HR\V:%($J M@-VMV?T'G2C-)2(F)6IJ,\B:K&3CAR@QMR5DOF! 1$=";/!YJZA(8X=H^&S9 M %3:)57-:7V4=[[7Q?&:?D!Q,)/R([1@ 0NBJSEXP7)*63=9CG*T=/;(ED[-=E90 M%THU3RL0]"F,(/LK4:Q,[5/,Q%-%G&*-&ML7-]V^=F-S/-9PFWZC],P MB%0^$OEF3B%#;GJ]%Q.@,ULKZWKMMW%#RW7N7"\*;M>FA"!>PH!7RE3Z1WT, M1JBE1#Q?Q7;G-([7Q7YY:%LSK\@[($A*1=7#7WEV>B@,O>3^/#$_L4+OEZ%5 M)2WN#V,SKS8.+U'@/OAL]T(U^(9&#W0"%Q.XHL9EV[G;2*K37+/J=] LE)H" M' @5FT[-=]MD(LDEO\VIB&RBS(64"?C%-J9-3[@'F,>LK.66.26?5\10#$?0 M_K$\^(*FCSJ;8J"V$J160Z#ZRZ,7*$*4]E\VVA2'#D23%!K[J MS9_.H/J(P!=>,7% >E V= &9G)FYJ$%+'ZFV-/+1D]/%X;B+)@[Y^0U[(^X- M8Q%T;J%!V>H.608\:'[5W7//?0G'O9 @%+:0>&0!B0_*A@YQEC,Y'S9H[%/5 M;=TAK[TQ?D*$W[I7Q 85N]MS)EQPV*:Z!7?9'037KH_Y1ET5&U2L;K'9<$&C MJFZIWQQRA\D5!1K(##(@\4'EW&8C\V&#QCY7;.R&2X*0_D!7'KYSO,[C(R;A ME%KHE6MT4;'!D=7##SGXX/Q:]3CD!C\C2'YP9.A@"SFS M"W"#]CY6[0N_]9K^$YK?)\/WAQFB@R-#2VLD?2((&33P9\4&_N%ZGNM,+I'W MX(PPU\!9HH,CJ_TC#!DT\*GJ/)!#F!F]Z83?4:R(#8ZMGGQGPX6,>GRHV*C? M\0O7FLOO!\>&3G62,^,*3M!^JB],[[;Z_&'PXOO!L=7O]PI.T'ZJ7^K^V"4S M;-^IAQ3,*;*%!R=6MTP>:#@HK+KOG)+AV D$$^$5J<&)U?/@3+2@14\46Y0= M+(-&;LBN"&,##T'3A<0')U:/J_BP06.;.PEQN$T_1(0VJRYMBO&K^&39@LIO)7=\9<"@J>HU;I,)]I/V'^[D1SHWX3E;*\Z+)7M@\'& HPX4Q9V\TM X.T/3, M+FZ(.\QJU?'1>B2S#6;- R9\[.IOF4Q9)CW@,)=Z=GRMK,A 1YBYM04,W)^ M> N=K[S'/5.^^R*8>NR(V@8"+RM/"MEN4@@Q9-%S<^N4'YW7^6W1\%'S0\K%I<"$'A*>NON0>U9RZ M3C)Q]Z7SB(.WJR_-'M8\NZ"&#GM&[,QVY ?1:071IT%U&HXQ;_,$ M3YC6R:;U^_05*\_?.JCE81:<=JFU!6'])E0=?K;+48GVWFEYF)F=E3I;A[)V M*&+(ICVM-!P[&8AN/8O8+OG(:X MJF N20<-)V(:3LSN B^2AKBJ8/)"!PV?Q31\-KQCO$@>$KK"P1 =3)R*F3A= MH/L ;CJA*\B$%D=])F;B;('N WCJA*X@$UI\];F8B?,%N@_@K!.Z@DQH<=?E M0XF)W.$"WP?PV$EE03*T..VRS*QZ,=FL? "WG506#LAI(4-B>EU>3CH_@.=. M*@N2H<5UER4FV0N90>4#..^DLB 96KQW66*JO9 95#Z _TXJ"Y*AQX%+3+@7 M,H/*1W#@"65!,O0X<(EI]T)F$)9D P] M#EQB\KV0,7;,2J%D))0%R=#CP"7FWPN9P:FAHX8*)2.A+$3&Z9'9)2AWBHS1 MF89!Z$2'!,WD@A_(?1BSBYZ>$'$>4*+(!7IP?9_*SF^;*@N6#%B">8O2:S:H):Y[TH)-+3%G MSZ7>T!^X'S1A3*@MQXZS,+KYESVSCSD&[^/W;.ZY=G9F:E-+$-(9E3L@ MH\)T0R-AI\9=\+#9T]YCJ]%M+M5I6N"=OXT.6$59%ZRP[Q=?OT<&4_I)9!,+ M?O,7%X^@4?S^EUDKZ5+@Q!U2\)%8U*C:*.S<-S"Y1VXXY;_FFU;]'EN$4MM MK2EV-X#1W'3;(3,K9>>H3[@YZE_.*N73=))Z6>>O,245*=*DW$Y0WWE! ?=H MY<^KP)OM6N>Z7NI7_ZSW8JI=Z6DQ;EB!>?NN;;%:J59%@ M:RYZ8Z(*33Y7Z?CTB8[0N)'UI)")5*BX56,N7.593P57\MTC0M"(#HRJ08#" MH$,[88?=P=/"05"CH]K7>TS84)\SSLA1B;$C1F7]=UY="HK,IV"QF5<<&?WB M OG4D=+X&>TE:1Y%B?/XF[]P5H:ASO%Z1O+TDB6&K#NNKI^2[XTUG 4W/ MP\]L_W .?M*%MX\L0 ?K<@19O4$.JJCT]G&S "T1*2\BT)8.K0@B;.=R(1:= M,;4N\JCU1S=L-40\0LH+L!T?KN+NUEO5?OVR=%/M]O\J];O5=J]:ZS<[[9[I MR\L _22"1N*2IC>90-Q=O":^D=U'DJLZ:P)2L@2#VS_6L*+U]W/)Z<2_=BM/ M'1;L#EF'QM4+/O,:S:*Q=!RBZ,:@+%DS-T^M87*8,WOO@]J,'"LC:_H(+#3> M]@<=4+Y>X0GV@I\N-^B6(6GHQB1.F\="O*H[+L"NM3%%A\C9X7&MQS5K6M#4 M'4AR9@7P@GW.!US;GLN>!A>RQY=K=9[IM!+'(+N<^^3YQ0;GYNTM,Q"6UD4B MLEO$[%HP4\U>:7%<7F.J:NRDA=UD=3=9W4U6=Y/5W61U-UG=359WD]754QE= MSW.=R27R'IP1?_-EEFCA"T5R301 Q&#OI7@Z0"?,>()D8P$I4;NGK2#BHB:N MU>&0[;L-;IQ7YM6D9EK<,L:NPUQGGB6AB<0LJ^"AN^,YA,*K^J,?S@-W)\F* MY-90P\5OW:AIOG.XCD=5N6+#D>-W=D\,_N;]$=YP-@ZN2VT('#[YU8:=% MGF.N9,MU[ES/93G"VI00E'D0\+RLL.B6$2:GC^KI"-1QC9[8QE]V&FMP1(617;)LMG8H?, MJ_C$T/H07Q'\'(Z7O2I@X+3@-ID80 \9N>@;!Z=W ?I[2E'5GYA?XV[8/DH= MY7A[T:O_^[;>[I?JW^E/X_NT5]1)$9.1:@5+&,HD)_&($L69TM;D@45TK.9_ M.;I;G]Y=!4\?Q<_E@@7,!7UY]N=3M:*M1:/A#*2B=!^GB)F4K,C:0F[L3<.J MI,?*J*U:"O4$;%6S"$;!LM4SFK\5ORU<:O2E]D (*6W2NZ_H/W.P+)+YMUZWR]"@HDMG 4Q*.KQV_U:IQ;9X6 MW+I\+J "Z.T5F_JJ5W,>W=#Q6-#)1R00F1PNL'5WKPI4 1N[8@I:"%,+H3D6 MD?T!Z:V[@I6G!]C#&SMQ-A7'=$+YL%DD/2@7?;&HDB!9##O$BFJWFP10H\]_ MP.05\KK9TM9;6XC=]D#7)0J&Q'T$ED=D6R-6QGJ")#4H9FJ8AR;>I6!M]!Q] MM>Z%:\OR6T-?#FU KV.*RAJ>3+ ?J= )QXC,4'>F81 ZT< <9E%8=%L(E%0$ MXF[=G++>US#29,U7,"J[+>S):@+19T>V6K!'^E@^;6U\:_0N@;U+8%M"W"Z! M;>6X?I? WB6P=PGL70)[E\#>);"W,QFZ2V!O'V=6>J9M3V"K22R]D[Q2<=GK M74JUN)2J@@L)[\*F']"),5.TR=1$0=AU0A0/6,$C-;GR@^T(U^501G4R4#&1 MT(BZ!NDW.:?LQ]WM#KZR?\#4$L#!!0 ( M ".%R59-;&Q!/$X %)=! 5 9V1S:2TR,#(R,3(S,5]L86(N>&ULY7UM M<^,VMN;WK=K_@$WNSB15=KKE3KK3R(D#>+H[U],OGGY M!<+1,O:#:/WW+S[<'D]OS^;S+U":>9'OA7&$__Y%%'_Q'__^/_\'(O_YV_\Z M/D87 0[]']!YO#R>1ZOX1W3E;? /Z!V.<.)EI?N09=OTAQ)MYV2ZM4GOY]++X3V[^MS"(/OY _W'OI1B1[Q6E/SREP=^_ MH.\M7OOIU3=QLGYQ\O+EY,5_O;^\73[@C7<<1/2[+?$7I15-160W>?OV[0OV MM(1RR*?[)"S?\>I%2:=*F3P-%/@&DS3X(67T+N.EE[%BU[X&21'TWXY+V#'] MZ7ARMT1*:4"5\$7QVT."5V(R89*\ MH/8O(KSV,NS3%[VE+YJ\IB_ZLOCYTKO'X1>((HD^I/EZVTJK,'IAF^P")T'L MSZ+]6'>M'=$G=2?)#LA T]YZ%N[BS OW(M^TM$[["N_WQ6L[^U^:^'F\WY=N M6(Y".^,I]_Z\XN\:TA\OR5\MBO@I(PT8]DN2- F%!V9O8 U#D7:5>KQLI1M2 M;QXG?-YIR\C27'GI/4MXEQZO/6]+7G!R\@*'65K^+[Q88&OX?WU7ORCTZH2#+4@B4XC7?)$OCXP^W7_Q[#D4U%OU&T?_]MQ?U&YQ(C##:Q-%M%B\_OL>;>YQ( M,BW V922E&93/AP(C&1DS+HRR7&( =%O.=2]1A8D&9PDV-?+1 RUJ105V:98 M1#@P>E&0ZTJF@D)3S=3W SK \<*%%_CSZ,S;!J3?II2/QL:FCHSH-P6E- "C M+!.678G5-H@:D8$U*LP&4]O:3P,FH$@71.E4Z&!G8IF=1$VZZ M%#'2N7",Z'7E4X)1B8:CH&F4!7X0[K+@$=_BY2XAW@ZGLZ=EN"-#Q0M2>+3? MOLO8?-WUJLS B>L3IP^BQ-0#-)&?:/55G+\3]=J8\=['9A:-7X>N?:]88!J M"SA#U.@1)UE 6IVK.%-W!PQM[ Y=#>BWA[$* S R-6')#V\K&\2,X/4FV"#J M>DOKEE)@ IS=J34)S?9T6@<$1CPR9I)ILQP)1R2_>DGB19E2(!V,37$(Z36% MT0* $86(55<0!0:.%"Z"R(N6@1?.HS1+=G1:6-'ODZ)MRD-#N2D4"12,9-3\ MNN*IT*B&0^GDG.,D>/1H#TSI57B83>7(2#8ET\6 T8J$6%J5T84H+)R*44QA;<30VW*2D6VJ2<1#HR0%.2Z"J+0XSN"111\ MA"A\(.\D617J3#UHEX?4>&OK1":TJP4C%=BY2DP9ZN9_X$W_W."0;8_TDNSY MCHPT4V])IQ[2T^?F$X7_Z9. W46GOAEK+T296CO7YMZ4^04K!D,,-ZY#NWQ7 MK*=?["*Z]U_NRF1(:TY,3;5R7V*8OCY_<_53(5< M"2*4-17(*58*X"$P2E_*JUOR/Z/WZ&=4SQF-7.I3WTNF(5Y=7I[)"UT LE;F M4H)5D7,(&"4NH\5O<_(21('HDOSW;.P"O\1Q%&18M2U.@;/G\!4T:W5$DK\ MZ)+ $7[T;N+LX09OO.3C3W'H2[>T&5G8$X@1]5HG2C@0N9APY%3#C!"U0KD9 M*NU&WRP;/&4/MUF"<7:)->,(.=;>MED-W7KOK 0(0R4:=MPN6@I'.1X5!J.[ M%2]YOGV('W&B<"0-77, M8ZR5LXQ>5Y%AKY:ZC6Y6_ M# A#!QIV73WD<,3PMH84%T&29N0?^%T8WWOA]78;)]F.#&J>Y0+1VU@3BBG] M2C Z QC",63)[U8B9HC:H=P0-2S'5M(B_H23#]NB@_(NB7=;N8048&O:T1*N M1"-%PE"+CAYW_I/BT8=MU9ED)J-W*7^ZG4>/.,WH'CK5^%2(L]>U5-"LNY<" M$ PM*)AQW4ST$[I%#?38"O@U",/ VYSC<.WYL5P!8IPU!:AH5@H0@6 H0,&, MVQJ=0U&!13EXK/;!2VB*X6ZC:!8XC+W60$*O;@0Z !BE+6'%N?P*-G8E_R5^ MDI=OXZ&U@N4(525:/8%1E%TZW3(DST>?#KB\4\P#U _M30!T"=4C__()C,+K MTN'&^N@2W8U=?'(O%HHJ7S^T5]F[A.IJ7CZ!4;9= M.ES51O2_8'8>Y\$;B*OQ:7@''*4LOD,>=&>ZRQ[B)/@7]C]$/DX:IZ<7)$OI MZ?/L"2?+(,6+)%CB&Y)+U1&)4=YD]?#[>)^J=7Q^^- MJ,KS!%QYGAB4YXF5\A2?$14\MUN>@O.?W$- Y:D^VYF7YW#G.%7E^:VF/+]U M4Y[?JLKS6W#E^:U!>7YKI3R_TY3G=V[*\SM5>7X'KCR_,RC/[ZR4YVM->;YV M4YZO5>7Y&EQYOC8HS]=6RO.-ICS?N"G/-ZKR? .N/-\8E.<;*^7YO:8\OW=3 MGM^KRO-[<.7YO4%Y?F^E/-]JRO.MF_)\JRK/M^#*\ZU!>;ZU4IZ3E[H)A9=N M2K1+K#.E\!)TTD:MY(O5$$<"9(J.I(CMS11/=9-'$T6Q1 MEUBG5.'-%TU,)HPF=F:,)KHIHXFC.:,NL4ZIPILUFIA,&TWLS!M-=!-'$T:6Q/O# MTB1K[ TC_U;O"R/_\OM9O(LRG&SI1N,K;R/:U"6'V1" CB25@0SC7 P:8GSP MTAJ**';<74SOO>P!?_H'#D.L.+TM0EFK^7**5?7G(N:MG+-L%/_[$9;!\\!+_YPL<^AM/?/>4"FBON5<1 MK9M]$0J&!%34N&Y CJ5Q0'.T91FHEBHOWO(JP&[>*IM4)VU8]AE+:0DS!<%T6-%J,K3>\2_!A$BI@) I#%*%T2 M@HTP71T$C.*5T>(#=:4I*H!NAW>WF9=A&JSC=HDC+PEBR?A.@K,UP%/2+$=X M0I!S8>B8<=$9"\BX0[OI,@L>E4&YN@B+YSI%U!JG.9N/G1>OG!-_!4=A27MQJ6PY$ M#.D^.,?N/L5_[,@@1C]1HPY>UO4JBCR\#D-\%)<,X%84!. M=RN8E;OAN)NJE+I0H=W=$"97AQP*0R!:?@97A1TA8C3Z?0\DS]G#>R]2RD.$ MLG>G@Y1B?8L#!X$A RDO[J8&!D0$.;!W:'4W4KS\9AT_OO!QD/07>=4HFP7]'F\W&V* MGK @!^W'MHI91*HLY>8S$(4L(-0MXQ+"Q@^6"WA*7NS3EU^$WEI O_/<5A$+ M:95EW'H(HI!%C+B%P1*#*,A5,9_C=)D$+,:B*A\MF/5"%Y#DRKZ!@24!GIA< M"0VL(\=^@]B'.Q($?^Y8_/JX;-6%!S2 MMBXD5+O2Z,! J4/,32J0"NY6(W>)%Z4!=6!:D?!0Z\,-"5ENZ-'!@=*)A)Q\ M2%+AW2KE]@&'(8T@[D5ZAR("VU:+G'!7+SP2E&*D]*2:81:H,($C&[;(!=BH>CK=)/!08KH2Y#0Q7E*V34SI&2%C@)8I]TLQ.=ACBD;?5(J'9U MTX&!4HR8FU0K.1PQO'N1S"+?2"(5SHU .C3%\BA ,719J:3!D&[%,9%D"Z] M,.=R07[K;NC18&T+1$JW*Q(."$HH,G92L>0&I6:8B5/!_!-[B9E<&D@W8N&H MBJ52P0 *I67WE7C2O M3$7S"K1H7NTE&E+P3GW-&?GS.KF+/XDV9TN13B3#4Q4*IH;!DPO'32<6:D#[ M,]3$I4Q8Q^HZ623Q8Q MY5UF&=R)8"2DA:KI8.%)1TQ0IY^J0US:.?4U>:=< M6TE*F!LOTR8I=C$Y!IY(VL2TSB5'NY3$(DXS+_P_P58Y$!>#G@A"!B)'P.I D7SNR M?DZ,=GFF"?8D'J']V%HA"TA59=QX!J.(>4)<";-Z33 N*O)E3/=(/<21?(, M#[%5TC)R96EWGX,H<0DI+MY+S/::49RCV?BG#$>IV'TWGEEKV;MTJH:\? "B M=+MLN&:Z?&ZY-']-@HR\^2S>;'91L!;8E"3[@4AQP)0B1:>EVQ$(/C9<,"Y2:( MV;B5S3Q-=SCI)1Z!B2,)2/"6N9!YQI@1-&V=;'S@PS[.9F+(/*B9>"%57A$T8RXWL2: M6@S)5\+1X&%HR(PD)Z?[HX9#>WVIAD)&(2<3!A*MLY0H^./U J59L5,F!,E_1*'NRCS$G:6 M/!%Y)@G.KG(D--N*Z8 *47,3**0"HQRM)L#VGGTB*J311V>, 2,&F[YN+:2 M=.?4MA +2#-*@K(SW$7,C[IOG%LY.F*987I?1/"(S[W,*[A)\RN#VSY4J2+= M/4TIP@*2D)*@]/QD94-#Q7BEIIR%C$G.2%=K'2MVB7=0]@/')&B[VE!2;FM$" 6D%14_B69*$Y3;E"%UW8CG MJ0XHGD=9E.=4 +4L&RG9CF8X'"3!R,AQ:@GQDLZW7,49NHO1AQ2C[ $CMIW5 M)[\W(L'GZ;BZ:62YI \AJ2Q0 M:6)9-==$PTES',=(S#.\D9YVT)O84I I^5)'.CP(-1F2[&J*F;4'U\P044N7 MT8R:P>WE7;P6R'+/6$"PTS%N($!H1$I+UBUNWA7@)G;>[CX,EA=A[,EG65H8 MRQ'S>'J=8'DU ) ">%:R$'D,B!C22?F?>M''9+?-EL^+)%YB3'=9I96WTLV_ M&5K;U4RO++759&0*2&=]^$H46">!&FD<-5HLEY-Y=-,XC>86+S_>/GCD U[O MLI2VH(28?!9<:61Y><$@ YU%!H4%(.D9T)0M.#!+Q$R/4&Z,&M:.QF=I'040 M^Z?/-WB%$WKNX X_9:?D11\5(PP#6]NC-^/L= =S6D,0(NS+5C;42U$S 71/ M]X@52:#?:"*(I6+[_G*VB21.)#N-6T^M[O%I4VIMY\D?@1 'ST>X22=.7.P= M+EY]$22;N6@*J//< M51L!%W$^'3V]IS:E*3V@4._[+*W1 M;Z7]L+V)?70Y35.#,&<>>G#-/+I_\W^V 6/7DB'4-/LS$N29S)T_\4+ M=]T!2T];FX+JE9VFP(P,P0BN#UM.@,3(N>Q:-<:D5CGT2UI_9%4669QYX:6I M,Y(=NJ2)H"4L5Y03OR*ETZ/Y$L'M*T5.FA<-CP7C5C0$Q0OA0'H^-WB)B2.\ M#W%Z04KH;)=F\88_RZ*'VU2/CG13/3(L&/5H"'+SM3N,Z-= "0[93"UFBPE' MZ*NK.,/H[=?.);5(\-8+_-G3%D.9?>F;<-2&\O^!?VZ;:D M78:3VWB5??(2_"Z)N4,4YF9VQW5FF6@/Z=0V8*1H2)0/YIECT#E^Q&&<*W,9 MIP Z8]V.I&%_TVW7W:3+#G&HIVT6\]%>S'KKH,9ZRFRY$(-< A +7EG<0 KZ M,O#N@S#( IR21I;M$'J(0Y\,"VAKFCUK!OGFYC;%TC=333F9VH)IG7H2YNX6 MJ,V1%_FHFZ:3(IK);@G8:ANH)-QJ$X5(,/)1TN-6;@LPVN9H"+I)=MCGZX \ MMS*\9?6H:7<$) 9#TI"2H4!&%(]P/O=TL/M9^VF^_6QR\FK"]$%_^?U\A^_B MFWS&--]]W>$O1=G0@H8B58 $XKSK;9AO$SQD5>C'V)@9U- MGV*L#^/TEU"_UK06V2$?D<* MM>9\-&0K#R3!.9>& ;FN&DHT"DHXVC*\ARJ$(^?.4JCAYQD@5D4$9;.+.!M,[(ZJJ5409::U9*"^=ZZD63OSVX M,D(1M2I'W$?E>JH?I&PLSM9/3[Y]??3MFY=LTO#?7G]WLG^.X=Z-=&S/NV.3K9.7, M\26@F6-ZGC[(V&%FNLL[9G&K<+0DW*0.66%AM\G34F^W=U(X&+^CY\BW=)4% M:[Y:-L5P_;7[2:*&Y(UW76ML'+DKL_W72@,POIR01BE!C]3N"+WZ[NCERY?T?RC-PXIY MN^PA3NA>Z2,TZ3X,Z!5*/NMSQW7X,>1EZ!PO,0W,BEY-CA!5R!%#D;\FL.:4 M&E'8E&>O.9CM49Z(9'=HU\2 $:B$F&@0%T=R:9Z4XI.I\WORZ+MO7QU]__9U M]9A([LVK-TZ;@>.IH-&6'--DCYB2<=4KBC1=UY%_UT MB\0,T@DES4R6T :6X S9BN77F"5GW6K 1/-S2N^[_8 M[])C[;+^XV#)6SYK,.A'Z1Q-&"1M,,WZP!E2-_YU^LYKSCF^S^91FB4L+/B' MR,LS2;Y"L"-W"I1E0*Z\K@50Q4EH:I7&35J#5-R<39+W^!"E@6NE MM8GK5):C02NL1=%47?D:!TAER:^>,K9RK3')Y5.&)J#5IK]^2B:Y>*2KIPY< MS^W9I3.R=+3JVZTZ6'.V/I<#R[XOG+EY/7+W^D@/S>M4)&<>1> M/E=Q%+?S450$3?_*P,YND"W#;+1#;FF,P#1]IDS%]T06O@I]%3!3]^%OZL"6 M]1[!]"K.SG$:K"-:^:;I3]A?L]Q6@'=>$-$Z)+^X;8!TW<0Y/? SB(.A[IFH M"U^K602?56.M79N4T>W.L$I M T*1E@E)N5P^%>%:*W7DS7O^3^>^M13^=73KA3B]7N4W5M'A$OUCOMD2M=,J M0C*4K*5#B_[)6)UTVS.3K9FYGFE $>^!_/D 9J17&D&0?&@@A]O=4: FW=Y2(,9":X4"-> M-+E%<6)'.SUI95E<1V_C"KJ\FY;?YI"RBJ (\&MD8;G3K*/>Z33+X%":0'.J MLK[SLC*C,HI 10:63CKWG:0&LA30:PD Y(J3CJWJ^GEPBP!Y!NZ\IR(/ISC" M\OU=4K3]#<%2ROR&8 X*Q7.9T93L"\Z\)S"]]WP'FV+5NPFP>V2T2ZQ].K1\ M"FL[!,>+"UZ/,_05??XURM4P4E>GC(17GOT[]=)@.8W\\R#<$4U/1"VQWL9: M=\>4?M7AT1G Z#4;LE2(AC1?I-.3GU6A*1RA>YH&VX[EYZDX]RF_XF#]0-<5 M2=?,6^.K'0T'?+WBCN*PW$LJ4L\T;'JFO;+7=%Z]$G NW$-876>:M"UV-=UZG(2SY=U+V+O\\++/U':'[I>-

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end